sample,_PATIENT,cancer type abbreviation,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,histological_type,initial_pathologic_dx_year,birth_days_to,vital_status,tumor_status,last_contact_days_to,OS,OS.time,DSS,DSS.time,PFI,PFI.time
TCGA-02-2485-01,TCGA-02-2485,GBM,53.0,MALE,BLACK OR AFRICAN AMERICAN,,Untreated primary (de novo) GBM,2009.0,-19494.0,Alive,WITH TUMOR,470.0,0.0,470.0,0.0,470.0,1.0,186.0
TCGA-05-4384-01,TCGA-05-4384,LUAD,66.0,MALE,,Stage IIIA,Lung Adenocarcinoma,2009.0,-24411.0,Alive,WITH TUMOR,426.0,0.0,426.0,0.0,426.0,1.0,183.0
TCGA-05-4396-01,TCGA-05-4396,LUAD,76.0,MALE,,Stage IIIB,Lung Adenocarcinoma,2006.0,-28094.0,Dead,,,1.0,303.0,,303.0,0.0,303.0
TCGA-05-4398-01,TCGA-05-4398,LUAD,47.0,FEMALE,,Stage IIIB,Lung Adenocarcinoma,2006.0,-17471.0,Alive,TUMOR FREE,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0
TCGA-05-4402-01,TCGA-05-4402,LUAD,57.0,FEMALE,,Stage IV,Lung Adenocarcinoma,2007.0,-20819.0,Dead,TUMOR FREE,,1.0,244.0,0.0,244.0,0.0,244.0
TCGA-05-4405-01,TCGA-05-4405,LUAD,74.0,FEMALE,,Stage IB,Lung Adenocarcinoma,2006.0,-27241.0,Alive,TUMOR FREE,610.0,0.0,610.0,0.0,610.0,0.0,610.0
TCGA-05-4410-01,TCGA-05-4410,LUAD,62.0,MALE,,Stage IB,Lung Adenocarcinoma,2007.0,-22888.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-05-4417-01,TCGA-05-4417,LUAD,51.0,FEMALE,,Stage IB,Lung Adenocarcinoma,2008.0,-18780.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-05-4418-01,TCGA-05-4418,LUAD,69.0,MALE,,Stage IIIA,Lung Adenocarcinoma,2008.0,-25417.0,Dead,,,1.0,274.0,,274.0,0.0,274.0
TCGA-05-4420-01,TCGA-05-4420,LUAD,41.0,MALE,,Stage IB,Lung Adenocarcinoma,2008.0,-15159.0,Alive,TUMOR FREE,912.0,0.0,912.0,0.0,912.0,0.0,912.0
TCGA-05-4422-01,TCGA-05-4422,LUAD,68.0,MALE,,Stage IB,Lung Adenocarcinoma,2008.0,-24837.0,Alive,,365.0,0.0,365.0,0.0,365.0,0.0,365.0
TCGA-05-4426-01,TCGA-05-4426,LUAD,71.0,MALE,,Stage IB,Lung Adenocarcinoma,2008.0,-26084.0,Alive,TUMOR FREE,791.0,0.0,791.0,0.0,791.0,1.0,457.0
TCGA-05-4430-01,TCGA-05-4430,LUAD,59.0,FEMALE,,Stage IB,Lung Adenocarcinoma,2008.0,-21884.0,Alive,TUMOR FREE,761.0,0.0,761.0,0.0,761.0,0.0,761.0
TCGA-05-5423-01,TCGA-05-5423,LUAD,65.0,MALE,,Stage IIB,Lung Adenocarcinoma,2006.0,-23863.0,Alive,TUMOR FREE,151.0,0.0,151.0,0.0,151.0,0.0,151.0
TCGA-05-5429-01,TCGA-05-5429,LUAD,60.0,MALE,,Stage IIIA,Lung Adenocarcinoma,2010.0,-22066.0,Dead,TUMOR FREE,,1.0,275.0,0.0,275.0,0.0,275.0
TCGA-05-5715-01,TCGA-05-5715,LUAD,69.0,FEMALE,,Stage IB,Lung Adenocarcinoma,2010.0,-25383.0,Alive,TUMOR FREE,62.0,0.0,62.0,0.0,62.0,0.0,62.0
TCGA-06-0125-01,TCGA-06-0125,GBM,63.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2001.0,-23343.0,Dead,WITH TUMOR,1439.0,1.0,1448.0,1.0,1448.0,1.0,797.0
TCGA-06-0129-01,TCGA-06-0129,GBM,30.0,MALE,ASIAN,,Untreated primary (de novo) GBM,2002.0,-11284.0,Dead,WITH TUMOR,989.0,1.0,1024.0,1.0,1024.0,1.0,148.0
TCGA-06-0130-01,TCGA-06-0130,GBM,54.0,MALE,WHITE,,Untreated primary (de novo) GBM,2003.0,-19812.0,Dead,WITH TUMOR,320.0,1.0,394.0,1.0,394.0,1.0,244.0
TCGA-06-0190-01,TCGA-06-0190,GBM,62.0,MALE,WHITE,,Untreated primary (de novo) GBM,2006.0,-22835.0,Dead,WITH TUMOR,313.0,1.0,317.0,1.0,317.0,1.0,88.0
TCGA-06-0238-01,TCGA-06-0238,GBM,46.0,MALE,WHITE,,Untreated primary (de novo) GBM,2007.0,-17037.0,Dead,WITH TUMOR,359.0,1.0,405.0,1.0,405.0,1.0,311.0
TCGA-06-0644-01,TCGA-06-0644,GBM,71.0,MALE,BLACK OR AFRICAN AMERICAN,,Untreated primary (de novo) GBM,2007.0,-26247.0,Dead,WITH TUMOR,,1.0,384.0,1.0,384.0,1.0,85.0
TCGA-06-0878-01,TCGA-06-0878,GBM,74.0,MALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-27319.0,Alive,WITH TUMOR,218.0,0.0,218.0,0.0,218.0,1.0,66.0
TCGA-06-0882-01,TCGA-06-0882,GBM,30.0,MALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-11112.0,Dead,WITH TUMOR,,1.0,632.0,1.0,632.0,1.0,213.0
TCGA-06-1804-01,TCGA-06-1804,GBM,81.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-29802.0,Dead,WITH TUMOR,414.0,1.0,414.0,1.0,414.0,1.0,414.0
TCGA-06-2557-01,TCGA-06-2557,GBM,76.0,MALE,BLACK OR AFRICAN AMERICAN,,Untreated primary (de novo) GBM,2008.0,-27980.0,Dead,WITH TUMOR,33.0,1.0,33.0,1.0,33.0,1.0,33.0
TCGA-06-2558-01,TCGA-06-2558,GBM,75.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-27511.0,Dead,,23.0,1.0,380.0,,380.0,0.0,380.0
TCGA-06-2559-01,TCGA-06-2559,GBM,83.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-30580.0,Dead,WITH TUMOR,150.0,1.0,150.0,1.0,150.0,1.0,150.0
TCGA-06-2562-01,TCGA-06-2562,GBM,81.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-29753.0,Dead,WITH TUMOR,,1.0,382.0,1.0,382.0,1.0,151.0
TCGA-06-2563-01,TCGA-06-2563,GBM,72.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-26643.0,Alive,WITH TUMOR,932.0,0.0,932.0,0.0,932.0,1.0,554.0
TCGA-06-2564-01,TCGA-06-2564,GBM,50.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-18435.0,Alive,WITH TUMOR,181.0,0.0,181.0,0.0,181.0,0.0,181.0
TCGA-06-2565-01,TCGA-06-2565,GBM,59.0,MALE,ASIAN,,Untreated primary (de novo) GBM,2009.0,-21559.0,Dead,WITH TUMOR,,1.0,506.0,1.0,506.0,1.0,178.0
TCGA-06-2567-01,TCGA-06-2567,GBM,65.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-23759.0,Dead,WITH TUMOR,133.0,1.0,133.0,1.0,133.0,1.0,133.0
TCGA-06-2570-01,TCGA-06-2570,GBM,21.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-7936.0,Alive,TUMOR FREE,958.0,0.0,958.0,0.0,958.0,0.0,958.0
TCGA-06-5408-01,TCGA-06-5408,GBM,54.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-20063.0,Dead,WITH TUMOR,342.0,1.0,357.0,1.0,357.0,1.0,158.0
TCGA-06-5410-01,TCGA-06-5410,GBM,72.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-26395.0,Dead,WITH TUMOR,108.0,1.0,108.0,1.0,108.0,1.0,108.0
TCGA-06-5411-01,TCGA-06-5411,GBM,51.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-18832.0,Dead,WITH TUMOR,254.0,1.0,254.0,1.0,254.0,1.0,214.0
TCGA-06-5412-01,TCGA-06-5412,GBM,78.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-28762.0,Dead,WITH TUMOR,138.0,1.0,138.0,1.0,138.0,1.0,88.0
TCGA-06-5413-01,TCGA-06-5413,GBM,67.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-24477.0,Alive,WITH TUMOR,268.0,0.0,268.0,0.0,268.0,1.0,195.0
TCGA-06-5414-01,TCGA-06-5414,GBM,61.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-22527.0,Alive,WITH TUMOR,273.0,0.0,273.0,0.0,273.0,1.0,167.0
TCGA-06-5415-01,TCGA-06-5415,GBM,60.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-22213.0,Alive,WITH TUMOR,260.0,0.0,260.0,0.0,260.0,0.0,260.0
TCGA-06-5416-01,TCGA-06-5416,GBM,23.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-8533.0,Alive,WITH TUMOR,204.0,0.0,204.0,0.0,204.0,0.0,204.0
TCGA-06-5417-01,TCGA-06-5417,GBM,45.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-16572.0,Alive,WITH TUMOR,155.0,0.0,155.0,0.0,155.0,0.0,155.0
TCGA-06-5418-01,TCGA-06-5418,GBM,75.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-27584.0,Dead,WITH TUMOR,83.0,1.0,83.0,1.0,83.0,1.0,83.0
TCGA-06-5856-01,TCGA-06-5856,GBM,58.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-21232.0,Dead,WITH TUMOR,114.0,1.0,114.0,1.0,114.0,1.0,114.0
TCGA-06-5858-01,TCGA-06-5858,GBM,45.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-16662.0,Alive,WITH TUMOR,187.0,0.0,187.0,0.0,187.0,1.0,97.0
TCGA-06-5859-01,TCGA-06-5859,GBM,63.0,MALE,WHITE,,Untreated primary (de novo) GBM,2011.0,-23211.0,Alive,WITH TUMOR,139.0,0.0,139.0,0.0,139.0,0.0,139.0
TCGA-08-0386-01,TCGA-08-0386,GBM,74.0,MALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-27053.0,Dead,WITH TUMOR,478.0,1.0,548.0,1.0,548.0,1.0,427.0
TCGA-09-2044-01,TCGA-09-2044,OV,77.0,FEMALE,ASIAN,,Serous Cystadenocarcinoma,2009.0,-28231.0,Alive,TUMOR FREE,186.0,0.0,186.0,0.0,186.0,0.0,186.0
TCGA-12-1597-01,TCGA-12-1597,GBM,62.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2002.0,-22865.0,Dead,WITH TUMOR,427.0,1.0,675.0,1.0,675.0,1.0,180.0
TCGA-12-3652-01,TCGA-12-3652,GBM,60.0,MALE,WHITE,,Untreated primary (de novo) GBM,2003.0,-21920.0,Dead,WITH TUMOR,1050.0,1.0,1062.0,1.0,1062.0,1.0,203.0
TCGA-12-3653-01,TCGA-12-3653,GBM,34.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-12529.0,Dead,WITH TUMOR,357.0,1.0,442.0,1.0,442.0,1.0,224.0
TCGA-12-5295-01,TCGA-12-5295,GBM,60.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-22161.0,Dead,WITH TUMOR,399.0,1.0,454.0,1.0,454.0,1.0,399.0
TCGA-13-1505-01,TCGA-13-1505,OV,63.0,FEMALE,WHITE,,Serous Cystadenocarcinoma,2008.0,-23238.0,Alive,WITH TUMOR,1998.0,0.0,1998.0,0.0,1998.0,1.0,1561.0
TCGA-14-0871-01,TCGA-14-0871,GBM,74.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,1998.0,-27387.0,Dead,,880.0,1.0,880.0,,880.0,0.0,880.0
TCGA-14-1823-01,TCGA-14-1823,GBM,58.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2007.0,-21384.0,Dead,WITH TUMOR,543.0,1.0,543.0,1.0,543.0,1.0,140.0
TCGA-16-0846-01,TCGA-16-0846,GBM,85.0,MALE,WHITE,,Untreated primary (de novo) GBM,2006.0,-31111.0,Dead,WITH TUMOR,119.0,1.0,119.0,1.0,119.0,1.0,119.0
TCGA-18-4721-01,TCGA-18-4721,LUSC,74.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2002.0,-27076.0,Alive,TUMOR FREE,4694.0,0.0,4694.0,0.0,4694.0,0.0,4694.0
TCGA-18-5592-01,TCGA-18-5592,LUSC,57.0,MALE,,Stage IIB,Lung Squamous Cell Carcinoma,2010.0,-21020.0,Alive,TUMOR FREE,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0
TCGA-19-1390-01,TCGA-19-1390,GBM,63.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2007.0,-23063.0,Dead,,772.0,1.0,772.0,,772.0,0.0,772.0
TCGA-19-2619-01,TCGA-19-2619,GBM,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Untreated primary (de novo) GBM,2009.0,-20159.0,Alive,WITH TUMOR,294.0,0.0,294.0,0.0,294.0,1.0,146.0
TCGA-19-2620-01,TCGA-19-2620,GBM,70.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-25665.0,Dead,TUMOR FREE,148.0,1.0,148.0,0.0,148.0,0.0,148.0
TCGA-19-4065-01,TCGA-19-4065,GBM,36.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-13257.0,Alive,WITH TUMOR,214.0,0.0,214.0,0.0,214.0,1.0,70.0
TCGA-19-5960-01,TCGA-19-5960,GBM,56.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-20641.0,Dead,WITH TUMOR,,1.0,455.0,1.0,455.0,1.0,382.0
TCGA-21-1071-01,TCGA-21-1071,LUSC,67.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2001.0,-24515.0,Dead,WITH TUMOR,1426.0,1.0,1426.0,1.0,1426.0,1.0,993.0
TCGA-21-1076-01,TCGA-21-1076,LUSC,54.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-19863.0,Alive,TUMOR FREE,1852.0,0.0,1852.0,0.0,1852.0,1.0,1575.0
TCGA-21-1081-01,TCGA-21-1081,LUSC,69.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,1996.0,-25440.0,Dead,WITH TUMOR,284.0,1.0,284.0,1.0,284.0,1.0,284.0
TCGA-21-5782-01,TCGA-21-5782,LUSC,68.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-24969.0,Dead,,962.0,1.0,962.0,,962.0,0.0,962.0
TCGA-21-5784-01,TCGA-21-5784,LUSC,80.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2008.0,-29362.0,Alive,TUMOR FREE,1268.0,0.0,1268.0,0.0,1268.0,0.0,1268.0
TCGA-21-5786-01,TCGA-21-5786,LUSC,64.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2009.0,-23649.0,Alive,TUMOR FREE,1032.0,0.0,1032.0,0.0,1032.0,1.0,817.0
TCGA-21-5787-01,TCGA-21-5787,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Lung Squamous Cell Carcinoma,2009.0,-24071.0,Dead,WITH TUMOR,329.0,1.0,329.0,1.0,329.0,1.0,103.0
TCGA-22-1011-01,TCGA-22-1011,LUSC,73.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2001.0,-26732.0,Dead,TUMOR FREE,53.0,1.0,53.0,0.0,53.0,0.0,53.0
TCGA-22-4591-01,TCGA-22-4591,LUSC,80.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2001.0,-29250.0,Dead,WITH TUMOR,623.0,1.0,623.0,1.0,623.0,1.0,443.0
TCGA-22-4607-01,TCGA-22-4607,LUSC,75.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2003.0,-27601.0,Dead,TUMOR FREE,587.0,1.0,587.0,0.0,587.0,0.0,587.0
TCGA-22-5471-01,TCGA-22-5471,LUSC,75.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-27749.0,Alive,,1845.0,0.0,1845.0,0.0,1845.0,1.0,229.0
TCGA-22-5472-01,TCGA-22-5472,LUSC,67.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-24482.0,Dead,TUMOR FREE,,1.0,1975.0,0.0,1975.0,1.0,746.0
TCGA-22-5473-01,TCGA-22-5473,LUSC,78.0,MALE,WHITE,[Discrepancy],Lung Squamous Cell Carcinoma,2005.0,-28826.0,Dead,TUMOR FREE,,1.0,1933.0,0.0,1933.0,1.0,1655.0
TCGA-22-5474-01,TCGA-22-5474,LUSC,74.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-27271.0,Dead,TUMOR FREE,445.0,1.0,445.0,0.0,445.0,0.0,445.0
TCGA-22-5477-01,TCGA-22-5477,LUSC,65.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2004.0,-24055.0,Dead,,1346.0,1.0,1346.0,,1346.0,1.0,511.0
TCGA-22-5478-01,TCGA-22-5478,LUSC,79.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-28978.0,Dead,TUMOR FREE,24.0,1.0,24.0,0.0,24.0,0.0,24.0
TCGA-22-5480-01,TCGA-22-5480,LUSC,66.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2002.0,-24245.0,Dead,WITH TUMOR,2170.0,1.0,2170.0,1.0,2170.0,1.0,1779.0
TCGA-22-5482-01,TCGA-22-5482,LUSC,81.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-29657.0,Dead,TUMOR FREE,357.0,1.0,357.0,0.0,357.0,0.0,357.0
TCGA-22-5485-01,TCGA-22-5485,LUSC,58.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2001.0,-21488.0,Dead,WITH TUMOR,916.0,1.0,916.0,1.0,916.0,1.0,840.0
TCGA-22-5489-01,TCGA-22-5489,LUSC,64.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2003.0,-23618.0,Dead,WITH TUMOR,1912.0,1.0,1912.0,1.0,1912.0,1.0,428.0
TCGA-22-5491-01,TCGA-22-5491,LUSC,74.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2003.0,-27145.0,Dead,,1713.0,1.0,1713.0,,1713.0,0.0,1713.0
TCGA-22-5492-01,TCGA-22-5492,LUSC,73.0,FEMALE,,Stage IIIA,Lung Squamous Cell Carcinoma,2003.0,-26838.0,Dead,,506.0,1.0,506.0,,506.0,0.0,506.0
TCGA-25-1319-01,TCGA-25-1319,OV,73.0,FEMALE,WHITE,,Serous Cystadenocarcinoma,2000.0,-26786.0,Dead,,1977.0,1.0,1977.0,,1977.0,1.0,730.0
TCGA-25-2397-01,TCGA-25-2397,OV,59.0,FEMALE,WHITE,,Serous Cystadenocarcinoma,2004.0,-21581.0,Dead,,365.0,1.0,365.0,,365.0,0.0,365.0
TCGA-26-1442-01,TCGA-26-1442,GBM,43.0,MALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-15950.0,Alive,WITH TUMOR,953.0,0.0,953.0,0.0,953.0,0.0,953.0
TCGA-26-5132-01,TCGA-26-5132,GBM,74.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-27196.0,Alive,TUMOR FREE,286.0,0.0,286.0,0.0,286.0,0.0,286.0
TCGA-26-5133-01,TCGA-26-5133,GBM,59.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-21560.0,Alive,TUMOR FREE,452.0,0.0,452.0,0.0,452.0,1.0,370.0
TCGA-26-5134-01,TCGA-26-5134,GBM,74.0,MALE,WHITE,,Untreated primary (de novo) GBM,2009.0,-27111.0,Alive,TUMOR FREE,167.0,0.0,167.0,0.0,167.0,0.0,167.0
TCGA-27-1830-01,TCGA-27-1830,GBM,57.0,MALE,WHITE,,Untreated primary (de novo) GBM,2007.0,-21131.0,Dead,WITH TUMOR,146.0,1.0,154.0,1.0,154.0,1.0,124.0
TCGA-27-1831-01,TCGA-27-1831,GBM,66.0,MALE,WHITE,,Untreated primary (de novo) GBM,2006.0,-24447.0,Dead,WITH TUMOR,505.0,1.0,505.0,1.0,505.0,1.0,144.0
TCGA-27-1832-01,TCGA-27-1832,GBM,59.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2007.0,-21678.0,Dead,WITH TUMOR,0.0,1.0,300.0,1.0,300.0,1.0,176.0
TCGA-27-1834-01,TCGA-27-1834,GBM,56.0,MALE,WHITE,,Untreated primary (de novo) GBM,2006.0,-20568.0,Dead,WITH TUMOR,1008.0,1.0,1233.0,1.0,1233.0,1.0,335.0
TCGA-28-1747-01,TCGA-28-1747,GBM,44.0,MALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-16301.0,Dead,,77.0,1.0,77.0,,77.0,0.0,77.0
TCGA-28-5208-01,TCGA-28-5208,GBM,52.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-19053.0,Dead,WITH TUMOR,,1.0,544.0,1.0,544.0,1.0,148.0
TCGA-2A-A8VL-01,TCGA-2A-A8VL,PRAD,51.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-18658.0,Alive,TUMOR FREE,621.0,0.0,621.0,0.0,621.0,0.0,621.0
TCGA-2A-A8VO-01,TCGA-2A-A8VO,PRAD,57.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-20958.0,Alive,TUMOR FREE,1701.0,0.0,1701.0,0.0,1701.0,0.0,1701.0
TCGA-2A-A8VT-01,TCGA-2A-A8VT,PRAD,47.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-17365.0,Alive,[Discrepancy],1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0
TCGA-2A-A8VV-01,TCGA-2A-A8VV,PRAD,52.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-19065.0,Alive,TUMOR FREE,671.0,0.0,671.0,0.0,671.0,0.0,671.0
TCGA-2A-A8W1-01,TCGA-2A-A8W1,PRAD,54.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-19964.0,Alive,,112.0,0.0,112.0,0.0,112.0,0.0,112.0
TCGA-2A-A8W3-01,TCGA-2A-A8W3,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-25557.0,Alive,[Discrepancy],863.0,0.0,863.0,0.0,863.0,1.0,198.0
TCGA-2H-A9GF-01,TCGA-2H-A9GF,ESCA,67.0,MALE,[Unknown],Stage III,"Esophagus Adenocarcinoma, NOS",2001.0,-24487.0,Dead,WITH TUMOR,,1.0,784.0,1.0,784.0,1.0,172.0
TCGA-2H-A9GI-01,TCGA-2H-A9GI,ESCA,68.0,MALE,[Unknown],Stage III,"Esophagus Adenocarcinoma, NOS",1999.0,-25097.0,Dead,WITH TUMOR,,1.0,435.0,1.0,435.0,1.0,400.0
TCGA-2H-A9GL-01,TCGA-2H-A9GL,ESCA,74.0,MALE,[Unknown],Stage III,"Esophagus Adenocarcinoma, NOS",2000.0,-27115.0,Dead,WITH TUMOR,,1.0,180.0,1.0,180.0,1.0,109.0
TCGA-2H-A9GR-01,TCGA-2H-A9GR,ESCA,80.0,MALE,[Unknown],Stage IIA,"Esophagus Adenocarcinoma, NOS",1999.0,-29451.0,Dead,WITH TUMOR,,1.0,987.0,1.0,987.0,1.0,987.0
TCGA-32-1970-01,TCGA-32-1970,GBM,59.0,MALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-21613.0,Dead,WITH TUMOR,468.0,1.0,468.0,1.0,468.0,1.0,408.0
TCGA-32-1982-01,TCGA-32-1982,GBM,76.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2008.0,-27764.0,Dead,WITH TUMOR,142.0,1.0,142.0,1.0,142.0,1.0,142.0
TCGA-32-5222-01,TCGA-32-5222,GBM,66.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-24134.0,Dead,WITH TUMOR,,1.0,585.0,1.0,585.0,1.0,118.0
TCGA-33-4532-01,TCGA-33-4532,LUSC,68.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2001.0,-25169.0,Dead,TUMOR FREE,,1.0,3924.0,0.0,3924.0,0.0,3924.0
TCGA-33-4547-01,TCGA-33-4547,LUSC,68.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-25056.0,Alive,TUMOR FREE,2419.0,0.0,2419.0,0.0,2419.0,0.0,2419.0
TCGA-33-4566-01,TCGA-33-4566,LUSC,40.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,1996.0,-14643.0,Dead,,,1.0,5287.0,,5287.0,0.0,5287.0
TCGA-33-4582-01,TCGA-33-4582,LUSC,55.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2000.0,-20402.0,Dead,WITH TUMOR,,1.0,3149.0,1.0,3149.0,1.0,2923.0
TCGA-33-4586-01,TCGA-33-4586,LUSC,57.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2007.0,-21148.0,Dead,,,1.0,428.0,,428.0,1.0,169.0
TCGA-34-2596-01,TCGA-34-2596,LUSC,70.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2004.0,-25574.0,Dead,TUMOR FREE,80.0,1.0,80.0,0.0,80.0,0.0,80.0
TCGA-34-2608-01,TCGA-34-2608,LUSC,84.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,1999.0,-30958.0,Dead,TUMOR FREE,1000.0,1.0,1000.0,0.0,1000.0,0.0,1000.0
TCGA-34-5231-01,TCGA-34-5231,LUSC,72.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2006.0,-26525.0,Dead,TUMOR FREE,,1.0,1984.0,0.0,1984.0,0.0,1984.0
TCGA-34-5232-01,TCGA-34-5232,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Lung Squamous Cell Carcinoma,2006.0,-27633.0,Alive,TUMOR FREE,2471.0,0.0,2471.0,0.0,2471.0,0.0,2471.0
TCGA-34-5234-01,TCGA-34-5234,LUSC,71.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2007.0,-26072.0,Alive,TUMOR FREE,2271.0,0.0,2271.0,0.0,2271.0,0.0,2271.0
TCGA-34-5236-01,TCGA-34-5236,LUSC,60.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2007.0,-21935.0,Dead,WITH TUMOR,,1.0,276.0,1.0,276.0,1.0,113.0
TCGA-34-5239-01,TCGA-34-5239,LUSC,75.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2010.0,-27528.0,Alive,WITH TUMOR,1834.0,0.0,1834.0,0.0,1834.0,1.0,1530.0
TCGA-34-5241-01,TCGA-34-5241,LUSC,79.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2009.0,-29098.0,Dead,TUMOR FREE,,1.0,515.0,0.0,515.0,0.0,515.0
TCGA-34-5927-01,TCGA-34-5927,LUSC,70.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2009.0,-25857.0,Alive,TUMOR FREE,1361.0,0.0,1361.0,0.0,1361.0,1.0,245.0
TCGA-34-5928-01,TCGA-34-5928,LUSC,83.0,FEMALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2010.0,-30334.0,Alive,TUMOR FREE,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0
TCGA-34-5929-01,TCGA-34-5929,LUSC,78.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2010.0,-28844.0,Dead,TUMOR FREE,,1.0,151.0,0.0,151.0,0.0,151.0
TCGA-35-3615-01,TCGA-35-3615,LUAD,57.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2007.0,-21076.0,Alive,TUMOR FREE,14.0,0.0,14.0,0.0,14.0,0.0,14.0
TCGA-37-4133-01,TCGA-37-4133,LUSC,63.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2010.0,-23083.0,Alive,TUMOR FREE,238.0,0.0,238.0,0.0,238.0,0.0,238.0
TCGA-37-4135-01,TCGA-37-4135,LUSC,68.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2010.0,-25041.0,Alive,TUMOR FREE,207.0,0.0,207.0,0.0,207.0,0.0,207.0
TCGA-37-4141-01,TCGA-37-4141,LUSC,65.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2010.0,-24048.0,Alive,TUMOR FREE,12.0,0.0,12.0,0.0,12.0,0.0,12.0
TCGA-37-5819-01,TCGA-37-5819,LUSC,64.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2010.0,-23726.0,Alive,TUMOR FREE,103.0,0.0,103.0,0.0,103.0,0.0,103.0
TCGA-38-4626-01,TCGA-38-4626,LUAD,57.0,FEMALE,WHITE,[Discrepancy],Lung Adenocarcinoma,2003.0,-20903.0,Alive,TUMOR FREE,3674.0,0.0,3674.0,0.0,3674.0,1.0,2518.0
TCGA-38-4627-01,TCGA-38-4627,LUAD,64.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2003.0,-23510.0,Dead,,,1.0,1147.0,,1147.0,0.0,1147.0
TCGA-38-6178-01,TCGA-38-6178,LUAD,70.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2010.0,-25593.0,Alive,WITH TUMOR,448.0,0.0,448.0,0.0,448.0,0.0,448.0
TCGA-39-5019-01,TCGA-39-5019,LUSC,70.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-25756.0,Alive,TUMOR FREE,3387.0,0.0,3387.0,0.0,3387.0,1.0,378.0
TCGA-39-5021-01,TCGA-39-5021,LUSC,70.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-25895.0,Dead,WITH TUMOR,2057.0,1.0,2086.0,1.0,2086.0,1.0,1875.0
TCGA-39-5022-01,TCGA-39-5022,LUSC,76.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2005.0,-27856.0,Dead,TUMOR FREE,,1.0,1679.0,0.0,1679.0,1.0,1448.0
TCGA-39-5024-01,TCGA-39-5024,LUSC,65.0,FEMALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2005.0,-23975.0,Alive,TUMOR FREE,2510.0,0.0,2510.0,0.0,2510.0,0.0,2510.0
TCGA-39-5028-01,TCGA-39-5028,LUSC,75.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2006.0,-27707.0,Dead,,52.0,1.0,52.0,,52.0,0.0,52.0
TCGA-39-5029-01,TCGA-39-5029,LUSC,67.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2006.0,-24713.0,Dead,WITH TUMOR,,1.0,740.0,1.0,740.0,1.0,491.0
TCGA-39-5030-01,TCGA-39-5030,LUSC,81.0,FEMALE,ASIAN,Stage IIIA,Lung Squamous Cell Carcinoma,2006.0,-29893.0,Dead,,59.0,1.0,59.0,,59.0,0.0,59.0
TCGA-39-5031-01,TCGA-39-5031,LUSC,76.0,FEMALE,,Stage IA,Lung Squamous Cell Carcinoma,2007.0,-28106.0,Dead,TUMOR FREE,,1.0,1841.0,0.0,1841.0,0.0,1841.0
TCGA-39-5035-01,TCGA-39-5035,LUSC,72.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2007.0,-26383.0,Alive,TUMOR FREE,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0
TCGA-39-5037-01,TCGA-39-5037,LUSC,65.0,MALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2007.0,-23868.0,Alive,TUMOR FREE,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0
TCGA-3C-AALI-01,TCGA-3C-AALI,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2003.0,-18538.0,Alive,TUMOR FREE,4005.0,0.0,4005.0,0.0,4005.0,0.0,4005.0
TCGA-3C-AALK-01,TCGA-3C-AALK,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-19074.0,Alive,TUMOR FREE,1448.0,0.0,1448.0,0.0,1448.0,0.0,1448.0
TCGA-3L-AA1B-01,TCGA-3L-AA1B,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Colon Adenocarcinoma,2013.0,-22379.0,Alive,TUMOR FREE,475.0,0.0,475.0,0.0,475.0,0.0,475.0
TCGA-3M-AB47-01,TCGA-3M-AB47,STAD,51.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,,Dead,WITH TUMOR,,1.0,,1.0,,1.0,395.0
TCGA-41-3915-01,TCGA-41-3915,GBM,48.0,MALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-17880.0,Dead,WITH TUMOR,,1.0,360.0,1.0,360.0,1.0,288.0
TCGA-41-4097-01,TCGA-41-4097,GBM,63.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2010.0,-23107.0,Dead,WITH TUMOR,6.0,1.0,6.0,1.0,6.0,1.0,6.0
TCGA-41-5651-01,TCGA-41-5651,GBM,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Untreated primary (de novo) GBM,2010.0,-21698.0,Dead,WITH TUMOR,,1.0,460.0,1.0,460.0,1.0,210.0
TCGA-43-2578-01,TCGA-43-2578,LUSC,59.0,FEMALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2009.0,-21747.0,Dead,TUMOR FREE,,1.0,684.0,0.0,684.0,0.0,684.0
TCGA-43-3394-01,TCGA-43-3394,LUSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,Lung Squamous Cell Carcinoma,2009.0,-19310.0,Dead,WITH TUMOR,,1.0,1190.0,1.0,1190.0,1.0,552.0
TCGA-43-5668-01,TCGA-43-5668,LUSC,78.0,MALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2010.0,-28635.0,Dead,WITH TUMOR,,1.0,559.0,1.0,559.0,1.0,470.0
TCGA-43-6143-01,TCGA-43-6143,LUSC,70.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2010.0,-25820.0,Alive,TUMOR FREE,699.0,0.0,699.0,0.0,699.0,0.0,699.0
TCGA-43-6770-01,TCGA-43-6770,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,Lung Squamous Cell Carcinoma,2011.0,-21683.0,Alive,TUMOR FREE,653.0,0.0,653.0,0.0,653.0,0.0,653.0
TCGA-43-6771-01,TCGA-43-6771,LUSC,85.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2006.0,-31052.0,Dead,WITH TUMOR,,1.0,166.0,1.0,166.0,1.0,154.0
TCGA-44-2656-01,TCGA-44-2656,LUAD,59.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2009.0,-21766.0,Alive,TUMOR FREE,1429.0,0.0,1429.0,0.0,1429.0,1.0,568.0
TCGA-44-2657-01,TCGA-44-2657,LUAD,74.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2009.0,-27298.0,Alive,TUMOR FREE,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0
TCGA-44-2665-01,TCGA-44-2665,LUAD,55.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2009.0,-20349.0,Alive,TUMOR FREE,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0
TCGA-44-3396-01,TCGA-44-3396,LUAD,74.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2009.0,-27073.0,Alive,TUMOR FREE,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0
TCGA-44-3919-01,TCGA-44-3919,LUAD,71.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-26081.0,Dead,WITH TUMOR,,1.0,1026.0,1.0,1026.0,1.0,921.0
TCGA-44-4112-01,TCGA-44-4112,LUAD,60.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2010.0,-22106.0,Dead,WITH TUMOR,,1.0,808.0,1.0,808.0,1.0,619.0
TCGA-44-5645-01,TCGA-44-5645,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Lung Adenocarcinoma,2010.0,-22471.0,Alive,TUMOR FREE,852.0,0.0,852.0,0.0,852.0,0.0,852.0
TCGA-44-6145-01,TCGA-44-6145,LUAD,62.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-22745.0,Alive,TUMOR FREE,595.0,0.0,595.0,0.0,595.0,0.0,595.0
TCGA-44-6146-01,TCGA-44-6146,LUAD,64.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2010.0,-23378.0,Alive,TUMOR FREE,728.0,0.0,728.0,0.0,728.0,1.0,631.0
TCGA-44-6774-01,TCGA-44-6774,LUAD,56.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2011.0,-20462.0,Alive,TUMOR FREE,658.0,0.0,658.0,0.0,658.0,0.0,658.0
TCGA-44-6775-01,TCGA-44-6775,LUAD,72.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-26415.0,Alive,WITH TUMOR,705.0,0.0,705.0,0.0,705.0,1.0,684.0
TCGA-44-6777-01,TCGA-44-6777,LUAD,85.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2006.0,-31234.0,Dead,TUMOR FREE,,1.0,987.0,0.0,987.0,0.0,987.0
TCGA-44-6779-01,TCGA-44-6779,LUAD,50.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2008.0,-18469.0,Dead,WITH TUMOR,,1.0,500.0,1.0,500.0,1.0,232.0
TCGA-44-7659-01,TCGA-44-7659,LUAD,70.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-25730.0,Alive,TUMOR FREE,691.0,0.0,691.0,0.0,691.0,0.0,691.0
TCGA-44-7662-01,TCGA-44-7662,LUAD,61.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-22543.0,Alive,TUMOR FREE,218.0,0.0,218.0,0.0,218.0,0.0,218.0
TCGA-44-7670-01,TCGA-44-7670,LUAD,47.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,-17392.0,Alive,TUMOR FREE,882.0,0.0,882.0,0.0,882.0,0.0,882.0
TCGA-44-7671-01,TCGA-44-7671,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,Lung Adenocarcinoma,2010.0,-23538.0,Alive,WITH TUMOR,889.0,0.0,889.0,0.0,889.0,1.0,883.0
TCGA-44-7672-01,TCGA-44-7672,LUAD,52.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-19200.0,Alive,TUMOR FREE,719.0,0.0,719.0,0.0,719.0,0.0,719.0
TCGA-46-6025-01,TCGA-46-6025,LUSC,71.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2010.0,-26168.0,Alive,TUMOR FREE,324.0,0.0,324.0,0.0,324.0,0.0,324.0
TCGA-46-6026-01,TCGA-46-6026,LUSC,81.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2010.0,-29890.0,Alive,TUMOR FREE,423.0,0.0,423.0,0.0,423.0,0.0,423.0
TCGA-49-4486-01,TCGA-49-4486,LUAD,72.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,1992.0,-26415.0,Dead,WITH TUMOR,,1.0,2318.0,1.0,2318.0,1.0,2045.0
TCGA-49-4487-01,TCGA-49-4487,LUAD,72.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,1992.0,-26583.0,Dead,WITH TUMOR,,1.0,855.0,1.0,855.0,1.0,697.0
TCGA-49-4488-01,TCGA-49-4488,LUAD,74.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,1992.0,-27332.0,Dead,,,1.0,869.0,,869.0,1.0,634.0
TCGA-49-4494-01,TCGA-49-4494,LUAD,77.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,1995.0,-28387.0,Dead,WITH TUMOR,,1.0,1081.0,1.0,1081.0,1.0,1081.0
TCGA-49-4501-01,TCGA-49-4501,LUAD,67.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,1996.0,-24817.0,Dead,WITH TUMOR,,1.0,1421.0,1.0,1421.0,1.0,545.0
TCGA-49-4505-01,TCGA-49-4505,LUAD,61.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,1996.0,-22628.0,Dead,WITH TUMOR,,1.0,428.0,1.0,428.0,1.0,417.0
TCGA-49-4506-01,TCGA-49-4506,LUAD,68.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,1997.0,-25132.0,Dead,[Discrepancy],,1.0,999.0,,999.0,1.0,692.0
TCGA-49-4507-01,TCGA-49-4507,LUAD,73.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,1997.0,-26851.0,Dead,WITH TUMOR,,1.0,268.0,1.0,268.0,1.0,158.0
TCGA-49-4510-01,TCGA-49-4510,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Lung Adenocarcinoma,2001.0,-18762.0,Dead,WITH TUMOR,,1.0,896.0,1.0,896.0,1.0,502.0
TCGA-49-4512-01,TCGA-49-4512,LUAD,69.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2007.0,-25502.0,Dead,WITH TUMOR,157.0,1.0,905.0,1.0,905.0,1.0,905.0
TCGA-49-4514-01,TCGA-49-4514,LUAD,79.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2007.0,-28908.0,Alive,TUMOR FREE,1700.0,0.0,1700.0,0.0,1700.0,0.0,1700.0
TCGA-49-6742-01,TCGA-49-6742,LUAD,70.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,-25839.0,Dead,WITH TUMOR,,1.0,488.0,1.0,488.0,1.0,214.0
TCGA-49-6744-01,TCGA-49-6744,LUAD,64.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,-23484.0,Alive,TUMOR FREE,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0
TCGA-49-6745-01,TCGA-49-6745,LUAD,82.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2011.0,-30133.0,Alive,TUMOR FREE,522.0,0.0,522.0,0.0,522.0,0.0,522.0
TCGA-49-6761-01,TCGA-49-6761,LUAD,68.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2009.0,-24849.0,Alive,TUMOR FREE,354.0,0.0,354.0,0.0,354.0,0.0,354.0
TCGA-49-6767-01,TCGA-49-6767,LUAD,46.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2010.0,-17108.0,Alive,TUMOR FREE,677.0,0.0,677.0,0.0,677.0,0.0,677.0
TCGA-4H-AAAK-01,TCGA-4H-AAAK,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2013.0,-18371.0,Alive,TUMOR FREE,348.0,0.0,348.0,0.0,348.0,0.0,348.0
TCGA-4N-A93T-01,TCGA-4N-A93T,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2013.0,-24523.0,Alive,WITH TUMOR,146.0,0.0,146.0,0.0,146.0,0.0,146.0
TCGA-4T-AA8H-01,TCGA-4T-AA8H,COAD,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Mucinous Adenocarcinoma,2013.0,-15494.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-50-5044-01,TCGA-50-5044,LUAD,72.0,FEMALE,WHITE,Stage IIIB,Lung Adenocarcinoma,2002.0,-26567.0,Dead,WITH TUMOR,,1.0,624.0,1.0,624.0,1.0,483.0
TCGA-50-5049-01,TCGA-50-5049,LUAD,70.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2006.0,-25577.0,Alive,WITH TUMOR,3094.0,0.0,3094.0,0.0,3094.0,1.0,1568.0
TCGA-50-5051-01,TCGA-50-5051,LUAD,42.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2007.0,-15585.0,Dead,WITH TUMOR,,1.0,478.0,1.0,478.0,1.0,184.0
TCGA-50-5068-01,TCGA-50-5068,LUAD,59.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2003.0,-21728.0,Dead,WITH TUMOR,1499.0,1.0,1499.0,1.0,1499.0,1.0,686.0
TCGA-50-5072-01,TCGA-50-5072,LUAD,74.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2009.0,-27036.0,Dead,WITH TUMOR,,1.0,250.0,1.0,250.0,1.0,213.0
TCGA-50-5931-01,TCGA-50-5931,LUAD,75.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2001.0,-27733.0,Dead,WITH TUMOR,,1.0,434.0,1.0,434.0,1.0,425.0
TCGA-50-5932-01,TCGA-50-5932,LUAD,75.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2001.0,-27454.0,Dead,WITH TUMOR,1091.0,1.0,1235.0,1.0,1235.0,1.0,1090.0
TCGA-50-5933-01,TCGA-50-5933,LUAD,72.0,MALE,WHITE,Stage IIIB,Lung Adenocarcinoma,2001.0,-26377.0,Dead,TUMOR FREE,2370.0,1.0,2393.0,0.0,2393.0,0.0,2393.0
TCGA-50-5936-01,TCGA-50-5936,LUAD,58.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2007.0,-21238.0,Dead,WITH TUMOR,,1.0,257.0,1.0,257.0,1.0,150.0
TCGA-50-5939-01,TCGA-50-5939,LUAD,85.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2008.0,-31236.0,Dead,TUMOR FREE,,1.0,460.0,0.0,460.0,0.0,460.0
TCGA-50-5941-01,TCGA-50-5941,LUAD,55.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2010.0,-20350.0,Alive,TUMOR FREE,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0
TCGA-50-5942-01,TCGA-50-5942,LUAD,67.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2009.0,-24781.0,Alive,WITH TUMOR,1847.0,0.0,1847.0,0.0,1847.0,1.0,1378.0
TCGA-50-5944-01,TCGA-50-5944,LUAD,69.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-25440.0,Alive,TUMOR FREE,1750.0,0.0,1750.0,0.0,1750.0,0.0,1750.0
TCGA-50-6593-01,TCGA-50-6593,LUAD,49.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2008.0,-18152.0,Dead,WITH TUMOR,,1.0,336.0,1.0,336.0,1.0,266.0
TCGA-50-6595-01,TCGA-50-6595,LUAD,74.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2009.0,-27197.0,Dead,WITH TUMOR,,1.0,189.0,1.0,189.0,1.0,182.0
TCGA-50-6597-01,TCGA-50-6597,LUAD,79.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2007.0,-29195.0,Dead,TUMOR FREE,,1.0,1268.0,0.0,1268.0,0.0,1268.0
TCGA-50-6673-01,TCGA-50-6673,LUAD,84.0,FEMALE,WHITE,Stage I,Lung Adenocarcinoma,2004.0,-30689.0,Dead,,,1.0,22.0,,22.0,0.0,22.0
TCGA-50-7109-01,TCGA-50-7109,LUAD,60.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-21979.0,Dead,WITH TUMOR,,1.0,308.0,1.0,308.0,1.0,15.0
TCGA-53-7626-01,TCGA-53-7626,LUAD,76.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2008.0,-28024.0,Dead,WITH TUMOR,,1.0,929.0,1.0,929.0,1.0,865.0
TCGA-53-7813-01,TCGA-53-7813,LUAD,51.0,FEMALE,WHITE,Stage IIIB,Lung Adenocarcinoma,2008.0,-18875.0,Alive,TUMOR FREE,424.0,0.0,424.0,0.0,424.0,0.0,424.0
TCGA-55-1592-01,TCGA-55-1592,LUAD,65.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2005.0,,Dead,WITH TUMOR,,1.0,701.0,1.0,701.0,1.0,452.0
TCGA-55-1594-01,TCGA-55-1594,LUAD,68.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2005.0,-25008.0,Alive,TUMOR FREE,1178.0,0.0,1178.0,0.0,1178.0,0.0,1178.0
TCGA-55-1596-01,TCGA-55-1596,LUAD,55.0,MALE,ASIAN,Stage IIB,Lung Adenocarcinoma,2004.0,-20381.0,Alive,TUMOR FREE,2065.0,0.0,2065.0,0.0,2065.0,0.0,2065.0
TCGA-55-6543-01,TCGA-55-6543,LUAD,60.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,,Alive,TUMOR FREE,435.0,0.0,435.0,0.0,435.0,0.0,435.0
TCGA-55-6712-01,TCGA-55-6712,LUAD,71.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,,Dead,WITH TUMOR,,1.0,171.0,1.0,171.0,1.0,171.0
TCGA-55-6970-01,TCGA-55-6970,LUAD,67.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2004.0,-24773.0,Dead,WITH TUMOR,,1.0,464.0,1.0,464.0,1.0,457.0
TCGA-55-6971-01,TCGA-55-6971,LUAD,59.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2010.0,-21734.0,Alive,TUMOR FREE,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0
TCGA-55-6978-01,TCGA-55-6978,LUAD,81.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,,Dead,WITH TUMOR,,1.0,176.0,1.0,176.0,1.0,42.0
TCGA-55-6979-01,TCGA-55-6979,LUAD,59.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2006.0,-21780.0,Dead,WITH TUMOR,,1.0,237.0,1.0,237.0,1.0,195.0
TCGA-55-6981-01,TCGA-55-6981,LUAD,53.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2005.0,-19497.0,Dead,TUMOR FREE,,1.0,1379.0,0.0,1379.0,0.0,1379.0
TCGA-55-6982-01,TCGA-55-6982,LUAD,79.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2004.0,,Dead,WITH TUMOR,,1.0,995.0,1.0,995.0,1.0,183.0
TCGA-55-7573-01,TCGA-55-7573,LUAD,72.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-26302.0,Alive,TUMOR FREE,487.0,0.0,487.0,0.0,487.0,0.0,487.0
TCGA-55-7574-01,TCGA-55-7574,LUAD,64.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-23703.0,Dead,WITH TUMOR,,1.0,995.0,1.0,995.0,1.0,478.0
TCGA-55-7728-01,TCGA-55-7728,LUAD,64.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-23505.0,Alive,TUMOR FREE,704.0,0.0,704.0,0.0,704.0,0.0,704.0
TCGA-55-7815-01,TCGA-55-7815,LUAD,76.0,MALE,,Stage IB,Lung Adenocarcinoma,2011.0,-28119.0,Alive,WITH TUMOR,773.0,0.0,773.0,0.0,773.0,1.0,466.0
TCGA-55-7911-01,TCGA-55-7911,LUAD,70.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-25746.0,Alive,TUMOR FREE,537.0,0.0,537.0,0.0,537.0,1.0,515.0
TCGA-56-5897-01,TCGA-56-5897,LUSC,74.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2010.0,-27118.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-56-5898-01,TCGA-56-5898,LUSC,69.0,MALE,WHITE,Stage IA,Lung Squamous Cell Carcinoma,2010.0,-25441.0,Alive,TUMOR FREE,555.0,0.0,555.0,0.0,555.0,0.0,555.0
TCGA-56-6545-01,TCGA-56-6545,LUSC,77.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2010.0,-28400.0,Alive,TUMOR FREE,666.0,0.0,666.0,0.0,666.0,0.0,666.0
TCGA-56-6546-01,TCGA-56-6546,LUSC,67.0,MALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2011.0,-24594.0,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-5M-AAT6-01,TCGA-5M-AAT6,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,Colon Adenocarcinoma,2009.0,-14852.0,Dead,WITH TUMOR,,1.0,290.0,1.0,290.0,1.0,219.0
TCGA-5T-A9QA-01,TCGA-5T-A9QA,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,"Other, specify",2013.0,-19031.0,Alive,,303.0,0.0,303.0,0.0,303.0,0.0,303.0
TCGA-60-2698-01,TCGA-60-2698,LUSC,62.0,MALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,1993.0,-22800.0,Dead,WITH TUMOR,,1.0,311.0,1.0,311.0,1.0,114.0
TCGA-60-2708-01,TCGA-60-2708,LUSC,64.0,FEMALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2004.0,-23691.0,Alive,TUMOR FREE,2447.0,0.0,2447.0,0.0,2447.0,0.0,2447.0
TCGA-60-2709-01,TCGA-60-2709,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-25453.0,Alive,TUMOR FREE,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0
TCGA-60-2710-01,TCGA-60-2710,LUSC,67.0,FEMALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2005.0,-24669.0,Alive,TUMOR FREE,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0
TCGA-60-2711-01,TCGA-60-2711,LUSC,64.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-23651.0,Alive,TUMOR FREE,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0
TCGA-60-2713-01,TCGA-60-2713,LUSC,64.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2006.0,-23630.0,Alive,,1731.0,0.0,1731.0,0.0,1731.0,1.0,1356.0
TCGA-60-2719-01,TCGA-60-2719,LUSC,83.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-30379.0,Alive,TUMOR FREE,1297.0,0.0,1297.0,0.0,1297.0,0.0,1297.0
TCGA-60-2720-01,TCGA-60-2720,LUSC,60.0,FEMALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-22238.0,Alive,TUMOR FREE,97.0,0.0,97.0,0.0,97.0,0.0,97.0
TCGA-60-2721-01,TCGA-60-2721,LUSC,73.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2008.0,-27007.0,Alive,TUMOR FREE,983.0,0.0,983.0,0.0,983.0,0.0,983.0
TCGA-60-2724-01,TCGA-60-2724,LUSC,47.0,MALE,WHITE,Stage IIIA,Lung Squamous Cell Carcinoma,2008.0,-17462.0,Alive,TUMOR FREE,717.0,0.0,717.0,0.0,717.0,0.0,717.0
TCGA-60-2725-01,TCGA-60-2725,LUSC,74.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2009.0,-27073.0,Alive,TUMOR FREE,816.0,0.0,816.0,0.0,816.0,0.0,816.0
TCGA-60-2726-01,TCGA-60-2726,LUSC,56.0,MALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2009.0,-20618.0,Dead,TUMOR FREE,358.0,1.0,358.0,0.0,358.0,0.0,358.0
TCGA-63-5128-01,TCGA-63-5128,LUSC,,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,,Dead,WITH TUMOR,,1.0,,1.0,,1.0,
TCGA-63-5131-01,TCGA-63-5131,LUSC,,MALE,,Stage IIB,Lung Squamous Cell Carcinoma,2008.0,,Dead,TUMOR FREE,,1.0,,0.0,,0.0,
TCGA-63-6202-01,TCGA-63-6202,LUSC,,MALE,,Stage IIA,Lung Squamous Cell Carcinoma,2008.0,,Alive,TUMOR FREE,1602.0,0.0,1602.0,0.0,1602.0,0.0,1602.0
TCGA-64-1676-01,TCGA-64-1676,LUAD,58.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2005.0,-21428.0,Alive,TUMOR FREE,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0
TCGA-64-1679-01,TCGA-64-1679,LUAD,58.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2007.0,-21310.0,Alive,TUMOR FREE,2488.0,0.0,2488.0,0.0,2488.0,0.0,2488.0
TCGA-64-1680-01,TCGA-64-1680,LUAD,63.0,MALE,WHITE,Stage IV,Lung Adenocarcinoma,2007.0,-23267.0,Alive,TUMOR FREE,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0
TCGA-64-1681-01,TCGA-64-1681,LUAD,61.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2008.0,-22525.0,Dead,,,1.0,1167.0,,1167.0,1.0,439.0
TCGA-64-5774-01,TCGA-64-5774,LUAD,60.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2004.0,-22059.0,Alive,TUMOR FREE,2676.0,0.0,2676.0,0.0,2676.0,1.0,246.0
TCGA-64-5778-01,TCGA-64-5778,LUAD,60.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2008.0,-21927.0,Alive,WITH TUMOR,1305.0,0.0,1305.0,0.0,1305.0,1.0,962.0
TCGA-64-5781-01,TCGA-64-5781,LUAD,55.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2007.0,-20219.0,Alive,TUMOR FREE,1559.0,0.0,1559.0,0.0,1559.0,1.0,96.0
TCGA-66-2727-01,TCGA-66-2727,LUSC,55.0,FEMALE,,Stage IB,Lung Squamous Cell Carcinoma,2004.0,-20150.0,Dead,,,1.0,516.0,,516.0,0.0,516.0
TCGA-66-2758-01,TCGA-66-2758,LUSC,71.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-26209.0,Alive,TUMOR FREE,639.0,0.0,639.0,0.0,639.0,0.0,639.0
TCGA-66-2766-01,TCGA-66-2766,LUSC,54.0,MALE,,Stage IIIA,Lung Squamous Cell Carcinoma,2007.0,-19814.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-66-2767-01,TCGA-66-2767,LUSC,62.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2007.0,-22888.0,Alive,TUMOR FREE,61.0,0.0,61.0,0.0,61.0,0.0,61.0
TCGA-66-2770-01,TCGA-66-2770,LUSC,79.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-28945.0,Alive,,700.0,0.0,700.0,0.0,700.0,0.0,700.0
TCGA-66-2773-01,TCGA-66-2773,LUSC,69.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-25355.0,Dead,TUMOR FREE,,1.0,92.0,0.0,92.0,0.0,92.0
TCGA-66-2777-01,TCGA-66-2777,LUSC,71.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-26085.0,Alive,TUMOR FREE,61.0,0.0,61.0,0.0,61.0,0.0,61.0
TCGA-66-2778-01,TCGA-66-2778,LUSC,68.0,FEMALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2007.0,-25080.0,Alive,TUMOR FREE,578.0,0.0,578.0,0.0,578.0,0.0,578.0
TCGA-66-2781-01,TCGA-66-2781,LUSC,67.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2007.0,-24471.0,Alive,TUMOR FREE,121.0,0.0,121.0,0.0,121.0,0.0,121.0
TCGA-66-2782-01,TCGA-66-2782,LUSC,71.0,MALE,,Stage IIB,Lung Squamous Cell Carcinoma,2004.0,-26237.0,Dead,WITH TUMOR,,1.0,365.0,1.0,365.0,1.0,304.0
TCGA-66-2783-01,TCGA-66-2783,LUSC,67.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2008.0,-24686.0,Alive,TUMOR FREE,759.0,0.0,759.0,0.0,759.0,0.0,759.0
TCGA-66-2785-01,TCGA-66-2785,LUSC,65.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2008.0,-23772.0,Alive,TUMOR FREE,60.0,0.0,60.0,0.0,60.0,0.0,60.0
TCGA-66-2788-01,TCGA-66-2788,LUSC,56.0,MALE,,Stage IB,Lung Squamous Cell Carcinoma,2008.0,-20637.0,Alive,TUMOR FREE,699.0,0.0,699.0,0.0,699.0,0.0,699.0
TCGA-66-2791-01,TCGA-66-2791,LUSC,66.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2008.0,-24138.0,Dead,,,1.0,153.0,,153.0,0.0,153.0
TCGA-66-2794-01,TCGA-66-2794,LUSC,64.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2006.0,-23710.0,Alive,TUMOR FREE,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0
TCGA-66-2795-01,TCGA-66-2795,LUSC,68.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2008.0,-24897.0,Alive,TUMOR FREE,122.0,0.0,122.0,0.0,122.0,0.0,122.0
TCGA-66-2800-01,TCGA-66-2800,LUSC,70.0,MALE,,Stage IIIB,Lung Squamous Cell Carcinoma,2004.0,-25810.0,Alive,TUMOR FREE,1492.0,0.0,1492.0,0.0,1492.0,0.0,1492.0
TCGA-67-3771-01,TCGA-67-3771,LUAD,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Lung Adenocarcinoma,2009.0,-28406.0,Alive,TUMOR FREE,610.0,0.0,610.0,0.0,610.0,0.0,610.0
TCGA-67-6215-01,TCGA-67-6215,LUAD,52.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2010.0,-19310.0,Alive,TUMOR FREE,174.0,0.0,174.0,0.0,174.0,0.0,174.0
TCGA-67-6216-01,TCGA-67-6216,LUAD,57.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-20967.0,Alive,TUMOR FREE,141.0,0.0,141.0,0.0,141.0,0.0,141.0
TCGA-67-6217-01,TCGA-67-6217,LUAD,73.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,-26920.0,Alive,WITH TUMOR,422.0,0.0,422.0,0.0,422.0,1.0,296.0
TCGA-69-7760-01,TCGA-69-7760,LUAD,73.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2011.0,-26777.0,Alive,TUMOR FREE,202.0,0.0,202.0,0.0,202.0,0.0,202.0
TCGA-69-7761-01,TCGA-69-7761,LUAD,84.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-31041.0,Alive,TUMOR FREE,186.0,0.0,186.0,0.0,186.0,0.0,186.0
TCGA-69-7763-01,TCGA-69-7763,LUAD,69.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-25316.0,Alive,,690.0,0.0,690.0,0.0,690.0,0.0,690.0
TCGA-69-7764-01,TCGA-69-7764,LUAD,75.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-27693.0,Alive,TUMOR FREE,414.0,0.0,414.0,0.0,414.0,0.0,414.0
TCGA-70-6722-01,TCGA-70-6722,LUSC,47.0,MALE,ASIAN,Stage IIIA,Lung Squamous Cell Carcinoma,2010.0,-17328.0,Alive,WITH TUMOR,367.0,0.0,367.0,0.0,367.0,1.0,293.0
TCGA-70-6723-01,TCGA-70-6723,LUSC,65.0,MALE,ASIAN,Stage IIA,Lung Squamous Cell Carcinoma,2010.0,-24035.0,Alive,WITH TUMOR,375.0,0.0,375.0,0.0,375.0,1.0,312.0
TCGA-71-6725-01,TCGA-71-6725,LUAD,48.0,FEMALE,ASIAN,Stage IB,Lung Adenocarcinoma,2011.0,-17793.0,Alive,WITH TUMOR,256.0,0.0,256.0,0.0,256.0,1.0,164.0
TCGA-73-4658-01,TCGA-73-4658,LUAD,80.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2004.0,-29508.0,Dead,TUMOR FREE,1600.0,1.0,1600.0,0.0,1600.0,0.0,1600.0
TCGA-73-4659-01,TCGA-73-4659,LUAD,66.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2006.0,-24253.0,Dead,WITH TUMOR,711.0,1.0,711.0,1.0,711.0,1.0,35.0
TCGA-73-4675-01,TCGA-73-4675,LUAD,59.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2010.0,-21614.0,Dead,TUMOR FREE,,1.0,922.0,0.0,922.0,1.0,361.0
TCGA-73-4676-01,TCGA-73-4676,LUAD,45.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2010.0,-16746.0,Dead,WITH TUMOR,,1.0,281.0,1.0,281.0,1.0,281.0
TCGA-73-7498-01,TCGA-73-7498,LUAD,58.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-21527.0,Alive,TUMOR FREE,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0
TCGA-73-7499-01,TCGA-73-7499,LUAD,81.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2010.0,-29683.0,Dead,TUMOR FREE,,1.0,1531.0,0.0,1531.0,1.0,1447.0
TCGA-75-5122-01,TCGA-75-5122,LUAD,,MALE,,Stage IB,Lung Adenocarcinoma,2005.0,,Dead,WITH TUMOR,,1.0,,1.0,,1.0,
TCGA-75-6203-01,TCGA-75-6203,LUAD,,FEMALE,,Stage IIIA,Lung Adenocarcinoma,2008.0,,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-75-6205-01,TCGA-75-6205,LUAD,,FEMALE,,Stage IB,Lung Adenocarcinoma,2006.0,,Dead,WITH TUMOR,,1.0,,1.0,,1.0,
TCGA-75-6207-01,TCGA-75-6207,LUAD,,MALE,,Stage IIIA,Lung Adenocarcinoma,2007.0,,Dead,,,1.0,,,,0.0,
TCGA-75-6211-01,TCGA-75-6211,LUAD,,FEMALE,,Stage IB,Lung Adenocarcinoma,2009.0,,Dead,WITH TUMOR,,1.0,,1.0,,1.0,
TCGA-75-6212-01,TCGA-75-6212,LUAD,,FEMALE,,Stage IIB,Lung Adenocarcinoma,,,Dead,WITH TUMOR,,1.0,1516.0,1.0,1516.0,1.0,1340.0
TCGA-75-6214-01,TCGA-75-6214,LUAD,,FEMALE,,Stage IIIA,Lung Adenocarcinoma,,,Dead,WITH TUMOR,,1.0,1115.0,1.0,1115.0,1.0,419.0
TCGA-75-7027-01,TCGA-75-7027,LUAD,,MALE,,Stage IB,Lung Adenocarcinoma,,,Alive,TUMOR FREE,3059.0,0.0,3059.0,0.0,3059.0,1.0,2949.0
TCGA-75-7030-01,TCGA-75-7030,LUAD,,MALE,,Stage IIB,Lung Adenocarcinoma,2007.0,,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-75-7031-01,TCGA-75-7031,LUAD,,FEMALE,,Stage IB,Lung Adenocarcinoma,2008.0,,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-76-4926-01,TCGA-76-4926,GBM,68.0,MALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-25085.0,Dead,WITH TUMOR,138.0,1.0,138.0,1.0,138.0,1.0,34.0
TCGA-76-4927-01,TCGA-76-4927,GBM,58.0,MALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-21193.0,Dead,WITH TUMOR,535.0,1.0,535.0,1.0,535.0,1.0,416.0
TCGA-76-4928-01,TCGA-76-4928,GBM,85.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-31267.0,Dead,WITH TUMOR,94.0,1.0,94.0,1.0,94.0,1.0,94.0
TCGA-76-4929-01,TCGA-76-4929,GBM,76.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-27831.0,Dead,WITH TUMOR,111.0,1.0,111.0,1.0,111.0,1.0,111.0
TCGA-76-4931-01,TCGA-76-4931,GBM,70.0,FEMALE,WHITE,,Untreated primary (de novo) GBM,2005.0,-25812.0,Dead,WITH TUMOR,279.0,1.0,279.0,1.0,279.0,1.0,112.0
TCGA-76-4932-01,TCGA-76-4932,GBM,50.0,FEMALE,WHITE,,Treated primary GBM,2006.0,-18433.0,Dead,WITH TUMOR,1458.0,1.0,1458.0,1.0,1458.0,1.0,1458.0
TCGA-78-7145-01,TCGA-78-7145,LUAD,52.0,FEMALE,WHITE,Stage IV,Lung Adenocarcinoma,2000.0,-19080.0,Dead,WITH TUMOR,,1.0,826.0,1.0,826.0,1.0,422.0
TCGA-78-7147-01,TCGA-78-7147,LUAD,67.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2001.0,-24809.0,Dead,WITH TUMOR,,1.0,586.0,1.0,586.0,1.0,578.0
TCGA-78-7148-01,TCGA-78-7148,LUAD,71.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2001.0,-25990.0,Dead,,,1.0,626.0,,626.0,1.0,182.0
TCGA-78-7149-01,TCGA-78-7149,LUAD,71.0,MALE,WHITE,Stage IIIB,Lung Adenocarcinoma,2002.0,-26285.0,Alive,,3940.0,0.0,3940.0,0.0,3940.0,0.0,3940.0
TCGA-78-7150-01,TCGA-78-7150,LUAD,59.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2002.0,-21891.0,Dead,WITH TUMOR,,1.0,666.0,1.0,666.0,1.0,139.0
TCGA-78-7152-01,TCGA-78-7152,LUAD,65.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2003.0,-23782.0,Dead,WITH TUMOR,,1.0,1215.0,1.0,1215.0,1.0,1202.0
TCGA-78-7153-01,TCGA-78-7153,LUAD,65.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2003.0,-23922.0,Alive,,3635.0,0.0,3635.0,0.0,3635.0,0.0,3635.0
TCGA-78-7154-01,TCGA-78-7154,LUAD,72.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2003.0,-26481.0,Dead,,,1.0,593.0,,593.0,0.0,593.0
TCGA-78-7155-01,TCGA-78-7155,LUAD,68.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2005.0,-24863.0,Dead,,,1.0,1171.0,,1171.0,1.0,209.0
TCGA-78-7156-01,TCGA-78-7156,LUAD,62.0,MALE,WHITE,Stage IV,Lung Adenocarcinoma,2006.0,-22720.0,Dead,,,1.0,976.0,,976.0,0.0,976.0
TCGA-78-7158-01,TCGA-78-7158,LUAD,59.0,FEMALE,WHITE,Stage IIIB,Lung Adenocarcinoma,2007.0,-21742.0,Dead,WITH TUMOR,,1.0,179.0,1.0,179.0,1.0,132.0
TCGA-78-7159-01,TCGA-78-7159,LUAD,60.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2008.0,-22261.0,Alive,,1974.0,0.0,1974.0,0.0,1974.0,0.0,1974.0
TCGA-78-7160-01,TCGA-78-7160,LUAD,61.0,MALE,WHITE,Stage IV,Lung Adenocarcinoma,2008.0,-22385.0,Dead,,,1.0,697.0,,697.0,0.0,697.0
TCGA-78-7161-01,TCGA-78-7161,LUAD,69.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2011.0,-25294.0,Dead,WITH TUMOR,,1.0,291.0,1.0,291.0,1.0,162.0
TCGA-78-7162-01,TCGA-78-7162,LUAD,75.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,1991.0,-27593.0,Dead,,,1.0,3169.0,,3169.0,1.0,2218.0
TCGA-78-7163-01,TCGA-78-7163,LUAD,60.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,1992.0,-22002.0,Alive,TUMOR FREE,7248.0,0.0,7248.0,0.0,7248.0,0.0,7248.0
TCGA-78-7166-01,TCGA-78-7166,LUAD,84.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2002.0,-30869.0,Dead,,,1.0,258.0,,258.0,0.0,258.0
TCGA-78-7167-01,TCGA-78-7167,LUAD,77.0,MALE,WHITE,Stage IV,Lung Adenocarcinoma,2002.0,-28295.0,Dead,WITH TUMOR,,1.0,2681.0,1.0,2681.0,1.0,726.0
TCGA-78-7535-01,TCGA-78-7535,LUAD,45.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2000.0,-16571.0,Dead,WITH TUMOR,,1.0,949.0,1.0,949.0,1.0,809.0
TCGA-78-7536-01,TCGA-78-7536,LUAD,69.0,MALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2001.0,-25558.0,Dead,WITH TUMOR,,1.0,244.0,1.0,244.0,1.0,231.0
TCGA-78-7537-01,TCGA-78-7537,LUAD,72.0,MALE,,Stage IB,Lung Adenocarcinoma,2002.0,-26610.0,Dead,,,1.0,1622.0,,1622.0,0.0,1622.0
TCGA-78-7539-01,TCGA-78-7539,LUAD,75.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2011.0,-27445.0,Alive,,791.0,0.0,791.0,0.0,791.0,1.0,688.0
TCGA-78-7540-01,TCGA-78-7540,LUAD,66.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,1999.0,-24440.0,Dead,,,1.0,1197.0,,1197.0,0.0,1197.0
TCGA-78-7542-01,TCGA-78-7542,LUAD,56.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,1993.0,-20763.0,Dead,,,1.0,321.0,,321.0,0.0,321.0
TCGA-78-7633-01,TCGA-78-7633,LUAD,67.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2009.0,-24713.0,Dead,WITH TUMOR,,1.0,1528.0,1.0,1528.0,1.0,1450.0
TCGA-80-5607-01,TCGA-80-5607,LUAD,,FEMALE,,Stage IIB,Lung Adenocarcinoma,2007.0,,Alive,WITH TUMOR,,0.0,,0.0,,0.0,
TCGA-80-5608-01,TCGA-80-5608,LUAD,,FEMALE,,Stage IA,Lung Adenocarcinoma,,,Alive,TUMOR FREE,2832.0,0.0,2832.0,0.0,2832.0,0.0,2832.0
TCGA-85-6175-01,TCGA-85-6175,LUSC,63.0,FEMALE,WHITE,Stage IIB,Lung Squamous Cell Carcinoma,2010.0,-23228.0,Dead,WITH TUMOR,,1.0,294.0,1.0,294.0,1.0,294.0
TCGA-85-6560-01,TCGA-85-6560,LUSC,59.0,MALE,WHITE,Stage IIA,Lung Squamous Cell Carcinoma,2011.0,-21768.0,Alive,TUMOR FREE,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0
TCGA-85-6561-01,TCGA-85-6561,LUSC,66.0,MALE,WHITE,Stage IB,Lung Squamous Cell Carcinoma,2011.0,-24234.0,Alive,TUMOR FREE,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0
TCGA-86-6562-01,TCGA-86-6562,LUAD,52.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2011.0,-19301.0,Dead,WITH TUMOR,,1.0,376.0,1.0,376.0,1.0,274.0
TCGA-86-6851-01,TCGA-86-6851,LUAD,73.0,FEMALE,WHITE,Stage IIA,Lung Adenocarcinoma,2011.0,-26808.0,Alive,TUMOR FREE,179.0,0.0,179.0,0.0,179.0,0.0,179.0
TCGA-86-7713-01,TCGA-86-7713,LUAD,70.0,MALE,WHITE,Stage IIA,Lung Adenocarcinoma,2011.0,-25791.0,Alive,TUMOR FREE,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0
TCGA-91-6828-01,TCGA-91-6828,LUAD,70.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-25870.0,Alive,TUMOR FREE,323.0,0.0,323.0,0.0,323.0,0.0,323.0
TCGA-91-6829-01,TCGA-91-6829,LUAD,78.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2001.0,-28841.0,Dead,TUMOR FREE,,1.0,1258.0,0.0,1258.0,0.0,1258.0
TCGA-91-6835-01,TCGA-91-6835,LUAD,81.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2010.0,-29887.0,Alive,TUMOR FREE,79.0,0.0,79.0,0.0,79.0,0.0,79.0
TCGA-91-6840-01,TCGA-91-6840,LUAD,59.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-21854.0,Alive,TUMOR FREE,372.0,0.0,372.0,0.0,372.0,0.0,372.0
TCGA-91-6847-01,TCGA-91-6847,LUAD,62.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2002.0,-22862.0,Alive,WITH TUMOR,842.0,0.0,842.0,0.0,842.0,1.0,772.0
TCGA-91-6849-01,TCGA-91-6849,LUAD,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Lung Adenocarcinoma,2009.0,-27676.0,Alive,,35.0,0.0,35.0,0.0,35.0,0.0,35.0
TCGA-91-7771-01,TCGA-91-7771,LUAD,62.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2011.0,-22926.0,Alive,TUMOR FREE,492.0,0.0,492.0,0.0,492.0,0.0,492.0
TCGA-93-7348-01,TCGA-93-7348,LUAD,75.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-27456.0,Alive,TUMOR FREE,531.0,0.0,531.0,0.0,531.0,0.0,531.0
TCGA-95-7039-01,TCGA-95-7039,LUAD,54.0,FEMALE,WHITE,Stage IIB,Lung Adenocarcinoma,2011.0,-19981.0,Alive,WITH TUMOR,1272.0,0.0,1272.0,0.0,1272.0,1.0,1258.0
TCGA-95-7043-01,TCGA-95-7043,LUAD,63.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-23165.0,Dead,WITH TUMOR,,1.0,503.0,1.0,503.0,1.0,503.0
TCGA-95-7567-01,TCGA-95-7567,LUAD,61.0,MALE,WHITE,Stage IIB,Lung Adenocarcinoma,2011.0,-22437.0,Alive,TUMOR FREE,568.0,0.0,568.0,0.0,568.0,0.0,568.0
TCGA-95-7947-01,TCGA-95-7947,LUAD,67.0,MALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-24752.0,Alive,TUMOR FREE,477.0,0.0,477.0,0.0,477.0,0.0,477.0
TCGA-95-7948-01,TCGA-95-7948,LUAD,42.0,FEMALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-15363.0,Alive,TUMOR FREE,476.0,0.0,476.0,0.0,476.0,0.0,476.0
TCGA-97-7546-01,TCGA-97-7546,LUAD,76.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2008.0,-27913.0,Alive,WITH TUMOR,1285.0,0.0,1285.0,0.0,1285.0,1.0,1255.0
TCGA-97-7552-01,TCGA-97-7552,LUAD,70.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2007.0,-25578.0,Alive,TUMOR FREE,1932.0,0.0,1932.0,0.0,1932.0,1.0,798.0
TCGA-97-7553-01,TCGA-97-7553,LUAD,58.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2007.0,-21518.0,Alive,TUMOR FREE,1870.0,0.0,1870.0,0.0,1870.0,0.0,1870.0
TCGA-97-7554-01,TCGA-97-7554,LUAD,83.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2010.0,-30327.0,Alive,TUMOR FREE,775.0,0.0,775.0,0.0,775.0,0.0,775.0
TCGA-97-7937-01,TCGA-97-7937,LUAD,65.0,MALE,WHITE,Stage IB,Lung Adenocarcinoma,2011.0,-23919.0,Alive,TUMOR FREE,564.0,0.0,564.0,0.0,564.0,0.0,564.0
TCGA-97-7938-01,TCGA-97-7938,LUAD,76.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-27980.0,Dead,TUMOR FREE,,1.0,18.0,0.0,18.0,0.0,18.0
TCGA-97-7941-01,TCGA-97-7941,LUAD,72.0,FEMALE,WHITE,Stage IA,Lung Adenocarcinoma,2011.0,-26298.0,Alive,TUMOR FREE,484.0,0.0,484.0,0.0,484.0,0.0,484.0
TCGA-99-7458-01,TCGA-99-7458,LUAD,74.0,FEMALE,WHITE,Stage IIIA,Lung Adenocarcinoma,2010.0,-27359.0,Alive,WITH TUMOR,747.0,0.0,747.0,0.0,747.0,0.0,747.0
TCGA-A1-A0SF-01,TCGA-A1-A0SF,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-19731.0,Alive,TUMOR FREE,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0
TCGA-A1-A0SH-01,TCGA-A1-A0SH,BRCA,39.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-14595.0,Alive,TUMOR FREE,1437.0,0.0,1437.0,0.0,1437.0,0.0,1437.0
TCGA-A1-A0SJ-01,TCGA-A1-A0SJ,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-14383.0,Alive,TUMOR FREE,416.0,0.0,416.0,0.0,416.0,0.0,416.0
TCGA-A1-A0SK-01,TCGA-A1-A0SK,BRCA,54.0,FEMALE,ASIAN,Stage IIA,"Other, specify",2007.0,-20048.0,Dead,WITH TUMOR,,1.0,967.0,1.0,967.0,1.0,967.0
TCGA-A1-A0SO-01,TCGA-A1-A0SO,BRCA,67.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-24826.0,Alive,TUMOR FREE,852.0,0.0,852.0,0.0,852.0,0.0,852.0
TCGA-A2-A04N-01,TCGA-A2-A04N,BRCA,66.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2002.0,-24155.0,Alive,TUMOR FREE,4354.0,0.0,4354.0,0.0,4354.0,0.0,4354.0
TCGA-A2-A04U-01,TCGA-A2-A04U,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2004.0,-17474.0,Alive,TUMOR FREE,2654.0,0.0,2654.0,0.0,2654.0,0.0,2654.0
TCGA-A2-A04W-01,TCGA-A2-A04W,BRCA,50.0,FEMALE,WHITE,Stage IIB,"Other, specify",2005.0,-18345.0,Alive,TUMOR FREE,3102.0,0.0,3102.0,0.0,3102.0,0.0,3102.0
TCGA-A2-A0CK-01,TCGA-A2-A0CK,BRCA,60.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2001.0,-22094.0,Alive,TUMOR FREE,4159.0,0.0,4159.0,0.0,4159.0,1.0,1364.0
TCGA-A2-A0CL-01,TCGA-A2-A0CL,BRCA,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-13556.0,Alive,TUMOR FREE,3015.0,0.0,3015.0,0.0,3015.0,0.0,3015.0
TCGA-A2-A0CR-01,TCGA-A2-A0CR,BRCA,54.0,FEMALE,ASIAN,Stage IIB,Infiltrating Lobular Carcinoma,2004.0,-20075.0,Alive,TUMOR FREE,3283.0,0.0,3283.0,0.0,3283.0,0.0,3283.0
TCGA-A2-A0CS-01,TCGA-A2-A0CS,BRCA,73.0,FEMALE,WHITE,Stage IV,Infiltrating Ductal Carcinoma,2004.0,-26817.0,Dead,TUMOR FREE,,1.0,2348.0,0.0,2348.0,0.0,2348.0
TCGA-A2-A0CV-01,TCGA-A2-A0CV,BRCA,41.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2005.0,-15289.0,Alive,TUMOR FREE,3011.0,0.0,3011.0,0.0,3011.0,0.0,3011.0
TCGA-A2-A0CW-01,TCGA-A2-A0CW,BRCA,67.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-24541.0,Alive,TUMOR FREE,3283.0,0.0,3283.0,0.0,3283.0,0.0,3283.0
TCGA-A2-A0D3-01,TCGA-A2-A0D3,BRCA,42.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2008.0,-15524.0,Alive,TUMOR FREE,1873.0,0.0,1873.0,0.0,1873.0,0.0,1873.0
TCGA-A2-A0EP-01,TCGA-A2-A0EP,BRCA,56.0,FEMALE,WHITE,Stage I,Infiltrating Lobular Carcinoma,2004.0,-20585.0,Alive,TUMOR FREE,3603.0,0.0,3603.0,0.0,3603.0,0.0,3603.0
TCGA-A2-A0ES-01,TCGA-A2-A0ES,BRCA,52.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2008.0,-19160.0,Alive,TUMOR FREE,2190.0,0.0,2190.0,0.0,2190.0,0.0,2190.0
TCGA-A2-A0EW-01,TCGA-A2-A0EW,BRCA,53.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2008.0,-19413.0,Dead,WITH TUMOR,,1.0,1884.0,1.0,1884.0,1.0,1353.0
TCGA-A2-A0ST-01,TCGA-A2-A0ST,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2003.0,-22922.0,Alive,WITH TUMOR,3017.0,0.0,3017.0,0.0,3017.0,0.0,3017.0
TCGA-A2-A0SU-01,TCGA-A2-A0SU,BRCA,66.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-24219.0,Alive,TUMOR FREE,1662.0,0.0,1662.0,0.0,1662.0,0.0,1662.0
TCGA-A2-A0SX-01,TCGA-A2-A0SX,BRCA,48.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2007.0,-17774.0,Alive,WITH TUMOR,1534.0,0.0,1534.0,0.0,1534.0,1.0,1239.0
TCGA-A2-A0T0-01,TCGA-A2-A0T0,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-21575.0,Alive,TUMOR FREE,533.0,0.0,533.0,0.0,533.0,0.0,533.0
TCGA-A2-A0T1-01,TCGA-A2-A0T1,BRCA,55.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,Infiltrating Ductal Carcinoma,2009.0,-20227.0,Alive,TUMOR FREE,521.0,0.0,521.0,0.0,521.0,0.0,521.0
TCGA-A2-A0T3-01,TCGA-A2-A0T3,BRCA,37.0,FEMALE,WHITE,Stage IB,Infiltrating Ductal Carcinoma,2009.0,-13680.0,Alive,TUMOR FREE,1516.0,0.0,1516.0,0.0,1516.0,0.0,1516.0
TCGA-A2-A0T4-01,TCGA-A2-A0T4,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2009.0,-22849.0,Alive,TUMOR FREE,624.0,0.0,624.0,0.0,624.0,0.0,624.0
TCGA-A2-A0T5-01,TCGA-A2-A0T5,BRCA,39.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-14503.0,Alive,TUMOR FREE,531.0,0.0,531.0,0.0,531.0,0.0,531.0
TCGA-A2-A0T6-01,TCGA-A2-A0T6,BRCA,50.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2009.0,-18334.0,Alive,TUMOR FREE,575.0,0.0,575.0,0.0,575.0,0.0,575.0
TCGA-A2-A0T7-01,TCGA-A2-A0T7,BRCA,51.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-18756.0,Alive,TUMOR FREE,631.0,0.0,631.0,0.0,631.0,0.0,631.0
TCGA-A2-A0YC-01,TCGA-A2-A0YC,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-21685.0,Alive,WITH TUMOR,990.0,0.0,990.0,0.0,990.0,1.0,756.0
TCGA-A2-A0YD-01,TCGA-A2-A0YD,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2009.0,-23021.0,Alive,TUMOR FREE,769.0,0.0,769.0,0.0,769.0,0.0,769.0
TCGA-A2-A0YE-01,TCGA-A2-A0YE,BRCA,48.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-17727.0,Alive,TUMOR FREE,554.0,0.0,554.0,0.0,554.0,0.0,554.0
TCGA-A2-A0YF-01,TCGA-A2-A0YF,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2009.0,-24660.0,Alive,TUMOR FREE,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0
TCGA-A2-A0YG-01,TCGA-A2-A0YG,BRCA,63.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2009.0,-23058.0,Alive,TUMOR FREE,666.0,0.0,666.0,0.0,666.0,0.0,666.0
TCGA-A2-A0YH-01,TCGA-A2-A0YH,BRCA,53.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2009.0,-19596.0,Alive,TUMOR FREE,659.0,0.0,659.0,0.0,659.0,0.0,659.0
TCGA-A2-A0YI-01,TCGA-A2-A0YI,BRCA,62.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-22961.0,Alive,TUMOR FREE,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0
TCGA-A2-A0YJ-01,TCGA-A2-A0YJ,BRCA,39.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-14448.0,Alive,WITH TUMOR,566.0,0.0,566.0,0.0,566.0,1.0,559.0
TCGA-A2-A0YK-01,TCGA-A2-A0YK,BRCA,61.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2009.0,-22625.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-A2-A0YL-01,TCGA-A2-A0YL,BRCA,48.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2010.0,-17702.0,Alive,TUMOR FREE,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0
TCGA-A2-A0YM-01,TCGA-A2-A0YM,BRCA,67.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-24831.0,Alive,TUMOR FREE,965.0,0.0,965.0,0.0,965.0,0.0,965.0
TCGA-A2-A0YT-01,TCGA-A2-A0YT,BRCA,56.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,2008.0,-20482.0,Dead,TUMOR FREE,,1.0,723.0,0.0,723.0,0.0,723.0
TCGA-A2-A1FV-01,TCGA-A2-A1FV,BRCA,74.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-27287.0,Alive,TUMOR FREE,714.0,0.0,714.0,0.0,714.0,0.0,714.0
TCGA-A2-A1FW-01,TCGA-A2-A1FW,BRCA,62.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-22779.0,Alive,TUMOR FREE,528.0,0.0,528.0,0.0,528.0,0.0,528.0
TCGA-A2-A1FX-01,TCGA-A2-A1FX,BRCA,61.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-22344.0,Alive,TUMOR FREE,1847.0,0.0,1847.0,0.0,1847.0,0.0,1847.0
TCGA-A2-A1FZ-01,TCGA-A2-A1FZ,BRCA,63.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-23055.0,Alive,TUMOR FREE,683.0,0.0,683.0,0.0,683.0,0.0,683.0
TCGA-A2-A1G0-01,TCGA-A2-A1G0,BRCA,49.0,FEMALE,WHITE,Stage IIB,"Other, specify",2010.0,-18002.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-A2-A1G1-01,TCGA-A2-A1G1,BRCA,85.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-31223.0,Alive,TUMOR FREE,584.0,0.0,584.0,0.0,584.0,0.0,584.0
TCGA-A2-A1G6-01,TCGA-A2-A1G6,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-18514.0,Alive,TUMOR FREE,501.0,0.0,501.0,0.0,501.0,0.0,501.0
TCGA-A2-A259-01,TCGA-A2-A259,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2007.0,-25666.0,Alive,TUMOR FREE,1596.0,0.0,1596.0,0.0,1596.0,0.0,1596.0
TCGA-A2-A25A-01,TCGA-A2-A25A,BRCA,44.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2003.0,-16084.0,Alive,TUMOR FREE,3276.0,0.0,3276.0,0.0,3276.0,0.0,3276.0
TCGA-A2-A25B-01,TCGA-A2-A25B,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-14454.0,Alive,WITH TUMOR,1291.0,0.0,1291.0,0.0,1291.0,1.0,1290.0
TCGA-A2-A25C-01,TCGA-A2-A25C,BRCA,50.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-18508.0,Alive,TUMOR FREE,523.0,0.0,523.0,0.0,523.0,0.0,523.0
TCGA-A2-A25D-01,TCGA-A2-A25D,BRCA,90.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2010.0,-32872.0,Alive,TUMOR FREE,552.0,0.0,552.0,0.0,552.0,0.0,552.0
TCGA-A2-A25E-01,TCGA-A2-A25E,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2004.0,-12601.0,Alive,TUMOR FREE,3204.0,0.0,3204.0,0.0,3204.0,1.0,2989.0
TCGA-A2-A25F-01,TCGA-A2-A25F,BRCA,66.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-24319.0,Alive,TUMOR FREE,322.0,0.0,322.0,0.0,322.0,0.0,322.0
TCGA-A2-A3KD-01,TCGA-A2-A3KD,BRCA,47.0,FEMALE,WHITE,Stage IIIA,Mucinous Carcinoma,2010.0,-17372.0,Alive,TUMOR FREE,1206.0,0.0,1206.0,0.0,1206.0,0.0,1206.0
TCGA-A2-A3XT-01,TCGA-A2-A3XT,BRCA,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-16649.0,Alive,TUMOR FREE,2770.0,0.0,2770.0,0.0,2770.0,0.0,2770.0
TCGA-A2-A3XU-01,TCGA-A2-A3XU,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-13046.0,Dead,WITH TUMOR,,1.0,912.0,1.0,912.0,1.0,574.0
TCGA-A2-A3XV-01,TCGA-A2-A3XV,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-16971.0,Alive,TUMOR FREE,996.0,0.0,996.0,0.0,996.0,0.0,996.0
TCGA-A2-A3XW-01,TCGA-A2-A3XW,BRCA,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-15670.0,Alive,TUMOR FREE,1712.0,0.0,1712.0,0.0,1712.0,0.0,1712.0
TCGA-A2-A3XX-01,TCGA-A2-A3XX,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-17981.0,Dead,TUMOR FREE,,1.0,1439.0,0.0,1439.0,0.0,1439.0
TCGA-A2-A3XZ-01,TCGA-A2-A3XZ,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2009.0,-16978.0,Alive,TUMOR FREE,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0
TCGA-A2-A4S1-01,TCGA-A2-A4S1,BRCA,66.0,FEMALE,WHITE,Stage IIA,Metaplastic Carcinoma,2012.0,-24353.0,Alive,TUMOR FREE,820.0,0.0,820.0,0.0,820.0,0.0,820.0
TCGA-A2-A4S2-01,TCGA-A2-A4S2,BRCA,62.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2012.0,-22936.0,Alive,TUMOR FREE,643.0,0.0,643.0,0.0,643.0,0.0,643.0
TCGA-A2-A4S3-01,TCGA-A2-A4S3,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2012.0,-21762.0,Alive,TUMOR FREE,666.0,0.0,666.0,0.0,666.0,0.0,666.0
TCGA-A3-3308-01,TCGA-A3-3308,KIRC,77.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-28287.0,Alive,TUMOR FREE,16.0,0.0,16.0,0.0,16.0,0.0,16.0
TCGA-A3-3311-01,TCGA-A3-3311,KIRC,57.0,MALE,,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-21183.0,Dead,TUMOR FREE,,1.0,1191.0,0.0,1191.0,0.0,1191.0
TCGA-A3-3316-01,TCGA-A3-3316,KIRC,57.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2005.0,-20931.0,Alive,TUMOR FREE,1493.0,0.0,1493.0,0.0,1493.0,0.0,1493.0
TCGA-A3-3317-01,TCGA-A3-3317,KIRC,67.0,MALE,,Stage II,Kidney Clear Cell Renal Carcinoma,2005.0,-24803.0,Alive,TUMOR FREE,1491.0,0.0,1491.0,0.0,1491.0,1.0,560.0
TCGA-A3-3319-01,TCGA-A3-3319,KIRC,70.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-25699.0,Alive,TUMOR FREE,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0
TCGA-A3-3320-01,TCGA-A3-3320,KIRC,52.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-19138.0,Alive,TUMOR FREE,1508.0,0.0,1508.0,0.0,1508.0,0.0,1508.0
TCGA-A3-3322-01,TCGA-A3-3322,KIRC,51.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-18754.0,Alive,TUMOR FREE,1478.0,0.0,1478.0,0.0,1478.0,0.0,1478.0
TCGA-A3-3323-01,TCGA-A3-3323,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-19456.0,Alive,TUMOR FREE,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0
TCGA-A3-3326-01,TCGA-A3-3326,KIRC,47.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-17285.0,Alive,TUMOR FREE,1137.0,0.0,1137.0,0.0,1137.0,0.0,1137.0
TCGA-A3-3346-01,TCGA-A3-3346,KIRC,68.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-25118.0,Dead,WITH TUMOR,,1.0,137.0,1.0,137.0,1.0,114.0
TCGA-A3-3347-01,TCGA-A3-3347,KIRC,76.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-27966.0,Dead,WITH TUMOR,,1.0,1610.0,1.0,1610.0,1.0,610.0
TCGA-A3-3349-01,TCGA-A3-3349,KIRC,34.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-12431.0,Alive,TUMOR FREE,1385.0,0.0,1385.0,0.0,1385.0,0.0,1385.0
TCGA-A3-3357-01,TCGA-A3-3357,KIRC,62.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2005.0,-22825.0,Alive,TUMOR FREE,2688.0,0.0,2688.0,0.0,2688.0,0.0,2688.0
TCGA-A3-3362-01,TCGA-A3-3362,KIRC,60.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-21988.0,Alive,TUMOR FREE,1559.0,0.0,1559.0,0.0,1559.0,0.0,1559.0
TCGA-A3-3363-01,TCGA-A3-3363,KIRC,50.0,MALE,ASIAN,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-18596.0,Alive,TUMOR FREE,319.0,0.0,319.0,0.0,319.0,0.0,319.0
TCGA-A3-3365-01,TCGA-A3-3365,KIRC,46.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-16915.0,Alive,,873.0,0.0,873.0,0.0,873.0,0.0,873.0
TCGA-A3-3367-01,TCGA-A3-3367,KIRC,72.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-26489.0,Alive,TUMOR FREE,2270.0,0.0,2270.0,0.0,2270.0,0.0,2270.0
TCGA-A3-3370-01,TCGA-A3-3370,KIRC,48.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-17621.0,Alive,TUMOR FREE,2274.0,0.0,2274.0,0.0,2274.0,0.0,2274.0
TCGA-A3-3373-01,TCGA-A3-3373,KIRC,54.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19964.0,Alive,TUMOR FREE,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0
TCGA-A3-3376-01,TCGA-A3-3376,KIRC,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-18954.0,Dead,TUMOR FREE,,1.0,1696.0,0.0,1696.0,0.0,1696.0
TCGA-A3-3378-01,TCGA-A3-3378,KIRC,60.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-22090.0,Alive,TUMOR FREE,630.0,0.0,630.0,0.0,630.0,0.0,630.0
TCGA-A3-3380-01,TCGA-A3-3380,KIRC,54.0,MALE,,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19828.0,Alive,TUMOR FREE,567.0,0.0,567.0,0.0,567.0,0.0,567.0
TCGA-A3-3382-01,TCGA-A3-3382,KIRC,69.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-25207.0,Alive,WITH TUMOR,574.0,0.0,574.0,0.0,574.0,1.0,514.0
TCGA-A3-3383-01,TCGA-A3-3383,KIRC,52.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-19324.0,Alive,,861.0,0.0,861.0,0.0,861.0,0.0,861.0
TCGA-A3-3385-01,TCGA-A3-3385,KIRC,46.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-17114.0,Alive,TUMOR FREE,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0
TCGA-A3-3387-01,TCGA-A3-3387,KIRC,49.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-17920.0,Alive,TUMOR FREE,617.0,0.0,617.0,0.0,617.0,0.0,617.0
TCGA-A4-7288-01,TCGA-A4-7288,KIRP,71.0,FEMALE,WHITE,,Kidney Papillary Renal Cell Carcinoma,2008.0,-26268.0,Alive,TUMOR FREE,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0
TCGA-A4-7583-01,TCGA-A4-7583,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-21962.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-A4-7584-01,TCGA-A4-7584,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-21782.0,Alive,TUMOR FREE,650.0,0.0,650.0,0.0,650.0,0.0,650.0
TCGA-A4-7585-01,TCGA-A4-7585,KIRP,67.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2007.0,-24778.0,Dead,TUMOR FREE,,1.0,1070.0,0.0,1070.0,0.0,1070.0
TCGA-A4-7734-01,TCGA-A4-7734,KIRP,53.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-19612.0,Alive,TUMOR FREE,27.0,0.0,27.0,0.0,27.0,0.0,27.0
TCGA-A4-7915-01,TCGA-A4-7915,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Papillary Renal Cell Carcinoma,2011.0,-12832.0,Alive,TUMOR FREE,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-A4-7997-01,TCGA-A4-7997,KIRP,67.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-24486.0,Alive,TUMOR FREE,927.0,0.0,927.0,0.0,927.0,0.0,927.0
TCGA-A4-8098-01,TCGA-A4-8098,KIRP,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-26685.0,Alive,TUMOR FREE,896.0,0.0,896.0,0.0,896.0,0.0,896.0
TCGA-A4-8311-01,TCGA-A4-8311,KIRP,60.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-22220.0,Alive,TUMOR FREE,729.0,0.0,729.0,0.0,729.0,0.0,729.0
TCGA-A4-8517-01,TCGA-A4-8517,KIRP,71.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-26090.0,Alive,TUMOR FREE,597.0,0.0,597.0,0.0,597.0,0.0,597.0
TCGA-A4-8630-01,TCGA-A4-8630,KIRP,59.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-21884.0,Alive,TUMOR FREE,436.0,0.0,436.0,0.0,436.0,0.0,436.0
TCGA-A4-A57E-01,TCGA-A4-A57E,KIRP,59.0,MALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2011.0,-21885.0,Dead,WITH TUMOR,,1.0,258.0,1.0,258.0,1.0,258.0
TCGA-A5-A1OH-01,TCGA-A5-A1OH,UCEC,86.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2010.0,-31451.0,Alive,TUMOR FREE,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0
TCGA-A5-A2K3-01,TCGA-A5-A2K3,UCEC,68.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2007.0,-24907.0,Alive,TUMOR FREE,2012.0,0.0,2012.0,0.0,2012.0,0.0,2012.0
TCGA-A5-A2K4-01,TCGA-A5-A2K4,UCEC,69.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2009.0,-25270.0,Dead,WITH TUMOR,,1.0,871.0,1.0,871.0,1.0,528.0
TCGA-A5-A2K5-01,TCGA-A5-A2K5,UCEC,76.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-28057.0,Alive,TUMOR FREE,752.0,0.0,752.0,0.0,752.0,0.0,752.0
TCGA-A5-A2K7-01,TCGA-A5-A2K7,UCEC,41.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2011.0,-14980.0,Alive,TUMOR FREE,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0
TCGA-A5-A3LO-01,TCGA-A5-A3LO,UCEC,64.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-23401.0,Alive,TUMOR FREE,776.0,0.0,776.0,0.0,776.0,0.0,776.0
TCGA-A5-A3LP-01,TCGA-A5-A3LP,UCEC,74.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-27131.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-A6-2685-01,TCGA-A6-2685,COAD,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2009.0,-17757.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,1.0,948.0
TCGA-A6-2686-01,TCGA-A6-2686,COAD,81.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2009.0,-29623.0,Dead,TUMOR FREE,,1.0,1126.0,0.0,1126.0,0.0,1126.0
TCGA-A6-5657-01,TCGA-A6-5657,COAD,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2010.0,-23920.0,Alive,TUMOR FREE,962.0,0.0,962.0,0.0,962.0,0.0,962.0
TCGA-A6-5660-01,TCGA-A6-5660,COAD,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2010.0,-26803.0,Alive,TUMOR FREE,888.0,0.0,888.0,0.0,888.0,0.0,888.0
TCGA-A6-5661-01,TCGA-A6-5661,COAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2010.0,-29446.0,Alive,TUMOR FREE,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0
TCGA-A6-5662-01,TCGA-A6-5662,COAD,46.0,MALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-16873.0,Alive,WITH TUMOR,718.0,0.0,718.0,0.0,718.0,1.0,495.0
TCGA-A6-5664-01,TCGA-A6-5664,COAD,80.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2010.0,-29426.0,Alive,WITH TUMOR,672.0,0.0,672.0,0.0,672.0,1.0,183.0
TCGA-A6-5665-01,TCGA-A6-5665,COAD,84.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-30915.0,Alive,TUMOR FREE,671.0,0.0,671.0,0.0,671.0,1.0,529.0
TCGA-A6-5666-01,TCGA-A6-5666,COAD,78.0,MALE,WHITE,Stage IIC,Colon Adenocarcinoma,2010.0,-28514.0,Alive,WITH TUMOR,995.0,0.0,995.0,0.0,995.0,1.0,509.0
TCGA-A6-5667-01,TCGA-A6-5667,COAD,40.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-14756.0,Alive,TUMOR FREE,887.0,0.0,887.0,0.0,887.0,0.0,887.0
TCGA-A6-6137-01,TCGA-A6-6137,COAD,55.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-20095.0,Alive,TUMOR FREE,824.0,0.0,824.0,0.0,824.0,0.0,824.0
TCGA-A6-6138-01,TCGA-A6-6138,COAD,61.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-22523.0,Alive,TUMOR FREE,685.0,0.0,685.0,0.0,685.0,0.0,685.0
TCGA-A6-6142-01,TCGA-A6-6142,COAD,56.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2011.0,-20485.0,Alive,WITH TUMOR,763.0,0.0,763.0,0.0,763.0,1.0,654.0
TCGA-A6-6648-01,TCGA-A6-6648,COAD,56.0,MALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-20641.0,Alive,WITH TUMOR,766.0,0.0,766.0,0.0,766.0,1.0,686.0
TCGA-A6-6649-01,TCGA-A6-6649,COAD,66.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-24237.0,Alive,TUMOR FREE,735.0,0.0,735.0,0.0,735.0,0.0,735.0
TCGA-A6-6651-01,TCGA-A6-6651,COAD,55.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-20110.0,Alive,TUMOR FREE,662.0,0.0,662.0,0.0,662.0,0.0,662.0
TCGA-A6-6652-01,TCGA-A6-6652,COAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Colon Adenocarcinoma,2011.0,-21638.0,Alive,WITH TUMOR,751.0,0.0,751.0,0.0,751.0,0.0,751.0
TCGA-A6-6653-01,TCGA-A6-6653,COAD,82.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-29996.0,Alive,TUMOR FREE,742.0,0.0,742.0,0.0,742.0,0.0,742.0
TCGA-A6-6654-01,TCGA-A6-6654,COAD,65.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2011.0,-23953.0,Alive,TUMOR FREE,726.0,0.0,726.0,0.0,726.0,0.0,726.0
TCGA-A6-6782-01,TCGA-A6-6782,COAD,82.0,MALE,WHITE,Stage IIB,Colon Adenocarcinoma,2011.0,-30012.0,Alive,TUMOR FREE,617.0,0.0,617.0,0.0,617.0,0.0,617.0
TCGA-A6-A566-01,TCGA-A6-A566,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Mucinous Adenocarcinoma,2007.0,-20181.0,Dead,WITH TUMOR,,1.0,758.0,1.0,758.0,1.0,257.0
TCGA-A7-A0CE-01,TCGA-A7-A0CE,BRCA,57.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-20863.0,Alive,TUMOR FREE,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0
TCGA-A7-A0CH-01,TCGA-A7-A0CH,BRCA,79.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-29104.0,Alive,TUMOR FREE,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0
TCGA-A7-A0D9-01,TCGA-A7-A0D9,BRCA,37.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-13836.0,Alive,TUMOR FREE,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0
TCGA-A7-A0DA-01,TCGA-A7-A0DA,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-22708.0,Alive,TUMOR FREE,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0
TCGA-A7-A0DB-01,TCGA-A7-A0DB,BRCA,56.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-20570.0,Alive,TUMOR FREE,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0
TCGA-A7-A13D-01,TCGA-A7-A13D,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-17070.0,Alive,TUMOR FREE,965.0,0.0,965.0,0.0,965.0,0.0,965.0
TCGA-A7-A13E-01,TCGA-A7-A13E,BRCA,62.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-22690.0,Dead,WITH TUMOR,,1.0,614.0,1.0,614.0,1.0,556.0
TCGA-A7-A13F-01,TCGA-A7-A13F,BRCA,44.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-16363.0,Alive,TUMOR FREE,765.0,0.0,765.0,0.0,765.0,0.0,765.0
TCGA-A7-A26E-01,TCGA-A7-A26E,BRCA,71.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2010.0,-26274.0,Alive,TUMOR FREE,954.0,0.0,954.0,0.0,954.0,0.0,954.0
TCGA-A7-A26F-01,TCGA-A7-A26F,BRCA,55.0,FEMALE,WHITE,Stage IA,"Other, specify",2010.0,-20210.0,Alive,TUMOR FREE,738.0,0.0,738.0,0.0,738.0,0.0,738.0
TCGA-A7-A26G-01,TCGA-A7-A26G,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,"Other, specify",2010.0,-18362.0,Alive,TUMOR FREE,722.0,0.0,722.0,0.0,722.0,0.0,722.0
TCGA-A7-A26H-01,TCGA-A7-A26H,BRCA,72.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-26423.0,Alive,WITH TUMOR,724.0,0.0,724.0,0.0,724.0,1.0,291.0
TCGA-A7-A26I-01,TCGA-A7-A26I,BRCA,65.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-23948.0,Alive,TUMOR FREE,661.0,0.0,661.0,0.0,661.0,0.0,661.0
TCGA-A7-A2KD-01,TCGA-A7-A2KD,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-19563.0,Alive,TUMOR FREE,679.0,0.0,679.0,0.0,679.0,0.0,679.0
TCGA-A7-A3RF-01,TCGA-A7-A3RF,BRCA,79.0,FEMALE,WHITE,Stage IIA,Mucinous Carcinoma,2012.0,-29184.0,Alive,WITH TUMOR,408.0,0.0,408.0,0.0,408.0,1.0,174.0
TCGA-A7-A425-01,TCGA-A7-A425,BRCA,70.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2012.0,-25678.0,Alive,WITH TUMOR,447.0,0.0,447.0,0.0,447.0,1.0,419.0
TCGA-A7-A4SC-01,TCGA-A7-A4SC,BRCA,62.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2012.0,-23008.0,Alive,TUMOR FREE,446.0,0.0,446.0,0.0,446.0,0.0,446.0
TCGA-A7-A4SD-01,TCGA-A7-A4SD,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2012.0,-19131.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-A7-A4SE-01,TCGA-A7-A4SE,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-20080.0,Alive,TUMOR FREE,644.0,0.0,644.0,0.0,644.0,0.0,644.0
TCGA-A7-A5ZV-01,TCGA-A7-A5ZV,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Carcinoma NOS,2012.0,-22966.0,Alive,TUMOR FREE,368.0,0.0,368.0,0.0,368.0,0.0,368.0
TCGA-A7-A6VV-01,TCGA-A7-A6VV,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-18695.0,Alive,TUMOR FREE,313.0,0.0,313.0,0.0,313.0,0.0,313.0
TCGA-A7-A6VX-01,TCGA-A7-A6VX,BRCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-25066.0,Alive,TUMOR FREE,317.0,0.0,317.0,0.0,317.0,0.0,317.0
TCGA-A8-A075-01,TCGA-A8-A075,BRCA,42.0,FEMALE,,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-15369.0,Alive,TUMOR FREE,518.0,0.0,518.0,0.0,518.0,0.0,518.0
TCGA-AA-3489-01,TCGA-AA-3489,COAD,75.0,MALE,,Stage II,Colon Adenocarcinoma,2002.0,-27606.0,Dead,WITH TUMOR,,1.0,214.0,1.0,214.0,1.0,214.0
TCGA-AA-3492-01,TCGA-AA-3492,COAD,90.0,FEMALE,,Stage II,Colon Adenocarcinoma,2002.0,-32871.0,Dead,TUMOR FREE,,1.0,92.0,0.0,92.0,0.0,92.0
TCGA-AA-3496-01,TCGA-AA-3496,COAD,83.0,FEMALE,,Stage II,Colon Adenocarcinoma,2002.0,-30438.0,Alive,WITH TUMOR,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-AA-3502-01,TCGA-AA-3502,COAD,73.0,MALE,,Stage I,Colon Adenocarcinoma,2003.0,-26724.0,Alive,WITH TUMOR,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0
TCGA-AA-3506-01,TCGA-AA-3506,COAD,77.0,MALE,,Stage I,Colon Adenocarcinoma,2004.0,-28275.0,Alive,WITH TUMOR,1765.0,0.0,1765.0,0.0,1765.0,0.0,1765.0
TCGA-AA-3511-01,TCGA-AA-3511,COAD,64.0,MALE,,Stage II,Colon Adenocarcinoma,2005.0,-23407.0,Alive,TUMOR FREE,212.0,0.0,212.0,0.0,212.0,1.0,59.0
TCGA-AA-3655-01,TCGA-AA-3655,COAD,68.0,MALE,,Stage II,Colon Adenocarcinoma,2005.0,-24896.0,Alive,TUMOR FREE,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0
TCGA-AA-3712-01,TCGA-AA-3712,COAD,65.0,MALE,,Stage III,Colon Adenocarcinoma,2004.0,-23831.0,Alive,WITH TUMOR,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-AA-3713-01,TCGA-AA-3713,COAD,68.0,MALE,,Stage IV,Colon Adenocarcinoma,2005.0,-24927.0,Alive,TUMOR FREE,579.0,0.0,579.0,0.0,579.0,0.0,579.0
TCGA-AA-A01P-01,TCGA-AA-A01P,COAD,80.0,FEMALE,,Stage III,Colon Adenocarcinoma,2003.0,-29554.0,Dead,WITH TUMOR,,1.0,1158.0,1.0,1158.0,1.0,762.0
TCGA-AC-A23C-01,TCGA-AC-A23C,BRCA,62.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-22751.0,Alive,TUMOR FREE,585.0,0.0,585.0,0.0,585.0,0.0,585.0
TCGA-AC-A23E-01,TCGA-AC-A23E,BRCA,50.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-18500.0,Alive,TUMOR FREE,698.0,0.0,698.0,0.0,698.0,0.0,698.0
TCGA-AC-A2B8-01,TCGA-AC-A2B8,BRCA,84.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-31003.0,Alive,TUMOR FREE,677.0,0.0,677.0,0.0,677.0,1.0,654.0
TCGA-AC-A2BK-01,TCGA-AC-A2BK,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-28625.0,Alive,TUMOR FREE,2222.0,0.0,2222.0,0.0,2222.0,0.0,2222.0
TCGA-AC-A2BM-01,TCGA-AC-A2BM,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2005.0,-15212.0,Alive,TUMOR FREE,3022.0,0.0,3022.0,0.0,3022.0,0.0,3022.0
TCGA-AC-A2FB-01,TCGA-AC-A2FB,BRCA,65.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2009.0,-23851.0,Alive,TUMOR FREE,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0
TCGA-AC-A2FF-01,TCGA-AC-A2FF,BRCA,40.0,FEMALE,ASIAN,Stage IIB,Infiltrating Lobular Carcinoma,2006.0,,Alive,TUMOR FREE,2759.0,0.0,2759.0,0.0,2759.0,0.0,2759.0
TCGA-AC-A2FG-01,TCGA-AC-A2FG,BRCA,79.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2007.0,-29211.0,Alive,TUMOR FREE,1853.0,0.0,1853.0,0.0,1853.0,0.0,1853.0
TCGA-AC-A3HN-01,TCGA-AC-A3HN,BRCA,87.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-32061.0,Alive,TUMOR FREE,496.0,0.0,496.0,0.0,496.0,0.0,496.0
TCGA-AC-A3QP-01,TCGA-AC-A3QP,BRCA,79.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-29113.0,Alive,TUMOR FREE,675.0,0.0,675.0,0.0,675.0,0.0,675.0
TCGA-AC-A3W5-01,TCGA-AC-A3W5,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-24029.0,Alive,TUMOR FREE,504.0,0.0,504.0,0.0,504.0,0.0,504.0
TCGA-AC-A3YJ-01,TCGA-AC-A3YJ,BRCA,66.0,FEMALE,WHITE,Stage IIA,"Other, specify",2012.0,-24439.0,Alive,TUMOR FREE,754.0,0.0,754.0,0.0,754.0,0.0,754.0
TCGA-AC-A4ZE-01,TCGA-AC-A4ZE,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2012.0,-23284.0,Alive,TUMOR FREE,890.0,0.0,890.0,0.0,890.0,0.0,890.0
TCGA-AC-A5XS-01,TCGA-AC-A5XS,BRCA,74.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-27160.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-AC-A5XU-01,TCGA-AC-A5XU,BRCA,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-27191.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-AC-A62X-01,TCGA-AC-A62X,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-26627.0,Alive,TUMOR FREE,417.0,0.0,417.0,0.0,417.0,0.0,417.0
TCGA-AC-A6IW-01,TCGA-AC-A6IW,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-26896.0,Alive,TUMOR FREE,413.0,0.0,413.0,0.0,413.0,0.0,413.0
TCGA-AC-A6IX-01,TCGA-AC-A6IX,BRCA,49.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2013.0,-17969.0,Alive,TUMOR FREE,373.0,0.0,373.0,0.0,373.0,0.0,373.0
TCGA-AC-A6NO-01,TCGA-AC-A6NO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-15996.0,Alive,TUMOR FREE,51.0,0.0,51.0,0.0,51.0,0.0,51.0
TCGA-AC-A8OQ-01,TCGA-AC-A8OQ,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-26535.0,Alive,TUMOR FREE,34.0,0.0,34.0,0.0,34.0,0.0,34.0
TCGA-AD-5900-01,TCGA-AD-5900,COAD,67.0,MALE,WHITE,Stage I,Colon Mucinous Adenocarcinoma,2010.0,-24776.0,Alive,TUMOR FREE,370.0,0.0,370.0,0.0,370.0,0.0,370.0
TCGA-AD-6548-01,TCGA-AD-6548,COAD,81.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-29758.0,Alive,TUMOR FREE,650.0,0.0,650.0,0.0,650.0,0.0,650.0
TCGA-AD-6889-01,TCGA-AD-6889,COAD,76.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2005.0,,Dead,TUMOR FREE,,1.0,2532.0,0.0,2532.0,1.0,1516.0
TCGA-AD-6899-01,TCGA-AD-6899,COAD,84.0,MALE,WHITE,Stage IIIC,Colon Mucinous Adenocarcinoma,2011.0,-30693.0,Dead,TUMOR FREE,,1.0,176.0,0.0,176.0,0.0,176.0
TCGA-AD-6965-01,TCGA-AD-6965,COAD,62.0,MALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2011.0,-22853.0,Alive,WITH TUMOR,805.0,0.0,805.0,0.0,805.0,1.0,648.0
TCGA-AD-A5EJ-01,TCGA-AD-A5EJ,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2012.0,-27180.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-AF-2690-01,TCGA-AF-2690,READ,76.0,FEMALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2009.0,-28119.0,Dead,TUMOR FREE,,1.0,524.0,0.0,524.0,0.0,524.0
TCGA-AF-6136-01,TCGA-AF-6136,READ,72.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2011.0,-26490.0,Alive,WITH TUMOR,741.0,0.0,741.0,0.0,741.0,1.0,199.0
TCGA-AF-6655-01,TCGA-AF-6655,READ,66.0,MALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2010.0,-24417.0,Alive,TUMOR FREE,609.0,0.0,609.0,0.0,609.0,0.0,609.0
TCGA-AF-6672-01,TCGA-AF-6672,READ,43.0,MALE,WHITE,Stage IV,Rectal Adenocarcinoma,2011.0,-15965.0,Alive,WITH TUMOR,748.0,0.0,748.0,0.0,748.0,1.0,279.0
TCGA-AF-A56N-01,TCGA-AF-A56N,READ,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Rectal Adenocarcinoma,2012.0,-17480.0,Alive,TUMOR FREE,360.0,0.0,360.0,0.0,360.0,0.0,360.0
TCGA-AG-3591-01,TCGA-AG-3591,READ,66.0,FEMALE,,Stage IIA,Rectal Adenocarcinoma,2007.0,-24167.0,Alive,TUMOR FREE,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0
TCGA-AG-3725-01,TCGA-AG-3725,READ,90.0,FEMALE,,Stage III,Rectal Adenocarcinoma,2005.0,-32872.0,Alive,TUMOR FREE,638.0,0.0,638.0,0.0,638.0,0.0,638.0
TCGA-AG-3731-01,TCGA-AG-3731,READ,65.0,MALE,,Stage IV,Rectal Adenocarcinoma,2004.0,-23923.0,Alive,TUMOR FREE,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0
TCGA-AG-3742-01,TCGA-AG-3742,READ,85.0,FEMALE,,Stage I,Rectal Adenocarcinoma,2004.0,-31078.0,Alive,WITH TUMOR,30.0,0.0,30.0,0.0,30.0,0.0,30.0
TCGA-AG-4021-01,TCGA-AG-4021,READ,84.0,FEMALE,,Stage IV,Rectal Adenocarcinoma,2005.0,-31015.0,Dead,WITH TUMOR,,1.0,121.0,1.0,121.0,1.0,0.0
TCGA-AG-4022-01,TCGA-AG-4022,READ,59.0,FEMALE,,Stage II,Rectal Adenocarcinoma,2006.0,-21823.0,Alive,TUMOR FREE,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0
TCGA-AH-6544-01,TCGA-AH-6544,READ,60.0,MALE,WHITE,,Rectal Adenocarcinoma,2010.0,-21977.0,Alive,WITH TUMOR,1173.0,0.0,1173.0,0.0,1173.0,0.0,1173.0
TCGA-AH-6547-01,TCGA-AH-6547,READ,79.0,FEMALE,WHITE,,Rectal Adenocarcinoma,2010.0,-29030.0,Dead,TUMOR FREE,,1.0,76.0,0.0,76.0,0.0,76.0
TCGA-AH-6643-01,TCGA-AH-6643,READ,50.0,MALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2010.0,-18273.0,Dead,WITH TUMOR,,1.0,1314.0,1.0,1314.0,1.0,1026.0
TCGA-AH-6644-01,TCGA-AH-6644,READ,73.0,MALE,WHITE,,Rectal Adenocarcinoma,2010.0,-26892.0,Alive,TUMOR FREE,838.0,0.0,838.0,0.0,838.0,0.0,838.0
TCGA-AH-6897-01,TCGA-AH-6897,READ,48.0,MALE,WHITE,Stage I,Rectal Adenocarcinoma,2010.0,-17536.0,Alive,TUMOR FREE,804.0,0.0,804.0,0.0,804.0,0.0,804.0
TCGA-AJ-A23N-01,TCGA-AJ-A23N,UCEC,70.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-25772.0,Dead,WITH TUMOR,,1.0,439.0,1.0,439.0,1.0,439.0
TCGA-AJ-A2QM-01,TCGA-AJ-A2QM,UCEC,67.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-24776.0,Alive,TUMOR FREE,894.0,0.0,894.0,0.0,894.0,0.0,894.0
TCGA-AJ-A3BD-01,TCGA-AJ-A3BD,UCEC,57.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-20998.0,Alive,TUMOR FREE,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0
TCGA-AJ-A3BF-01,TCGA-AJ-A3BF,UCEC,65.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-23906.0,Alive,TUMOR FREE,551.0,0.0,551.0,0.0,551.0,1.0,384.0
TCGA-AJ-A3BH-01,TCGA-AJ-A3BH,UCEC,,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-AJ-A3BK-01,TCGA-AJ-A3BK,UCEC,68.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-24943.0,Alive,TUMOR FREE,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0
TCGA-AJ-A3EK-01,TCGA-AJ-A3EK,UCEC,53.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-19609.0,Alive,TUMOR FREE,446.0,0.0,446.0,0.0,446.0,0.0,446.0
TCGA-AJ-A3NG-01,TCGA-AJ-A3NG,UCEC,83.0,FEMALE,WHITE,,Mixed serous and endometrioid,2011.0,-30351.0,Alive,TUMOR FREE,475.0,0.0,475.0,0.0,475.0,0.0,475.0
TCGA-AJ-A3OJ-01,TCGA-AJ-A3OJ,UCEC,54.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-19826.0,Alive,TUMOR FREE,467.0,0.0,467.0,0.0,467.0,0.0,467.0
TCGA-AJ-A3OK-01,TCGA-AJ-A3OK,UCEC,73.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-26851.0,Alive,TUMOR FREE,485.0,0.0,485.0,0.0,485.0,0.0,485.0
TCGA-AJ-A3OL-01,TCGA-AJ-A3OL,UCEC,55.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-20115.0,Dead,WITH TUMOR,,1.0,449.0,1.0,449.0,1.0,424.0
TCGA-AJ-A3TW-01,TCGA-AJ-A3TW,UCEC,78.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2012.0,-28559.0,Alive,TUMOR FREE,513.0,0.0,513.0,0.0,513.0,0.0,513.0
TCGA-AK-3436-01,TCGA-AK-3436,KIRC,40.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2005.0,-14842.0,Alive,TUMOR FREE,3331.0,0.0,3331.0,0.0,3331.0,1.0,1189.0
TCGA-AK-3444-01,TCGA-AK-3444,KIRC,80.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-29497.0,Alive,TUMOR FREE,1471.0,0.0,1471.0,0.0,1471.0,0.0,1471.0
TCGA-AK-3451-01,TCGA-AK-3451,KIRC,48.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-17859.0,Alive,TUMOR FREE,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0
TCGA-AK-3456-01,TCGA-AK-3456,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Clear Cell Renal Carcinoma,2007.0,-17821.0,Alive,,1143.0,0.0,1143.0,0.0,1143.0,0.0,1143.0
TCGA-AL-3472-01,TCGA-AL-3472,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,,Kidney Papillary Renal Cell Carcinoma,2008.0,-21166.0,Alive,TUMOR FREE,2029.0,0.0,2029.0,0.0,2029.0,0.0,2029.0
TCGA-AL-3473-01,TCGA-AL-3473,KIRP,55.0,MALE,WHITE,Stage II,Kidney Papillary Renal Cell Carcinoma,2008.0,-20104.0,Alive,TUMOR FREE,1906.0,0.0,1906.0,0.0,1906.0,0.0,1906.0
TCGA-AL-7173-01,TCGA-AL-7173,KIRP,72.0,FEMALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2008.0,-26326.0,Alive,WITH TUMOR,2060.0,0.0,2060.0,0.0,2060.0,1.0,332.0
TCGA-AM-5820-01,TCGA-AM-5820,COAD,59.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-21902.0,Alive,TUMOR FREE,14.0,0.0,14.0,0.0,14.0,0.0,14.0
TCGA-AM-5821-01,TCGA-AM-5821,COAD,68.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-24903.0,Alive,TUMOR FREE,28.0,0.0,28.0,0.0,28.0,0.0,28.0
TCGA-AN-A0XN-01,TCGA-AN-A0XN,BRCA,68.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-25029.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-AN-A0XO-01,TCGA-AN-A0XO,BRCA,59.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-21640.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-AN-A0XP-01,TCGA-AN-A0XP,BRCA,69.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-25305.0,Alive,TUMOR FREE,9.0,0.0,9.0,0.0,9.0,0.0,9.0
TCGA-AN-A0XS-01,TCGA-AN-A0XS,BRCA,63.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-23358.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-AN-A0XT-01,TCGA-AN-A0XT,BRCA,54.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-19794.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-AN-A0XU-01,TCGA-AN-A0XU,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-20052.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-AN-A0XW-01,TCGA-AN-A0XW,BRCA,36.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-13208.0,Alive,TUMOR FREE,170.0,0.0,170.0,0.0,170.0,0.0,170.0
TCGA-AO-A03M-01,TCGA-AO-A03M,BRCA,29.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2006.0,-10616.0,Alive,TUMOR FREE,1866.0,0.0,1866.0,0.0,1866.0,0.0,1866.0
TCGA-AO-A03N-01,TCGA-AO-A03N,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-21816.0,Alive,WITH TUMOR,2031.0,0.0,2031.0,0.0,2031.0,1.0,1645.0
TCGA-AO-A03U-01,TCGA-AO-A03U,BRCA,31.0,FEMALE,WHITE,Stage I,"Other, specify",2001.0,-11354.0,Dead,TUMOR FREE,,1.0,1793.0,0.0,1793.0,1.0,1614.0
TCGA-AO-A0JG-01,TCGA-AO-A0JG,BRCA,49.0,FEMALE,WHITE,Stage IIIA,"Other, specify",2009.0,-18021.0,Alive,TUMOR FREE,798.0,0.0,798.0,0.0,798.0,0.0,798.0
TCGA-AO-A124-01,TCGA-AO-A124,BRCA,38.0,FEMALE,WHITE,Stage IIA,"Other, specify",2002.0,-14174.0,Alive,TUMOR FREE,3506.0,0.0,3506.0,0.0,3506.0,0.0,3506.0
TCGA-AO-A126-01,TCGA-AO-A126,BRCA,39.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2002.0,-14264.0,Alive,TUMOR FREE,3307.0,0.0,3307.0,0.0,3307.0,1.0,267.0
TCGA-AO-A128-01,TCGA-AO-A128,BRCA,61.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2002.0,-22340.0,Alive,TUMOR FREE,3248.0,0.0,3248.0,0.0,3248.0,0.0,3248.0
TCGA-AO-A129-01,TCGA-AO-A129,BRCA,29.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2002.0,-10898.0,Alive,TUMOR FREE,3286.0,0.0,3286.0,0.0,3286.0,0.0,3286.0
TCGA-AO-A12A-01,TCGA-AO-A12A,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2003.0,-17420.0,Alive,TUMOR FREE,3112.0,0.0,3112.0,0.0,3112.0,0.0,3112.0
TCGA-AO-A12B-01,TCGA-AO-A12B,BRCA,63.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2004.0,-23150.0,Alive,TUMOR FREE,2989.0,0.0,2989.0,0.0,2989.0,0.0,2989.0
TCGA-AO-A12D-01,TCGA-AO-A12D,BRCA,43.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2005.0,-15774.0,Alive,TUMOR FREE,2515.0,0.0,2515.0,0.0,2515.0,0.0,2515.0
TCGA-AO-A12E-01,TCGA-AO-A12E,BRCA,51.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2005.0,-18721.0,Alive,TUMOR FREE,2142.0,0.0,2142.0,0.0,2142.0,0.0,2142.0
TCGA-AO-A12F-01,TCGA-AO-A12F,BRCA,36.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-13409.0,Alive,TUMOR FREE,1842.0,0.0,1842.0,0.0,1842.0,0.0,1842.0
TCGA-AO-A12G-01,TCGA-AO-A12G,BRCA,75.0,FEMALE,WHITE,Stage IIA,"Other, specify",2006.0,-27705.0,Alive,TUMOR FREE,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0
TCGA-AO-A12H-01,TCGA-AO-A12H,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,"Other, specify",2008.0,-25515.0,Alive,TUMOR FREE,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0
TCGA-AO-A1KO-01,TCGA-AO-A1KO,BRCA,46.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2008.0,-16817.0,Alive,TUMOR FREE,622.0,0.0,622.0,0.0,622.0,0.0,622.0
TCGA-AO-A1KR-01,TCGA-AO-A1KR,BRCA,51.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2005.0,-18900.0,Alive,TUMOR FREE,2513.0,0.0,2513.0,0.0,2513.0,0.0,2513.0
TCGA-AO-A1KT-01,TCGA-AO-A1KT,BRCA,78.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-28660.0,Alive,TUMOR FREE,541.0,0.0,541.0,0.0,541.0,0.0,541.0
TCGA-AQ-A1H2-01,TCGA-AQ-A1H2,BRCA,84.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-30958.0,Alive,TUMOR FREE,475.0,0.0,475.0,0.0,475.0,0.0,475.0
TCGA-AQ-A54O-01,TCGA-AQ-A54O,BRCA,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-18694.0,Alive,TUMOR FREE,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0
TCGA-AQ-A7U7-01,TCGA-AQ-A7U7,BRCA,55.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2013.0,-20239.0,Dead,TUMOR FREE,,1.0,584.0,0.0,584.0,0.0,584.0
TCGA-AR-A0TP-01,TCGA-AR-A0TP,BRCA,43.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2003.0,-15812.0,Alive,TUMOR FREE,4275.0,0.0,4275.0,0.0,4275.0,0.0,4275.0
TCGA-AR-A0TQ-01,TCGA-AR-A0TQ,BRCA,27.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-9873.0,Alive,TUMOR FREE,2991.0,0.0,2991.0,0.0,2991.0,0.0,2991.0
TCGA-AR-A0TR-01,TCGA-AR-A0TR,BRCA,68.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-25190.0,Dead,,,1.0,160.0,,160.0,0.0,160.0
TCGA-AR-A0TS-01,TCGA-AR-A0TS,BRCA,46.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-17141.0,Alive,TUMOR FREE,2558.0,0.0,2558.0,0.0,2558.0,0.0,2558.0
TCGA-AR-A0TT-01,TCGA-AR-A0TT,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-19679.0,Alive,TUMOR FREE,3316.0,0.0,3316.0,0.0,3316.0,0.0,3316.0
TCGA-AR-A0TU-01,TCGA-AR-A0TU,BRCA,35.0,FEMALE,,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-13039.0,Alive,TUMOR FREE,709.0,0.0,709.0,0.0,709.0,0.0,709.0
TCGA-AR-A0TV-01,TCGA-AR-A0TV,BRCA,66.0,FEMALE,,Stage IIA,Infiltrating Ductal Carcinoma,2005.0,-24279.0,Alive,TUMOR FREE,2288.0,0.0,2288.0,0.0,2288.0,0.0,2288.0
TCGA-AR-A0TW-01,TCGA-AR-A0TW,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2005.0,-18263.0,Alive,TUMOR FREE,3009.0,0.0,3009.0,0.0,3009.0,1.0,739.0
TCGA-AR-A0TX-01,TCGA-AR-A0TX,BRCA,64.0,FEMALE,,Stage IIA,Infiltrating Ductal Carcinoma,2005.0,-23653.0,Alive,TUMOR FREE,1972.0,0.0,1972.0,0.0,1972.0,0.0,1972.0
TCGA-AR-A0TZ-01,TCGA-AR-A0TZ,BRCA,43.0,FEMALE,WHITE,[Discrepancy],Infiltrating Ductal Carcinoma,2004.0,-15720.0,Dead,,,1.0,3262.0,,3262.0,1.0,1313.0
TCGA-AR-A0U0-01,TCGA-AR-A0U0,BRCA,73.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2004.0,-26993.0,Alive,TUMOR FREE,1988.0,0.0,1988.0,0.0,1988.0,0.0,1988.0
TCGA-AR-A0U2-01,TCGA-AR-A0U2,BRCA,47.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2004.0,-17390.0,Dead,WITH TUMOR,,1.0,2551.0,1.0,2551.0,1.0,1609.0
TCGA-AR-A0U3-01,TCGA-AR-A0U3,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2004.0,-21755.0,Alive,TUMOR FREE,4080.0,0.0,4080.0,0.0,4080.0,0.0,4080.0
TCGA-AR-A0U4-01,TCGA-AR-A0U4,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-19729.0,Alive,TUMOR FREE,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0
TCGA-AR-A1AH-01,TCGA-AR-A1AH,BRCA,51.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2004.0,-18991.0,Alive,TUMOR FREE,3807.0,0.0,3807.0,0.0,3807.0,1.0,1136.0
TCGA-AR-A1AI-01,TCGA-AR-A1AI,BRCA,47.0,FEMALE,WHITE,Stage IIA,Medullary Carcinoma,2005.0,-17229.0,Alive,TUMOR FREE,3296.0,0.0,3296.0,0.0,3296.0,1.0,588.0
TCGA-AR-A1AJ-01,TCGA-AR-A1AJ,BRCA,83.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2005.0,-30489.0,Alive,TUMOR FREE,3072.0,0.0,3072.0,0.0,3072.0,0.0,3072.0
TCGA-AR-A1AK-01,TCGA-AR-A1AK,BRCA,70.0,FEMALE,WHITE,Stage I,Infiltrating Lobular Carcinoma,2006.0,-25825.0,Alive,TUMOR FREE,3159.0,0.0,3159.0,0.0,3159.0,0.0,3159.0
TCGA-AR-A1AL-01,TCGA-AR-A1AL,BRCA,60.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2006.0,-22023.0,Alive,TUMOR FREE,2971.0,0.0,2971.0,0.0,2971.0,0.0,2971.0
TCGA-AR-A1AO-01,TCGA-AR-A1AO,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-17332.0,Alive,TUMOR FREE,2618.0,0.0,2618.0,0.0,2618.0,0.0,2618.0
TCGA-AR-A1AP-01,TCGA-AR-A1AP,BRCA,80.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-29406.0,Alive,TUMOR FREE,2856.0,0.0,2856.0,0.0,2856.0,0.0,2856.0
TCGA-AR-A1AQ-01,TCGA-AR-A1AQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-18109.0,Alive,TUMOR FREE,3021.0,0.0,3021.0,0.0,3021.0,0.0,3021.0
TCGA-AR-A1AS-01,TCGA-AR-A1AS,BRCA,54.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-20028.0,Alive,TUMOR FREE,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0
TCGA-AR-A1AT-01,TCGA-AR-A1AT,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2007.0,-22942.0,Dead,,,1.0,1272.0,,1272.0,0.0,1272.0
TCGA-AR-A1AU-01,TCGA-AR-A1AU,BRCA,39.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-14564.0,Alive,TUMOR FREE,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0
TCGA-AR-A1AV-01,TCGA-AR-A1AV,BRCA,68.0,MALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-24875.0,Alive,TUMOR FREE,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0
TCGA-AR-A1AW-01,TCGA-AR-A1AW,BRCA,65.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-23855.0,Alive,TUMOR FREE,2632.0,0.0,2632.0,0.0,2632.0,0.0,2632.0
TCGA-AR-A1AX-01,TCGA-AR-A1AX,BRCA,64.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-23507.0,Alive,TUMOR FREE,2629.0,0.0,2629.0,0.0,2629.0,0.0,2629.0
TCGA-AR-A1AY-01,TCGA-AR-A1AY,BRCA,65.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2008.0,-23927.0,Alive,TUMOR FREE,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0
TCGA-AR-A24K-01,TCGA-AR-A24K,BRCA,46.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2004.0,-16961.0,Alive,TUMOR FREE,1548.0,0.0,1548.0,0.0,1548.0,0.0,1548.0
TCGA-AR-A24L-01,TCGA-AR-A24L,BRCA,26.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2005.0,-9706.0,Dead,WITH TUMOR,,1.0,2866.0,1.0,2866.0,1.0,1414.0
TCGA-AR-A24M-01,TCGA-AR-A24M,BRCA,38.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),2005.0,-14119.0,Alive,TUMOR FREE,3660.0,0.0,3660.0,0.0,3660.0,0.0,3660.0
TCGA-AR-A24N-01,TCGA-AR-A24N,BRCA,54.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2005.0,-19989.0,Alive,TUMOR FREE,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0
TCGA-AR-A24O-01,TCGA-AR-A24O,BRCA,43.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),2005.0,-15977.0,Alive,WITH TUMOR,3607.0,0.0,3607.0,0.0,3607.0,1.0,2561.0
TCGA-AR-A24P-01,TCGA-AR-A24P,BRCA,47.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2005.0,-17490.0,Alive,,84.0,0.0,84.0,0.0,84.0,0.0,84.0
TCGA-AR-A24Q-01,TCGA-AR-A24Q,BRCA,49.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-18084.0,Alive,TUMOR FREE,3172.0,0.0,3172.0,0.0,3172.0,0.0,3172.0
TCGA-AR-A24R-01,TCGA-AR-A24R,BRCA,45.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-16642.0,Alive,TUMOR FREE,3430.0,0.0,3430.0,0.0,3430.0,0.0,3430.0
TCGA-AR-A24S-01,TCGA-AR-A24S,BRCA,61.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2006.0,-22587.0,Alive,,2976.0,0.0,2976.0,0.0,2976.0,0.0,2976.0
TCGA-AR-A24T-01,TCGA-AR-A24T,BRCA,46.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2006.0,-17135.0,Alive,TUMOR FREE,3202.0,0.0,3202.0,0.0,3202.0,0.0,3202.0
TCGA-AR-A24U-01,TCGA-AR-A24U,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-17523.0,Alive,TUMOR FREE,3128.0,0.0,3128.0,0.0,3128.0,0.0,3128.0
TCGA-AR-A24V-01,TCGA-AR-A24V,BRCA,52.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-19027.0,Alive,TUMOR FREE,3203.0,0.0,3203.0,0.0,3203.0,0.0,3203.0
TCGA-AR-A24W-01,TCGA-AR-A24W,BRCA,55.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-20123.0,Alive,TUMOR FREE,1550.0,0.0,1550.0,0.0,1550.0,0.0,1550.0
TCGA-AR-A24X-01,TCGA-AR-A24X,BRCA,52.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),2006.0,-19030.0,Alive,TUMOR FREE,3004.0,0.0,3004.0,0.0,3004.0,0.0,3004.0
TCGA-AR-A24Z-01,TCGA-AR-A24Z,BRCA,57.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-20900.0,Alive,TUMOR FREE,3001.0,0.0,3001.0,0.0,3001.0,0.0,3001.0
TCGA-AR-A250-01,TCGA-AR-A250,BRCA,58.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-21309.0,Alive,TUMOR FREE,2707.0,0.0,2707.0,0.0,2707.0,0.0,2707.0
TCGA-AR-A251-01,TCGA-AR-A251,BRCA,51.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2006.0,-18771.0,Alive,TUMOR FREE,3030.0,0.0,3030.0,0.0,3030.0,0.0,3030.0
TCGA-AR-A252-01,TCGA-AR-A252,BRCA,50.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-18611.0,Alive,TUMOR FREE,2838.0,0.0,2838.0,0.0,2838.0,0.0,2838.0
TCGA-AR-A254-01,TCGA-AR-A254,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-18270.0,Alive,TUMOR FREE,2605.0,0.0,2605.0,0.0,2605.0,0.0,2605.0
TCGA-AR-A256-01,TCGA-AR-A256,BRCA,45.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2001.0,-16642.0,Dead,,,1.0,2854.0,,2854.0,1.0,1640.0
TCGA-AR-A2LE-01,TCGA-AR-A2LE,BRCA,69.0,FEMALE,WHITE,Stage I,Infiltrating Lobular Carcinoma,2001.0,-25499.0,Alive,TUMOR FREE,5062.0,0.0,5062.0,0.0,5062.0,1.0,4203.0
TCGA-AR-A2LH-01,TCGA-AR-A2LH,BRCA,55.0,FEMALE,WHITE,Stage III,Infiltrating Lobular Carcinoma,2007.0,-20288.0,Dead,,,1.0,616.0,,616.0,1.0,434.0
TCGA-AR-A2LK-01,TCGA-AR-A2LK,BRCA,62.0,FEMALE,WHITE,Stage III,Infiltrating Lobular Carcinoma,2007.0,-22800.0,Dead,,,1.0,1649.0,,1649.0,1.0,1304.0
TCGA-AR-A2LM-01,TCGA-AR-A2LM,BRCA,49.0,FEMALE,WHITE,Stage II,Infiltrating Lobular Carcinoma,2007.0,-18053.0,Alive,TUMOR FREE,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0
TCGA-AR-A2LN-01,TCGA-AR-A2LN,BRCA,65.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-23992.0,Alive,TUMOR FREE,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0
TCGA-AR-A2LO-01,TCGA-AR-A2LO,BRCA,46.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-17080.0,Alive,TUMOR FREE,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0
TCGA-AR-A2LQ-01,TCGA-AR-A2LQ,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-21865.0,Alive,TUMOR FREE,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0
TCGA-AR-A5QM-01,TCGA-AR-A5QM,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2008.0,-22780.0,Alive,TUMOR FREE,2231.0,0.0,2231.0,0.0,2231.0,1.0,968.0
TCGA-AR-A5QN-01,TCGA-AR-A5QN,BRCA,68.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2012.0,-25089.0,Alive,TUMOR FREE,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0
TCGA-AR-A5QP-01,TCGA-AR-A5QP,BRCA,54.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-19805.0,Alive,TUMOR FREE,1185.0,0.0,1185.0,0.0,1185.0,0.0,1185.0
TCGA-AR-A5QQ-01,TCGA-AR-A5QQ,BRCA,68.0,FEMALE,WHITE,Stage IIIA,"Other, specify",2011.0,-24841.0,Dead,WITH TUMOR,,1.0,322.0,1.0,322.0,1.0,301.0
TCGA-AU-6004-01,TCGA-AU-6004,COAD,69.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-25259.0,Alive,TUMOR FREE,824.0,0.0,824.0,0.0,824.0,0.0,824.0
TCGA-AX-A2HH-01,TCGA-AX-A2HH,UCEC,60.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-21924.0,Alive,WITH TUMOR,540.0,0.0,540.0,0.0,540.0,0.0,540.0
TCGA-AX-A3FS-01,TCGA-AX-A3FS,UCEC,82.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-30102.0,Alive,,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-AX-A3FT-01,TCGA-AX-A3FT,UCEC,64.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-23543.0,Alive,,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-AX-A3FV-01,TCGA-AX-A3FV,UCEC,62.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-22752.0,Alive,,-6.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-AX-A3FW-01,TCGA-AX-A3FW,UCEC,66.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-24419.0,Alive,,17.0,0.0,17.0,0.0,17.0,0.0,17.0
TCGA-AX-A3FX-01,TCGA-AX-A3FX,UCEC,69.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-25260.0,Dead,,,1.0,1333.0,,1333.0,1.0,938.0
TCGA-AX-A3FZ-01,TCGA-AX-A3FZ,UCEC,33.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-12331.0,Alive,,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-AX-A3G4-01,TCGA-AX-A3G4,UCEC,60.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,,Serous endometrial adenocarcinoma,2010.0,-22099.0,Alive,,9.0,0.0,9.0,0.0,9.0,0.0,9.0
TCGA-AX-A3G8-01,TCGA-AX-A3G8,UCEC,76.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-27899.0,Alive,,36.0,0.0,36.0,0.0,36.0,0.0,36.0
TCGA-AX-A3G9-01,TCGA-AX-A3G9,UCEC,63.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-23361.0,Alive,,558.0,0.0,558.0,0.0,558.0,0.0,558.0
TCGA-AX-A3GI-01,TCGA-AX-A3GI,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Serous endometrial adenocarcinoma,2011.0,-24388.0,Alive,,12.0,0.0,12.0,0.0,12.0,0.0,12.0
TCGA-AY-5543-01,TCGA-AY-5543,COAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Colon Adenocarcinoma,2010.0,-23870.0,Alive,TUMOR FREE,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0
TCGA-AY-6196-01,TCGA-AY-6196,COAD,47.0,MALE,WHITE,Stage IIIC,Colon Mucinous Adenocarcinoma,2010.0,-17311.0,Alive,TUMOR FREE,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-AY-6197-01,TCGA-AY-6197,COAD,60.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-21957.0,Alive,TUMOR FREE,652.0,0.0,652.0,0.0,652.0,0.0,652.0
TCGA-AY-6386-01,TCGA-AY-6386,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2010.0,-24453.0,Alive,TUMOR FREE,542.0,0.0,542.0,0.0,542.0,0.0,542.0
TCGA-AY-A54L-01,TCGA-AY-A54L,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Colon Adenocarcinoma,2012.0,-27074.0,Alive,WITH TUMOR,525.0,0.0,525.0,0.0,525.0,1.0,396.0
TCGA-AY-A69D-01,TCGA-AY-A69D,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2012.0,-20299.0,Alive,TUMOR FREE,543.0,0.0,543.0,0.0,543.0,0.0,543.0
TCGA-AY-A71X-01,TCGA-AY-A71X,COAD,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Colon Adenocarcinoma,2013.0,-19904.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-AY-A8YK-01,TCGA-AY-A8YK,COAD,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Colon Adenocarcinoma,2013.0,-16140.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-AZ-4315-01,TCGA-AZ-4315,COAD,61.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2006.0,-22340.0,Alive,TUMOR FREE,1776.0,0.0,1776.0,0.0,1776.0,0.0,1776.0
TCGA-AZ-4323-01,TCGA-AZ-4323,COAD,37.0,MALE,WHITE,Stage IV,Colon Adenocarcinoma,2002.0,-13755.0,Dead,WITH TUMOR,,1.0,43.0,1.0,43.0,1.0,43.0
TCGA-AZ-4614-01,TCGA-AZ-4614,COAD,71.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2008.0,-26267.0,Dead,WITH TUMOR,,1.0,172.0,1.0,172.0,1.0,172.0
TCGA-AZ-4615-01,TCGA-AZ-4615,COAD,84.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2009.0,-30908.0,Alive,WITH TUMOR,1002.0,0.0,1002.0,0.0,1002.0,1.0,688.0
TCGA-AZ-4682-01,TCGA-AZ-4682,COAD,61.0,MALE,WHITE,Stage IVA,Colon Adenocarcinoma,2006.0,-22409.0,Dead,WITH TUMOR,,1.0,680.0,1.0,680.0,1.0,680.0
TCGA-AZ-5407-01,TCGA-AZ-5407,COAD,51.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2007.0,-18820.0,Alive,TUMOR FREE,2683.0,0.0,2683.0,0.0,2683.0,0.0,2683.0
TCGA-AZ-6598-01,TCGA-AZ-6598,COAD,77.0,FEMALE,WHITE,Stage II,Colon Adenocarcinoma,2000.0,-28182.0,Dead,TUMOR FREE,,1.0,1503.0,0.0,1503.0,0.0,1503.0
TCGA-AZ-6599-01,TCGA-AZ-6599,COAD,72.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2001.0,-26438.0,Dead,TUMOR FREE,,1.0,206.0,0.0,206.0,0.0,206.0
TCGA-AZ-6600-01,TCGA-AZ-6600,COAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Colon Adenocarcinoma,2001.0,-23581.0,Dead,WITH TUMOR,,1.0,368.0,1.0,368.0,1.0,368.0
TCGA-AZ-6603-01,TCGA-AZ-6603,COAD,77.0,FEMALE,WHITE,,Colon Adenocarcinoma,2002.0,-28424.0,Dead,TUMOR FREE,,1.0,899.0,0.0,899.0,0.0,899.0
TCGA-AZ-6605-01,TCGA-AZ-6605,COAD,77.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2008.0,-28485.0,Dead,TUMOR FREE,,1.0,159.0,0.0,159.0,0.0,159.0
TCGA-AZ-6606-01,TCGA-AZ-6606,COAD,81.0,MALE,WHITE,Stage IV,Colon Adenocarcinoma,2009.0,-29704.0,Dead,WITH TUMOR,,1.0,357.0,1.0,357.0,1.0,357.0
TCGA-B0-4700-01,TCGA-B0-4700,KIRC,60.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-22034.0,Dead,WITH TUMOR,,1.0,1980.0,1.0,1980.0,1.0,1980.0
TCGA-B0-4706-01,TCGA-B0-4706,KIRC,61.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-22331.0,Dead,TUMOR FREE,26.0,1.0,65.0,0.0,65.0,0.0,65.0
TCGA-B0-4710-01,TCGA-B0-4710,KIRC,75.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-27396.0,Alive,TUMOR FREE,1755.0,0.0,1755.0,0.0,1755.0,0.0,1755.0
TCGA-B0-4712-01,TCGA-B0-4712,KIRC,76.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-28095.0,Dead,WITH TUMOR,,1.0,1337.0,1.0,1337.0,1.0,1337.0
TCGA-B0-4810-01,TCGA-B0-4810,KIRC,47.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2001.0,-17402.0,Dead,WITH TUMOR,,1.0,478.0,1.0,478.0,1.0,205.0
TCGA-B0-4811-01,TCGA-B0-4811,KIRC,48.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2001.0,-17792.0,Dead,WITH TUMOR,,1.0,1417.0,1.0,1417.0,1.0,458.0
TCGA-B0-4815-01,TCGA-B0-4815,KIRC,65.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2001.0,-23873.0,Dead,WITH TUMOR,,1.0,1588.0,1.0,1588.0,1.0,1588.0
TCGA-B0-4816-01,TCGA-B0-4816,KIRC,49.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2002.0,-18133.0,Dead,WITH TUMOR,,1.0,1371.0,1.0,1371.0,1.0,1371.0
TCGA-B0-4818-01,TCGA-B0-4818,KIRC,68.0,FEMALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2002.0,-24853.0,Dead,WITH TUMOR,,1.0,510.0,1.0,510.0,1.0,127.0
TCGA-B0-4823-01,TCGA-B0-4823,KIRC,88.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-32290.0,Dead,TUMOR FREE,,1.0,454.0,0.0,454.0,0.0,454.0
TCGA-B0-4827-01,TCGA-B0-4827,KIRC,77.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2002.0,-28467.0,Dead,WITH TUMOR,,1.0,885.0,1.0,885.0,1.0,668.0
TCGA-B0-4842-01,TCGA-B0-4842,KIRC,73.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2004.0,-27019.0,Dead,WITH TUMOR,,1.0,1724.0,1.0,1724.0,1.0,250.0
TCGA-B0-4852-01,TCGA-B0-4852,KIRC,78.0,FEMALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2004.0,-28552.0,Dead,WITH TUMOR,,1.0,1121.0,1.0,1121.0,1.0,860.0
TCGA-B0-4945-01,TCGA-B0-4945,KIRC,75.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-27523.0,Dead,TUMOR FREE,,1.0,2145.0,0.0,2145.0,0.0,2145.0
TCGA-B0-5075-01,TCGA-B0-5075,KIRC,77.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-28205.0,Dead,TUMOR FREE,,1.0,637.0,0.0,637.0,0.0,637.0
TCGA-B0-5077-01,TCGA-B0-5077,KIRC,77.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-28405.0,Dead,TUMOR FREE,,1.0,1317.0,0.0,1317.0,0.0,1317.0
TCGA-B0-5080-01,TCGA-B0-5080,KIRC,63.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2005.0,-23052.0,Dead,WITH TUMOR,,1.0,342.0,1.0,342.0,1.0,103.0
TCGA-B0-5081-01,TCGA-B0-5081,KIRC,79.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-29219.0,Dead,WITH TUMOR,,1.0,362.0,1.0,362.0,1.0,213.0
TCGA-B0-5085-01,TCGA-B0-5085,KIRC,76.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-27793.0,Dead,TUMOR FREE,,1.0,770.0,0.0,770.0,0.0,770.0
TCGA-B0-5088-01,TCGA-B0-5088,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-19677.0,Dead,TUMOR FREE,,1.0,563.0,0.0,563.0,0.0,563.0
TCGA-B0-5092-01,TCGA-B0-5092,KIRC,53.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2008.0,-19611.0,Dead,WITH TUMOR,,1.0,459.0,1.0,459.0,1.0,459.0
TCGA-B0-5094-01,TCGA-B0-5094,KIRC,62.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2008.0,-22965.0,Dead,WITH TUMOR,,1.0,333.0,1.0,333.0,1.0,75.0
TCGA-B0-5095-01,TCGA-B0-5095,KIRC,81.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2008.0,-29921.0,Dead,TUMOR FREE,,1.0,245.0,0.0,245.0,0.0,245.0
TCGA-B0-5096-01,TCGA-B0-5096,KIRC,72.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,1998.0,-26574.0,Dead,TUMOR FREE,,1.0,68.0,0.0,68.0,0.0,68.0
TCGA-B0-5097-01,TCGA-B0-5097,KIRC,59.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-21852.0,Alive,WITH TUMOR,665.0,0.0,665.0,0.0,665.0,1.0,359.0
TCGA-B0-5099-01,TCGA-B0-5099,KIRC,88.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2002.0,-32364.0,Dead,[Discrepancy],,1.0,485.0,,485.0,0.0,485.0
TCGA-B0-5100-01,TCGA-B0-5100,KIRC,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Clear Cell Renal Carcinoma,1998.0,-26478.0,Dead,WITH TUMOR,,1.0,1913.0,1.0,1913.0,1.0,1426.0
TCGA-B0-5102-01,TCGA-B0-5102,KIRC,74.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,1999.0,-27152.0,Dead,[Discrepancy],,1.0,2764.0,,2764.0,1.0,2734.0
TCGA-B0-5104-01,TCGA-B0-5104,KIRC,90.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-32873.0,Dead,TUMOR FREE,,1.0,2752.0,0.0,2752.0,0.0,2752.0
TCGA-B0-5106-01,TCGA-B0-5106,KIRC,64.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-23547.0,Dead,TUMOR FREE,,1.0,1598.0,0.0,1598.0,0.0,1598.0
TCGA-B0-5107-01,TCGA-B0-5107,KIRC,65.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2007.0,-23929.0,Dead,WITH TUMOR,,1.0,927.0,1.0,927.0,1.0,549.0
TCGA-B0-5108-01,TCGA-B0-5108,KIRC,54.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2009.0,-19932.0,Alive,TUMOR FREE,1782.0,0.0,1782.0,0.0,1782.0,0.0,1782.0
TCGA-B0-5109-01,TCGA-B0-5109,KIRC,69.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2009.0,-25428.0,Dead,WITH TUMOR,,1.0,587.0,1.0,587.0,1.0,70.0
TCGA-B0-5110-01,TCGA-B0-5110,KIRC,71.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2009.0,-25976.0,Alive,TUMOR FREE,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0
TCGA-B0-5113-01,TCGA-B0-5113,KIRC,69.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-25369.0,Alive,TUMOR FREE,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0
TCGA-B0-5115-01,TCGA-B0-5115,KIRC,43.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2009.0,-15935.0,Alive,WITH TUMOR,1604.0,0.0,1604.0,0.0,1604.0,1.0,75.0
TCGA-B0-5116-01,TCGA-B0-5116,KIRC,52.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-19352.0,Alive,WITH TUMOR,1274.0,0.0,1274.0,0.0,1274.0,1.0,1129.0
TCGA-B0-5119-01,TCGA-B0-5119,KIRC,61.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-22607.0,Alive,TUMOR FREE,1552.0,0.0,1552.0,0.0,1552.0,0.0,1552.0
TCGA-B0-5120-01,TCGA-B0-5120,KIRC,72.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-26559.0,Alive,TUMOR FREE,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0
TCGA-B0-5121-01,TCGA-B0-5121,KIRC,56.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-20635.0,Alive,TUMOR FREE,1485.0,0.0,1485.0,0.0,1485.0,0.0,1485.0
TCGA-B0-5399-01,TCGA-B0-5399,KIRC,46.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-17145.0,Alive,TUMOR FREE,1411.0,0.0,1411.0,0.0,1411.0,0.0,1411.0
TCGA-B0-5400-01,TCGA-B0-5400,KIRC,59.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2008.0,-21819.0,Alive,TUMOR FREE,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0
TCGA-B0-5402-01,TCGA-B0-5402,KIRC,64.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2010.0,-23477.0,Alive,WITH TUMOR,1290.0,0.0,1290.0,0.0,1290.0,1.0,444.0
TCGA-B0-5690-01,TCGA-B0-5690,KIRC,53.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-19685.0,Alive,WITH TUMOR,3392.0,0.0,3392.0,0.0,3392.0,0.0,3392.0
TCGA-B0-5691-01,TCGA-B0-5691,KIRC,66.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-24120.0,Alive,WITH TUMOR,3431.0,0.0,3431.0,0.0,3431.0,1.0,3250.0
TCGA-B0-5692-01,TCGA-B0-5692,KIRC,66.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2004.0,-24140.0,Alive,TUMOR FREE,3944.0,0.0,3944.0,0.0,3944.0,0.0,3944.0
TCGA-B0-5693-01,TCGA-B0-5693,KIRC,47.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-17177.0,Alive,TUMOR FREE,4074.0,0.0,4074.0,0.0,4074.0,0.0,4074.0
TCGA-B0-5694-01,TCGA-B0-5694,KIRC,71.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2008.0,-26060.0,Dead,WITH TUMOR,,1.0,480.0,1.0,480.0,1.0,288.0
TCGA-B0-5695-01,TCGA-B0-5695,KIRC,61.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-22320.0,Alive,TUMOR FREE,2150.0,0.0,2150.0,0.0,2150.0,0.0,2150.0
TCGA-B0-5696-01,TCGA-B0-5696,KIRC,69.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-25552.0,Alive,WITH TUMOR,2609.0,0.0,2609.0,0.0,2609.0,1.0,1717.0
TCGA-B0-5697-01,TCGA-B0-5697,KIRC,50.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-18486.0,Alive,TUMOR FREE,2630.0,0.0,2630.0,0.0,2630.0,0.0,2630.0
TCGA-B0-5698-01,TCGA-B0-5698,KIRC,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-28438.0,Alive,TUMOR FREE,3631.0,0.0,3631.0,0.0,3631.0,0.0,3631.0
TCGA-B0-5699-01,TCGA-B0-5699,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-19647.0,Alive,TUMOR FREE,3841.0,0.0,3841.0,0.0,3841.0,1.0,94.0
TCGA-B0-5700-01,TCGA-B0-5700,KIRC,77.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2009.0,-28184.0,Alive,TUMOR FREE,1790.0,0.0,1790.0,0.0,1790.0,0.0,1790.0
TCGA-B0-5701-01,TCGA-B0-5701,KIRC,65.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-23915.0,Alive,TUMOR FREE,2461.0,0.0,2461.0,0.0,2461.0,1.0,224.0
TCGA-B0-5702-01,TCGA-B0-5702,KIRC,71.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-26186.0,Alive,TUMOR FREE,2172.0,0.0,2172.0,0.0,2172.0,0.0,2172.0
TCGA-B0-5703-01,TCGA-B0-5703,KIRC,73.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2009.0,-26897.0,Alive,TUMOR FREE,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0
TCGA-B0-5705-01,TCGA-B0-5705,KIRC,65.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-23746.0,Alive,TUMOR FREE,4537.0,0.0,4537.0,0.0,4537.0,1.0,842.0
TCGA-B0-5706-01,TCGA-B0-5706,KIRC,45.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2004.0,-16442.0,Alive,TUMOR FREE,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0
TCGA-B0-5707-01,TCGA-B0-5707,KIRC,39.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-14598.0,Alive,TUMOR FREE,3744.0,0.0,3744.0,0.0,3744.0,0.0,3744.0
TCGA-B0-5709-01,TCGA-B0-5709,KIRC,62.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2003.0,-22843.0,Alive,TUMOR FREE,3974.0,0.0,3974.0,0.0,3974.0,0.0,3974.0
TCGA-B0-5710-01,TCGA-B0-5710,KIRC,57.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2008.0,-21168.0,Alive,WITH TUMOR,2430.0,0.0,2430.0,0.0,2430.0,1.0,1441.0
TCGA-B0-5711-01,TCGA-B0-5711,KIRC,50.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2004.0,-18444.0,Alive,WITH TUMOR,3989.0,0.0,3989.0,0.0,3989.0,1.0,3766.0
TCGA-B0-5713-01,TCGA-B0-5713,KIRC,75.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-27644.0,Alive,TUMOR FREE,2782.0,0.0,2782.0,0.0,2782.0,0.0,2782.0
TCGA-B0-5812-01,TCGA-B0-5812,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-19600.0,Alive,TUMOR FREE,3834.0,0.0,3834.0,0.0,3834.0,0.0,3834.0
TCGA-B1-5398-01,TCGA-B1-5398,KIRP,73.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2010.0,-26820.0,Alive,TUMOR FREE,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0
TCGA-B1-7332-01,TCGA-B1-7332,KIRP,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Papillary Renal Cell Carcinoma,2011.0,-22277.0,Alive,TUMOR FREE,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0
TCGA-B1-A47M-01,TCGA-B1-A47M,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-29068.0,Alive,WITH TUMOR,659.0,0.0,659.0,0.0,659.0,1.0,408.0
TCGA-B1-A47N-01,TCGA-B1-A47N,KIRP,62.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-22800.0,Alive,TUMOR FREE,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0
TCGA-B1-A654-01,TCGA-B1-A654,KIRP,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-15721.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-B1-A657-01,TCGA-B1-A657,KIRP,54.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-19806.0,Alive,TUMOR FREE,641.0,0.0,641.0,0.0,641.0,0.0,641.0
TCGA-B2-4098-01,TCGA-B2-4098,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-26606.0,Dead,TUMOR FREE,,1.0,51.0,0.0,51.0,0.0,51.0
TCGA-B2-4099-01,TCGA-B2-4099,KIRC,83.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-30355.0,Alive,TUMOR FREE,972.0,0.0,972.0,0.0,972.0,0.0,972.0
TCGA-B2-4101-01,TCGA-B2-4101,KIRC,52.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2010.0,-19059.0,Alive,TUMOR FREE,648.0,0.0,648.0,0.0,648.0,0.0,648.0
TCGA-B2-4102-01,TCGA-B2-4102,KIRC,61.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-22492.0,Alive,TUMOR FREE,952.0,0.0,952.0,0.0,952.0,0.0,952.0
TCGA-B2-5633-01,TCGA-B2-5633,KIRC,56.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-20493.0,Alive,TUMOR FREE,963.0,0.0,963.0,0.0,963.0,0.0,963.0
TCGA-B2-5635-01,TCGA-B2-5635,KIRC,74.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-27183.0,Alive,TUMOR FREE,755.0,0.0,755.0,0.0,755.0,0.0,755.0
TCGA-B2-5636-01,TCGA-B2-5636,KIRC,79.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-28901.0,Alive,TUMOR FREE,919.0,0.0,919.0,0.0,919.0,0.0,919.0
TCGA-B2-5641-01,TCGA-B2-5641,KIRC,79.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-28953.0,Alive,TUMOR FREE,656.0,0.0,656.0,0.0,656.0,0.0,656.0
TCGA-B3-8121-01,TCGA-B3-8121,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-17760.0,Alive,TUMOR FREE,379.0,0.0,379.0,0.0,379.0,0.0,379.0
TCGA-B4-5377-01,TCGA-B4-5377,KIRC,68.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2010.0,-25115.0,Alive,TUMOR FREE,365.0,0.0,365.0,0.0,365.0,0.0,365.0
TCGA-B5-A0JN-01,TCGA-B5-A0JN,UCEC,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Serous endometrial adenocarcinoma,2004.0,-30933.0,Alive,TUMOR FREE,2445.0,0.0,2445.0,0.0,2445.0,0.0,2445.0
TCGA-B5-A0K9-01,TCGA-B5-A0K9,UCEC,88.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-32289.0,Dead,TUMOR FREE,,1.0,409.0,0.0,409.0,0.0,409.0
TCGA-B5-A1MS-01,TCGA-B5-A1MS,UCEC,60.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2003.0,-22068.0,Dead,WITH TUMOR,,1.0,3112.0,1.0,3112.0,1.0,2706.0
TCGA-B5-A1MW-01,TCGA-B5-A1MW,UCEC,55.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-20183.0,Alive,TUMOR FREE,447.0,0.0,447.0,0.0,447.0,1.0,311.0
TCGA-B5-A3FA-01,TCGA-B5-A3FA,UCEC,73.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2004.0,-26850.0,Alive,TUMOR FREE,2929.0,0.0,2929.0,0.0,2929.0,0.0,2929.0
TCGA-B5-A3FB-01,TCGA-B5-A3FB,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2006.0,-26779.0,Alive,TUMOR FREE,2844.0,0.0,2844.0,0.0,2844.0,0.0,2844.0
TCGA-B5-A3FC-01,TCGA-B5-A3FC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2006.0,-19422.0,Alive,TUMOR FREE,2185.0,0.0,2185.0,0.0,2185.0,0.0,2185.0
TCGA-B5-A3FD-01,TCGA-B5-A3FD,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2009.0,-25813.0,Dead,TUMOR FREE,,1.0,1197.0,0.0,1197.0,1.0,562.0
TCGA-B5-A3FH-01,TCGA-B5-A3FH,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2011.0,-27221.0,Alive,TUMOR FREE,841.0,0.0,841.0,0.0,841.0,0.0,841.0
TCGA-B5-A3S1-01,TCGA-B5-A3S1,UCEC,71.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-26031.0,Alive,WITH TUMOR,902.0,0.0,902.0,0.0,902.0,0.0,902.0
TCGA-B6-A0RH-01,TCGA-B6-A0RH,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,1991.0,-18759.0,Dead,TUMOR FREE,,1.0,6456.0,0.0,6456.0,1.0,2165.0
TCGA-B6-A0RL-01,TCGA-B6-A0RL,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,1993.0,-22238.0,Dead,TUMOR FREE,,1.0,2469.0,0.0,2469.0,0.0,2469.0
TCGA-B6-A0RM-01,TCGA-B6-A0RM,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,Infiltrating Ductal Carcinoma,1993.0,-21047.0,Dead,TUMOR FREE,,1.0,2373.0,0.0,2373.0,0.0,2373.0
TCGA-B6-A0RN-01,TCGA-B6-A0RN,BRCA,60.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,1993.0,-22077.0,Alive,TUMOR FREE,8008.0,0.0,8008.0,0.0,8008.0,0.0,8008.0
TCGA-B6-A0RO-01,TCGA-B6-A0RO,BRCA,71.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,1993.0,-26269.0,Alive,TUMOR FREE,4929.0,0.0,4929.0,0.0,4929.0,0.0,4929.0
TCGA-B6-A0RP-01,TCGA-B6-A0RP,BRCA,73.0,FEMALE,WHITE,[Discrepancy],Mixed Histology (please specify),1994.0,-26941.0,Dead,WITH TUMOR,,1.0,3126.0,1.0,3126.0,1.0,2787.0
TCGA-B6-A0RQ-01,TCGA-B6-A0RQ,BRCA,68.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,1994.0,-25010.0,Dead,TUMOR FREE,,1.0,4267.0,0.0,4267.0,0.0,4267.0
TCGA-B6-A0RT-01,TCGA-B6-A0RT,BRCA,39.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,1996.0,-14374.0,Alive,TUMOR FREE,2721.0,0.0,2721.0,0.0,2721.0,0.0,2721.0
TCGA-B6-A0RU-01,TCGA-B6-A0RU,BRCA,40.0,FEMALE,WHITE,Stage IA,"Other, specify",1990.0,-14920.0,Alive,TUMOR FREE,8605.0,0.0,8605.0,0.0,8605.0,1.0,3076.0
TCGA-B6-A0RV-01,TCGA-B6-A0RV,BRCA,42.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),1996.0,-15507.0,Alive,TUMOR FREE,5156.0,0.0,5156.0,0.0,5156.0,0.0,5156.0
TCGA-B6-A0WX-01,TCGA-B6-A0WX,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,"Other, specify",1998.0,-14784.0,Dead,WITH TUMOR,,1.0,639.0,1.0,639.0,1.0,563.0
TCGA-B6-A0X0-01,TCGA-B6-A0X0,BRCA,54.0,FEMALE,WHITE,Stage I,"Other, specify",1996.0,-19802.0,Dead,,,1.0,3945.0,,3945.0,0.0,3945.0
TCGA-B6-A0X1-01,TCGA-B6-A0X1,BRCA,48.0,FEMALE,WHITE,[Discrepancy],Infiltrating Ductal Carcinoma,1994.0,-17624.0,Dead,TUMOR FREE,,1.0,7455.0,0.0,7455.0,1.0,490.0
TCGA-B6-A2IU-01,TCGA-B6-A2IU,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,1998.0,-22905.0,Alive,WITH TUMOR,5176.0,0.0,5176.0,0.0,5176.0,1.0,4224.0
TCGA-B7-5816-01,TCGA-B7-5816,STAD,51.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-18698.0,Alive,TUMOR FREE,812.0,0.0,812.0,0.0,812.0,0.0,812.0
TCGA-B7-5818-01,TCGA-B7-5818,STAD,62.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-22792.0,Alive,TUMOR FREE,356.0,0.0,356.0,0.0,356.0,0.0,356.0
TCGA-B7-A5TI-01,TCGA-B7-A5TI,STAD,52.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-19014.0,Alive,TUMOR FREE,595.0,0.0,595.0,0.0,595.0,0.0,595.0
TCGA-B7-A5TJ-01,TCGA-B7-A5TJ,STAD,74.0,MALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-27057.0,Alive,TUMOR FREE,335.0,0.0,335.0,0.0,335.0,0.0,335.0
TCGA-B7-A5TK-01,TCGA-B7-A5TK,STAD,51.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-18750.0,Alive,TUMOR FREE,288.0,0.0,288.0,0.0,288.0,0.0,288.0
TCGA-B7-A5TN-01,TCGA-B7-A5TN,STAD,60.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-21962.0,Alive,TUMOR FREE,287.0,0.0,287.0,0.0,287.0,0.0,287.0
TCGA-B8-4143-01,TCGA-B8-4143,KIRC,66.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2002.0,-24132.0,Dead,WITH TUMOR,,1.0,709.0,1.0,709.0,1.0,709.0
TCGA-B8-4146-01,TCGA-B8-4146,KIRC,41.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2009.0,-15063.0,Alive,TUMOR FREE,511.0,0.0,511.0,0.0,511.0,0.0,511.0
TCGA-B8-4153-01,TCGA-B8-4153,KIRC,74.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-27031.0,Alive,WITH TUMOR,762.0,0.0,762.0,0.0,762.0,1.0,223.0
TCGA-B8-4621-01,TCGA-B8-4621,KIRC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-23176.0,Alive,TUMOR FREE,788.0,0.0,788.0,0.0,788.0,0.0,788.0
TCGA-B8-5158-01,TCGA-B8-5158,KIRC,56.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-20764.0,Alive,TUMOR FREE,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0
TCGA-B8-5159-01,TCGA-B8-5159,KIRC,61.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-22462.0,Alive,TUMOR FREE,722.0,0.0,722.0,0.0,722.0,0.0,722.0
TCGA-B8-5163-01,TCGA-B8-5163,KIRC,63.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-23293.0,Alive,TUMOR FREE,822.0,0.0,822.0,0.0,822.0,0.0,822.0
TCGA-B8-5164-01,TCGA-B8-5164,KIRC,65.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-23863.0,Alive,TUMOR FREE,26.0,0.0,26.0,0.0,26.0,0.0,26.0
TCGA-B8-5165-01,TCGA-B8-5165,KIRC,43.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-15898.0,Alive,TUMOR FREE,737.0,0.0,737.0,0.0,737.0,0.0,737.0
TCGA-B8-5545-01,TCGA-B8-5545,KIRC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-15376.0,Alive,TUMOR FREE,1525.0,0.0,1525.0,0.0,1525.0,0.0,1525.0
TCGA-B8-5546-01,TCGA-B8-5546,KIRC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-14113.0,Alive,TUMOR FREE,505.0,0.0,505.0,0.0,505.0,0.0,505.0
TCGA-B8-5549-01,TCGA-B8-5549,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-19561.0,Alive,TUMOR FREE,194.0,0.0,194.0,0.0,194.0,0.0,194.0
TCGA-B8-5550-01,TCGA-B8-5550,KIRC,71.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-25937.0,Alive,WITH TUMOR,1476.0,0.0,1476.0,0.0,1476.0,1.0,694.0
TCGA-B8-5551-01,TCGA-B8-5551,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-23976.0,Alive,TUMOR FREE,16.0,0.0,16.0,0.0,16.0,0.0,16.0
TCGA-B8-5552-01,TCGA-B8-5552,KIRC,41.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-15219.0,Alive,TUMOR FREE,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0
TCGA-B8-5553-01,TCGA-B8-5553,KIRC,67.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-24729.0,Alive,TUMOR FREE,435.0,0.0,435.0,0.0,435.0,0.0,435.0
TCGA-B9-5155-01,TCGA-B9-5155,KIRP,71.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2010.0,-26149.0,Alive,TUMOR FREE,665.0,0.0,665.0,0.0,665.0,0.0,665.0
TCGA-B9-5156-01,TCGA-B9-5156,KIRP,51.0,MALE,WHITE,,Kidney Papillary Renal Cell Carcinoma,2010.0,-18841.0,Alive,TUMOR FREE,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0
TCGA-B9-7268-01,TCGA-B9-7268,KIRP,59.0,MALE,WHITE,Stage II,Kidney Papillary Renal Cell Carcinoma,2011.0,-21705.0,Alive,TUMOR FREE,671.0,0.0,671.0,0.0,671.0,0.0,671.0
TCGA-B9-A44B-01,TCGA-B9-A44B,KIRP,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2012.0,-25763.0,Alive,TUMOR FREE,361.0,0.0,361.0,0.0,361.0,0.0,361.0
TCGA-B9-A5W7-01,TCGA-B9-A5W7,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-17465.0,Alive,TUMOR FREE,585.0,0.0,585.0,0.0,585.0,1.0,564.0
TCGA-B9-A5W8-01,TCGA-B9-A5W8,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Papillary Renal Cell Carcinoma,2012.0,-18440.0,Alive,TUMOR FREE,524.0,0.0,524.0,0.0,524.0,0.0,524.0
TCGA-B9-A5W9-01,TCGA-B9-A5W9,KIRP,40.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-14668.0,Alive,TUMOR FREE,5.0,0.0,5.0,0.0,5.0,0.0,5.0
TCGA-B9-A69E-01,TCGA-B9-A69E,KIRP,71.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2013.0,-26198.0,Alive,TUMOR FREE,452.0,0.0,452.0,0.0,452.0,0.0,452.0
TCGA-BA-4074-01,TCGA-BA-4074,HNSC,69.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2003.0,-25282.0,Dead,WITH TUMOR,,1.0,462.0,1.0,462.0,1.0,396.0
TCGA-BA-4078-01,TCGA-BA-4078,HNSC,83.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2003.0,-30480.0,Dead,WITH TUMOR,,1.0,276.0,1.0,276.0,1.0,276.0
TCGA-BA-5149-01,TCGA-BA-5149,HNSC,47.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-17177.0,Dead,WITH TUMOR,,1.0,806.0,1.0,806.0,1.0,389.0
TCGA-BA-5151-01,TCGA-BA-5151,HNSC,72.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-26569.0,Alive,TUMOR FREE,722.0,0.0,722.0,0.0,722.0,1.0,517.0
TCGA-BA-5152-01,TCGA-BA-5152,HNSC,56.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-20783.0,Alive,TUMOR FREE,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0
TCGA-BA-5153-01,TCGA-BA-5153,HNSC,51.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2005.0,-18743.0,Dead,WITH TUMOR,,1.0,1762.0,1.0,1762.0,1.0,1522.0
TCGA-BA-5555-01,TCGA-BA-5555,HNSC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-19956.0,Alive,TUMOR FREE,520.0,0.0,520.0,0.0,520.0,1.0,248.0
TCGA-BA-5556-01,TCGA-BA-5556,HNSC,58.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-21444.0,Alive,TUMOR FREE,725.0,0.0,725.0,0.0,725.0,0.0,725.0
TCGA-BA-5559-01,TCGA-BA-5559,HNSC,71.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2006.0,-26286.0,Dead,WITH TUMOR,,1.0,2083.0,1.0,2083.0,1.0,1614.0
TCGA-BA-6869-01,TCGA-BA-6869,HNSC,62.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-22765.0,Alive,TUMOR FREE,644.0,0.0,644.0,0.0,644.0,0.0,644.0
TCGA-BA-6870-01,TCGA-BA-6870,HNSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Head & Neck Squamous Cell Carcinoma,2010.0,-22222.0,Dead,,,1.0,451.0,,451.0,0.0,451.0
TCGA-BA-6871-01,TCGA-BA-6871,HNSC,75.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2011.0,-27708.0,Dead,WITH TUMOR,,1.0,108.0,1.0,108.0,1.0,108.0
TCGA-BA-6872-01,TCGA-BA-6872,HNSC,47.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2004.0,-17296.0,Dead,WITH TUMOR,,1.0,384.0,1.0,384.0,1.0,384.0
TCGA-BA-6873-01,TCGA-BA-6873,HNSC,28.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-10512.0,Alive,WITH TUMOR,122.0,0.0,122.0,0.0,122.0,1.0,66.0
TCGA-BB-4217-01,TCGA-BB-4217,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-25020.0,Alive,WITH TUMOR,187.0,0.0,187.0,0.0,187.0,0.0,187.0
TCGA-BC-A10R-01,TCGA-BC-A10R,LIHC,66.0,FEMALE,WHITE,,Hepatocellular Carcinoma,1999.0,-24274.0,Dead,WITH TUMOR,,1.0,308.0,1.0,308.0,1.0,199.0
TCGA-BC-A10T-01,TCGA-BC-A10T,LIHC,76.0,MALE,WHITE,,Hepatocellular Carcinoma,2000.0,-27944.0,Dead,WITH TUMOR,,1.0,837.0,1.0,837.0,1.0,598.0
TCGA-BC-A10U-01,TCGA-BC-A10U,LIHC,69.0,MALE,WHITE,,Hepatocellular Carcinoma,2000.0,-25305.0,Dead,WITH TUMOR,,1.0,837.0,1.0,837.0,1.0,586.0
TCGA-BC-A10W-01,TCGA-BC-A10W,LIHC,50.0,MALE,ASIAN,,Hepatocellular Carcinoma,2002.0,-18562.0,Dead,WITH TUMOR,,1.0,91.0,1.0,91.0,1.0,91.0
TCGA-BC-A10X-01,TCGA-BC-A10X,LIHC,52.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2002.0,-19140.0,Dead,TUMOR FREE,,1.0,770.0,0.0,770.0,0.0,770.0
TCGA-BC-A10Y-01,TCGA-BC-A10Y,LIHC,76.0,MALE,WHITE,,Hepatocellular Carcinoma,2002.0,-28049.0,Dead,WITH TUMOR,,1.0,711.0,1.0,711.0,1.0,400.0
TCGA-BC-A10Z-01,TCGA-BC-A10Z,LIHC,62.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2003.0,-22913.0,Dead,TUMOR FREE,,1.0,34.0,0.0,34.0,0.0,34.0
TCGA-BC-A216-01,TCGA-BC-A216,LIHC,62.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2008.0,-22968.0,Alive,TUMOR FREE,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0
TCGA-BC-A217-01,TCGA-BC-A217,LIHC,75.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2010.0,-27411.0,Dead,TUMOR FREE,,1.0,1397.0,0.0,1397.0,0.0,1397.0
TCGA-BC-A3KF-01,TCGA-BC-A3KF,LIHC,66.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-24328.0,Alive,TUMOR FREE,8.0,0.0,8.0,0.0,8.0,0.0,8.0
TCGA-BC-A5W4-01,TCGA-BC-A5W4,LIHC,69.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2012.0,-25503.0,Dead,TUMOR FREE,,1.0,547.0,0.0,547.0,1.0,384.0
TCGA-BC-A69H-01,TCGA-BC-A69H,LIHC,64.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2013.0,-23380.0,Alive,TUMOR FREE,444.0,0.0,444.0,0.0,444.0,0.0,444.0
TCGA-BD-A2L6-01,TCGA-BD-A2L6,LIHC,69.0,MALE,WHITE,,Hepatocellular Carcinoma,2011.0,-25489.0,Alive,WITH TUMOR,1363.0,0.0,1363.0,0.0,1363.0,1.0,415.0
TCGA-BD-A3EP-01,TCGA-BD-A3EP,LIHC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2010.0,-27756.0,Alive,TUMOR FREE,409.0,0.0,409.0,0.0,409.0,0.0,409.0
TCGA-BF-A1PU-01,TCGA-BF-A1PU,SKCM,46.0,FEMALE,WHITE,Stage IIC,,2010.0,-17025.0,Alive,TUMOR FREE,387.0,0.0,387.0,0.0,387.0,1.0,484.0
TCGA-BF-A1PX-01,TCGA-BF-A1PX,SKCM,56.0,MALE,WHITE,Stage IIIB,,2010.0,-20626.0,Dead,TUMOR FREE,,1.0,282.0,0.0,282.0,0.0,282.0
TCGA-BF-A1PZ-01,TCGA-BF-A1PZ,SKCM,71.0,FEMALE,WHITE,Stage IIB,,2010.0,-26240.0,Alive,TUMOR FREE,853.0,0.0,853.0,0.0,853.0,0.0,853.0
TCGA-BF-A3DJ-01,TCGA-BF-A3DJ,SKCM,36.0,FEMALE,WHITE,Stage IIIB,,2011.0,-13332.0,Alive,TUMOR FREE,464.0,0.0,464.0,0.0,464.0,1.0,217.0
TCGA-BF-A3DL-01,TCGA-BF-A3DL,SKCM,84.0,FEMALE,WHITE,Stage IIIB,,2011.0,-30805.0,Alive,TUMOR FREE,769.0,0.0,769.0,0.0,769.0,0.0,769.0
TCGA-BF-A3DM-01,TCGA-BF-A3DM,SKCM,63.0,MALE,WHITE,Stage IIA,,2011.0,-23076.0,Alive,TUMOR FREE,601.0,0.0,601.0,0.0,601.0,0.0,601.0
TCGA-BF-A3DN-01,TCGA-BF-A3DN,SKCM,81.0,FEMALE,WHITE,Stage IIIC,,2011.0,-29801.0,Alive,TUMOR FREE,717.0,0.0,717.0,0.0,717.0,0.0,717.0
TCGA-BF-A5EO-01,TCGA-BF-A5EO,SKCM,65.0,MALE,WHITE,Stage IIC,,2012.0,-23940.0,Alive,TUMOR FREE,703.0,0.0,703.0,0.0,703.0,0.0,703.0
TCGA-BF-A5EP-01,TCGA-BF-A5EP,SKCM,75.0,FEMALE,WHITE,Stage IIIC,,2012.0,-27622.0,Alive,TUMOR FREE,335.0,0.0,335.0,0.0,335.0,0.0,335.0
TCGA-BF-A5EQ-01,TCGA-BF-A5EQ,SKCM,63.0,MALE,WHITE,Stage IIC,,2012.0,-23353.0,Alive,TUMOR FREE,323.0,0.0,323.0,0.0,323.0,0.0,323.0
TCGA-BF-A5ER-01,TCGA-BF-A5ER,SKCM,63.0,MALE,WHITE,Stage IIC,,2012.0,-23199.0,Alive,TUMOR FREE,327.0,0.0,327.0,0.0,327.0,0.0,327.0
TCGA-BF-A5ES-01,TCGA-BF-A5ES,SKCM,76.0,FEMALE,WHITE,Stage IIC,,2012.0,-28092.0,Alive,TUMOR FREE,490.0,0.0,490.0,0.0,490.0,0.0,490.0
TCGA-BG-A0MK-01,TCGA-BG-A0MK,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2006.0,-19034.0,Dead,WITH TUMOR,,1.0,1317.0,1.0,1317.0,1.0,1317.0
TCGA-BG-A3EW-01,TCGA-BG-A3EW,UCEC,62.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-22705.0,Alive,TUMOR FREE,344.0,0.0,344.0,0.0,344.0,0.0,344.0
TCGA-BG-A3PP-01,TCGA-BG-A3PP,UCEC,82.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-30227.0,Alive,WITH TUMOR,681.0,0.0,681.0,0.0,681.0,1.0,665.0
TCGA-BH-A0AU-01,TCGA-BH-A0AU,BRCA,45.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-16688.0,Alive,TUMOR FREE,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0
TCGA-BH-A0AV-01,TCGA-BH-A0AV,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2008.0,-19314.0,Alive,TUMOR FREE,1820.0,0.0,1820.0,0.0,1820.0,0.0,1820.0
TCGA-BH-A0AZ-01,TCGA-BH-A0AZ,BRCA,47.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-17465.0,Alive,TUMOR FREE,1919.0,0.0,1919.0,0.0,1919.0,0.0,1919.0
TCGA-BH-A0B0-01,TCGA-BH-A0B0,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2006.0,-20776.0,Alive,TUMOR FREE,2477.0,0.0,2477.0,0.0,2477.0,0.0,2477.0
TCGA-BH-A0B3-01,TCGA-BH-A0B3,BRCA,53.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-19479.0,Alive,TUMOR FREE,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0
TCGA-BH-A0B7-01,TCGA-BH-A0B7,BRCA,42.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-15593.0,Alive,TUMOR FREE,2559.0,0.0,2559.0,0.0,2559.0,0.0,2559.0
TCGA-BH-A0BA-01,TCGA-BH-A0BA,BRCA,51.0,FEMALE,WHITE,Stage IIIC,Mixed Histology (please specify),2006.0,-18839.0,Alive,TUMOR FREE,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0
TCGA-BH-A0BC-01,TCGA-BH-A0BC,BRCA,60.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2007.0,-21949.0,Alive,TUMOR FREE,974.0,0.0,974.0,0.0,974.0,0.0,974.0
TCGA-BH-A0BF-01,TCGA-BH-A0BF,BRCA,56.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-20691.0,Dead,TUMOR FREE,,1.0,1324.0,0.0,1324.0,0.0,1324.0
TCGA-BH-A0BJ-01,TCGA-BH-A0BJ,BRCA,41.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-15027.0,Alive,TUMOR FREE,660.0,0.0,660.0,0.0,660.0,0.0,660.0
TCGA-BH-A0BM-01,TCGA-BH-A0BM,BRCA,54.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-20049.0,Alive,TUMOR FREE,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0
TCGA-BH-A0BO-01,TCGA-BH-A0BO,BRCA,54.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-19767.0,Alive,TUMOR FREE,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0
TCGA-BH-A0BP-01,TCGA-BH-A0BP,BRCA,76.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2006.0,-27917.0,Dead,TUMOR FREE,,1.0,2296.0,0.0,2296.0,0.0,2296.0
TCGA-BH-A0BQ-01,TCGA-BH-A0BQ,BRCA,39.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-14494.0,Alive,TUMOR FREE,2255.0,0.0,2255.0,0.0,2255.0,1.0,1709.0
TCGA-BH-A0BS-01,TCGA-BH-A0BS,BRCA,55.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-20374.0,Alive,TUMOR FREE,2612.0,0.0,2612.0,0.0,2612.0,0.0,2612.0
TCGA-BH-A0BT-01,TCGA-BH-A0BT,BRCA,56.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-20625.0,Alive,TUMOR FREE,2365.0,0.0,2365.0,0.0,2365.0,0.0,2365.0
TCGA-BH-A0BV-01,TCGA-BH-A0BV,BRCA,78.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-28699.0,Alive,TUMOR FREE,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0
TCGA-BH-A0BW-01,TCGA-BH-A0BW,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2006.0,-25974.0,Alive,TUMOR FREE,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0
TCGA-BH-A0BZ-01,TCGA-BH-A0BZ,BRCA,59.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-21856.0,Alive,TUMOR FREE,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0
TCGA-BH-A0C0-01,TCGA-BH-A0C0,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-23006.0,Alive,TUMOR FREE,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0
TCGA-BH-A0C1-01,TCGA-BH-A0C1,BRCA,61.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2007.0,-22377.0,Dead,WITH TUMOR,,1.0,1411.0,1.0,1411.0,1.0,1123.0
TCGA-BH-A0C3-01,TCGA-BH-A0C3,BRCA,47.0,FEMALE,WHITE,Stage I,Mixed Histology (please specify),2006.0,-17221.0,Alive,WITH TUMOR,2709.0,0.0,2709.0,0.0,2709.0,1.0,2674.0
TCGA-BH-A0C7-01,TCGA-BH-A0C7,BRCA,48.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-17871.0,Alive,TUMOR FREE,2767.0,0.0,2767.0,0.0,2767.0,0.0,2767.0
TCGA-BH-A0DD-01,TCGA-BH-A0DD,BRCA,58.0,MALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2006.0,-21386.0,Alive,TUMOR FREE,2486.0,0.0,2486.0,0.0,2486.0,0.0,2486.0
TCGA-BH-A0DG-01,TCGA-BH-A0DG,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-11204.0,Alive,TUMOR FREE,2041.0,0.0,2041.0,0.0,2041.0,0.0,2041.0
TCGA-BH-A0DH-01,TCGA-BH-A0DH,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-23366.0,Alive,TUMOR FREE,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0
TCGA-BH-A0DI-01,TCGA-BH-A0DI,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-23327.0,Alive,TUMOR FREE,912.0,0.0,912.0,0.0,912.0,0.0,912.0
TCGA-BH-A0DK-01,TCGA-BH-A0DK,BRCA,49.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-18237.0,Alive,TUMOR FREE,423.0,0.0,423.0,0.0,423.0,0.0,423.0
TCGA-BH-A0DL-01,TCGA-BH-A0DL,BRCA,64.0,FEMALE,WHITE,Stage IIA,"Other, specify",2007.0,-23628.0,Alive,TUMOR FREE,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0
TCGA-BH-A0DP-01,TCGA-BH-A0DP,BRCA,60.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2009.0,-22199.0,Alive,TUMOR FREE,476.0,0.0,476.0,0.0,476.0,0.0,476.0
TCGA-BH-A0DT-01,TCGA-BH-A0DT,BRCA,41.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-15078.0,Alive,TUMOR FREE,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0
TCGA-BH-A0DV-01,TCGA-BH-A0DV,BRCA,54.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-19781.0,Alive,TUMOR FREE,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0
TCGA-BH-A0E0-01,TCGA-BH-A0E0,BRCA,38.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2009.0,-14175.0,Alive,TUMOR FREE,134.0,0.0,134.0,0.0,134.0,0.0,134.0
TCGA-BH-A0E1-01,TCGA-BH-A0E1,BRCA,52.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-19192.0,Alive,TUMOR FREE,477.0,0.0,477.0,0.0,477.0,0.0,477.0
TCGA-BH-A0E9-01,TCGA-BH-A0E9,BRCA,53.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2006.0,-19415.0,Alive,TUMOR FREE,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0
TCGA-BH-A0EA-01,TCGA-BH-A0EA,BRCA,72.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-26548.0,Dead,TUMOR FREE,,1.0,991.0,0.0,991.0,0.0,991.0
TCGA-BH-A0EI-01,TCGA-BH-A0EI,BRCA,51.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-18741.0,Alive,TUMOR FREE,1926.0,0.0,1926.0,0.0,1926.0,0.0,1926.0
TCGA-BH-A0H5-01,TCGA-BH-A0H5,BRCA,45.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2008.0,-16719.0,Alive,TUMOR FREE,1620.0,0.0,1620.0,0.0,1620.0,0.0,1620.0
TCGA-BH-A0H7-01,TCGA-BH-A0H7,BRCA,65.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-23972.0,Alive,TUMOR FREE,702.0,0.0,702.0,0.0,702.0,0.0,702.0
TCGA-BH-A0H9-01,TCGA-BH-A0H9,BRCA,69.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-25289.0,Alive,TUMOR FREE,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0
TCGA-BH-A0HA-01,TCGA-BH-A0HA,BRCA,31.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2008.0,-11379.0,Alive,TUMOR FREE,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0
TCGA-BH-A0HK-01,TCGA-BH-A0HK,BRCA,81.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-29751.0,Alive,TUMOR FREE,178.0,0.0,178.0,0.0,178.0,0.0,178.0
TCGA-BH-A0HN-01,TCGA-BH-A0HN,BRCA,67.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2009.0,-24731.0,Alive,TUMOR FREE,516.0,0.0,516.0,0.0,516.0,0.0,516.0
TCGA-BH-A0HP-01,TCGA-BH-A0HP,BRCA,65.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2009.0,-23883.0,Alive,TUMOR FREE,414.0,0.0,414.0,0.0,414.0,0.0,414.0
TCGA-BH-A0RX-01,TCGA-BH-A0RX,BRCA,59.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-21857.0,Alive,TUMOR FREE,170.0,0.0,170.0,0.0,170.0,0.0,170.0
TCGA-BH-A0W4-01,TCGA-BH-A0W4,BRCA,46.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-16911.0,Alive,TUMOR FREE,759.0,0.0,759.0,0.0,759.0,0.0,759.0
TCGA-BH-A0W5-01,TCGA-BH-A0W5,BRCA,77.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-28304.0,Alive,TUMOR FREE,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0
TCGA-BH-A18F-01,TCGA-BH-A18F,BRCA,50.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-18594.0,Alive,TUMOR FREE,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0
TCGA-BH-A18G-01,TCGA-BH-A18G,BRCA,81.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-29820.0,Alive,TUMOR FREE,149.0,0.0,149.0,0.0,149.0,0.0,149.0
TCGA-BH-A18H-01,TCGA-BH-A18H,BRCA,63.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-23065.0,Alive,TUMOR FREE,652.0,0.0,652.0,0.0,652.0,0.0,652.0
TCGA-BH-A18J-01,TCGA-BH-A18J,BRCA,56.0,FEMALE,WHITE,Stage IV,Infiltrating Ductal Carcinoma,2000.0,-20678.0,Dead,WITH TUMOR,,1.0,612.0,1.0,612.0,1.0,612.0
TCGA-BH-A18L-01,TCGA-BH-A18L,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2003.0,-18519.0,Dead,,,1.0,811.0,,811.0,0.0,811.0
TCGA-BH-A18M-01,TCGA-BH-A18M,BRCA,39.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2001.0,-14532.0,Dead,,,1.0,2207.0,,2207.0,0.0,2207.0
TCGA-BH-A18N-01,TCGA-BH-A18N,BRCA,88.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2001.0,-32404.0,Dead,,,1.0,1148.0,,1148.0,0.0,1148.0
TCGA-BH-A18P-01,TCGA-BH-A18P,BRCA,60.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2003.0,-22222.0,Dead,WITH TUMOR,,1.0,921.0,1.0,921.0,1.0,921.0
TCGA-BH-A18Q-01,TCGA-BH-A18Q,BRCA,56.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2001.0,-20675.0,Dead,,,1.0,1692.0,,1692.0,0.0,1692.0
TCGA-BH-A18R-01,TCGA-BH-A18R,BRCA,50.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2001.0,-18524.0,Dead,TUMOR FREE,,1.0,1142.0,0.0,1142.0,0.0,1142.0
TCGA-BH-A18S-01,TCGA-BH-A18S,BRCA,79.0,FEMALE,WHITE,Stage I,Mucinous Carcinoma,2003.0,-28974.0,Dead,TUMOR FREE,,1.0,2009.0,0.0,2009.0,0.0,2009.0
TCGA-BH-A18T-01,TCGA-BH-A18T,BRCA,70.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2003.0,-25674.0,Dead,WITH TUMOR,,1.0,224.0,1.0,224.0,1.0,224.0
TCGA-BH-A18V-01,TCGA-BH-A18V,BRCA,48.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2001.0,-17682.0,Dead,,,1.0,1556.0,,1556.0,0.0,1556.0
TCGA-BH-A1EO-01,TCGA-BH-A1EO,BRCA,68.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),1999.0,-25136.0,Dead,TUMOR FREE,,1.0,2798.0,0.0,2798.0,0.0,2798.0
TCGA-BH-A1ET-01,TCGA-BH-A1ET,BRCA,55.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,1999.0,-20425.0,Dead,TUMOR FREE,,1.0,2520.0,0.0,2520.0,0.0,2520.0
TCGA-BH-A1EU-01,TCGA-BH-A1EU,BRCA,83.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,1999.0,-30339.0,Dead,TUMOR FREE,,1.0,1286.0,0.0,1286.0,0.0,1286.0
TCGA-BH-A1EV-01,TCGA-BH-A1EV,BRCA,45.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,1999.0,-16504.0,Dead,WITH TUMOR,,1.0,365.0,1.0,365.0,1.0,365.0
TCGA-BH-A1EW-01,TCGA-BH-A1EW,BRCA,38.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,1999.0,-14090.0,Dead,WITH TUMOR,,1.0,1694.0,1.0,1694.0,1.0,1694.0
TCGA-BH-A1EX-01,TCGA-BH-A1EX,BRCA,67.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2000.0,-24544.0,Dead,WITH TUMOR,,1.0,1508.0,1.0,1508.0,1.0,1508.0
TCGA-BH-A1EY-01,TCGA-BH-A1EY,BRCA,79.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2000.0,-28940.0,Dead,WITH TUMOR,,1.0,538.0,1.0,538.0,1.0,396.0
TCGA-BH-A1F0-01,TCGA-BH-A1F0,BRCA,80.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2000.0,-29335.0,Dead,WITH TUMOR,,1.0,785.0,1.0,785.0,1.0,785.0
TCGA-BH-A1F2-01,TCGA-BH-A1F2,BRCA,53.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,1999.0,-19701.0,Dead,TUMOR FREE,,1.0,959.0,0.0,959.0,0.0,959.0
TCGA-BH-A1F6-01,TCGA-BH-A1F6,BRCA,51.0,FEMALE,WHITE,,Infiltrating Ductal Carcinoma,1996.0,-18691.0,Dead,,,1.0,2965.0,,2965.0,0.0,2965.0
TCGA-BH-A1F8-01,TCGA-BH-A1F8,BRCA,90.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,1999.0,-32871.0,Dead,WITH TUMOR,,1.0,763.0,1.0,763.0,1.0,763.0
TCGA-BH-A1FC-01,TCGA-BH-A1FC,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Medullary Carcinoma,1998.0,-28706.0,Dead,TUMOR FREE,,1.0,3472.0,0.0,3472.0,0.0,3472.0
TCGA-BH-A1FE-01,TCGA-BH-A1FE,BRCA,31.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,1998.0,-11650.0,Dead,WITH TUMOR,,1.0,2273.0,1.0,2273.0,1.0,2273.0
TCGA-BH-A1FG-01,TCGA-BH-A1FG,BRCA,88.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,1998.0,-32295.0,Dead,,,1.0,3736.0,,3736.0,0.0,3736.0
TCGA-BH-A1FH-01,TCGA-BH-A1FH,BRCA,47.0,FEMALE,WHITE,Stage IV,Infiltrating Ductal Carcinoma,1998.0,-17172.0,Dead,WITH TUMOR,,1.0,1034.0,1.0,1034.0,1.0,1034.0
TCGA-BH-A1FJ-01,TCGA-BH-A1FJ,BRCA,66.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,1998.0,-24262.0,Dead,,,1.0,1927.0,,1927.0,0.0,1927.0
TCGA-BH-A1FL-01,TCGA-BH-A1FL,BRCA,69.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,1998.0,-25558.0,Dead,WITH TUMOR,,1.0,1673.0,1.0,1673.0,1.0,1673.0
TCGA-BH-A1FM-01,TCGA-BH-A1FM,BRCA,44.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,1998.0,-16289.0,Dead,,,1.0,1388.0,,1388.0,0.0,1388.0
TCGA-BH-A1FN-01,TCGA-BH-A1FN,BRCA,34.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,1997.0,-12525.0,Dead,WITH TUMOR,,1.0,2192.0,1.0,2192.0,1.0,2192.0
TCGA-BH-A1FR-01,TCGA-BH-A1FR,BRCA,73.0,FEMALE,WHITE,Stage IIIB,"Other, specify",1997.0,-26684.0,Dead,WITH TUMOR,,1.0,1642.0,1.0,1642.0,1.0,1642.0
TCGA-BH-A201-01,TCGA-BH-A201,BRCA,64.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-23423.0,Alive,TUMOR FREE,856.0,0.0,856.0,0.0,856.0,0.0,856.0
TCGA-BH-A202-01,TCGA-BH-A202,BRCA,60.0,FEMALE,WHITE,Stage II,Infiltrating Ductal Carcinoma,2011.0,-22052.0,Alive,TUMOR FREE,795.0,0.0,795.0,0.0,795.0,0.0,795.0
TCGA-BH-A203-01,TCGA-BH-A203,BRCA,78.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,1996.0,-28609.0,Dead,WITH TUMOR,,1.0,1174.0,1.0,1174.0,1.0,1174.0
TCGA-BH-A204-01,TCGA-BH-A204,BRCA,80.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,1996.0,-29529.0,Dead,,,1.0,2534.0,,2534.0,0.0,2534.0
TCGA-BH-A208-01,TCGA-BH-A208,BRCA,48.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,1995.0,-17715.0,Dead,TUMOR FREE,,1.0,1759.0,0.0,1759.0,0.0,1759.0
TCGA-BH-A209-01,TCGA-BH-A209,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Medullary Carcinoma,1996.0,-28403.0,Dead,TUMOR FREE,,1.0,3959.0,0.0,3959.0,0.0,3959.0
TCGA-BH-A28Q-01,TCGA-BH-A28Q,BRCA,46.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-16882.0,Alive,TUMOR FREE,1119.0,0.0,1119.0,0.0,1119.0,0.0,1119.0
TCGA-BH-A2L8-01,TCGA-BH-A2L8,BRCA,45.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-16658.0,Alive,TUMOR FREE,612.0,0.0,612.0,0.0,612.0,0.0,612.0
TCGA-BH-A42U-01,TCGA-BH-A42U,BRCA,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Lobular Carcinoma,2004.0,-29330.0,Alive,TUMOR FREE,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0
TCGA-BH-A42V-01,TCGA-BH-A42V,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,Infiltrating Ductal Carcinoma,2012.0,-15158.0,Alive,TUMOR FREE,635.0,0.0,635.0,0.0,635.0,0.0,635.0
TCGA-BH-A6R8-01,TCGA-BH-A6R8,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2012.0,-16829.0,Alive,TUMOR FREE,293.0,0.0,293.0,0.0,293.0,0.0,293.0
TCGA-BH-A6R9-01,TCGA-BH-A6R9,BRCA,61.0,FEMALE,WHITE,Stage IIA,Metaplastic Carcinoma,2012.0,-22325.0,Alive,TUMOR FREE,160.0,0.0,160.0,0.0,160.0,0.0,160.0
TCGA-BH-A8FY-01,TCGA-BH-A8FY,BRCA,87.0,FEMALE,WHITE,Stage IA,Infiltrating Lobular Carcinoma,2012.0,-31932.0,Dead,TUMOR FREE,,1.0,295.0,0.0,295.0,0.0,295.0
TCGA-BH-A8FZ-01,TCGA-BH-A8FZ,BRCA,58.0,FEMALE,WHITE,Stage IA,Infiltrating Lobular Carcinoma,2012.0,-21343.0,Alive,TUMOR FREE,574.0,0.0,574.0,0.0,574.0,0.0,574.0
TCGA-BH-A8G0-01,TCGA-BH-A8G0,BRCA,54.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2012.0,-19975.0,Alive,TUMOR FREE,662.0,0.0,662.0,0.0,662.0,0.0,662.0
TCGA-BJ-A0YZ-01,TCGA-BJ-A0YZ,THCA,65.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-24102.0,Alive,TUMOR FREE,754.0,0.0,754.0,0.0,754.0,0.0,754.0
TCGA-BJ-A0Z0-01,TCGA-BJ-A0Z0,THCA,55.0,MALE,,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20361.0,Alive,TUMOR FREE,419.0,0.0,419.0,0.0,419.0,0.0,419.0
TCGA-BJ-A0Z2-01,TCGA-BJ-A0Z2,THCA,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVC,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-21008.0,Alive,WITH TUMOR,1514.0,0.0,1514.0,0.0,1514.0,1.0,158.0
TCGA-BJ-A0Z3-01,TCGA-BJ-A0Z3,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-12295.0,Alive,TUMOR FREE,497.0,0.0,497.0,0.0,497.0,0.0,497.0
TCGA-BJ-A0Z9-01,TCGA-BJ-A0Z9,THCA,57.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2010.0,-21061.0,Alive,TUMOR FREE,1257.0,0.0,1257.0,0.0,1257.0,0.0,1257.0
TCGA-BJ-A0ZA-01,TCGA-BJ-A0ZA,THCA,67.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-24528.0,Alive,TUMOR FREE,574.0,0.0,574.0,0.0,574.0,0.0,574.0
TCGA-BJ-A0ZB-01,TCGA-BJ-A0ZB,THCA,66.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-24415.0,Alive,TUMOR FREE,122.0,0.0,122.0,0.0,122.0,0.0,122.0
TCGA-BJ-A0ZC-01,TCGA-BJ-A0ZC,THCA,55.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20282.0,Alive,TUMOR FREE,352.0,0.0,352.0,0.0,352.0,0.0,352.0
TCGA-BJ-A0ZE-01,TCGA-BJ-A0ZE,THCA,63.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-23250.0,Alive,TUMOR FREE,509.0,0.0,509.0,0.0,509.0,0.0,509.0
TCGA-BJ-A0ZG-01,TCGA-BJ-A0ZG,THCA,80.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-29375.0,Alive,TUMOR FREE,775.0,0.0,775.0,0.0,775.0,0.0,775.0
TCGA-BJ-A0ZJ-01,TCGA-BJ-A0ZJ,THCA,36.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-13149.0,Alive,TUMOR FREE,1280.0,0.0,1280.0,0.0,1280.0,0.0,1280.0
TCGA-BJ-A18Y-01,TCGA-BJ-A18Y,THCA,29.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-10832.0,Alive,TUMOR FREE,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0
TCGA-BJ-A18Z-01,TCGA-BJ-A18Z,THCA,58.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-21519.0,Alive,TUMOR FREE,1263.0,0.0,1263.0,0.0,1263.0,0.0,1263.0
TCGA-BJ-A191-01,TCGA-BJ-A191,THCA,49.0,FEMALE,WHITE,Stage I,"Other, specify",2010.0,-18162.0,Alive,TUMOR FREE,147.0,0.0,147.0,0.0,147.0,0.0,147.0
TCGA-BJ-A192-01,TCGA-BJ-A192,THCA,54.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-19878.0,Alive,TUMOR FREE,1349.0,0.0,1349.0,0.0,1349.0,0.0,1349.0
TCGA-BJ-A28R-01,TCGA-BJ-A28R,THCA,38.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-14044.0,Alive,TUMOR FREE,1282.0,0.0,1282.0,0.0,1282.0,0.0,1282.0
TCGA-BJ-A28S-01,TCGA-BJ-A28S,THCA,79.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-29143.0,Alive,TUMOR FREE,640.0,0.0,640.0,0.0,640.0,0.0,640.0
TCGA-BJ-A28T-01,TCGA-BJ-A28T,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-12698.0,Alive,TUMOR FREE,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0
TCGA-BJ-A28V-01,TCGA-BJ-A28V,THCA,80.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-29508.0,Alive,TUMOR FREE,987.0,0.0,987.0,0.0,987.0,0.0,987.0
TCGA-BJ-A28X-01,TCGA-BJ-A28X,THCA,32.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2010.0,-11735.0,Alive,TUMOR FREE,942.0,0.0,942.0,0.0,942.0,1.0,494.0
TCGA-BJ-A28Z-01,TCGA-BJ-A28Z,THCA,46.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-16912.0,Alive,TUMOR FREE,337.0,0.0,337.0,0.0,337.0,0.0,337.0
TCGA-BJ-A290-01,TCGA-BJ-A290,THCA,70.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2010.0,-25803.0,Alive,WITH TUMOR,919.0,0.0,919.0,0.0,919.0,1.0,329.0
TCGA-BJ-A2N7-01,TCGA-BJ-A2N7,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-11188.0,Alive,TUMOR FREE,559.0,0.0,559.0,0.0,559.0,0.0,559.0
TCGA-BJ-A2N9-01,TCGA-BJ-A2N9,THCA,42.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15411.0,Alive,WITH TUMOR,623.0,0.0,623.0,0.0,623.0,1.0,225.0
TCGA-BJ-A2NA-01,TCGA-BJ-A2NA,THCA,77.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-28147.0,Alive,WITH TUMOR,577.0,0.0,577.0,0.0,577.0,1.0,127.0
TCGA-BJ-A2P4-01,TCGA-BJ-A2P4,THCA,29.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-10602.0,Alive,TUMOR FREE,390.0,0.0,390.0,0.0,390.0,0.0,390.0
TCGA-BJ-A3EZ-01,TCGA-BJ-A3EZ,THCA,51.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18882.0,Alive,TUMOR FREE,487.0,0.0,487.0,0.0,487.0,0.0,487.0
TCGA-BJ-A3F0-01,TCGA-BJ-A3F0,THCA,64.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-23545.0,Alive,TUMOR FREE,424.0,0.0,424.0,0.0,424.0,0.0,424.0
TCGA-BJ-A3PR-01,TCGA-BJ-A3PR,THCA,69.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-25565.0,Alive,TUMOR FREE,1107.0,0.0,1107.0,0.0,1107.0,0.0,1107.0
TCGA-BJ-A3PU-01,TCGA-BJ-A3PU,THCA,52.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19007.0,Alive,TUMOR FREE,567.0,0.0,567.0,0.0,567.0,1.0,174.0
TCGA-BJ-A45D-01,TCGA-BJ-A45D,THCA,36.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-13335.0,Alive,TUMOR FREE,331.0,0.0,331.0,0.0,331.0,0.0,331.0
TCGA-BJ-A45F-01,TCGA-BJ-A45F,THCA,59.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-21713.0,Alive,TUMOR FREE,105.0,0.0,105.0,0.0,105.0,0.0,105.0
TCGA-BJ-A45G-01,TCGA-BJ-A45G,THCA,48.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-17831.0,Alive,TUMOR FREE,725.0,0.0,725.0,0.0,725.0,0.0,725.0
TCGA-BJ-A45H-01,TCGA-BJ-A45H,THCA,45.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-16541.0,Alive,WITH TUMOR,865.0,0.0,865.0,0.0,865.0,0.0,865.0
TCGA-BJ-A45J-01,TCGA-BJ-A45J,THCA,39.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2012.0,-14510.0,Alive,TUMOR FREE,658.0,0.0,658.0,0.0,658.0,0.0,658.0
TCGA-BJ-A45K-01,TCGA-BJ-A45K,THCA,33.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-12138.0,Alive,TUMOR FREE,705.0,0.0,705.0,0.0,705.0,0.0,705.0
TCGA-BJ-A4O8-01,TCGA-BJ-A4O8,THCA,47.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-17430.0,Alive,TUMOR FREE,591.0,0.0,591.0,0.0,591.0,0.0,591.0
TCGA-BJ-A4O9-01,TCGA-BJ-A4O9,THCA,51.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-18938.0,Alive,TUMOR FREE,714.0,0.0,714.0,0.0,714.0,0.0,714.0
TCGA-BK-A0CA-01,TCGA-BK-A0CA,UCEC,61.0,FEMALE,WHITE,,Mixed serous and endometrioid,2010.0,-22378.0,Alive,TUMOR FREE,1064.0,0.0,1064.0,0.0,1064.0,0.0,1064.0
TCGA-BK-A0CC-01,TCGA-BK-A0CC,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Serous endometrial adenocarcinoma,2010.0,-25479.0,Alive,WITH TUMOR,1067.0,0.0,1067.0,0.0,1067.0,1.0,1010.0
TCGA-BK-A139-01,TCGA-BK-A139,UCEC,74.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-27077.0,Dead,WITH TUMOR,,1.0,943.0,1.0,943.0,1.0,684.0
TCGA-BK-A13B-01,TCGA-BK-A13B,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2010.0,-21493.0,Alive,WITH TUMOR,966.0,0.0,966.0,0.0,966.0,1.0,760.0
TCGA-BK-A26L-01,TCGA-BK-A26L,UCEC,71.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2010.0,-26002.0,Alive,TUMOR FREE,734.0,0.0,734.0,0.0,734.0,0.0,734.0
TCGA-BL-A13I-01,TCGA-BL-A13I,BLCA,57.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-20885.0,Dead,WITH TUMOR,,1.0,223.0,1.0,223.0,1.0,216.0
TCGA-BL-A13J-01,TCGA-BL-A13J,BLCA,65.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-23927.0,Dead,WITH TUMOR,,1.0,81.0,1.0,81.0,1.0,81.0
TCGA-BL-A3JM-01,TCGA-BL-A3JM,BLCA,62.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-23000.0,Dead,WITH TUMOR,,1.0,205.0,1.0,205.0,1.0,111.0
TCGA-BP-4161-01,TCGA-BP-4161,KIRC,74.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-27119.0,Alive,WITH TUMOR,2746.0,0.0,2746.0,0.0,2746.0,1.0,2685.0
TCGA-BP-4164-01,TCGA-BP-4164,KIRC,51.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2002.0,-18898.0,Dead,TUMOR FREE,,1.0,992.0,0.0,992.0,0.0,992.0
TCGA-BP-4770-01,TCGA-BP-4770,KIRC,73.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2005.0,-26824.0,Dead,WITH TUMOR,,1.0,329.0,1.0,329.0,1.0,169.0
TCGA-BP-4801-01,TCGA-BP-4801,KIRC,57.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-20825.0,Alive,TUMOR FREE,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0
TCGA-BP-4960-01,TCGA-BP-4960,KIRC,46.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2004.0,-17099.0,Alive,TUMOR FREE,2172.0,0.0,2172.0,0.0,2172.0,0.0,2172.0
TCGA-BP-4961-01,TCGA-BP-4961,KIRC,47.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-17284.0,Alive,TUMOR FREE,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0
TCGA-BP-4962-01,TCGA-BP-4962,KIRC,58.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2005.0,-21255.0,Alive,TUMOR FREE,1785.0,0.0,1785.0,0.0,1785.0,0.0,1785.0
TCGA-BP-4963-01,TCGA-BP-4963,KIRC,63.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-23373.0,Alive,TUMOR FREE,1834.0,0.0,1834.0,0.0,1834.0,0.0,1834.0
TCGA-BP-4967-01,TCGA-BP-4967,KIRC,76.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-27857.0,Alive,TUMOR FREE,205.0,0.0,205.0,0.0,205.0,0.0,205.0
TCGA-BP-4968-01,TCGA-BP-4968,KIRC,40.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-14651.0,Alive,TUMOR FREE,1746.0,0.0,1746.0,0.0,1746.0,0.0,1746.0
TCGA-BP-4970-01,TCGA-BP-4970,KIRC,44.0,MALE,ASIAN,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-16228.0,Alive,TUMOR FREE,433.0,0.0,433.0,0.0,433.0,0.0,433.0
TCGA-BP-4971-01,TCGA-BP-4971,KIRC,40.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-14675.0,Alive,TUMOR FREE,1487.0,0.0,1487.0,0.0,1487.0,0.0,1487.0
TCGA-BP-4972-01,TCGA-BP-4972,KIRC,43.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-16038.0,Alive,TUMOR FREE,1502.0,0.0,1502.0,0.0,1502.0,0.0,1502.0
TCGA-BP-4973-01,TCGA-BP-4973,KIRC,47.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-17461.0,Alive,TUMOR FREE,1384.0,0.0,1384.0,0.0,1384.0,0.0,1384.0
TCGA-BP-4974-01,TCGA-BP-4974,KIRC,58.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-21310.0,Dead,WITH TUMOR,,1.0,211.0,1.0,211.0,1.0,35.0
TCGA-BP-4975-01,TCGA-BP-4975,KIRC,40.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-14710.0,Alive,TUMOR FREE,1433.0,0.0,1433.0,0.0,1433.0,0.0,1433.0
TCGA-BP-4977-01,TCGA-BP-4977,KIRC,57.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-20950.0,Alive,TUMOR FREE,454.0,0.0,454.0,0.0,454.0,0.0,454.0
TCGA-BP-4981-01,TCGA-BP-4981,KIRC,75.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-27676.0,Dead,TUMOR FREE,,1.0,1097.0,0.0,1097.0,0.0,1097.0
TCGA-BP-4982-01,TCGA-BP-4982,KIRC,42.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-15451.0,Alive,TUMOR FREE,1014.0,0.0,1014.0,0.0,1014.0,0.0,1014.0
TCGA-BP-4983-01,TCGA-BP-4983,KIRC,67.0,FEMALE,ASIAN,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-24558.0,Alive,TUMOR FREE,1413.0,0.0,1413.0,0.0,1413.0,0.0,1413.0
TCGA-BP-4985-01,TCGA-BP-4985,KIRC,72.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-26611.0,Dead,WITH TUMOR,,1.0,952.0,1.0,952.0,1.0,205.0
TCGA-BP-4987-01,TCGA-BP-4987,KIRC,41.0,FEMALE,ASIAN,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-15041.0,Alive,TUMOR FREE,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0
TCGA-BP-4989-01,TCGA-BP-4989,KIRC,58.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-21382.0,Alive,TUMOR FREE,118.0,0.0,118.0,0.0,118.0,0.0,118.0
TCGA-BP-4991-01,TCGA-BP-4991,KIRC,54.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19739.0,Alive,TUMOR FREE,1413.0,0.0,1413.0,0.0,1413.0,0.0,1413.0
TCGA-BP-4992-01,TCGA-BP-4992,KIRC,66.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-24438.0,Alive,TUMOR FREE,501.0,0.0,501.0,0.0,501.0,0.0,501.0
TCGA-BP-4993-01,TCGA-BP-4993,KIRC,58.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-21407.0,Alive,TUMOR FREE,177.0,0.0,177.0,0.0,177.0,0.0,177.0
TCGA-BP-4998-01,TCGA-BP-4998,KIRC,49.0,MALE,ASIAN,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-17997.0,Alive,TUMOR FREE,932.0,0.0,932.0,0.0,932.0,0.0,932.0
TCGA-BP-4999-01,TCGA-BP-4999,KIRC,56.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-20518.0,Alive,TUMOR FREE,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0
TCGA-BP-5000-01,TCGA-BP-5000,KIRC,40.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-14868.0,Alive,TUMOR FREE,563.0,0.0,563.0,0.0,563.0,0.0,563.0
TCGA-BP-5001-01,TCGA-BP-5001,KIRC,43.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-15858.0,Alive,TUMOR FREE,1177.0,0.0,1177.0,0.0,1177.0,0.0,1177.0
TCGA-BP-5004-01,TCGA-BP-5004,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19383.0,Alive,TUMOR FREE,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0
TCGA-BP-5007-01,TCGA-BP-5007,KIRC,45.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2007.0,-16793.0,Alive,TUMOR FREE,1140.0,0.0,1140.0,0.0,1140.0,0.0,1140.0
TCGA-BP-5008-01,TCGA-BP-5008,KIRC,46.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-17008.0,Alive,TUMOR FREE,1071.0,0.0,1071.0,0.0,1071.0,0.0,1071.0
TCGA-BP-5010-01,TCGA-BP-5010,KIRC,63.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-23130.0,Dead,WITH TUMOR,,1.0,878.0,1.0,878.0,1.0,582.0
TCGA-BP-5168-01,TCGA-BP-5168,KIRC,75.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2002.0,-27692.0,Dead,TUMOR FREE,,1.0,1463.0,0.0,1463.0,0.0,1463.0
TCGA-BP-5169-01,TCGA-BP-5169,KIRC,70.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-25615.0,Alive,TUMOR FREE,193.0,0.0,193.0,0.0,193.0,0.0,193.0
TCGA-BP-5170-01,TCGA-BP-5170,KIRC,55.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-20229.0,Alive,TUMOR FREE,2412.0,0.0,2412.0,0.0,2412.0,0.0,2412.0
TCGA-BP-5173-01,TCGA-BP-5173,KIRC,75.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-27436.0,Dead,TUMOR FREE,,1.0,62.0,0.0,62.0,0.0,62.0
TCGA-BP-5174-01,TCGA-BP-5174,KIRC,45.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-16693.0,Alive,TUMOR FREE,2257.0,0.0,2257.0,0.0,2257.0,0.0,2257.0
TCGA-BP-5175-01,TCGA-BP-5175,KIRC,60.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-21949.0,Alive,TUMOR FREE,932.0,0.0,932.0,0.0,932.0,0.0,932.0
TCGA-BP-5176-01,TCGA-BP-5176,KIRC,78.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-28727.0,Dead,TUMOR FREE,,1.0,1590.0,0.0,1590.0,0.0,1590.0
TCGA-BP-5177-01,TCGA-BP-5177,KIRC,46.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-17147.0,Alive,TUMOR FREE,293.0,0.0,293.0,0.0,293.0,0.0,293.0
TCGA-BP-5178-01,TCGA-BP-5178,KIRC,71.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-26070.0,Dead,WITH TUMOR,,1.0,1912.0,1.0,1912.0,1.0,396.0
TCGA-BP-5180-01,TCGA-BP-5180,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-19413.0,Alive,TUMOR FREE,2263.0,0.0,2263.0,0.0,2263.0,0.0,2263.0
TCGA-BP-5182-01,TCGA-BP-5182,KIRC,56.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-20597.0,Alive,TUMOR FREE,1165.0,0.0,1165.0,0.0,1165.0,0.0,1165.0
TCGA-BP-5183-01,TCGA-BP-5183,KIRC,57.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-20881.0,Alive,TUMOR FREE,1291.0,0.0,1291.0,0.0,1291.0,1.0,485.0
TCGA-BP-5184-01,TCGA-BP-5184,KIRC,54.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19746.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0
TCGA-BP-5185-01,TCGA-BP-5185,KIRC,56.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-20470.0,Alive,WITH TUMOR,1132.0,0.0,1132.0,0.0,1132.0,1.0,736.0
TCGA-BP-5186-01,TCGA-BP-5186,KIRC,50.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-18348.0,Alive,TUMOR FREE,693.0,0.0,693.0,0.0,693.0,0.0,693.0
TCGA-BP-5187-01,TCGA-BP-5187,KIRC,54.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-19999.0,Alive,TUMOR FREE,406.0,0.0,406.0,0.0,406.0,0.0,406.0
TCGA-BP-5189-01,TCGA-BP-5189,KIRC,60.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-22156.0,Dead,WITH TUMOR,,1.0,822.0,1.0,822.0,1.0,634.0
TCGA-BP-5190-01,TCGA-BP-5190,KIRC,61.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-22285.0,Alive,TUMOR FREE,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0
TCGA-BP-5191-01,TCGA-BP-5191,KIRC,79.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-29207.0,Alive,TUMOR FREE,967.0,0.0,967.0,0.0,967.0,0.0,967.0
TCGA-BP-5192-01,TCGA-BP-5192,KIRC,59.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-21891.0,Alive,TUMOR FREE,714.0,0.0,714.0,0.0,714.0,0.0,714.0
TCGA-BP-5194-01,TCGA-BP-5194,KIRC,39.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2008.0,-14551.0,Alive,TUMOR FREE,408.0,0.0,408.0,0.0,408.0,0.0,408.0
TCGA-BP-5195-01,TCGA-BP-5195,KIRC,75.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2008.0,-27547.0,Alive,TUMOR FREE,749.0,0.0,749.0,0.0,749.0,0.0,749.0
TCGA-BP-5196-01,TCGA-BP-5196,KIRC,53.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2008.0,-19719.0,Alive,TUMOR FREE,1018.0,0.0,1018.0,0.0,1018.0,0.0,1018.0
TCGA-BP-5198-01,TCGA-BP-5198,KIRC,72.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2008.0,-26360.0,Alive,TUMOR FREE,603.0,0.0,603.0,0.0,603.0,0.0,603.0
TCGA-BP-5200-01,TCGA-BP-5200,KIRC,44.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2008.0,-16197.0,Alive,TUMOR FREE,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0
TCGA-BP-5201-01,TCGA-BP-5201,KIRC,63.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2008.0,-23125.0,Alive,WITH TUMOR,951.0,0.0,951.0,0.0,951.0,1.0,
TCGA-BP-5202-01,TCGA-BP-5202,KIRC,75.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2008.0,-27556.0,Alive,TUMOR FREE,29.0,0.0,29.0,0.0,29.0,0.0,29.0
TCGA-BQ-5875-01,TCGA-BQ-5875,KIRP,66.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2004.0,-24153.0,Alive,TUMOR FREE,2639.0,0.0,2639.0,0.0,2639.0,0.0,2639.0
TCGA-BQ-5877-01,TCGA-BQ-5877,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Kidney Papillary Renal Cell Carcinoma,2004.0,-22095.0,Dead,WITH TUMOR,,1.0,270.0,1.0,270.0,1.0,127.0
TCGA-BQ-5878-01,TCGA-BQ-5878,KIRP,79.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2005.0,-29010.0,Alive,WITH TUMOR,1938.0,0.0,1938.0,0.0,1938.0,1.0,1022.0
TCGA-BQ-5879-01,TCGA-BQ-5879,KIRP,32.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2005.0,-11862.0,Dead,WITH TUMOR,,1.0,697.0,1.0,697.0,1.0,130.0
TCGA-BQ-5880-01,TCGA-BQ-5880,KIRP,79.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2006.0,-29053.0,Dead,WITH TUMOR,,1.0,1314.0,1.0,1314.0,1.0,972.0
TCGA-BQ-5881-01,TCGA-BQ-5881,KIRP,69.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2006.0,-25481.0,Alive,TUMOR FREE,1454.0,0.0,1454.0,0.0,1454.0,0.0,1454.0
TCGA-BQ-5882-01,TCGA-BQ-5882,KIRP,54.0,MALE,,Stage III,Kidney Papillary Renal Cell Carcinoma,2007.0,-20042.0,Dead,WITH TUMOR,,1.0,658.0,1.0,658.0,1.0,340.0
TCGA-BQ-5883-01,TCGA-BQ-5883,KIRP,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2007.0,-28877.0,Alive,TUMOR FREE,1242.0,0.0,1242.0,0.0,1242.0,0.0,1242.0
TCGA-BQ-5885-01,TCGA-BQ-5885,KIRP,63.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2008.0,-23173.0,Alive,TUMOR FREE,921.0,0.0,921.0,0.0,921.0,0.0,921.0
TCGA-BQ-5887-01,TCGA-BQ-5887,KIRP,54.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2009.0,-19747.0,Alive,TUMOR FREE,771.0,0.0,771.0,0.0,771.0,0.0,771.0
TCGA-BQ-5888-01,TCGA-BQ-5888,KIRP,74.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2009.0,-27346.0,Alive,TUMOR FREE,403.0,0.0,403.0,0.0,403.0,0.0,403.0
TCGA-BQ-5889-01,TCGA-BQ-5889,KIRP,63.0,MALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2009.0,-23267.0,Dead,WITH TUMOR,,1.0,329.0,1.0,329.0,1.0,
TCGA-BQ-5890-01,TCGA-BQ-5890,KIRP,69.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2009.0,-25272.0,Alive,TUMOR FREE,233.0,0.0,233.0,0.0,233.0,0.0,233.0
TCGA-BQ-5891-01,TCGA-BQ-5891,KIRP,57.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2009.0,-20945.0,Alive,TUMOR FREE,29.0,0.0,29.0,0.0,29.0,0.0,29.0
TCGA-BQ-5892-01,TCGA-BQ-5892,KIRP,51.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-18785.0,Alive,TUMOR FREE,364.0,0.0,364.0,0.0,364.0,0.0,364.0
TCGA-BQ-5893-01,TCGA-BQ-5893,KIRP,61.0,MALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2010.0,-22320.0,Dead,WITH TUMOR,,1.0,241.0,1.0,241.0,1.0,188.0
TCGA-BQ-5894-01,TCGA-BQ-5894,KIRP,42.0,MALE,,Stage IV,Kidney Papillary Renal Cell Carcinoma,2010.0,-15510.0,Alive,WITH TUMOR,84.0,0.0,84.0,0.0,84.0,0.0,84.0
TCGA-BQ-7044-01,TCGA-BQ-7044,KIRP,73.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2000.0,-26831.0,Alive,TUMOR FREE,3760.0,0.0,3760.0,0.0,3760.0,0.0,3760.0
TCGA-BQ-7046-01,TCGA-BQ-7046,KIRP,61.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2002.0,-22337.0,Alive,TUMOR FREE,2948.0,0.0,2948.0,0.0,2948.0,0.0,2948.0
TCGA-BQ-7048-01,TCGA-BQ-7048,KIRP,64.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2003.0,-23460.0,Alive,WITH TUMOR,2839.0,0.0,2839.0,0.0,2839.0,1.0,229.0
TCGA-BQ-7050-01,TCGA-BQ-7050,KIRP,53.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2006.0,-19550.0,Alive,TUMOR FREE,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0
TCGA-BQ-7051-01,TCGA-BQ-7051,KIRP,74.0,MALE,WHITE,Stage II,Kidney Papillary Renal Cell Carcinoma,2007.0,-27120.0,Alive,TUMOR FREE,1533.0,0.0,1533.0,0.0,1533.0,0.0,1533.0
TCGA-BQ-7053-01,TCGA-BQ-7053,KIRP,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2007.0,-20837.0,Alive,TUMOR FREE,1516.0,0.0,1516.0,0.0,1516.0,0.0,1516.0
TCGA-BQ-7055-01,TCGA-BQ-7055,KIRP,73.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2008.0,-26749.0,Alive,TUMOR FREE,799.0,0.0,799.0,0.0,799.0,0.0,799.0
TCGA-BQ-7058-01,TCGA-BQ-7058,KIRP,81.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2010.0,-29856.0,Dead,WITH TUMOR,,1.0,343.0,1.0,343.0,1.0,50.0
TCGA-BQ-7059-01,TCGA-BQ-7059,KIRP,71.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-26136.0,Alive,TUMOR FREE,232.0,0.0,232.0,0.0,232.0,0.0,232.0
TCGA-BQ-7060-01,TCGA-BQ-7060,KIRP,53.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-19479.0,Alive,TUMOR FREE,214.0,0.0,214.0,0.0,214.0,0.0,214.0
TCGA-BQ-7061-01,TCGA-BQ-7061,KIRP,83.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-30662.0,Alive,TUMOR FREE,218.0,0.0,218.0,0.0,218.0,0.0,218.0
TCGA-BQ-7062-01,TCGA-BQ-7062,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-23559.0,Alive,TUMOR FREE,116.0,0.0,116.0,0.0,116.0,0.0,116.0
TCGA-BR-4187-01,TCGA-BR-4187,STAD,56.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-20635.0,Dead,,,1.0,141.0,,141.0,0.0,141.0
TCGA-BR-4191-01,TCGA-BR-4191,STAD,72.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-26562.0,Dead,,,1.0,558.0,,558.0,0.0,558.0
TCGA-BR-4201-01,TCGA-BR-4201,STAD,66.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-24354.0,Dead,,,1.0,940.0,,940.0,0.0,940.0
TCGA-BR-4253-01,TCGA-BR-4253,STAD,80.0,FEMALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-29397.0,Dead,,,1.0,124.0,,124.0,0.0,124.0
TCGA-BR-4255-01,TCGA-BR-4255,STAD,76.0,FEMALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-27893.0,Dead,,,1.0,124.0,,124.0,0.0,124.0
TCGA-BR-4256-01,TCGA-BR-4256,STAD,80.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-29441.0,Dead,,,1.0,284.0,,284.0,0.0,284.0
TCGA-BR-4257-01,TCGA-BR-4257,STAD,79.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-29014.0,Dead,,,1.0,294.0,,294.0,0.0,294.0
TCGA-BR-4267-01,TCGA-BR-4267,STAD,51.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-18699.0,Dead,,,1.0,188.0,,188.0,0.0,188.0
TCGA-BR-4279-01,TCGA-BR-4279,STAD,43.0,MALE,WHITE,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-16065.0,Dead,,,1.0,291.0,,291.0,0.0,291.0
TCGA-BR-4280-01,TCGA-BR-4280,STAD,78.0,FEMALE,WHITE,Stage III,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-28515.0,Dead,,,1.0,201.0,,201.0,0.0,201.0
TCGA-BR-4292-01,TCGA-BR-4292,STAD,73.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-26670.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4294-01,TCGA-BR-4294,STAD,65.0,MALE,WHITE,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2009.0,-23758.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4357-01,TCGA-BR-4357,STAD,58.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-21295.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4361-01,TCGA-BR-4361,STAD,66.0,FEMALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-24260.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4362-01,TCGA-BR-4362,STAD,74.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-27179.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4363-01,TCGA-BR-4363,STAD,60.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-22196.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4366-01,TCGA-BR-4366,STAD,87.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-32024.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4368-01,TCGA-BR-4368,STAD,78.0,FEMALE,WHITE,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-28770.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4369-01,TCGA-BR-4369,STAD,75.0,MALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-27509.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4370-01,TCGA-BR-4370,STAD,74.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-27344.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-4371-01,TCGA-BR-4371,STAD,71.0,FEMALE,WHITE,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-26290.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-6452-01,TCGA-BR-6452,STAD,78.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-28827.0,Alive,TUMOR FREE,1055.0,0.0,1055.0,0.0,1055.0,0.0,1055.0
TCGA-BR-6453-01,TCGA-BR-6453,STAD,54.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-20061.0,Alive,TUMOR FREE,485.0,0.0,485.0,0.0,485.0,0.0,485.0
TCGA-BR-6454-01,TCGA-BR-6454,STAD,58.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21501.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-6455-01,TCGA-BR-6455,STAD,59.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21865.0,Dead,WITH TUMOR,,1.0,422.0,1.0,422.0,1.0,385.0
TCGA-BR-6456-01,TCGA-BR-6456,STAD,74.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27288.0,Dead,TUMOR FREE,,1.0,526.0,0.0,526.0,0.0,526.0
TCGA-BR-6457-01,TCGA-BR-6457,STAD,69.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25396.0,Alive,TUMOR FREE,416.0,0.0,416.0,0.0,416.0,0.0,416.0
TCGA-BR-6458-01,TCGA-BR-6458,STAD,57.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21069.0,Dead,WITH TUMOR,,1.0,588.0,1.0,588.0,1.0,574.0
TCGA-BR-6564-01,TCGA-BR-6564,STAD,46.0,FEMALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-17129.0,Dead,TUMOR FREE,,1.0,794.0,0.0,794.0,0.0,794.0
TCGA-BR-6565-01,TCGA-BR-6565,STAD,67.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-24495.0,Dead,WITH TUMOR,,1.0,279.0,1.0,279.0,1.0,279.0
TCGA-BR-6566-01,TCGA-BR-6566,STAD,64.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23404.0,Alive,TUMOR FREE,997.0,0.0,997.0,0.0,997.0,0.0,997.0
TCGA-BR-6705-01,TCGA-BR-6705,STAD,68.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25073.0,Dead,WITH TUMOR,,1.0,779.0,1.0,779.0,1.0,779.0
TCGA-BR-6706-01,TCGA-BR-6706,STAD,63.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-23053.0,Dead,WITH TUMOR,,1.0,549.0,1.0,549.0,1.0,402.0
TCGA-BR-6707-01,TCGA-BR-6707,STAD,75.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27529.0,Alive,WITH TUMOR,491.0,0.0,491.0,0.0,491.0,1.0,426.0
TCGA-BR-6801-01,TCGA-BR-6801,STAD,70.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25637.0,Alive,TUMOR FREE,1223.0,0.0,1223.0,0.0,1223.0,0.0,1223.0
TCGA-BR-6802-01,TCGA-BR-6802,STAD,65.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23915.0,Alive,TUMOR FREE,940.0,0.0,940.0,0.0,940.0,1.0,807.0
TCGA-BR-6803-01,TCGA-BR-6803,STAD,54.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-19751.0,Alive,TUMOR FREE,949.0,0.0,949.0,0.0,949.0,0.0,949.0
TCGA-BR-6852-01,TCGA-BR-6852,STAD,64.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23469.0,Alive,TUMOR FREE,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0
TCGA-BR-7196-01,TCGA-BR-7196,STAD,64.0,MALE,WHITE,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23611.0,Alive,WITH TUMOR,666.0,0.0,666.0,0.0,666.0,1.0,348.0
TCGA-BR-7197-01,TCGA-BR-7197,STAD,69.0,MALE,WHITE,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25445.0,Alive,TUMOR FREE,280.0,0.0,280.0,0.0,280.0,0.0,280.0
TCGA-BR-7703-01,TCGA-BR-7703,STAD,81.0,MALE,WHITE,Stage IA,"Stomach, Intestinal Adenocarcinoma, Papillary Type",2011.0,-29711.0,Alive,TUMOR FREE,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0
TCGA-BR-7715-01,TCGA-BR-7715,STAD,65.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23861.0,Alive,TUMOR FREE,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0
TCGA-BR-7716-01,TCGA-BR-7716,STAD,62.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22829.0,Alive,TUMOR FREE,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0
TCGA-BR-7717-01,TCGA-BR-7717,STAD,63.0,MALE,WHITE,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-23102.0,Dead,TUMOR FREE,,1.0,552.0,0.0,552.0,0.0,552.0
TCGA-BR-7722-01,TCGA-BR-7722,STAD,62.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22701.0,Dead,TUMOR FREE,,1.0,466.0,0.0,466.0,0.0,466.0
TCGA-BR-7723-01,TCGA-BR-7723,STAD,59.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21839.0,Dead,WITH TUMOR,,1.0,874.0,1.0,874.0,1.0,559.0
TCGA-BR-7851-01,TCGA-BR-7851,STAD,74.0,MALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27091.0,Dead,TUMOR FREE,574.0,1.0,,0.0,,0.0,
TCGA-BR-7901-01,TCGA-BR-7901,STAD,74.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27031.0,Dead,TUMOR FREE,,1.0,105.0,0.0,105.0,1.0,91.0
TCGA-BR-7957-01,TCGA-BR-7957,STAD,50.0,FEMALE,WHITE,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-18517.0,Dead,TUMOR FREE,,1.0,276.0,0.0,276.0,0.0,276.0
TCGA-BR-7958-01,TCGA-BR-7958,STAD,60.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22204.0,Alive,TUMOR FREE,899.0,0.0,899.0,0.0,899.0,0.0,899.0
TCGA-BR-7959-01,TCGA-BR-7959,STAD,59.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2011.0,-21730.0,Alive,TUMOR FREE,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0
TCGA-BR-8058-01,TCGA-BR-8058,STAD,53.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-19658.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,1.0,89.0
TCGA-BR-8059-01,TCGA-BR-8059,STAD,72.0,MALE,WHITE,Stage III,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-26474.0,Dead,TUMOR FREE,,1.0,439.0,0.0,439.0,0.0,439.0
TCGA-BR-8080-01,TCGA-BR-8080,STAD,72.0,FEMALE,WHITE,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2011.0,-26546.0,Dead,TUMOR FREE,,1.0,292.0,0.0,292.0,0.0,292.0
TCGA-BR-8081-01,TCGA-BR-8081,STAD,71.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-26095.0,Alive,TUMOR FREE,981.0,0.0,981.0,0.0,981.0,0.0,981.0
TCGA-BR-8284-01,TCGA-BR-8284,STAD,72.0,FEMALE,WHITE,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-26526.0,Dead,TUMOR FREE,,1.0,245.0,0.0,245.0,0.0,245.0
TCGA-BR-8286-01,TCGA-BR-8286,STAD,49.0,MALE,WHITE,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-17966.0,Alive,TUMOR FREE,895.0,0.0,895.0,0.0,895.0,0.0,895.0
TCGA-BR-8289-01,TCGA-BR-8289,STAD,57.0,MALE,WHITE,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-20849.0,Dead,TUMOR FREE,,1.0,81.0,0.0,81.0,0.0,81.0
TCGA-BR-8291-01,TCGA-BR-8291,STAD,61.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-22552.0,Dead,TUMOR FREE,,1.0,607.0,0.0,607.0,0.0,607.0
TCGA-BR-8297-01,TCGA-BR-8297,STAD,58.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-21224.0,Alive,WITH TUMOR,225.0,0.0,225.0,0.0,225.0,0.0,225.0
TCGA-BR-8361-01,TCGA-BR-8361,STAD,71.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25999.0,Alive,TUMOR FREE,946.0,0.0,946.0,0.0,946.0,0.0,946.0
TCGA-BR-8363-01,TCGA-BR-8363,STAD,73.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26976.0,Dead,TUMOR FREE,,1.0,8.0,0.0,8.0,0.0,8.0
TCGA-BR-8364-01,TCGA-BR-8364,STAD,42.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-15389.0,Alive,TUMOR FREE,675.0,0.0,675.0,0.0,675.0,0.0,675.0
TCGA-BR-8365-01,TCGA-BR-8365,STAD,70.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25725.0,Dead,WITH TUMOR,,1.0,533.0,1.0,533.0,1.0,533.0
TCGA-BR-8366-01,TCGA-BR-8366,STAD,80.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-29394.0,Alive,TUMOR FREE,29.0,0.0,29.0,0.0,29.0,0.0,29.0
TCGA-BR-8367-01,TCGA-BR-8367,STAD,55.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-20441.0,Dead,WITH TUMOR,,1.0,801.0,1.0,801.0,1.0,580.0
TCGA-BR-8368-01,TCGA-BR-8368,STAD,84.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-30874.0,Alive,TUMOR FREE,131.0,0.0,131.0,0.0,131.0,0.0,131.0
TCGA-BR-8369-01,TCGA-BR-8369,STAD,76.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-28051.0,Alive,WITH TUMOR,427.0,0.0,427.0,0.0,427.0,1.0,419.0
TCGA-BR-8371-01,TCGA-BR-8371,STAD,62.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22883.0,Dead,WITH TUMOR,,1.0,359.0,1.0,359.0,1.0,357.0
TCGA-BR-8372-01,TCGA-BR-8372,STAD,63.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-23346.0,Alive,TUMOR FREE,951.0,0.0,951.0,0.0,951.0,0.0,951.0
TCGA-BR-8380-01,TCGA-BR-8380,STAD,55.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-20157.0,Alive,WITH TUMOR,21.0,0.0,21.0,0.0,21.0,1.0,467.0
TCGA-BR-8381-01,TCGA-BR-8381,STAD,51.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-18843.0,Alive,TUMOR FREE,224.0,0.0,224.0,0.0,224.0,0.0,224.0
TCGA-BR-8382-01,TCGA-BR-8382,STAD,67.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-24737.0,Dead,TUMOR FREE,,1.0,762.0,0.0,762.0,0.0,762.0
TCGA-BR-8384-01,TCGA-BR-8384,STAD,69.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25281.0,Alive,TUMOR FREE,113.0,0.0,113.0,0.0,113.0,0.0,113.0
TCGA-BR-8483-01,TCGA-BR-8483,STAD,59.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-21731.0,Alive,TUMOR FREE,164.0,0.0,164.0,0.0,164.0,0.0,164.0
TCGA-BR-8484-01,TCGA-BR-8484,STAD,61.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-22583.0,Dead,TUMOR FREE,,1.0,766.0,0.0,766.0,0.0,766.0
TCGA-BR-8485-01,TCGA-BR-8485,STAD,68.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-24845.0,Alive,TUMOR FREE,280.0,0.0,280.0,0.0,280.0,0.0,280.0
TCGA-BR-8486-01,TCGA-BR-8486,STAD,90.0,FEMALE,WHITE,Stage IA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-32872.0,Alive,TUMOR FREE,615.0,0.0,615.0,0.0,615.0,0.0,615.0
TCGA-BR-8588-01,TCGA-BR-8588,STAD,55.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-20177.0,Alive,TUMOR FREE,389.0,0.0,389.0,0.0,389.0,0.0,389.0
TCGA-BR-8589-01,TCGA-BR-8589,STAD,56.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-20727.0,Alive,TUMOR FREE,825.0,0.0,825.0,0.0,825.0,0.0,825.0
TCGA-BR-8590-01,TCGA-BR-8590,STAD,62.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22937.0,Dead,WITH TUMOR,,1.0,284.0,1.0,284.0,1.0,223.0
TCGA-BR-8591-01,TCGA-BR-8591,STAD,79.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-29054.0,Alive,TUMOR FREE,856.0,0.0,856.0,0.0,856.0,0.0,856.0
TCGA-BR-8592-01,TCGA-BR-8592,STAD,63.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-23133.0,Dead,TUMOR FREE,,1.0,191.0,0.0,191.0,0.0,191.0
TCGA-BR-8677-01,TCGA-BR-8677,STAD,74.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-27223.0,Alive,TUMOR FREE,813.0,0.0,813.0,0.0,813.0,0.0,813.0
TCGA-BR-8678-01,TCGA-BR-8678,STAD,76.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-28037.0,Alive,TUMOR FREE,754.0,0.0,754.0,0.0,754.0,0.0,754.0
TCGA-BR-8679-01,TCGA-BR-8679,STAD,63.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-23084.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-8680-01,TCGA-BR-8680,STAD,45.0,MALE,ASIAN,Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-16637.0,Alive,TUMOR FREE,972.0,0.0,972.0,0.0,972.0,0.0,972.0
TCGA-BR-8682-01,TCGA-BR-8682,STAD,52.0,MALE,ASIAN,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2012.0,-19165.0,Alive,TUMOR FREE,991.0,0.0,991.0,0.0,991.0,0.0,991.0
TCGA-BR-8683-01,TCGA-BR-8683,STAD,75.0,MALE,ASIAN,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-27549.0,Dead,TUMOR FREE,,1.0,300.0,0.0,300.0,0.0,300.0
TCGA-BR-8686-01,TCGA-BR-8686,STAD,69.0,MALE,ASIAN,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-25372.0,Dead,TUMOR FREE,,1.0,635.0,0.0,635.0,0.0,635.0
TCGA-BR-8687-01,TCGA-BR-8687,STAD,67.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-24472.0,Dead,WITH TUMOR,,1.0,250.0,1.0,250.0,1.0,250.0
TCGA-BR-A44T-01,TCGA-BR-A44T,STAD,53.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-19407.0,Alive,WITH TUMOR,1038.0,0.0,1038.0,0.0,1038.0,1.0,682.0
TCGA-BR-A44U-01,TCGA-BR-A44U,STAD,70.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25577.0,Dead,TUMOR FREE,,1.0,422.0,0.0,422.0,0.0,422.0
TCGA-BR-A452-01,TCGA-BR-A452,STAD,57.0,MALE,ASIAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-21107.0,Dead,TUMOR FREE,,1.0,229.0,0.0,229.0,0.0,229.0
TCGA-BR-A453-01,TCGA-BR-A453,STAD,51.0,MALE,ASIAN,Stage IV,"Stomach Adenocarcinoma, Signet Ring Type",2012.0,-18988.0,Dead,TUMOR FREE,,1.0,185.0,0.0,185.0,0.0,185.0
TCGA-BR-A4CR-01,TCGA-BR-A4CR,STAD,70.0,FEMALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25669.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-BR-A4CS-01,TCGA-BR-A4CS,STAD,77.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-28211.0,Dead,TUMOR FREE,,1.0,45.0,0.0,45.0,0.0,45.0
TCGA-BR-A4IU-01,TCGA-BR-A4IU,STAD,34.0,FEMALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-12601.0,Alive,TUMOR FREE,838.0,0.0,838.0,0.0,838.0,0.0,838.0
TCGA-BR-A4IV-01,TCGA-BR-A4IV,STAD,47.0,MALE,ASIAN,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-17515.0,Dead,WITH TUMOR,,1.0,869.0,1.0,869.0,1.0,737.0
TCGA-BR-A4IY-01,TCGA-BR-A4IY,STAD,58.0,MALE,ASIAN,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-21314.0,Alive,TUMOR FREE,392.0,0.0,392.0,0.0,392.0,0.0,392.0
TCGA-BR-A4IZ-01,TCGA-BR-A4IZ,STAD,45.0,FEMALE,ASIAN,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-16695.0,Dead,TUMOR FREE,,1.0,273.0,0.0,273.0,0.0,273.0
TCGA-BR-A4J1-01,TCGA-BR-A4J1,STAD,63.0,MALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-23266.0,Dead,,,1.0,22.0,,22.0,0.0,22.0
TCGA-BR-A4J2-01,TCGA-BR-A4J2,STAD,70.0,MALE,ASIAN,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-25891.0,Alive,TUMOR FREE,431.0,0.0,431.0,0.0,431.0,0.0,431.0
TCGA-BR-A4J4-01,TCGA-BR-A4J4,STAD,39.0,MALE,ASIAN,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-14459.0,Alive,TUMOR FREE,16.0,0.0,16.0,0.0,16.0,0.0,16.0
TCGA-BR-A4J5-01,TCGA-BR-A4J5,STAD,56.0,MALE,ASIAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2012.0,-20714.0,Alive,TUMOR FREE,862.0,0.0,862.0,0.0,862.0,0.0,862.0
TCGA-BR-A4J6-01,TCGA-BR-A4J6,STAD,69.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25279.0,Alive,TUMOR FREE,20.0,0.0,20.0,0.0,20.0,0.0,20.0
TCGA-BR-A4J7-01,TCGA-BR-A4J7,STAD,49.0,MALE,ASIAN,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2012.0,-17932.0,Alive,TUMOR FREE,989.0,0.0,989.0,0.0,989.0,0.0,989.0
TCGA-BR-A4J8-01,TCGA-BR-A4J8,STAD,71.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26048.0,Alive,TUMOR FREE,411.0,0.0,411.0,0.0,411.0,0.0,411.0
TCGA-BR-A4J9-01,TCGA-BR-A4J9,STAD,55.0,MALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-20093.0,Alive,TUMOR FREE,14.0,0.0,14.0,0.0,14.0,0.0,14.0
TCGA-BR-A4PD-01,TCGA-BR-A4PD,STAD,72.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26334.0,Alive,TUMOR FREE,628.0,0.0,628.0,0.0,628.0,0.0,628.0
TCGA-BR-A4PE-01,TCGA-BR-A4PE,STAD,68.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-24986.0,Alive,TUMOR FREE,621.0,0.0,621.0,0.0,621.0,0.0,621.0
TCGA-BR-A4PF-01,TCGA-BR-A4PF,STAD,72.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26412.0,Alive,TUMOR FREE,35.0,0.0,35.0,0.0,35.0,0.0,35.0
TCGA-BR-A4QI-01,TCGA-BR-A4QI,STAD,70.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25928.0,Dead,WITH TUMOR,,1.0,652.0,1.0,652.0,1.0,383.0
TCGA-BS-A0V4-01,TCGA-BS-A0V4,UCEC,56.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2006.0,-20777.0,Alive,TUMOR FREE,1810.0,0.0,1810.0,0.0,1810.0,0.0,1810.0
TCGA-BS-A0V7-01,TCGA-BS-A0V7,UCEC,48.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,,Endometrioid endometrial adenocarcinoma,2006.0,-17810.0,Alive,TUMOR FREE,1934.0,0.0,1934.0,0.0,1934.0,0.0,1934.0
TCGA-BT-A0S7-01,TCGA-BT-A0S7,BLCA,75.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,-27533.0,Dead,WITH TUMOR,,1.0,200.0,1.0,200.0,1.0,200.0
TCGA-BT-A0YX-01,TCGA-BT-A0YX,BLCA,70.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-25570.0,Dead,WITH TUMOR,,1.0,400.0,1.0,400.0,1.0,326.0
TCGA-BT-A20J-01,TCGA-BT-A20J,BLCA,75.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),1999.0,-27646.0,Dead,WITH TUMOR,,1.0,579.0,1.0,579.0,1.0,254.0
TCGA-BT-A20N-01,TCGA-BT-A20N,BLCA,72.0,MALE,,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2003.0,-26456.0,Dead,WITH TUMOR,,1.0,795.0,1.0,795.0,1.0,795.0
TCGA-BT-A20O-01,TCGA-BT-A20O,BLCA,75.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2003.0,-27534.0,Dead,WITH TUMOR,,1.0,370.0,1.0,370.0,1.0,315.0
TCGA-BT-A20P-01,TCGA-BT-A20P,BLCA,81.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2005.0,-29634.0,Dead,,,1.0,544.0,,544.0,0.0,544.0
TCGA-BT-A20Q-01,TCGA-BT-A20Q,BLCA,73.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2006.0,-26778.0,Dead,WITH TUMOR,,1.0,593.0,1.0,593.0,1.0,593.0
TCGA-BT-A20R-01,TCGA-BT-A20R,BLCA,79.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2006.0,-28987.0,Dead,,,1.0,154.0,,154.0,0.0,154.0
TCGA-BT-A20T-01,TCGA-BT-A20T,BLCA,63.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,-23220.0,Dead,WITH TUMOR,,1.0,453.0,1.0,453.0,1.0,314.0
TCGA-BT-A20U-01,TCGA-BT-A20U,BLCA,70.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-25761.0,Dead,TUMOR FREE,,1.0,455.0,0.0,455.0,0.0,455.0
TCGA-BT-A20W-01,TCGA-BT-A20W,BLCA,71.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-26078.0,Dead,TUMOR FREE,,1.0,254.0,0.0,254.0,0.0,254.0
TCGA-BT-A2LB-01,TCGA-BT-A2LB,BLCA,73.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-26846.0,Dead,TUMOR FREE,,1.0,492.0,0.0,492.0,0.0,492.0
TCGA-BT-A2LD-01,TCGA-BT-A2LD,BLCA,78.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-28673.0,Dead,WITH TUMOR,,1.0,623.0,1.0,623.0,1.0,555.0
TCGA-BT-A3PH-01,TCGA-BT-A3PH,BLCA,76.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-28030.0,Dead,WITH TUMOR,,1.0,142.0,1.0,142.0,1.0,142.0
TCGA-BT-A3PJ-01,TCGA-BT-A3PJ,BLCA,76.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27821.0,Alive,TUMOR FREE,789.0,0.0,789.0,0.0,789.0,0.0,789.0
TCGA-BT-A3PK-01,TCGA-BT-A3PK,BLCA,80.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-29314.0,Dead,WITH TUMOR,,1.0,303.0,1.0,303.0,1.0,303.0
TCGA-BT-A42C-01,TCGA-BT-A42C,BLCA,64.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-23584.0,Alive,TUMOR FREE,873.0,0.0,873.0,0.0,873.0,0.0,873.0
TCGA-BW-A5NO-01,TCGA-BW-A5NO,LIHC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-18510.0,Alive,TUMOR FREE,20.0,0.0,20.0,0.0,20.0,0.0,20.0
TCGA-BW-A5NP-01,TCGA-BW-A5NP,LIHC,26.0,FEMALE,WHITE,Stage IV,Hepatocellular Carcinoma,2010.0,-9809.0,Alive,WITH TUMOR,0.0,0.0,0.0,0.0,0.0,1.0,102.0
TCGA-BW-A5NQ-01,TCGA-BW-A5NQ,LIHC,63.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2010.0,-23353.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-C4-A0F0-01,TCGA-C4-A0F0,BLCA,60.0,MALE,,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,-22068.0,Alive,TUMOR FREE,59.0,0.0,59.0,0.0,59.0,0.0,59.0
TCGA-C4-A0F1-01,TCGA-C4-A0F1,BLCA,71.0,MALE,,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2006.0,-26178.0,Alive,TUMOR FREE,89.0,0.0,89.0,0.0,89.0,0.0,89.0
TCGA-C4-A0F6-01,TCGA-C4-A0F6,BLCA,82.0,FEMALE,,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-29951.0,Alive,TUMOR FREE,700.0,0.0,700.0,0.0,700.0,0.0,700.0
TCGA-C4-A0F7-01,TCGA-C4-A0F7,BLCA,77.0,MALE,,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-28428.0,Dead,WITH TUMOR,,1.0,62.0,1.0,62.0,1.0,62.0
TCGA-C8-A12K-01,TCGA-C8-A12K,BRCA,80.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-29463.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-C8-A12L-01,TCGA-C8-A12L,BRCA,67.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-24710.0,Alive,TUMOR FREE,363.0,0.0,363.0,0.0,363.0,0.0,363.0
TCGA-C8-A12M-01,TCGA-C8-A12M,BRCA,70.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-25811.0,Alive,TUMOR FREE,358.0,0.0,358.0,0.0,358.0,0.0,358.0
TCGA-C8-A12O-01,TCGA-C8-A12O,BRCA,50.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-18506.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-C8-A12P-01,TCGA-C8-A12P,BRCA,55.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-20332.0,Alive,TUMOR FREE,358.0,0.0,358.0,0.0,358.0,0.0,358.0
TCGA-C8-A12Q-01,TCGA-C8-A12Q,BRCA,78.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-28733.0,Dead,WITH TUMOR,,1.0,385.0,1.0,385.0,1.0,385.0
TCGA-C8-A12T-01,TCGA-C8-A12T,BRCA,43.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-C8-A12U-01,TCGA-C8-A12U,BRCA,46.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-17045.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-C8-A12V-01,TCGA-C8-A12V,BRCA,55.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-20346.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-C8-A12W-01,TCGA-C8-A12W,BRCA,49.0,FEMALE,ASIAN,Stage IIIB,Infiltrating Ductal Carcinoma,2010.0,-18140.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-C8-A12X-01,TCGA-C8-A12X,BRCA,62.0,FEMALE,ASIAN,Stage IIB,Mucinous Carcinoma,2010.0,-22889.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-C8-A12Y-01,TCGA-C8-A12Y,BRCA,44.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0
TCGA-C8-A12Z-01,TCGA-C8-A12Z,BRCA,45.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-16508.0,Alive,TUMOR FREE,382.0,0.0,382.0,0.0,382.0,0.0,382.0
TCGA-C8-A130-01,TCGA-C8-A130,BRCA,52.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-19117.0,Alive,TUMOR FREE,370.0,0.0,370.0,0.0,370.0,0.0,370.0
TCGA-C8-A131-01,TCGA-C8-A131,BRCA,82.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-29966.0,Alive,TUMOR FREE,411.0,0.0,411.0,0.0,411.0,0.0,411.0
TCGA-C8-A132-01,TCGA-C8-A132,BRCA,56.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-20471.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-C8-A133-01,TCGA-C8-A133,BRCA,65.0,FEMALE,WHITE,Stage IIIA,"Other, specify",2010.0,-23922.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-C8-A134-01,TCGA-C8-A134,BRCA,52.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-19010.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-C8-A135-01,TCGA-C8-A135,BRCA,64.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-23667.0,Alive,TUMOR FREE,393.0,0.0,393.0,0.0,393.0,0.0,393.0
TCGA-C8-A137-01,TCGA-C8-A137,BRCA,34.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-12729.0,Alive,WITH TUMOR,379.0,0.0,379.0,0.0,379.0,1.0,136.0
TCGA-C8-A138-01,TCGA-C8-A138,BRCA,54.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-20053.0,Alive,TUMOR FREE,380.0,0.0,380.0,0.0,380.0,0.0,380.0
TCGA-C8-A1HE-01,TCGA-C8-A1HE,BRCA,59.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-C8-A1HG-01,TCGA-C8-A1HG,BRCA,50.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,345.0,0.0,345.0,0.0,345.0,0.0,345.0
TCGA-C8-A1HI-01,TCGA-C8-A1HI,BRCA,40.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,343.0,0.0,343.0,0.0,343.0,0.0,343.0
TCGA-C8-A1HJ-01,TCGA-C8-A1HJ,BRCA,53.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-19629.0,Alive,TUMOR FREE,5.0,0.0,5.0,0.0,5.0,0.0,5.0
TCGA-C8-A1HK-01,TCGA-C8-A1HK,BRCA,53.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,366.0,0.0,366.0,0.0,366.0,0.0,366.0
TCGA-C8-A1HL-01,TCGA-C8-A1HL,BRCA,38.0,FEMALE,ASIAN,Stage IIIA,"Other, specify",2010.0,,Alive,TUMOR FREE,317.0,0.0,317.0,0.0,317.0,0.0,317.0
TCGA-C8-A1HM-01,TCGA-C8-A1HM,BRCA,74.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-27063.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-C8-A1HN-01,TCGA-C8-A1HN,BRCA,56.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-20712.0,Alive,TUMOR FREE,394.0,0.0,394.0,0.0,394.0,0.0,394.0
TCGA-C8-A1HO-01,TCGA-C8-A1HO,BRCA,34.0,FEMALE,ASIAN,Stage IIIC,Infiltrating Ductal Carcinoma,2010.0,-12715.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-C8-A26V-01,TCGA-C8-A26V,BRCA,47.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-17468.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-C8-A26W-01,TCGA-C8-A26W,BRCA,58.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-21391.0,Alive,TUMOR FREE,381.0,0.0,381.0,0.0,381.0,0.0,381.0
TCGA-C8-A26X-01,TCGA-C8-A26X,BRCA,58.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-21463.0,Alive,TUMOR FREE,376.0,0.0,376.0,0.0,376.0,0.0,376.0
TCGA-C8-A26Y-01,TCGA-C8-A26Y,BRCA,90.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-32872.0,Alive,TUMOR FREE,394.0,0.0,394.0,0.0,394.0,0.0,394.0
TCGA-C8-A26Z-01,TCGA-C8-A26Z,BRCA,59.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,470.0,0.0,470.0,0.0,470.0,0.0,470.0
TCGA-C8-A273-01,TCGA-C8-A273,BRCA,29.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,513.0,0.0,513.0,0.0,513.0,0.0,513.0
TCGA-C8-A274-01,TCGA-C8-A274,BRCA,63.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-23337.0,Alive,TUMOR FREE,508.0,0.0,508.0,0.0,508.0,0.0,508.0
TCGA-C8-A275-01,TCGA-C8-A275,BRCA,56.0,FEMALE,ASIAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-20774.0,Alive,TUMOR FREE,1.0,0.0,1.0,0.0,1.0,0.0,1.0
TCGA-C8-A278-01,TCGA-C8-A278,BRCA,61.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-22598.0,Alive,TUMOR FREE,297.0,0.0,297.0,0.0,297.0,0.0,297.0
TCGA-C8-A27A-01,TCGA-C8-A27A,BRCA,48.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-17779.0,Alive,TUMOR FREE,747.0,0.0,747.0,0.0,747.0,0.0,747.0
TCGA-C8-A27B-01,TCGA-C8-A27B,BRCA,48.0,FEMALE,ASIAN,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-17763.0,Alive,TUMOR FREE,439.0,0.0,439.0,0.0,439.0,0.0,439.0
TCGA-C8-A3M7-01,TCGA-C8-A3M7,BRCA,60.0,FEMALE,ASIAN,Stage IIIB,Infiltrating Lobular Carcinoma,2010.0,-22096.0,Dead,WITH TUMOR,,1.0,1034.0,1.0,1034.0,1.0,1034.0
TCGA-C8-A3M8-01,TCGA-C8-A3M8,BRCA,68.0,FEMALE,ASIAN,Stage IA,Infiltrating Lobular Carcinoma,2011.0,-24877.0,Alive,TUMOR FREE,394.0,0.0,394.0,0.0,394.0,0.0,394.0
TCGA-C8-A8HP-01,TCGA-C8-A8HP,BRCA,59.0,FEMALE,ASIAN,Stage IIIA,Metaplastic Carcinoma,2013.0,-21613.0,Alive,TUMOR FREE,396.0,0.0,396.0,0.0,396.0,0.0,396.0
TCGA-C8-A8HQ-01,TCGA-C8-A8HQ,BRCA,53.0,FEMALE,ASIAN,Stage IIB,Mucinous Carcinoma,2013.0,-19432.0,Alive,TUMOR FREE,380.0,0.0,380.0,0.0,380.0,0.0,380.0
TCGA-C8-A8HR-01,TCGA-C8-A8HR,BRCA,49.0,FEMALE,ASIAN,Stage IIIA,Infiltrating Lobular Carcinoma,2013.0,-17921.0,Alive,TUMOR FREE,408.0,0.0,408.0,0.0,408.0,0.0,408.0
TCGA-CA-5254-01,TCGA-CA-5254,COAD,42.0,FEMALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-15415.0,Alive,TUMOR FREE,386.0,0.0,386.0,0.0,386.0,0.0,386.0
TCGA-CA-5255-01,TCGA-CA-5255,COAD,45.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-16743.0,Alive,TUMOR FREE,376.0,0.0,376.0,0.0,376.0,0.0,376.0
TCGA-CA-5256-01,TCGA-CA-5256,COAD,54.0,FEMALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-19785.0,Alive,TUMOR FREE,379.0,0.0,379.0,0.0,379.0,0.0,379.0
TCGA-CA-5796-01,TCGA-CA-5796,COAD,52.0,FEMALE,ASIAN,Stage IIA,Colon Mucinous Adenocarcinoma,2010.0,-19353.0,Alive,TUMOR FREE,377.0,0.0,377.0,0.0,377.0,0.0,377.0
TCGA-CA-5797-01,TCGA-CA-5797,COAD,56.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-20662.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-CA-6715-01,TCGA-CA-6715,COAD,63.0,MALE,ASIAN,Stage IIIB,Colon Adenocarcinoma,2010.0,-23075.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-CA-6716-01,TCGA-CA-6716,COAD,65.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-23943.0,Alive,TUMOR FREE,371.0,0.0,371.0,0.0,371.0,0.0,371.0
TCGA-CA-6717-01,TCGA-CA-6717,COAD,57.0,MALE,ASIAN,Stage IIA,Colon Mucinous Adenocarcinoma,2010.0,-20984.0,Alive,TUMOR FREE,388.0,0.0,388.0,0.0,388.0,0.0,388.0
TCGA-CA-6718-01,TCGA-CA-6718,COAD,46.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2010.0,-17109.0,Dead,WITH TUMOR,,1.0,306.0,1.0,306.0,1.0,207.0
TCGA-CA-6719-01,TCGA-CA-6719,COAD,77.0,MALE,ASIAN,Stage IIA,Colon Adenocarcinoma,2011.0,-28343.0,Alive,WITH TUMOR,435.0,0.0,435.0,0.0,435.0,1.0,354.0
TCGA-CC-5258-01,TCGA-CC-5258,LIHC,48.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2010.0,-17586.0,Dead,TUMOR FREE,,1.0,129.0,0.0,129.0,0.0,129.0
TCGA-CC-5260-01,TCGA-CC-5260,LIHC,61.0,FEMALE,ASIAN,Stage IIIC,Hepatocellular Carcinoma,2010.0,-22345.0,Dead,TUMOR FREE,,1.0,87.0,0.0,87.0,0.0,87.0
TCGA-CC-5262-01,TCGA-CC-5262,LIHC,67.0,MALE,ASIAN,Stage IIIC,Hepatocellular Carcinoma,2010.0,-24787.0,Dead,TUMOR FREE,,1.0,103.0,0.0,103.0,0.0,103.0
TCGA-CC-5263-01,TCGA-CC-5263,LIHC,35.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-12863.0,Dead,TUMOR FREE,,1.0,129.0,0.0,129.0,0.0,129.0
TCGA-CC-5264-01,TCGA-CC-5264,LIHC,71.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-25979.0,Dead,TUMOR FREE,,1.0,102.0,0.0,102.0,0.0,102.0
TCGA-CC-A123-01,TCGA-CC-A123,LIHC,24.0,FEMALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-9107.0,Alive,WITH TUMOR,219.0,0.0,219.0,0.0,219.0,1.0,145.0
TCGA-CC-A1HT-01,TCGA-CC-A1HT,LIHC,50.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-18553.0,Dead,TUMOR FREE,,1.0,101.0,0.0,101.0,0.0,101.0
TCGA-CC-A3M9-01,TCGA-CC-A3M9,LIHC,45.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2011.0,-16460.0,Dead,WITH TUMOR,,1.0,300.0,1.0,300.0,1.0,219.0
TCGA-CC-A3MA-01,TCGA-CC-A3MA,LIHC,61.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2011.0,-22375.0,Dead,WITH TUMOR,,1.0,303.0,1.0,303.0,1.0,261.0
TCGA-CC-A3MB-01,TCGA-CC-A3MB,LIHC,36.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2011.0,-13255.0,Dead,WITH TUMOR,,1.0,315.0,1.0,315.0,1.0,260.0
TCGA-CC-A3MC-01,TCGA-CC-A3MC,LIHC,54.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2011.0,-20067.0,Alive,WITH TUMOR,363.0,0.0,363.0,0.0,363.0,1.0,297.0
TCGA-CC-A5UC-01,TCGA-CC-A5UC,LIHC,63.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2012.0,-23156.0,Dead,WITH TUMOR,,1.0,347.0,1.0,347.0,1.0,312.0
TCGA-CC-A5UD-01,TCGA-CC-A5UD,LIHC,45.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2012.0,-16702.0,Dead,WITH TUMOR,,1.0,304.0,1.0,304.0,1.0,182.0
TCGA-CC-A5UE-01,TCGA-CC-A5UE,LIHC,48.0,MALE,ASIAN,Stage IIIB,Hepatocellular Carcinoma,2012.0,-17805.0,Dead,WITH TUMOR,,1.0,272.0,1.0,272.0,1.0,175.0
TCGA-CC-A7IF-01,TCGA-CC-A7IF,LIHC,59.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-21845.0,Dead,WITH TUMOR,,1.0,649.0,1.0,649.0,1.0,254.0
TCGA-CC-A7IG-01,TCGA-CC-A7IG,LIHC,47.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-17453.0,Dead,WITH TUMOR,,1.0,299.0,1.0,299.0,1.0,195.0
TCGA-CC-A7IH-01,TCGA-CC-A7IH,LIHC,58.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-21381.0,Alive,TUMOR FREE,365.0,0.0,365.0,0.0,365.0,0.0,365.0
TCGA-CC-A7II-01,TCGA-CC-A7II,LIHC,54.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-20079.0,Alive,WITH TUMOR,399.0,0.0,399.0,0.0,399.0,1.0,278.0
TCGA-CC-A7IJ-01,TCGA-CC-A7IJ,LIHC,56.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-20751.0,Alive,TUMOR FREE,382.0,0.0,382.0,0.0,382.0,0.0,382.0
TCGA-CC-A7IK-01,TCGA-CC-A7IK,LIHC,59.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-21552.0,Dead,WITH TUMOR,,1.0,262.0,1.0,262.0,1.0,150.0
TCGA-CC-A7IL-01,TCGA-CC-A7IL,LIHC,61.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-22319.0,Dead,WITH TUMOR,,1.0,278.0,1.0,278.0,1.0,179.0
TCGA-CD-5798-01,TCGA-CD-5798,STAD,82.0,MALE,ASIAN,Stage II,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2010.0,-30310.0,Alive,TUMOR FREE,408.0,0.0,408.0,0.0,408.0,0.0,408.0
TCGA-CD-5799-01,TCGA-CD-5799,STAD,45.0,MALE,ASIAN,Stage II,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-16533.0,Alive,TUMOR FREE,396.0,0.0,396.0,0.0,396.0,0.0,396.0
TCGA-CD-5800-01,TCGA-CD-5800,STAD,51.0,FEMALE,ASIAN,Stage II,"Stomach, Intestinal Adenocarcinoma, Papillary Type",2010.0,,Alive,TUMOR FREE,400.0,0.0,400.0,0.0,400.0,0.0,400.0
TCGA-CD-5801-01,TCGA-CD-5801,STAD,69.0,MALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,,Dead,WITH TUMOR,,1.0,401.0,1.0,401.0,1.0,401.0
TCGA-CD-5803-01,TCGA-CD-5803,STAD,78.0,FEMALE,ASIAN,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-28608.0,Dead,WITH TUMOR,,1.0,341.0,1.0,341.0,1.0,300.0
TCGA-CD-5804-01,TCGA-CD-5804,STAD,90.0,MALE,ASIAN,[Discrepancy],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-32872.0,Alive,TUMOR FREE,368.0,0.0,368.0,0.0,368.0,0.0,368.0
TCGA-CD-8524-01,TCGA-CD-8524,STAD,61.0,FEMALE,ASIAN,Stage II,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-22445.0,Alive,WITH TUMOR,388.0,0.0,388.0,0.0,388.0,1.0,69.0
TCGA-CD-8526-01,TCGA-CD-8526,STAD,73.0,FEMALE,ASIAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-26840.0,Alive,TUMOR FREE,381.0,0.0,381.0,0.0,381.0,0.0,381.0
TCGA-CD-8528-01,TCGA-CD-8528,STAD,43.0,FEMALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-15986.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-CD-8529-01,TCGA-CD-8529,STAD,65.0,MALE,ASIAN,Stage IV,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2011.0,-23979.0,Alive,TUMOR FREE,374.0,0.0,374.0,0.0,374.0,0.0,374.0
TCGA-CD-8530-01,TCGA-CD-8530,STAD,51.0,MALE,ASIAN,Stage II,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-18992.0,Alive,TUMOR FREE,377.0,0.0,377.0,0.0,377.0,0.0,377.0
TCGA-CD-8531-01,TCGA-CD-8531,STAD,66.0,FEMALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-24453.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-CD-8532-01,TCGA-CD-8532,STAD,52.0,MALE,ASIAN,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-19284.0,Dead,WITH TUMOR,,1.0,354.0,1.0,354.0,1.0,282.0
TCGA-CD-8534-01,TCGA-CD-8534,STAD,41.0,MALE,ASIAN,Stage II,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-15227.0,Alive,WITH TUMOR,367.0,0.0,367.0,0.0,367.0,1.0,201.0
TCGA-CD-8535-01,TCGA-CD-8535,STAD,59.0,MALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21559.0,Alive,TUMOR FREE,390.0,0.0,390.0,0.0,390.0,0.0,390.0
TCGA-CD-8536-01,TCGA-CD-8536,STAD,74.0,MALE,ASIAN,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27328.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-CD-A486-01,TCGA-CD-A486,STAD,68.0,MALE,ASIAN,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-24879.0,Dead,WITH TUMOR,,1.0,192.0,1.0,192.0,1.0,79.0
TCGA-CD-A489-01,TCGA-CD-A489,STAD,58.0,MALE,ASIAN,Stage IIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-21517.0,Dead,WITH TUMOR,,1.0,344.0,1.0,344.0,1.0,277.0
TCGA-CD-A48A-01,TCGA-CD-A48A,STAD,57.0,MALE,ASIAN,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-20839.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-CD-A48C-01,TCGA-CD-A48C,STAD,79.0,FEMALE,ASIAN,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-29203.0,Dead,WITH TUMOR,,1.0,353.0,1.0,353.0,1.0,230.0
TCGA-CD-A4MG-01,TCGA-CD-A4MG,STAD,76.0,MALE,ASIAN,Stage IIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-28019.0,Dead,WITH TUMOR,,1.0,200.0,1.0,200.0,1.0,74.0
TCGA-CD-A4MH-01,TCGA-CD-A4MH,STAD,86.0,FEMALE,ASIAN,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-31683.0,Alive,TUMOR FREE,371.0,0.0,371.0,0.0,371.0,0.0,371.0
TCGA-CD-A4MI-01,TCGA-CD-A4MI,STAD,62.0,MALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-22721.0,Dead,WITH TUMOR,,1.0,358.0,1.0,358.0,1.0,271.0
TCGA-CD-A4MJ-01,TCGA-CD-A4MJ,STAD,60.0,MALE,ASIAN,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21932.0,Alive,WITH TUMOR,384.0,0.0,384.0,0.0,384.0,1.0,69.0
TCGA-CE-A13K-01,TCGA-CE-A13K,THCA,30.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-11122.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-CE-A27D-01,TCGA-CE-A27D,THCA,28.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-10536.0,Alive,TUMOR FREE,374.0,0.0,374.0,0.0,374.0,0.0,374.0
TCGA-CE-A3MD-01,TCGA-CE-A3MD,THCA,31.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-11399.0,Alive,TUMOR FREE,389.0,0.0,389.0,0.0,389.0,0.0,389.0
TCGA-CE-A3ME-01,TCGA-CE-A3ME,THCA,51.0,FEMALE,ASIAN,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18714.0,Alive,TUMOR FREE,379.0,0.0,379.0,0.0,379.0,0.0,379.0
TCGA-CE-A481-01,TCGA-CE-A481,THCA,41.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15268.0,Alive,TUMOR FREE,346.0,0.0,346.0,0.0,346.0,0.0,346.0
TCGA-CE-A482-01,TCGA-CE-A482,THCA,27.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-10192.0,Alive,TUMOR FREE,325.0,0.0,325.0,0.0,325.0,0.0,325.0
TCGA-CE-A483-01,TCGA-CE-A483,THCA,34.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-12768.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-CE-A484-01,TCGA-CE-A484,THCA,37.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-13815.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-CE-A485-01,TCGA-CE-A485,THCA,32.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-11997.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-CF-A1HR-01,TCGA-CF-A1HR,BLCA,62.0,MALE,ASIAN,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-22777.0,Alive,WITH TUMOR,389.0,0.0,389.0,0.0,389.0,1.0,294.0
TCGA-CF-A1HS-01,TCGA-CF-A1HS,BLCA,75.0,FEMALE,ASIAN,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-27565.0,Alive,WITH TUMOR,382.0,0.0,382.0,0.0,382.0,1.0,133.0
TCGA-CF-A27C-01,TCGA-CF-A27C,BLCA,52.0,MALE,ASIAN,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-19270.0,Alive,TUMOR FREE,425.0,0.0,425.0,0.0,425.0,0.0,425.0
TCGA-CF-A3MF-01,TCGA-CF-A3MF,BLCA,34.0,MALE,ASIAN,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-12557.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-CF-A3MG-01,TCGA-CF-A3MG,BLCA,48.0,MALE,ASIAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-17600.0,Alive,TUMOR FREE,369.0,0.0,369.0,0.0,369.0,0.0,369.0
TCGA-CF-A3MH-01,TCGA-CF-A3MH,BLCA,75.0,MALE,ASIAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27458.0,Alive,TUMOR FREE,398.0,0.0,398.0,0.0,398.0,0.0,398.0
TCGA-CF-A3MI-01,TCGA-CF-A3MI,BLCA,62.0,MALE,ASIAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-22716.0,Alive,TUMOR FREE,370.0,0.0,370.0,0.0,370.0,0.0,370.0
TCGA-CG-4301-01,TCGA-CG-4301,STAD,75.0,FEMALE,,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-27516.0,Alive,WITH TUMOR,92.0,0.0,92.0,0.0,92.0,0.0,92.0
TCGA-CG-4304-01,TCGA-CG-4304,STAD,84.0,MALE,,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-31017.0,Alive,,,0.0,,0.0,,0.0,
TCGA-CG-4305-01,TCGA-CG-4305,STAD,69.0,MALE,,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-25295.0,Alive,TUMOR FREE,485.0,0.0,485.0,0.0,485.0,1.0,457.0
TCGA-CG-4306-01,TCGA-CG-4306,STAD,90.0,MALE,,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-32871.0,Dead,,,1.0,31.0,,31.0,0.0,31.0
TCGA-CG-4436-01,TCGA-CG-4436,STAD,57.0,MALE,,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2005.0,-20941.0,Alive,TUMOR FREE,243.0,0.0,243.0,0.0,243.0,0.0,243.0
TCGA-CG-4437-01,TCGA-CG-4437,STAD,83.0,MALE,,Stage II,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-30467.0,Alive,TUMOR FREE,245.0,0.0,245.0,0.0,245.0,0.0,245.0
TCGA-CG-4438-01,TCGA-CG-4438,STAD,56.0,MALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-20574.0,Alive,,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0
TCGA-CG-4442-01,TCGA-CG-4442,STAD,85.0,MALE,,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-31350.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-CG-4443-01,TCGA-CG-4443,STAD,68.0,MALE,,Stage IA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-24990.0,Alive,,912.0,0.0,912.0,0.0,912.0,0.0,912.0
TCGA-CG-4444-01,TCGA-CG-4444,STAD,76.0,MALE,,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2006.0,-27912.0,Alive,TUMOR FREE,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0
TCGA-CG-4449-01,TCGA-CG-4449,STAD,81.0,MALE,,Stage II,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2007.0,-29705.0,Alive,WITH TUMOR,580.0,0.0,580.0,0.0,580.0,1.0,336.0
TCGA-CG-4465-01,TCGA-CG-4465,STAD,69.0,FEMALE,,Stage IV,"Stomach, Adenocarcinoma, Diffuse Type",2008.0,-25233.0,Dead,,,1.0,274.0,,274.0,0.0,274.0
TCGA-CG-4466-01,TCGA-CG-4466,STAD,81.0,FEMALE,,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-29739.0,Alive,TUMOR FREE,577.0,0.0,577.0,0.0,577.0,0.0,577.0
TCGA-CG-4469-01,TCGA-CG-4469,STAD,70.0,MALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-25598.0,Dead,,,1.0,215.0,,215.0,0.0,215.0
TCGA-CG-4474-01,TCGA-CG-4474,STAD,67.0,FEMALE,,Stage IV,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-24686.0,Alive,WITH TUMOR,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-CG-4475-01,TCGA-CG-4475,STAD,76.0,MALE,,Stage IIB,,2010.0,-28065.0,Alive,TUMOR FREE,699.0,0.0,699.0,0.0,699.0,0.0,699.0
TCGA-CG-4476-01,TCGA-CG-4476,STAD,69.0,MALE,,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-25506.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-CG-4477-01,TCGA-CG-4477,STAD,58.0,FEMALE,,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-21427.0,Alive,WITH TUMOR,942.0,0.0,942.0,0.0,942.0,1.0,365.0
TCGA-CG-5717-01,TCGA-CG-5717,STAD,58.0,MALE,,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2006.0,-21458.0,Dead,WITH TUMOR,,1.0,212.0,1.0,212.0,1.0,120.0
TCGA-CG-5718-01,TCGA-CG-5718,STAD,78.0,FEMALE,,Stage II,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,-28763.0,Dead,TUMOR FREE,,1.0,1095.0,0.0,1095.0,0.0,1095.0
TCGA-CG-5719-01,TCGA-CG-5719,STAD,54.0,FEMALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-19966.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CG-5720-01,TCGA-CG-5720,STAD,71.0,MALE,,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2003.0,-26176.0,Dead,TUMOR FREE,,1.0,30.0,0.0,30.0,0.0,30.0
TCGA-CG-5721-01,TCGA-CG-5721,STAD,58.0,MALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2005.0,-21244.0,Alive,TUMOR FREE,183.0,0.0,183.0,0.0,183.0,0.0,183.0
TCGA-CG-5723-01,TCGA-CG-5723,STAD,83.0,MALE,,Stage II,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2003.0,-30376.0,Alive,,3196.0,0.0,3196.0,0.0,3196.0,0.0,3196.0
TCGA-CG-5724-01,TCGA-CG-5724,STAD,59.0,MALE,,Stage IV,"Stomach, Adenocarcinoma, Diffuse Type",2003.0,-21762.0,Dead,WITH TUMOR,,1.0,366.0,1.0,366.0,1.0,122.0
TCGA-CG-5726-01,TCGA-CG-5726,STAD,73.0,MALE,,Stage IA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2004.0,-26998.0,Dead,TUMOR FREE,,1.0,881.0,0.0,881.0,0.0,881.0
TCGA-CG-5732-01,TCGA-CG-5732,STAD,66.0,MALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2003.0,-24379.0,Dead,WITH TUMOR,,1.0,2100.0,1.0,2100.0,1.0,1949.0
TCGA-CG-5734-01,TCGA-CG-5734,STAD,68.0,MALE,,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2005.0,-25079.0,Dead,,,1.0,243.0,,243.0,0.0,243.0
TCGA-CH-5737-01,TCGA-CH-5737,PRAD,73.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-26753.0,Alive,TUMOR FREE,91.0,0.0,91.0,0.0,91.0,0.0,91.0
TCGA-CH-5738-01,TCGA-CH-5738,PRAD,72.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-26329.0,Alive,TUMOR FREE,212.0,0.0,212.0,0.0,212.0,0.0,212.0
TCGA-CH-5739-01,TCGA-CH-5739,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-23953.0,Alive,TUMOR FREE,671.0,0.0,671.0,0.0,671.0,0.0,671.0
TCGA-CH-5740-01,TCGA-CH-5740,PRAD,57.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-20880.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CH-5741-01,TCGA-CH-5741,PRAD,56.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-20759.0,Alive,TUMOR FREE,395.0,0.0,395.0,0.0,395.0,0.0,395.0
TCGA-CH-5744-01,TCGA-CH-5744,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23621.0,Alive,TUMOR FREE,60.0,0.0,60.0,0.0,60.0,0.0,60.0
TCGA-CH-5748-01,TCGA-CH-5748,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-23649.0,Alive,WITH TUMOR,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CH-5750-01,TCGA-CH-5750,PRAD,72.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-26389.0,Alive,TUMOR FREE,396.0,0.0,396.0,0.0,396.0,0.0,396.0
TCGA-CH-5751-01,TCGA-CH-5751,PRAD,68.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-24957.0,Alive,WITH TUMOR,1065.0,0.0,1065.0,0.0,1065.0,1.0,365.0
TCGA-CH-5752-01,TCGA-CH-5752,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-24290.0,Alive,TUMOR FREE,943.0,0.0,943.0,0.0,943.0,0.0,943.0
TCGA-CH-5753-01,TCGA-CH-5753,PRAD,70.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-25780.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CH-5754-01,TCGA-CH-5754,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23803.0,Alive,WITH TUMOR,62.0,0.0,62.0,0.0,62.0,0.0,62.0
TCGA-CH-5761-01,TCGA-CH-5761,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-22433.0,Alive,TUMOR FREE,28.0,0.0,28.0,0.0,28.0,0.0,28.0
TCGA-CH-5762-01,TCGA-CH-5762,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2005.0,-22068.0,Alive,[Discrepancy],1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0
TCGA-CH-5763-01,TCGA-CH-5763,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-24380.0,Alive,TUMOR FREE,365.0,0.0,365.0,0.0,365.0,0.0,365.0
TCGA-CH-5764-01,TCGA-CH-5764,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-24257.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CH-5765-01,TCGA-CH-5765,PRAD,55.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-20364.0,Alive,TUMOR FREE,700.0,0.0,700.0,0.0,700.0,0.0,700.0
TCGA-CH-5766-01,TCGA-CH-5766,PRAD,55.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-20392.0,Alive,TUMOR FREE,31.0,0.0,31.0,0.0,31.0,0.0,31.0
TCGA-CH-5767-01,TCGA-CH-5767,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-24287.0,Alive,TUMOR FREE,458.0,0.0,458.0,0.0,458.0,0.0,458.0
TCGA-CH-5768-01,TCGA-CH-5768,PRAD,72.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-26480.0,Alive,TUMOR FREE,731.0,0.0,731.0,0.0,731.0,0.0,731.0
TCGA-CH-5769-01,TCGA-CH-5769,PRAD,48.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-17807.0,Alive,WITH TUMOR,62.0,0.0,62.0,0.0,62.0,0.0,62.0
TCGA-CH-5771-01,TCGA-CH-5771,PRAD,63.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23101.0,Alive,TUMOR FREE,396.0,0.0,396.0,0.0,396.0,0.0,396.0
TCGA-CH-5772-01,TCGA-CH-5772,PRAD,63.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23194.0,Alive,TUMOR FREE,486.0,0.0,486.0,0.0,486.0,0.0,486.0
TCGA-CH-5788-01,TCGA-CH-5788,PRAD,69.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2007.0,-25233.0,Alive,WITH TUMOR,821.0,0.0,821.0,0.0,821.0,0.0,821.0
TCGA-CH-5789-01,TCGA-CH-5789,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-22494.0,Alive,TUMOR FREE,304.0,0.0,304.0,0.0,304.0,0.0,304.0
TCGA-CH-5790-01,TCGA-CH-5790,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-23529.0,Alive,TUMOR FREE,974.0,0.0,974.0,0.0,974.0,0.0,974.0
TCGA-CH-5791-01,TCGA-CH-5791,PRAD,72.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-26390.0,Alive,,1004.0,0.0,1004.0,0.0,1004.0,1.0,396.0
TCGA-CH-5792-01,TCGA-CH-5792,PRAD,57.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-21002.0,Alive,WITH TUMOR,91.0,0.0,91.0,0.0,91.0,0.0,91.0
TCGA-CH-5794-01,TCGA-CH-5794,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-23924.0,Alive,TUMOR FREE,882.0,0.0,882.0,0.0,882.0,0.0,882.0
TCGA-CI-6621-01,TCGA-CI-6621,READ,63.0,MALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-23240.0,Alive,,419.0,0.0,419.0,0.0,419.0,0.0,419.0
TCGA-CJ-4634-01,TCGA-CJ-4634,KIRC,60.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-22155.0,Alive,TUMOR FREE,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0
TCGA-CJ-4638-01,TCGA-CJ-4638,KIRC,46.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-17110.0,Dead,WITH TUMOR,,1.0,431.0,1.0,431.0,1.0,70.0
TCGA-CJ-4640-01,TCGA-CJ-4640,KIRC,49.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2004.0,-18178.0,Alive,TUMOR FREE,3480.0,0.0,3480.0,0.0,3480.0,0.0,3480.0
TCGA-CJ-4882-01,TCGA-CJ-4882,KIRC,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-21074.0,Alive,TUMOR FREE,1883.0,0.0,1883.0,0.0,1883.0,0.0,1883.0
TCGA-CJ-4899-01,TCGA-CJ-4899,KIRC,42.0,MALE,ASIAN,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-15637.0,Alive,TUMOR FREE,1528.0,0.0,1528.0,0.0,1528.0,0.0,1528.0
TCGA-CJ-4901-01,TCGA-CJ-4901,KIRC,47.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-17396.0,Alive,TUMOR FREE,1450.0,0.0,1450.0,0.0,1450.0,0.0,1450.0
TCGA-CJ-4902-01,TCGA-CJ-4902,KIRC,61.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-22424.0,Alive,TUMOR FREE,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0
TCGA-CJ-4903-01,TCGA-CJ-4903,KIRC,50.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-18510.0,Alive,TUMOR FREE,1560.0,0.0,1560.0,0.0,1560.0,0.0,1560.0
TCGA-CJ-4904-01,TCGA-CJ-4904,KIRC,60.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-22036.0,Alive,WITH TUMOR,3302.0,0.0,3302.0,0.0,3302.0,1.0,278.0
TCGA-CJ-4905-01,TCGA-CJ-4905,KIRC,62.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-22864.0,Alive,TUMOR FREE,1496.0,0.0,1496.0,0.0,1496.0,0.0,1496.0
TCGA-CJ-4907-01,TCGA-CJ-4907,KIRC,58.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-21208.0,Alive,TUMOR FREE,1499.0,0.0,1499.0,0.0,1499.0,0.0,1499.0
TCGA-CJ-4908-01,TCGA-CJ-4908,KIRC,38.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-14226.0,Alive,TUMOR FREE,1531.0,0.0,1531.0,0.0,1531.0,0.0,1531.0
TCGA-CJ-4912-01,TCGA-CJ-4912,KIRC,61.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-22623.0,Alive,TUMOR FREE,1657.0,0.0,1657.0,0.0,1657.0,0.0,1657.0
TCGA-CJ-4916-01,TCGA-CJ-4916,KIRC,69.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-25470.0,Alive,TUMOR FREE,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0
TCGA-CJ-4918-01,TCGA-CJ-4918,KIRC,64.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2005.0,-23379.0,Dead,WITH TUMOR,,1.0,93.0,1.0,93.0,1.0,33.0
TCGA-CJ-4920-01,TCGA-CJ-4920,KIRC,64.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-23656.0,Dead,TUMOR FREE,,1.0,139.0,0.0,139.0,0.0,139.0
TCGA-CJ-4923-01,TCGA-CJ-4923,KIRC,63.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-23353.0,Dead,WITH TUMOR,,1.0,572.0,1.0,572.0,1.0,25.0
TCGA-CJ-5671-01,TCGA-CJ-5671,KIRC,51.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-18954.0,Alive,TUMOR FREE,3987.0,0.0,3987.0,0.0,3987.0,0.0,3987.0
TCGA-CJ-5672-01,TCGA-CJ-5672,KIRC,84.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-30900.0,Dead,TUMOR FREE,,1.0,2190.0,0.0,2190.0,0.0,2190.0
TCGA-CJ-5675-01,TCGA-CJ-5675,KIRC,70.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2004.0,-25617.0,Alive,WITH TUMOR,3936.0,0.0,3936.0,0.0,3936.0,1.0,900.0
TCGA-CJ-5676-01,TCGA-CJ-5676,KIRC,47.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2004.0,-17170.0,Alive,WITH TUMOR,4067.0,0.0,4067.0,0.0,4067.0,1.0,2219.0
TCGA-CJ-5677-01,TCGA-CJ-5677,KIRC,54.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-19849.0,Dead,WITH TUMOR,,1.0,782.0,1.0,782.0,1.0,288.0
TCGA-CJ-5678-01,TCGA-CJ-5678,KIRC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-22944.0,Dead,WITH TUMOR,,1.0,574.0,1.0,574.0,1.0,399.0
TCGA-CJ-5679-01,TCGA-CJ-5679,KIRC,73.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2003.0,-26858.0,Dead,WITH TUMOR,,1.0,679.0,1.0,679.0,1.0,595.0
TCGA-CJ-5680-01,TCGA-CJ-5680,KIRC,65.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-23778.0,Dead,WITH TUMOR,,1.0,768.0,1.0,768.0,1.0,153.0
TCGA-CJ-5681-01,TCGA-CJ-5681,KIRC,44.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-16121.0,Dead,WITH TUMOR,,1.0,552.0,1.0,552.0,1.0,17.0
TCGA-CJ-5682-01,TCGA-CJ-5682,KIRC,60.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-22244.0,Alive,WITH TUMOR,3736.0,0.0,3736.0,0.0,3736.0,1.0,55.0
TCGA-CJ-5683-01,TCGA-CJ-5683,KIRC,78.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-28745.0,Alive,TUMOR FREE,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0
TCGA-CJ-5684-01,TCGA-CJ-5684,KIRC,61.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2005.0,-22561.0,Alive,TUMOR FREE,2231.0,0.0,2231.0,0.0,2231.0,0.0,2231.0
TCGA-CJ-5686-01,TCGA-CJ-5686,KIRC,59.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-21836.0,Alive,TUMOR FREE,2038.0,0.0,2038.0,0.0,2038.0,0.0,2038.0
TCGA-CJ-5689-01,TCGA-CJ-5689,KIRC,90.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-32872.0,Dead,TUMOR FREE,,1.0,1620.0,0.0,1620.0,0.0,1620.0
TCGA-CJ-6027-01,TCGA-CJ-6027,KIRC,77.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-28359.0,Dead,TUMOR FREE,,1.0,3615.0,0.0,3615.0,0.0,3615.0
TCGA-CJ-6028-01,TCGA-CJ-6028,KIRC,58.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-21380.0,Dead,WITH TUMOR,,1.0,1625.0,1.0,1625.0,1.0,137.0
TCGA-CJ-6030-01,TCGA-CJ-6030,KIRC,65.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-24096.0,Dead,TUMOR FREE,,1.0,2299.0,0.0,2299.0,0.0,2299.0
TCGA-CJ-6032-01,TCGA-CJ-6032,KIRC,63.0,FEMALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2004.0,-23310.0,Alive,TUMOR FREE,3639.0,0.0,3639.0,0.0,3639.0,0.0,3639.0
TCGA-CJ-6033-01,TCGA-CJ-6033,KIRC,54.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-19919.0,Dead,WITH TUMOR,,1.0,224.0,1.0,224.0,1.0,144.0
TCGA-CK-5914-01,TCGA-CK-5914,COAD,81.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2008.0,-29586.0,Alive,TUMOR FREE,669.0,0.0,669.0,0.0,669.0,0.0,669.0
TCGA-CK-5916-01,TCGA-CK-5916,COAD,71.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2003.0,-26024.0,Dead,WITH TUMOR,,1.0,643.0,1.0,643.0,1.0,292.0
TCGA-CK-6746-01,TCGA-CK-6746,COAD,84.0,FEMALE,WHITE,Stage IIB,Colon Adenocarcinoma,2009.0,-30957.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-CK-6747-01,TCGA-CK-6747,COAD,87.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2008.0,-32052.0,Alive,TUMOR FREE,2523.0,0.0,2523.0,0.0,2523.0,0.0,2523.0
TCGA-CK-6748-01,TCGA-CK-6748,COAD,45.0,FEMALE,WHITE,Stage IV,Colon Mucinous Adenocarcinoma,2008.0,-16529.0,Alive,WITH TUMOR,61.0,0.0,61.0,0.0,61.0,0.0,61.0
TCGA-CK-6751-01,TCGA-CK-6751,COAD,88.0,FEMALE,WHITE,Stage I,Colon Mucinous Adenocarcinoma,2002.0,-32354.0,Alive,TUMOR FREE,3780.0,0.0,3780.0,0.0,3780.0,0.0,3780.0
TCGA-CL-5918-01,TCGA-CL-5918,READ,90.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2008.0,-32873.0,Alive,TUMOR FREE,218.0,0.0,218.0,0.0,218.0,0.0,218.0
TCGA-CM-4743-01,TCGA-CM-4743,COAD,69.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-25291.0,Alive,TUMOR FREE,701.0,0.0,701.0,0.0,701.0,0.0,701.0
TCGA-CM-4744-01,TCGA-CM-4744,COAD,69.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-25506.0,Alive,TUMOR FREE,609.0,0.0,609.0,0.0,609.0,0.0,609.0
TCGA-CM-4747-01,TCGA-CM-4747,COAD,47.0,MALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-17198.0,Alive,[Discrepancy],761.0,0.0,761.0,0.0,761.0,0.0,761.0
TCGA-CM-5344-01,TCGA-CM-5344,COAD,39.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-14426.0,Alive,TUMOR FREE,670.0,0.0,670.0,0.0,670.0,0.0,670.0
TCGA-CM-5348-01,TCGA-CM-5348,COAD,72.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-26543.0,Alive,TUMOR FREE,699.0,0.0,699.0,0.0,699.0,0.0,699.0
TCGA-CM-5349-01,TCGA-CM-5349,COAD,68.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-24867.0,Alive,TUMOR FREE,915.0,0.0,915.0,0.0,915.0,0.0,915.0
TCGA-CM-5860-01,TCGA-CM-5860,COAD,44.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-16344.0,Alive,TUMOR FREE,974.0,0.0,974.0,0.0,974.0,0.0,974.0
TCGA-CM-5861-01,TCGA-CM-5861,COAD,63.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-23253.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,1.0,335.0
TCGA-CM-5862-01,TCGA-CM-5862,COAD,80.0,MALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-29493.0,Dead,WITH TUMOR,,1.0,153.0,1.0,153.0,1.0,31.0
TCGA-CM-5863-01,TCGA-CM-5863,COAD,60.0,FEMALE,WHITE,Stage IIIB,Colon Mucinous Adenocarcinoma,2010.0,-22127.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-CM-5864-01,TCGA-CM-5864,COAD,60.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-22219.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-CM-5868-01,TCGA-CM-5868,COAD,59.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2010.0,-21672.0,Alive,WITH TUMOR,518.0,0.0,518.0,0.0,518.0,0.0,518.0
TCGA-CM-6161-01,TCGA-CM-6161,COAD,36.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-13363.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-CM-6163-01,TCGA-CM-6163,COAD,74.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-27150.0,Alive,TUMOR FREE,427.0,0.0,427.0,0.0,427.0,0.0,427.0
TCGA-CM-6165-01,TCGA-CM-6165,COAD,74.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-27302.0,Alive,TUMOR FREE,488.0,0.0,488.0,0.0,488.0,0.0,488.0
TCGA-CM-6166-01,TCGA-CM-6166,COAD,48.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-17807.0,Alive,TUMOR FREE,669.0,0.0,669.0,0.0,669.0,0.0,669.0
TCGA-CM-6167-01,TCGA-CM-6167,COAD,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2010.0,-21031.0,Alive,TUMOR FREE,456.0,0.0,456.0,0.0,456.0,0.0,456.0
TCGA-CM-6168-01,TCGA-CM-6168,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2010.0,-30834.0,Alive,TUMOR FREE,395.0,0.0,395.0,0.0,395.0,0.0,395.0
TCGA-CM-6169-01,TCGA-CM-6169,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2010.0,-24564.0,Alive,TUMOR FREE,396.0,0.0,396.0,0.0,396.0,0.0,396.0
TCGA-CM-6170-01,TCGA-CM-6170,COAD,73.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-26663.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-CM-6171-01,TCGA-CM-6171,COAD,77.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-28307.0,Alive,TUMOR FREE,427.0,0.0,427.0,0.0,427.0,0.0,427.0
TCGA-CM-6172-01,TCGA-CM-6172,COAD,70.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-25902.0,Alive,TUMOR FREE,335.0,0.0,335.0,0.0,335.0,0.0,335.0
TCGA-CM-6674-01,TCGA-CM-6674,COAD,39.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-14368.0,Alive,TUMOR FREE,394.0,0.0,394.0,0.0,394.0,0.0,394.0
TCGA-CM-6675-01,TCGA-CM-6675,COAD,35.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Colon Adenocarcinoma,2011.0,-12935.0,Alive,WITH TUMOR,397.0,0.0,397.0,0.0,397.0,1.0,337.0
TCGA-CM-6676-01,TCGA-CM-6676,COAD,82.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-30223.0,Alive,TUMOR FREE,337.0,0.0,337.0,0.0,337.0,0.0,337.0
TCGA-CM-6677-01,TCGA-CM-6677,COAD,75.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-27575.0,Alive,TUMOR FREE,337.0,0.0,337.0,0.0,337.0,0.0,337.0
TCGA-CM-6678-01,TCGA-CM-6678,COAD,63.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2011.0,-23070.0,Alive,WITH TUMOR,335.0,0.0,335.0,0.0,335.0,1.0,0.0
TCGA-CM-6679-01,TCGA-CM-6679,COAD,58.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-21519.0,Alive,TUMOR FREE,306.0,0.0,306.0,0.0,306.0,0.0,306.0
TCGA-CM-6680-01,TCGA-CM-6680,COAD,78.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2011.0,-28701.0,Alive,TUMOR FREE,366.0,0.0,366.0,0.0,366.0,0.0,366.0
TCGA-CN-4723-01,TCGA-CN-4723,HNSC,67.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-24815.0,Alive,TUMOR FREE,1699.0,0.0,1699.0,0.0,1699.0,0.0,1699.0
TCGA-CN-4725-01,TCGA-CN-4725,HNSC,60.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-22171.0,Alive,TUMOR FREE,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0
TCGA-CN-4726-01,TCGA-CN-4726,HNSC,68.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-25194.0,Dead,WITH TUMOR,,1.0,142.0,1.0,142.0,1.0,79.0
TCGA-CN-4728-01,TCGA-CN-4728,HNSC,56.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-20660.0,Alive,TUMOR FREE,1724.0,0.0,1724.0,0.0,1724.0,0.0,1724.0
TCGA-CN-4729-01,TCGA-CN-4729,HNSC,73.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-26713.0,Alive,TUMOR FREE,392.0,0.0,392.0,0.0,392.0,0.0,392.0
TCGA-CN-4730-01,TCGA-CN-4730,HNSC,62.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-22828.0,Alive,TUMOR FREE,817.0,0.0,817.0,0.0,817.0,0.0,817.0
TCGA-CN-4731-01,TCGA-CN-4731,HNSC,63.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-23194.0,Dead,WITH TUMOR,,1.0,998.0,1.0,998.0,1.0,243.0
TCGA-CN-4733-01,TCGA-CN-4733,HNSC,61.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-22561.0,Alive,TUMOR FREE,1586.0,0.0,1586.0,0.0,1586.0,0.0,1586.0
TCGA-CN-4736-01,TCGA-CN-4736,HNSC,70.0,FEMALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2010.0,-25683.0,Dead,WITH TUMOR,,1.0,395.0,1.0,395.0,1.0,209.0
TCGA-CN-4737-01,TCGA-CN-4737,HNSC,19.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-7301.0,Alive,TUMOR FREE,625.0,0.0,625.0,0.0,625.0,0.0,625.0
TCGA-CN-4738-01,TCGA-CN-4738,HNSC,53.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-19621.0,Dead,,,1.0,436.0,,436.0,0.0,436.0
TCGA-CN-4740-01,TCGA-CN-4740,HNSC,79.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-29186.0,Dead,WITH TUMOR,,1.0,839.0,1.0,839.0,1.0,224.0
TCGA-CN-4741-01,TCGA-CN-4741,HNSC,75.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-27506.0,Alive,TUMOR FREE,2239.0,0.0,2239.0,0.0,2239.0,1.0,1716.0
TCGA-CN-4742-01,TCGA-CN-4742,HNSC,48.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-17793.0,Dead,WITH TUMOR,,1.0,397.0,1.0,397.0,1.0,397.0
TCGA-CN-5355-01,TCGA-CN-5355,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-23670.0,Alive,TUMOR FREE,1278.0,0.0,1278.0,0.0,1278.0,0.0,1278.0
TCGA-CN-5356-01,TCGA-CN-5356,HNSC,56.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-20540.0,Alive,TUMOR FREE,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0
TCGA-CN-5358-01,TCGA-CN-5358,HNSC,60.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-22138.0,Dead,TUMOR FREE,,1.0,261.0,0.0,261.0,1.0,145.0
TCGA-CN-5360-01,TCGA-CN-5360,HNSC,68.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-25034.0,Alive,TUMOR FREE,2169.0,0.0,2169.0,0.0,2169.0,0.0,2169.0
TCGA-CN-5363-01,TCGA-CN-5363,HNSC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Head & Neck Squamous Cell Carcinoma,2007.0,-17635.0,Dead,WITH TUMOR,,1.0,253.0,1.0,253.0,1.0,53.0
TCGA-CN-5364-01,TCGA-CN-5364,HNSC,55.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2006.0,-20362.0,Dead,TUMOR FREE,,1.0,493.0,0.0,493.0,0.0,493.0
TCGA-CN-5365-01,TCGA-CN-5365,HNSC,38.0,MALE,WHITE,Stage IVB,Head & Neck Squamous Cell Carcinoma,2006.0,-14190.0,Dead,WITH TUMOR,,1.0,351.0,1.0,351.0,1.0,351.0
TCGA-CN-5366-01,TCGA-CN-5366,HNSC,51.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2006.0,-18904.0,Dead,WITH TUMOR,,1.0,360.0,1.0,360.0,1.0,276.0
TCGA-CN-5367-01,TCGA-CN-5367,HNSC,60.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2006.0,-22246.0,Dead,TUMOR FREE,,1.0,352.0,0.0,352.0,0.0,352.0
TCGA-CN-5369-01,TCGA-CN-5369,HNSC,90.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2006.0,-32871.0,Dead,TUMOR FREE,,1.0,380.0,0.0,380.0,0.0,380.0
TCGA-CN-5370-01,TCGA-CN-5370,HNSC,78.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2006.0,-28549.0,Dead,WITH TUMOR,,1.0,259.0,1.0,259.0,1.0,123.0
TCGA-CN-5373-01,TCGA-CN-5373,HNSC,55.0,FEMALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2010.0,-20143.0,Alive,TUMOR FREE,1584.0,0.0,1584.0,0.0,1584.0,0.0,1584.0
TCGA-CN-5374-01,TCGA-CN-5374,HNSC,56.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2007.0,-20464.0,Dead,TUMOR FREE,,1.0,1732.0,0.0,1732.0,1.0,1369.0
TCGA-CN-6010-01,TCGA-CN-6010,HNSC,53.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-19475.0,Alive,TUMOR FREE,1523.0,0.0,1523.0,0.0,1523.0,1.0,540.0
TCGA-CN-6011-01,TCGA-CN-6011,HNSC,57.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-21016.0,Alive,TUMOR FREE,933.0,0.0,933.0,0.0,933.0,0.0,933.0
TCGA-CN-6013-01,TCGA-CN-6013,HNSC,56.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-20703.0,Dead,WITH TUMOR,,1.0,727.0,1.0,727.0,1.0,323.0
TCGA-CN-6016-01,TCGA-CN-6016,HNSC,64.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-23664.0,Alive,TUMOR FREE,1443.0,0.0,1443.0,0.0,1443.0,0.0,1443.0
TCGA-CN-6017-01,TCGA-CN-6017,HNSC,55.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-20358.0,Dead,TUMOR FREE,,1.0,853.0,0.0,853.0,0.0,853.0
TCGA-CN-6018-01,TCGA-CN-6018,HNSC,85.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-31242.0,Dead,TUMOR FREE,,1.0,580.0,0.0,580.0,0.0,580.0
TCGA-CN-6019-01,TCGA-CN-6019,HNSC,61.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-22485.0,Alive,TUMOR FREE,1038.0,0.0,1038.0,0.0,1038.0,0.0,1038.0
TCGA-CN-6020-01,TCGA-CN-6020,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Head & Neck Squamous Cell Carcinoma,2011.0,-21232.0,Dead,TUMOR FREE,,1.0,205.0,0.0,205.0,0.0,205.0
TCGA-CN-6021-01,TCGA-CN-6021,HNSC,63.0,FEMALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2010.0,-23212.0,Dead,WITH TUMOR,,1.0,276.0,1.0,276.0,1.0,276.0
TCGA-CN-6022-01,TCGA-CN-6022,HNSC,49.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-17971.0,Dead,WITH TUMOR,,1.0,281.0,1.0,281.0,1.0,101.0
TCGA-CN-6023-01,TCGA-CN-6023,HNSC,73.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-26769.0,Alive,TUMOR FREE,1584.0,0.0,1584.0,0.0,1584.0,0.0,1584.0
TCGA-CN-6024-01,TCGA-CN-6024,HNSC,66.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-24259.0,Dead,WITH TUMOR,,1.0,337.0,1.0,337.0,1.0,156.0
TCGA-CN-6988-01,TCGA-CN-6988,HNSC,47.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-17308.0,Alive,TUMOR FREE,318.0,0.0,318.0,0.0,318.0,0.0,318.0
TCGA-CN-6989-01,TCGA-CN-6989,HNSC,64.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-23515.0,Dead,WITH TUMOR,,1.0,980.0,1.0,980.0,1.0,436.0
TCGA-CN-6992-01,TCGA-CN-6992,HNSC,61.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-22598.0,Alive,TUMOR FREE,1066.0,0.0,1066.0,0.0,1066.0,0.0,1066.0
TCGA-CN-6994-01,TCGA-CN-6994,HNSC,67.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-24778.0,Alive,TUMOR FREE,1183.0,0.0,1183.0,0.0,1183.0,0.0,1183.0
TCGA-CN-6995-01,TCGA-CN-6995,HNSC,78.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-28850.0,Dead,TUMOR FREE,,1.0,112.0,0.0,112.0,0.0,112.0
TCGA-CN-6997-01,TCGA-CN-6997,HNSC,66.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-24298.0,Dead,TUMOR FREE,,1.0,988.0,0.0,988.0,1.0,279.0
TCGA-CN-6998-01,TCGA-CN-6998,HNSC,53.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-19447.0,Dead,WITH TUMOR,,1.0,357.0,1.0,357.0,1.0,244.0
TCGA-CQ-5323-01,TCGA-CQ-5323,HNSC,82.0,MALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2007.0,-30173.0,Alive,TUMOR FREE,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0
TCGA-CQ-5324-01,TCGA-CQ-5324,HNSC,59.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2007.0,-21803.0,Alive,TUMOR FREE,1593.0,0.0,1593.0,0.0,1593.0,0.0,1593.0
TCGA-CQ-5325-01,TCGA-CQ-5325,HNSC,65.0,MALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2007.0,-23833.0,Dead,WITH TUMOR,,1.0,654.0,1.0,654.0,1.0,204.0
TCGA-CQ-5329-01,TCGA-CQ-5329,HNSC,46.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2008.0,-17028.0,Alive,TUMOR FREE,2143.0,0.0,2143.0,0.0,2143.0,0.0,2143.0
TCGA-CQ-5330-01,TCGA-CQ-5330,HNSC,69.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-25255.0,Alive,TUMOR FREE,1897.0,0.0,1897.0,0.0,1897.0,0.0,1897.0
TCGA-CQ-5331-01,TCGA-CQ-5331,HNSC,73.0,FEMALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2008.0,-26901.0,Alive,TUMOR FREE,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0
TCGA-CQ-5332-01,TCGA-CQ-5332,HNSC,87.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2008.0,-32032.0,Dead,,317.0,1.0,317.0,,317.0,0.0,317.0
TCGA-CQ-5334-01,TCGA-CQ-5334,HNSC,87.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-32024.0,Dead,WITH TUMOR,,1.0,129.0,1.0,129.0,1.0,50.0
TCGA-CQ-6218-01,TCGA-CQ-6218,HNSC,52.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-19096.0,Alive,TUMOR FREE,1253.0,0.0,1253.0,0.0,1253.0,0.0,1253.0
TCGA-CQ-6220-01,TCGA-CQ-6220,HNSC,69.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2007.0,-25366.0,Dead,,,1.0,985.0,,985.0,0.0,985.0
TCGA-CQ-6224-01,TCGA-CQ-6224,HNSC,52.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-19051.0,Alive,TUMOR FREE,1721.0,0.0,1721.0,0.0,1721.0,0.0,1721.0
TCGA-CQ-6225-01,TCGA-CQ-6225,HNSC,65.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2008.0,-23988.0,Dead,,,1.0,403.0,,403.0,1.0,180.0
TCGA-CQ-6227-01,TCGA-CQ-6227,HNSC,77.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-28466.0,Dead,WITH TUMOR,,1.0,129.0,1.0,129.0,1.0,129.0
TCGA-CQ-6228-01,TCGA-CQ-6228,HNSC,71.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-25942.0,Dead,,,1.0,456.0,,456.0,1.0,273.0
TCGA-CQ-6229-01,TCGA-CQ-6229,HNSC,61.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2009.0,-22541.0,Alive,TUMOR FREE,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0
TCGA-CQ-7065-01,TCGA-CQ-7065,HNSC,40.0,MALE,ASIAN,Stage II,Head & Neck Squamous Cell Carcinoma,2009.0,-14676.0,Alive,TUMOR FREE,1628.0,0.0,1628.0,0.0,1628.0,1.0,230.0
TCGA-CQ-7068-01,TCGA-CQ-7068,HNSC,80.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-29530.0,Alive,TUMOR FREE,1309.0,0.0,1309.0,0.0,1309.0,1.0,1148.0
TCGA-CS-4942-01,TCGA-CS-4942,LGG,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2006.0,-16297.0,Dead,WITH TUMOR,,1.0,1335.0,1.0,1335.0,1.0,1184.0
TCGA-CS-4943-01,TCGA-CS-4943,LGG,37.0,MALE,WHITE,,Astrocytoma,2009.0,-13565.0,Dead,WITH TUMOR,,1.0,1106.0,1.0,1106.0,1.0,1106.0
TCGA-CS-4944-01,TCGA-CS-4944,LGG,50.0,MALE,WHITE,,Astrocytoma,2010.0,-18494.0,Alive,WITH TUMOR,1828.0,0.0,1828.0,0.0,1828.0,0.0,1828.0
TCGA-CS-5390-01,TCGA-CS-5390,LGG,47.0,FEMALE,WHITE,,Oligodendroglioma,2005.0,-17460.0,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-CS-5393-01,TCGA-CS-5393,LGG,39.0,MALE,WHITE,,Astrocytoma,2008.0,-14418.0,Alive,TUMOR FREE,1222.0,0.0,1222.0,0.0,1222.0,0.0,1222.0
TCGA-CS-5394-01,TCGA-CS-5394,LGG,40.0,MALE,WHITE,,Astrocytoma,2005.0,-14920.0,Alive,,8.0,0.0,8.0,0.0,8.0,0.0,8.0
TCGA-CS-5396-01,TCGA-CS-5396,LGG,53.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-19399.0,Alive,WITH TUMOR,1631.0,0.0,1631.0,0.0,1631.0,0.0,1631.0
TCGA-CS-5397-01,TCGA-CS-5397,LGG,54.0,FEMALE,WHITE,,Astrocytoma,2010.0,-19866.0,Dead,WITH TUMOR,,1.0,194.0,1.0,194.0,1.0,194.0
TCGA-CS-6186-01,TCGA-CS-6186,LGG,58.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-21321.0,Dead,WITH TUMOR,,1.0,538.0,1.0,538.0,1.0,188.0
TCGA-CS-6188-01,TCGA-CS-6188,LGG,48.0,MALE,WHITE,,Astrocytoma,2009.0,-17729.0,Dead,WITH TUMOR,,1.0,814.0,1.0,814.0,1.0,647.0
TCGA-CS-6666-01,TCGA-CS-6666,LGG,22.0,MALE,WHITE,,Astrocytoma,2010.0,-8340.0,Alive,TUMOR FREE,1428.0,0.0,1428.0,0.0,1428.0,0.0,1428.0
TCGA-CS-6668-01,TCGA-CS-6668,LGG,57.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-20836.0,Alive,WITH TUMOR,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0
TCGA-CS-6670-01,TCGA-CS-6670,LGG,43.0,MALE,WHITE,,Oligodendroglioma,2011.0,-16066.0,Alive,WITH TUMOR,1426.0,0.0,1426.0,0.0,1426.0,0.0,1426.0
TCGA-CU-A0YN-01,TCGA-CU-A0YN,BLCA,60.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2005.0,-21927.0,Dead,,,1.0,393.0,,393.0,0.0,393.0
TCGA-CU-A3KJ-01,TCGA-CU-A3KJ,BLCA,75.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27692.0,Alive,WITH TUMOR,562.0,0.0,562.0,0.0,562.0,1.0,166.0
TCGA-CU-A3QU-01,TCGA-CU-A3QU,BLCA,58.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-21233.0,Alive,TUMOR FREE,158.0,0.0,158.0,0.0,158.0,0.0,158.0
TCGA-CU-A3YL-01,TCGA-CU-A3YL,BLCA,67.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24524.0,Alive,TUMOR FREE,906.0,0.0,906.0,0.0,906.0,1.0,370.0
TCGA-CV-5430-01,TCGA-CV-5430,HNSC,61.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-22577.0,Alive,TUMOR FREE,4241.0,0.0,4241.0,0.0,4241.0,1.0,783.0
TCGA-CV-5432-01,TCGA-CV-5432,HNSC,68.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2000.0,-25006.0,Alive,TUMOR FREE,3930.0,0.0,3930.0,0.0,3930.0,0.0,3930.0
TCGA-CV-5434-01,TCGA-CV-5434,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-22182.0,Dead,TUMOR FREE,3295.0,1.0,3314.0,0.0,3314.0,1.0,1859.0
TCGA-CV-5436-01,TCGA-CV-5436,HNSC,65.0,MALE,,Stage IVA,Head & Neck Squamous Cell Carcinoma,2001.0,-23923.0,Dead,WITH TUMOR,548.0,1.0,584.0,1.0,584.0,1.0,584.0
TCGA-CV-5439-01,TCGA-CV-5439,HNSC,62.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2002.0,-22686.0,Dead,WITH TUMOR,546.0,1.0,546.0,1.0,546.0,1.0,211.0
TCGA-CV-5440-01,TCGA-CV-5440,HNSC,52.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2002.0,-19197.0,Alive,TUMOR FREE,3270.0,0.0,3270.0,0.0,3270.0,0.0,3270.0
TCGA-CV-5441-01,TCGA-CV-5441,HNSC,58.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2003.0,-21305.0,Alive,TUMOR FREE,2886.0,0.0,2886.0,0.0,2886.0,0.0,2886.0
TCGA-CV-5442-01,TCGA-CV-5442,HNSC,76.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2004.0,-28040.0,Alive,TUMOR FREE,2327.0,0.0,2327.0,0.0,2327.0,0.0,2327.0
TCGA-CV-5443-01,TCGA-CV-5443,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Head & Neck Squamous Cell Carcinoma,2004.0,-23287.0,Alive,TUMOR FREE,2784.0,0.0,2784.0,0.0,2784.0,0.0,2784.0
TCGA-CV-5444-01,TCGA-CV-5444,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2004.0,-23650.0,Alive,TUMOR FREE,2437.0,0.0,2437.0,0.0,2437.0,0.0,2437.0
TCGA-CV-5966-01,TCGA-CV-5966,HNSC,63.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2005.0,-23119.0,Dead,TUMOR FREE,,1.0,545.0,0.0,545.0,0.0,545.0
TCGA-CV-5970-01,TCGA-CV-5970,HNSC,59.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-21890.0,Dead,WITH TUMOR,406.0,1.0,406.0,1.0,406.0,1.0,406.0
TCGA-CV-5973-01,TCGA-CV-5973,HNSC,62.0,FEMALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2005.0,-22771.0,Alive,TUMOR FREE,2641.0,0.0,2641.0,0.0,2641.0,0.0,2641.0
TCGA-CV-5976-01,TCGA-CV-5976,HNSC,50.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2006.0,-18267.0,Alive,TUMOR FREE,1478.0,0.0,1478.0,0.0,1478.0,0.0,1478.0
TCGA-CV-5977-01,TCGA-CV-5977,HNSC,66.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2007.0,-24115.0,Alive,TUMOR FREE,1840.0,0.0,1840.0,0.0,1840.0,0.0,1840.0
TCGA-CV-5978-01,TCGA-CV-5978,HNSC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Head & Neck Squamous Cell Carcinoma,2008.0,-19480.0,Dead,WITH TUMOR,215.0,1.0,215.0,1.0,215.0,1.0,215.0
TCGA-CV-5979-01,TCGA-CV-5979,HNSC,26.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2007.0,-9567.0,Alive,TUMOR FREE,1315.0,0.0,1315.0,0.0,1315.0,0.0,1315.0
TCGA-CV-6003-01,TCGA-CV-6003,HNSC,50.0,FEMALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2007.0,-18600.0,Alive,TUMOR FREE,1665.0,0.0,1665.0,0.0,1665.0,0.0,1665.0
TCGA-CV-6436-01,TCGA-CV-6436,HNSC,62.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2007.0,-22885.0,Alive,TUMOR FREE,1899.0,0.0,1899.0,0.0,1899.0,0.0,1899.0
TCGA-CV-6441-01,TCGA-CV-6441,HNSC,60.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-22025.0,Dead,WITH TUMOR,,1.0,292.0,1.0,292.0,1.0,95.0
TCGA-CV-6933-01,TCGA-CV-6933,HNSC,53.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1998.0,-19518.0,Dead,TUMOR FREE,,1.0,2741.0,0.0,2741.0,0.0,2741.0
TCGA-CV-6934-01,TCGA-CV-6934,HNSC,66.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1998.0,-24180.0,Dead,WITH TUMOR,,1.0,65.0,1.0,65.0,1.0,65.0
TCGA-CV-6935-01,TCGA-CV-6935,HNSC,67.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-24799.0,Dead,WITH TUMOR,,1.0,295.0,1.0,295.0,1.0,295.0
TCGA-CV-6936-01,TCGA-CV-6936,HNSC,68.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2004.0,-25020.0,Dead,WITH TUMOR,,1.0,166.0,1.0,166.0,1.0,157.0
TCGA-CV-6937-01,TCGA-CV-6937,HNSC,71.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2003.0,-26156.0,Dead,TUMOR FREE,,1.0,624.0,0.0,624.0,0.0,624.0
TCGA-CV-6938-01,TCGA-CV-6938,HNSC,87.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1996.0,-31825.0,Dead,TUMOR FREE,,1.0,144.0,0.0,144.0,0.0,144.0
TCGA-CV-6939-01,TCGA-CV-6939,HNSC,60.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1994.0,-21947.0,Dead,WITH TUMOR,,1.0,666.0,1.0,666.0,1.0,666.0
TCGA-CV-6940-01,TCGA-CV-6940,HNSC,80.0,FEMALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2002.0,-29382.0,Dead,TUMOR FREE,,1.0,804.0,0.0,804.0,0.0,804.0
TCGA-CV-6941-01,TCGA-CV-6941,HNSC,51.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1999.0,-18812.0,Dead,TUMOR FREE,,1.0,342.0,0.0,342.0,0.0,342.0
TCGA-CV-6942-01,TCGA-CV-6942,HNSC,73.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2000.0,-26941.0,Alive,TUMOR FREE,4282.0,0.0,4282.0,0.0,4282.0,0.0,4282.0
TCGA-CV-6943-01,TCGA-CV-6943,HNSC,74.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1999.0,-27310.0,Dead,WITH TUMOR,,1.0,602.0,1.0,602.0,1.0,602.0
TCGA-CV-6945-01,TCGA-CV-6945,HNSC,41.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1993.0,-15158.0,Dead,WITH TUMOR,,1.0,366.0,1.0,366.0,1.0,366.0
TCGA-CV-6948-01,TCGA-CV-6948,HNSC,79.0,FEMALE,WHITE,Stage IVB,Head & Neck Squamous Cell Carcinoma,1994.0,-29153.0,Dead,TUMOR FREE,,1.0,1289.0,0.0,1289.0,0.0,1289.0
TCGA-CV-6950-01,TCGA-CV-6950,HNSC,64.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1994.0,-23549.0,Dead,WITH TUMOR,,1.0,459.0,1.0,459.0,1.0,258.0
TCGA-CV-6951-01,TCGA-CV-6951,HNSC,57.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1996.0,-21166.0,Dead,WITH TUMOR,,1.0,915.0,1.0,915.0,1.0,915.0
TCGA-CV-6952-01,TCGA-CV-6952,HNSC,65.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1996.0,-23892.0,Dead,TUMOR FREE,,1.0,185.0,0.0,185.0,0.0,185.0
TCGA-CV-6953-01,TCGA-CV-6953,HNSC,80.0,FEMALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1997.0,-29465.0,Dead,WITH TUMOR,,1.0,1641.0,1.0,1641.0,1.0,1521.0
TCGA-CV-6954-01,TCGA-CV-6954,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,1998.0,-21557.0,Dead,TUMOR FREE,,1.0,2002.0,0.0,2002.0,0.0,2002.0
TCGA-CV-6955-01,TCGA-CV-6955,HNSC,74.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2000.0,-27261.0,Dead,WITH TUMOR,,1.0,334.0,1.0,334.0,1.0,334.0
TCGA-CV-6956-01,TCGA-CV-6956,HNSC,67.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1993.0,-24720.0,Dead,WITH TUMOR,,1.0,217.0,1.0,217.0,1.0,217.0
TCGA-CV-6959-01,TCGA-CV-6959,HNSC,48.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1999.0,-17679.0,Dead,WITH TUMOR,,1.0,256.0,1.0,256.0,1.0,103.0
TCGA-CV-6960-01,TCGA-CV-6960,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Head & Neck Squamous Cell Carcinoma,1999.0,-18194.0,Dead,TUMOR FREE,,1.0,862.0,0.0,862.0,0.0,862.0
TCGA-CV-6961-01,TCGA-CV-6961,HNSC,61.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1999.0,-22532.0,Dead,WITH TUMOR,,1.0,76.0,1.0,76.0,1.0,76.0
TCGA-CV-6962-01,TCGA-CV-6962,HNSC,65.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-24103.0,Dead,TUMOR FREE,,1.0,126.0,0.0,126.0,0.0,126.0
TCGA-CV-7089-01,TCGA-CV-7089,HNSC,74.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2001.0,-27149.0,Dead,TUMOR FREE,,1.0,1972.0,0.0,1972.0,0.0,1972.0
TCGA-CV-7090-01,TCGA-CV-7090,HNSC,39.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2001.0,-14515.0,Alive,TUMOR FREE,5252.0,0.0,5252.0,0.0,5252.0,0.0,5252.0
TCGA-CV-7091-01,TCGA-CV-7091,HNSC,54.0,MALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2001.0,-19938.0,Alive,TUMOR FREE,3381.0,0.0,3381.0,0.0,3381.0,0.0,3381.0
TCGA-CV-7095-01,TCGA-CV-7095,HNSC,87.0,FEMALE,,Stage II,Head & Neck Squamous Cell Carcinoma,2001.0,-32022.0,Dead,TUMOR FREE,,1.0,572.0,0.0,572.0,0.0,572.0
TCGA-CV-7097-01,TCGA-CV-7097,HNSC,53.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2002.0,-19382.0,Dead,WITH TUMOR,,1.0,385.0,1.0,385.0,1.0,385.0
TCGA-CV-7099-01,TCGA-CV-7099,HNSC,85.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2002.0,-31134.0,Dead,TUMOR FREE,,1.0,243.0,0.0,243.0,0.0,243.0
TCGA-CV-7100-01,TCGA-CV-7100,HNSC,66.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2001.0,-24183.0,Dead,WITH TUMOR,,1.0,274.0,1.0,274.0,1.0,274.0
TCGA-CV-7101-01,TCGA-CV-7101,HNSC,80.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1999.0,-29550.0,Dead,TUMOR FREE,,1.0,160.0,0.0,160.0,0.0,160.0
TCGA-CV-7102-01,TCGA-CV-7102,HNSC,76.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-27805.0,Dead,,,1.0,56.0,,56.0,0.0,56.0
TCGA-CV-7103-01,TCGA-CV-7103,HNSC,49.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-18219.0,Dead,WITH TUMOR,,1.0,1591.0,1.0,1591.0,1.0,1591.0
TCGA-CV-7104-01,TCGA-CV-7104,HNSC,61.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-22349.0,Dead,TUMOR FREE,,1.0,393.0,0.0,393.0,0.0,393.0
TCGA-CV-7177-01,TCGA-CV-7177,HNSC,82.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1999.0,-30180.0,Dead,WITH TUMOR,,1.0,663.0,1.0,663.0,1.0,663.0
TCGA-CV-7178-01,TCGA-CV-7178,HNSC,64.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-23430.0,Dead,WITH TUMOR,,1.0,2166.0,1.0,2166.0,1.0,2166.0
TCGA-CV-7180-01,TCGA-CV-7180,HNSC,34.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1996.0,-12523.0,Dead,WITH TUMOR,,1.0,327.0,1.0,327.0,1.0,327.0
TCGA-CV-7183-01,TCGA-CV-7183,HNSC,53.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2002.0,-19358.0,Alive,TUMOR FREE,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0
TCGA-CV-7235-01,TCGA-CV-7235,HNSC,67.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2007.0,-24800.0,Alive,TUMOR FREE,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0
TCGA-CV-7236-01,TCGA-CV-7236,HNSC,77.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2007.0,-28250.0,Dead,TUMOR FREE,,1.0,144.0,0.0,144.0,0.0,144.0
TCGA-CV-7238-01,TCGA-CV-7238,HNSC,69.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2007.0,-25471.0,Alive,TUMOR FREE,2727.0,0.0,2727.0,0.0,2727.0,0.0,2727.0
TCGA-CV-7242-01,TCGA-CV-7242,HNSC,60.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2008.0,-22136.0,Alive,TUMOR FREE,1095.0,0.0,1095.0,0.0,1095.0,0.0,1095.0
TCGA-CV-7243-01,TCGA-CV-7243,HNSC,50.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2008.0,-18466.0,Alive,TUMOR FREE,954.0,0.0,954.0,0.0,954.0,0.0,954.0
TCGA-CV-7245-01,TCGA-CV-7245,HNSC,62.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-22646.0,Alive,TUMOR FREE,797.0,0.0,797.0,0.0,797.0,0.0,797.0
TCGA-CV-7247-01,TCGA-CV-7247,HNSC,55.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1995.0,-20433.0,Dead,WITH TUMOR,,1.0,577.0,1.0,577.0,1.0,577.0
TCGA-CV-7248-01,TCGA-CV-7248,HNSC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2001.0,-23082.0,Dead,TUMOR FREE,,1.0,521.0,0.0,521.0,0.0,521.0
TCGA-CV-7250-01,TCGA-CV-7250,HNSC,64.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2000.0,-23489.0,Dead,TUMOR FREE,,1.0,2900.0,0.0,2900.0,1.0,111.0
TCGA-CV-7252-01,TCGA-CV-7252,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,1994.0,-22934.0,Dead,WITH TUMOR,,1.0,151.0,1.0,151.0,1.0,151.0
TCGA-CV-7253-01,TCGA-CV-7253,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,1993.0,-21473.0,Dead,WITH TUMOR,,1.0,361.0,1.0,361.0,1.0,361.0
TCGA-CV-7254-01,TCGA-CV-7254,HNSC,55.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1996.0,-20306.0,Dead,WITH TUMOR,,1.0,1459.0,1.0,1459.0,1.0,1459.0
TCGA-CV-7255-01,TCGA-CV-7255,HNSC,32.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1995.0,-11931.0,Dead,WITH TUMOR,,1.0,64.0,1.0,64.0,1.0,64.0
TCGA-CV-7261-01,TCGA-CV-7261,HNSC,57.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2008.0,-20992.0,Alive,TUMOR FREE,1512.0,0.0,1512.0,0.0,1512.0,0.0,1512.0
TCGA-CV-7263-01,TCGA-CV-7263,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Head & Neck Squamous Cell Carcinoma,1997.0,-23513.0,Dead,WITH TUMOR,,1.0,560.0,1.0,560.0,1.0,560.0
TCGA-CV-7406-01,TCGA-CV-7406,HNSC,49.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1999.0,-18250.0,Dead,,,1.0,1748.0,,1748.0,0.0,1748.0
TCGA-CV-7407-01,TCGA-CV-7407,HNSC,67.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1992.0,-24475.0,Dead,,,1.0,1081.0,,1081.0,0.0,1081.0
TCGA-CV-7410-01,TCGA-CV-7410,HNSC,61.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,1993.0,-22302.0,Dead,WITH TUMOR,,1.0,6417.0,1.0,6417.0,1.0,6417.0
TCGA-CV-7411-01,TCGA-CV-7411,HNSC,64.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1994.0,-23696.0,Dead,,,1.0,2717.0,,2717.0,0.0,2717.0
TCGA-CV-7413-01,TCGA-CV-7413,HNSC,74.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1995.0,-27231.0,Dead,,,1.0,294.0,,294.0,0.0,294.0
TCGA-CV-7414-01,TCGA-CV-7414,HNSC,78.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1995.0,-28603.0,Dead,,,1.0,14.0,,14.0,0.0,14.0
TCGA-CV-7415-01,TCGA-CV-7415,HNSC,60.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1995.0,-22062.0,Dead,WITH TUMOR,,1.0,695.0,1.0,695.0,1.0,695.0
TCGA-CV-7416-01,TCGA-CV-7416,HNSC,29.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1994.0,-10936.0,Dead,,,1.0,763.0,,763.0,0.0,763.0
TCGA-CV-7418-01,TCGA-CV-7418,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,1996.0,-22805.0,Dead,TUMOR FREE,,1.0,789.0,0.0,789.0,1.0,494.0
TCGA-CV-7421-01,TCGA-CV-7421,HNSC,76.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1997.0,-27961.0,Dead,,,1.0,2.0,,2.0,0.0,2.0
TCGA-CV-7422-01,TCGA-CV-7422,HNSC,60.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1997.0,-22098.0,Dead,WITH TUMOR,,1.0,1037.0,1.0,1037.0,1.0,733.0
TCGA-CV-7423-01,TCGA-CV-7423,HNSC,65.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1997.0,-24071.0,Dead,,,1.0,3059.0,,3059.0,0.0,3059.0
TCGA-CV-7424-01,TCGA-CV-7424,HNSC,67.0,MALE,ASIAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,1997.0,-24775.0,Dead,WITH TUMOR,,1.0,453.0,1.0,453.0,1.0,453.0
TCGA-CV-7427-01,TCGA-CV-7427,HNSC,73.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1997.0,-26975.0,Dead,TUMOR FREE,,1.0,4760.0,0.0,4760.0,1.0,3282.0
TCGA-CV-7429-01,TCGA-CV-7429,HNSC,55.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1998.0,-20188.0,Dead,WITH TUMOR,,1.0,107.0,1.0,107.0,1.0,107.0
TCGA-CV-7430-01,TCGA-CV-7430,HNSC,56.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1996.0,-20763.0,Dead,WITH TUMOR,,1.0,495.0,1.0,495.0,1.0,495.0
TCGA-CV-7432-01,TCGA-CV-7432,HNSC,79.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,1998.0,-28875.0,Dead,WITH TUMOR,,1.0,2570.0,1.0,2570.0,1.0,2570.0
TCGA-CV-7433-01,TCGA-CV-7433,HNSC,49.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-18004.0,Dead,WITH TUMOR,,1.0,601.0,1.0,601.0,1.0,445.0
TCGA-CV-7434-01,TCGA-CV-7434,HNSC,64.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-23465.0,Dead,TUMOR FREE,,1.0,218.0,0.0,218.0,0.0,218.0
TCGA-CV-7435-01,TCGA-CV-7435,HNSC,57.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,1999.0,-21049.0,Dead,TUMOR FREE,,1.0,4680.0,0.0,4680.0,0.0,4680.0
TCGA-CV-7437-01,TCGA-CV-7437,HNSC,77.0,MALE,,Stage II,Head & Neck Squamous Cell Carcinoma,1996.0,-28221.0,Dead,WITH TUMOR,,1.0,506.0,1.0,506.0,1.0,506.0
TCGA-CV-7438-01,TCGA-CV-7438,HNSC,87.0,FEMALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2000.0,-32021.0,Dead,WITH TUMOR,,1.0,194.0,1.0,194.0,1.0,194.0
TCGA-CV-7440-01,TCGA-CV-7440,HNSC,38.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2000.0,-13992.0,Dead,,,1.0,675.0,,675.0,0.0,675.0
TCGA-CW-5580-01,TCGA-CW-5580,KIRC,73.0,FEMALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-26696.0,Dead,,,1.0,1964.0,,1964.0,0.0,1964.0
TCGA-CW-5581-01,TCGA-CW-5581,KIRC,44.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-16195.0,Alive,TUMOR FREE,2799.0,0.0,2799.0,0.0,2799.0,0.0,2799.0
TCGA-CW-5583-01,TCGA-CW-5583,KIRC,51.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-18666.0,Alive,TUMOR FREE,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0
TCGA-CW-5585-01,TCGA-CW-5585,KIRC,51.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-18898.0,Alive,WITH TUMOR,2609.0,0.0,2609.0,0.0,2609.0,0.0,2609.0
TCGA-CW-5587-01,TCGA-CW-5587,KIRC,62.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2003.0,-22693.0,Alive,TUMOR FREE,2226.0,0.0,2226.0,0.0,2226.0,1.0,2003.0
TCGA-CW-5591-01,TCGA-CW-5591,KIRC,56.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2004.0,-20712.0,Alive,WITH TUMOR,2271.0,0.0,2271.0,0.0,2271.0,0.0,2271.0
TCGA-CW-6087-01,TCGA-CW-6087,KIRC,61.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2003.0,-22438.0,Dead,TUMOR FREE,,1.0,41.0,0.0,41.0,0.0,41.0
TCGA-CW-6090-01,TCGA-CW-6090,KIRC,68.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2003.0,-24909.0,Alive,TUMOR FREE,2552.0,0.0,2552.0,0.0,2552.0,1.0,2780.0
TCGA-CW-6093-01,TCGA-CW-6093,KIRC,73.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2004.0,-26909.0,Alive,TUMOR FREE,3146.0,0.0,3146.0,0.0,3146.0,0.0,3146.0
TCGA-CX-7085-01,TCGA-CX-7085,HNSC,77.0,FEMALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2010.0,-28221.0,Alive,WITH TUMOR,321.0,0.0,321.0,0.0,321.0,1.0,92.0
TCGA-CX-7086-01,TCGA-CX-7086,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Head & Neck Squamous Cell Carcinoma,2011.0,-19434.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-CX-7219-01,TCGA-CX-7219,HNSC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Head & Neck Squamous Cell Carcinoma,2009.0,-17222.0,Alive,TUMOR FREE,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0
TCGA-CZ-4853-01,TCGA-CZ-4853,KIRC,82.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-30191.0,Alive,TUMOR FREE,774.0,0.0,774.0,0.0,774.0,0.0,774.0
TCGA-CZ-4856-01,TCGA-CZ-4856,KIRC,62.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-22684.0,Alive,,18.0,0.0,18.0,0.0,18.0,0.0,18.0
TCGA-CZ-4859-01,TCGA-CZ-4859,KIRC,59.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-21842.0,Alive,TUMOR FREE,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0
TCGA-CZ-4863-01,TCGA-CZ-4863,KIRC,51.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-18730.0,Alive,TUMOR FREE,1928.0,0.0,1928.0,0.0,1928.0,0.0,1928.0
TCGA-CZ-4866-01,TCGA-CZ-4866,KIRC,79.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-28878.0,Alive,WITH TUMOR,3267.0,0.0,3267.0,0.0,3267.0,0.0,3267.0
TCGA-CZ-5451-01,TCGA-CZ-5451,KIRC,74.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-27312.0,Alive,TUMOR FREE,1929.0,0.0,1929.0,0.0,1929.0,0.0,1929.0
TCGA-CZ-5452-01,TCGA-CZ-5452,KIRC,69.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-25486.0,Alive,TUMOR FREE,1789.0,0.0,1789.0,0.0,1789.0,0.0,1789.0
TCGA-CZ-5453-01,TCGA-CZ-5453,KIRC,67.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-24640.0,Dead,,,1.0,2419.0,,2419.0,0.0,2419.0
TCGA-CZ-5454-01,TCGA-CZ-5454,KIRC,63.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-23083.0,Dead,WITH TUMOR,,1.0,722.0,1.0,722.0,1.0,423.0
TCGA-CZ-5455-01,TCGA-CZ-5455,KIRC,63.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-23150.0,Dead,WITH TUMOR,,1.0,561.0,1.0,561.0,1.0,561.0
TCGA-CZ-5456-01,TCGA-CZ-5456,KIRC,57.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-21164.0,Alive,WITH TUMOR,2422.0,0.0,2422.0,0.0,2422.0,1.0,951.0
TCGA-CZ-5457-01,TCGA-CZ-5457,KIRC,62.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-22763.0,Alive,WITH TUMOR,2754.0,0.0,2754.0,0.0,2754.0,1.0,174.0
TCGA-CZ-5458-01,TCGA-CZ-5458,KIRC,43.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-15790.0,Alive,TUMOR FREE,2789.0,0.0,2789.0,0.0,2789.0,0.0,2789.0
TCGA-CZ-5459-01,TCGA-CZ-5459,KIRC,63.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2006.0,-23318.0,Alive,TUMOR FREE,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0
TCGA-CZ-5460-01,TCGA-CZ-5460,KIRC,55.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-20392.0,Alive,WITH TUMOR,2873.0,0.0,2873.0,0.0,2873.0,0.0,2873.0
TCGA-CZ-5461-01,TCGA-CZ-5461,KIRC,52.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-19030.0,Dead,WITH TUMOR,330.0,1.0,330.0,1.0,330.0,1.0,48.0
TCGA-CZ-5462-01,TCGA-CZ-5462,KIRC,83.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2007.0,-30659.0,Dead,WITH TUMOR,,1.0,311.0,1.0,311.0,1.0,311.0
TCGA-CZ-5463-01,TCGA-CZ-5463,KIRC,76.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2007.0,-27911.0,Alive,,662.0,0.0,662.0,0.0,662.0,0.0,662.0
TCGA-CZ-5465-01,TCGA-CZ-5465,KIRC,76.0,FEMALE,,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-27838.0,Dead,TUMOR FREE,,1.0,2564.0,0.0,2564.0,0.0,2564.0
TCGA-CZ-5466-01,TCGA-CZ-5466,KIRC,67.0,MALE,,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-24669.0,Alive,TUMOR FREE,685.0,0.0,685.0,0.0,685.0,0.0,685.0
TCGA-CZ-5467-01,TCGA-CZ-5467,KIRC,86.0,FEMALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2007.0,-31473.0,Dead,WITH TUMOR,,1.0,73.0,1.0,73.0,1.0,62.0
TCGA-CZ-5468-01,TCGA-CZ-5468,KIRC,84.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2007.0,-30729.0,Dead,WITH TUMOR,59.0,1.0,59.0,1.0,59.0,1.0,59.0
TCGA-CZ-5469-01,TCGA-CZ-5469,KIRC,41.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2007.0,-15242.0,Dead,WITH TUMOR,,1.0,946.0,1.0,946.0,1.0,110.0
TCGA-CZ-5470-01,TCGA-CZ-5470,KIRC,72.0,FEMALE,,Stage II,Kidney Clear Cell Renal Carcinoma,2008.0,-26494.0,Alive,,386.0,0.0,386.0,0.0,386.0,0.0,386.0
TCGA-CZ-5982-01,TCGA-CZ-5982,KIRC,59.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-21592.0,Alive,TUMOR FREE,2439.0,0.0,2439.0,0.0,2439.0,0.0,2439.0
TCGA-CZ-5984-01,TCGA-CZ-5984,KIRC,51.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2005.0,-18775.0,Alive,TUMOR FREE,2067.0,0.0,2067.0,0.0,2067.0,0.0,2067.0
TCGA-CZ-5985-01,TCGA-CZ-5985,KIRC,58.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-21242.0,Alive,TUMOR FREE,1997.0,0.0,1997.0,0.0,1997.0,0.0,1997.0
TCGA-CZ-5986-01,TCGA-CZ-5986,KIRC,61.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-22456.0,Alive,TUMOR FREE,373.0,0.0,373.0,0.0,373.0,0.0,373.0
TCGA-CZ-5987-01,TCGA-CZ-5987,KIRC,60.0,MALE,WHITE,Stage IV,Kidney Clear Cell Renal Carcinoma,2006.0,-21928.0,Dead,WITH TUMOR,,1.0,445.0,1.0,445.0,1.0,377.0
TCGA-CZ-5988-01,TCGA-CZ-5988,KIRC,38.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2006.0,-14131.0,Alive,TUMOR FREE,693.0,0.0,693.0,0.0,693.0,0.0,693.0
TCGA-CZ-5989-01,TCGA-CZ-5989,KIRC,60.0,MALE,WHITE,Stage II,Kidney Clear Cell Renal Carcinoma,2006.0,-22170.0,Alive,TUMOR FREE,1905.0,0.0,1905.0,0.0,1905.0,0.0,1905.0
TCGA-D1-A2G0-01,TCGA-D1-A2G0,UCEC,70.0,FEMALE,WHITE,,Mixed serous and endometrioid,2007.0,-25573.0,Alive,TUMOR FREE,1484.0,0.0,1484.0,0.0,1484.0,0.0,1484.0
TCGA-D1-A3DA-01,TCGA-D1-A3DA,UCEC,77.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-28142.0,Alive,TUMOR FREE,483.0,0.0,483.0,0.0,483.0,0.0,483.0
TCGA-D1-A3DG-01,TCGA-D1-A3DG,UCEC,81.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-29771.0,Dead,TUMOR FREE,,1.0,130.0,0.0,130.0,0.0,130.0
TCGA-D1-A3DH-01,TCGA-D1-A3DH,UCEC,71.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-25935.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-D1-A3JQ-01,TCGA-D1-A3JQ,UCEC,61.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-22297.0,Alive,TUMOR FREE,526.0,0.0,526.0,0.0,526.0,0.0,526.0
TCGA-D5-5539-01,TCGA-D5-5539,COAD,60.0,MALE,WHITE,Stage IIIA,Colon Mucinous Adenocarcinoma,2010.0,-22097.0,Alive,WITH TUMOR,596.0,0.0,596.0,0.0,596.0,1.0,579.0
TCGA-D5-5540-01,TCGA-D5-5540,COAD,73.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-26972.0,Alive,TUMOR FREE,1706.0,0.0,1706.0,0.0,1706.0,0.0,1706.0
TCGA-D5-5541-01,TCGA-D5-5541,COAD,63.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-23109.0,Alive,TUMOR FREE,1701.0,0.0,1701.0,0.0,1701.0,0.0,1701.0
TCGA-D5-6529-01,TCGA-D5-6529,COAD,69.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-25394.0,Alive,WITH TUMOR,614.0,0.0,614.0,0.0,614.0,1.0,386.0
TCGA-D5-6530-01,TCGA-D5-6530,COAD,53.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2010.0,-19591.0,Alive,TUMOR FREE,621.0,0.0,621.0,0.0,621.0,0.0,621.0
TCGA-D5-6531-01,TCGA-D5-6531,COAD,75.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-27633.0,Alive,TUMOR FREE,540.0,0.0,540.0,0.0,540.0,0.0,540.0
TCGA-D5-6532-01,TCGA-D5-6532,COAD,61.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-22344.0,Alive,TUMOR FREE,555.0,0.0,555.0,0.0,555.0,0.0,555.0
TCGA-D5-6533-01,TCGA-D5-6533,COAD,68.0,FEMALE,WHITE,[Discrepancy],Colon Adenocarcinoma,2010.0,-24971.0,Alive,TUMOR FREE,775.0,0.0,775.0,0.0,775.0,0.0,775.0
TCGA-D5-6534-01,TCGA-D5-6534,COAD,62.0,FEMALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,2010.0,-22778.0,Alive,TUMOR FREE,1316.0,0.0,1316.0,0.0,1316.0,0.0,1316.0
TCGA-D5-6535-01,TCGA-D5-6535,COAD,80.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-29278.0,Alive,TUMOR FREE,460.0,0.0,460.0,0.0,460.0,0.0,460.0
TCGA-D5-6536-01,TCGA-D5-6536,COAD,73.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-26890.0,Alive,WITH TUMOR,543.0,0.0,543.0,0.0,543.0,1.0,493.0
TCGA-D5-6537-01,TCGA-D5-6537,COAD,64.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-23381.0,Dead,WITH TUMOR,,1.0,146.0,1.0,146.0,1.0,123.0
TCGA-D5-6538-01,TCGA-D5-6538,COAD,79.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2010.0,-29194.0,Alive,TUMOR FREE,521.0,0.0,521.0,0.0,521.0,0.0,521.0
TCGA-D5-6539-01,TCGA-D5-6539,COAD,45.0,FEMALE,WHITE,[Discrepancy],Colon Adenocarcinoma,2010.0,-16703.0,Alive,TUMOR FREE,380.0,0.0,380.0,0.0,380.0,0.0,380.0
TCGA-D5-6540-01,TCGA-D5-6540,COAD,66.0,MALE,WHITE,Stage I,Colon Mucinous Adenocarcinoma,2010.0,-24282.0,Alive,TUMOR FREE,491.0,0.0,491.0,0.0,491.0,0.0,491.0
TCGA-D5-6541-01,TCGA-D5-6541,COAD,49.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2010.0,-18029.0,Alive,TUMOR FREE,474.0,0.0,474.0,0.0,474.0,0.0,474.0
TCGA-D5-6920-01,TCGA-D5-6920,COAD,77.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-28124.0,Alive,TUMOR FREE,377.0,0.0,377.0,0.0,377.0,0.0,377.0
TCGA-D5-6922-01,TCGA-D5-6922,COAD,76.0,MALE,WHITE,Stage IIIA,Colon Adenocarcinoma,2011.0,-27771.0,Alive,TUMOR FREE,308.0,0.0,308.0,0.0,308.0,0.0,308.0
TCGA-D5-6924-01,TCGA-D5-6924,COAD,68.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-24964.0,Alive,TUMOR FREE,435.0,0.0,435.0,0.0,435.0,0.0,435.0
TCGA-D5-6926-01,TCGA-D5-6926,COAD,65.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2011.0,-23768.0,Alive,TUMOR FREE,275.0,0.0,275.0,0.0,275.0,0.0,275.0
TCGA-D5-6927-01,TCGA-D5-6927,COAD,34.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-12737.0,Alive,TUMOR FREE,287.0,0.0,287.0,0.0,287.0,0.0,287.0
TCGA-D5-6928-01,TCGA-D5-6928,COAD,80.0,MALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,2011.0,-29411.0,Alive,TUMOR FREE,354.0,0.0,354.0,0.0,354.0,0.0,354.0
TCGA-D5-6930-01,TCGA-D5-6930,COAD,67.0,MALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,2011.0,-24764.0,Alive,TUMOR FREE,406.0,0.0,406.0,0.0,406.0,0.0,406.0
TCGA-D5-6931-01,TCGA-D5-6931,COAD,77.0,MALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2011.0,-28292.0,Alive,TUMOR FREE,365.0,0.0,365.0,0.0,365.0,0.0,365.0
TCGA-D5-6932-01,TCGA-D5-6932,COAD,69.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-25466.0,Alive,TUMOR FREE,346.0,0.0,346.0,0.0,346.0,0.0,346.0
TCGA-D6-6515-01,TCGA-D6-6515,HNSC,82.0,FEMALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-30099.0,Dead,TUMOR FREE,,1.0,403.0,0.0,403.0,1.0,195.0
TCGA-D6-6516-01,TCGA-D6-6516,HNSC,69.0,MALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2010.0,-25242.0,Alive,TUMOR FREE,773.0,0.0,773.0,0.0,773.0,0.0,773.0
TCGA-D6-6517-01,TCGA-D6-6517,HNSC,59.0,MALE,WHITE,Stage III,Head & Neck Squamous Cell Carcinoma,2010.0,-21791.0,Alive,WITH TUMOR,292.0,0.0,292.0,0.0,292.0,1.0,161.0
TCGA-D6-6823-01,TCGA-D6-6823,HNSC,50.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2010.0,-18611.0,Alive,TUMOR FREE,701.0,0.0,701.0,0.0,701.0,0.0,701.0
TCGA-D6-6824-01,TCGA-D6-6824,HNSC,61.0,MALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2010.0,-22633.0,Alive,TUMOR FREE,77.0,0.0,77.0,0.0,77.0,0.0,77.0
TCGA-D6-6825-01,TCGA-D6-6825,HNSC,73.0,MALE,WHITE,Stage I,Head & Neck Squamous Cell Carcinoma,2011.0,-26976.0,Alive,TUMOR FREE,491.0,0.0,491.0,0.0,491.0,0.0,491.0
TCGA-D6-6826-01,TCGA-D6-6826,HNSC,64.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-23722.0,Dead,TUMOR FREE,,1.0,348.0,0.0,348.0,0.0,348.0
TCGA-D7-5577-01,TCGA-D7-5577,STAD,53.0,FEMALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-19668.0,Dead,WITH TUMOR,,1.0,782.0,1.0,782.0,1.0,376.0
TCGA-D7-5578-01,TCGA-D7-5578,STAD,80.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-29390.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-D7-6518-01,TCGA-D7-6518,STAD,75.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-27594.0,Alive,TUMOR FREE,582.0,0.0,582.0,0.0,582.0,0.0,582.0
TCGA-D7-6519-01,TCGA-D7-6519,STAD,64.0,FEMALE,WHITE,[Discrepancy],"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-23413.0,Alive,WITH TUMOR,625.0,0.0,625.0,0.0,625.0,1.0,429.0
TCGA-D7-6520-01,TCGA-D7-6520,STAD,53.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-19467.0,Alive,WITH TUMOR,573.0,0.0,573.0,0.0,573.0,1.0,46.0
TCGA-D7-6521-01,TCGA-D7-6521,STAD,65.0,MALE,WHITE,[Discrepancy],"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-23776.0,Alive,WITH TUMOR,564.0,0.0,564.0,0.0,564.0,1.0,192.0
TCGA-D7-6522-01,TCGA-D7-6522,STAD,58.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-21465.0,Alive,TUMOR FREE,566.0,0.0,566.0,0.0,566.0,0.0,566.0
TCGA-D7-6524-01,TCGA-D7-6524,STAD,53.0,MALE,WHITE,Stage II,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-19532.0,Alive,WITH TUMOR,543.0,0.0,543.0,0.0,543.0,1.0,543.0
TCGA-D7-6525-01,TCGA-D7-6525,STAD,58.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2010.0,-21223.0,Dead,WITH TUMOR,,1.0,406.0,1.0,406.0,1.0,171.0
TCGA-D7-6527-01,TCGA-D7-6527,STAD,62.0,MALE,WHITE,Stage II,"Stomach, Intestinal Adenocarcinoma, Papillary Type",2010.0,-22793.0,Dead,WITH TUMOR,,1.0,312.0,1.0,312.0,1.0,75.0
TCGA-D7-6528-01,TCGA-D7-6528,STAD,70.0,FEMALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-25815.0,Alive,TUMOR FREE,463.0,0.0,463.0,0.0,463.0,0.0,463.0
TCGA-D7-6815-01,TCGA-D7-6815,STAD,70.0,FEMALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-25811.0,Alive,TUMOR FREE,486.0,0.0,486.0,0.0,486.0,0.0,486.0
TCGA-D7-6817-01,TCGA-D7-6817,STAD,63.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-23142.0,Alive,TUMOR FREE,389.0,0.0,389.0,0.0,389.0,0.0,389.0
TCGA-D7-6818-01,TCGA-D7-6818,STAD,53.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-19391.0,Dead,WITH TUMOR,,1.0,376.0,1.0,376.0,1.0,247.0
TCGA-D7-6820-01,TCGA-D7-6820,STAD,64.0,MALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-23486.0,Alive,TUMOR FREE,344.0,0.0,344.0,0.0,344.0,0.0,344.0
TCGA-D7-6822-01,TCGA-D7-6822,STAD,77.0,MALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-28214.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-D7-8570-01,TCGA-D7-8570,STAD,44.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-16150.0,Alive,WITH TUMOR,752.0,0.0,752.0,0.0,752.0,0.0,752.0
TCGA-D7-8572-01,TCGA-D7-8572,STAD,57.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-20870.0,Alive,WITH TUMOR,511.0,0.0,511.0,0.0,511.0,0.0,511.0
TCGA-D7-8573-01,TCGA-D7-8573,STAD,57.0,MALE,WHITE,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-20963.0,Alive,WITH TUMOR,593.0,0.0,593.0,0.0,593.0,0.0,593.0
TCGA-D7-8574-01,TCGA-D7-8574,STAD,72.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26586.0,Alive,TUMOR FREE,523.0,0.0,523.0,0.0,523.0,0.0,523.0
TCGA-D7-8575-01,TCGA-D7-8575,STAD,75.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-27712.0,Dead,WITH TUMOR,,1.0,554.0,1.0,554.0,1.0,427.0
TCGA-D7-8578-01,TCGA-D7-8578,STAD,72.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-26620.0,Alive,WITH TUMOR,643.0,0.0,643.0,0.0,643.0,1.0,451.0
TCGA-D7-A4YT-01,TCGA-D7-A4YT,STAD,56.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-20742.0,Alive,TUMOR FREE,434.0,0.0,434.0,0.0,434.0,0.0,434.0
TCGA-D7-A4YU-01,TCGA-D7-A4YU,STAD,73.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-26781.0,Alive,WITH TUMOR,500.0,0.0,500.0,0.0,500.0,0.0,500.0
TCGA-D7-A4YV-01,TCGA-D7-A4YV,STAD,69.0,FEMALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-25421.0,Dead,TUMOR FREE,,1.0,180.0,0.0,180.0,0.0,180.0
TCGA-D7-A4YX-01,TCGA-D7-A4YX,STAD,63.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-23249.0,Alive,TUMOR FREE,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0
TCGA-D7-A4YY-01,TCGA-D7-A4YY,STAD,61.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-22287.0,Alive,TUMOR FREE,419.0,0.0,419.0,0.0,419.0,0.0,419.0
TCGA-D7-A4Z0-01,TCGA-D7-A4Z0,STAD,60.0,FEMALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2012.0,-22129.0,Alive,TUMOR FREE,449.0,0.0,449.0,0.0,449.0,0.0,449.0
TCGA-D7-A6EV-01,TCGA-D7-A6EV,STAD,71.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-26226.0,Alive,TUMOR FREE,342.0,0.0,342.0,0.0,342.0,0.0,342.0
TCGA-D7-A6EX-01,TCGA-D7-A6EX,STAD,72.0,FEMALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2013.0,-26525.0,Alive,TUMOR FREE,344.0,0.0,344.0,0.0,344.0,0.0,344.0
TCGA-D7-A6EY-01,TCGA-D7-A6EY,STAD,72.0,FEMALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2013.0,-26526.0,Dead,WITH TUMOR,,1.0,348.0,1.0,348.0,1.0,348.0
TCGA-D7-A6EZ-01,TCGA-D7-A6EZ,STAD,66.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-24425.0,Dead,WITH TUMOR,,1.0,618.0,1.0,618.0,1.0,618.0
TCGA-D7-A6F0-01,TCGA-D7-A6F0,STAD,79.0,FEMALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-28923.0,Alive,TUMOR FREE,678.0,0.0,678.0,0.0,678.0,0.0,678.0
TCGA-D7-A748-01,TCGA-D7-A748,STAD,41.0,FEMALE,WHITE,Stage IV,"Stomach, Adenocarcinoma, Diffuse Type",2013.0,-15190.0,Dead,WITH TUMOR,,1.0,132.0,1.0,132.0,1.0,99.0
TCGA-D8-A13Y-01,TCGA-D8-A13Y,BRCA,52.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-19028.0,Alive,TUMOR FREE,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0
TCGA-D8-A13Z-01,TCGA-D8-A13Z,BRCA,51.0,FEMALE,WHITE,,Infiltrating Ductal Carcinoma,2010.0,-18942.0,Alive,TUMOR FREE,635.0,0.0,635.0,0.0,635.0,0.0,635.0
TCGA-D8-A140-01,TCGA-D8-A140,BRCA,62.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-22900.0,Alive,TUMOR FREE,403.0,0.0,403.0,0.0,403.0,0.0,403.0
TCGA-D8-A142-01,TCGA-D8-A142,BRCA,74.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-27313.0,Alive,TUMOR FREE,425.0,0.0,425.0,0.0,425.0,0.0,425.0
TCGA-D8-A143-01,TCGA-D8-A143,BRCA,51.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-18984.0,Alive,TUMOR FREE,431.0,0.0,431.0,0.0,431.0,0.0,431.0
TCGA-D8-A145-01,TCGA-D8-A145,BRCA,80.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-29280.0,Alive,TUMOR FREE,410.0,0.0,410.0,0.0,410.0,0.0,410.0
TCGA-D8-A147-01,TCGA-D8-A147,BRCA,45.0,FEMALE,WHITE,,Infiltrating Ductal Carcinoma,2010.0,-16736.0,Alive,TUMOR FREE,584.0,0.0,584.0,0.0,584.0,0.0,584.0
TCGA-D8-A1J8-01,TCGA-D8-A1J8,BRCA,77.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-28444.0,Alive,TUMOR FREE,431.0,0.0,431.0,0.0,431.0,0.0,431.0
TCGA-D8-A1J9-01,TCGA-D8-A1J9,BRCA,48.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-17879.0,Alive,TUMOR FREE,532.0,0.0,532.0,0.0,532.0,0.0,532.0
TCGA-D8-A1JB-01,TCGA-D8-A1JB,BRCA,54.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-19822.0,Alive,TUMOR FREE,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0
TCGA-D8-A1JC-01,TCGA-D8-A1JC,BRCA,59.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-21898.0,Alive,TUMOR FREE,480.0,0.0,480.0,0.0,480.0,0.0,480.0
TCGA-D8-A1JD-01,TCGA-D8-A1JD,BRCA,41.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-15166.0,Alive,TUMOR FREE,552.0,0.0,552.0,0.0,552.0,0.0,552.0
TCGA-D8-A1JE-01,TCGA-D8-A1JE,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-22683.0,Alive,TUMOR FREE,575.0,0.0,575.0,0.0,575.0,0.0,575.0
TCGA-D8-A1JF-01,TCGA-D8-A1JF,BRCA,79.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-29199.0,Alive,TUMOR FREE,366.0,0.0,366.0,0.0,366.0,0.0,366.0
TCGA-D8-A1JG-01,TCGA-D8-A1JG,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-22878.0,Alive,TUMOR FREE,1612.0,0.0,1612.0,0.0,1612.0,0.0,1612.0
TCGA-D8-A1JH-01,TCGA-D8-A1JH,BRCA,56.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-20497.0,Alive,TUMOR FREE,426.0,0.0,426.0,0.0,426.0,0.0,426.0
TCGA-D8-A1JI-01,TCGA-D8-A1JI,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-20072.0,Alive,TUMOR FREE,577.0,0.0,577.0,0.0,577.0,0.0,577.0
TCGA-D8-A1JJ-01,TCGA-D8-A1JJ,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-19966.0,Alive,TUMOR FREE,611.0,0.0,611.0,0.0,611.0,0.0,611.0
TCGA-D8-A1JK-01,TCGA-D8-A1JK,BRCA,90.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-32872.0,Alive,TUMOR FREE,612.0,0.0,612.0,0.0,612.0,0.0,612.0
TCGA-D8-A1JL-01,TCGA-D8-A1JL,BRCA,72.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-26484.0,Alive,TUMOR FREE,611.0,0.0,611.0,0.0,611.0,0.0,611.0
TCGA-D8-A1JM-01,TCGA-D8-A1JM,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-21602.0,Alive,TUMOR FREE,590.0,0.0,590.0,0.0,590.0,0.0,590.0
TCGA-D8-A1JN-01,TCGA-D8-A1JN,BRCA,80.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2010.0,-29331.0,Alive,TUMOR FREE,620.0,0.0,620.0,0.0,620.0,0.0,620.0
TCGA-D8-A1JP-01,TCGA-D8-A1JP,BRCA,73.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-26862.0,Alive,TUMOR FREE,639.0,0.0,639.0,0.0,639.0,0.0,639.0
TCGA-D8-A1JS-01,TCGA-D8-A1JS,BRCA,77.0,FEMALE,WHITE,Stage IA,"Other, specify",2010.0,-28178.0,Alive,TUMOR FREE,371.0,0.0,371.0,0.0,371.0,0.0,371.0
TCGA-D8-A1JT-01,TCGA-D8-A1JT,BRCA,70.0,FEMALE,WHITE,Stage IIA,"Other, specify",2010.0,-25677.0,Alive,TUMOR FREE,405.0,0.0,405.0,0.0,405.0,0.0,405.0
TCGA-D8-A1JU-01,TCGA-D8-A1JU,BRCA,51.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-18733.0,Alive,TUMOR FREE,447.0,0.0,447.0,0.0,447.0,0.0,447.0
TCGA-D8-A1X6-01,TCGA-D8-A1X6,BRCA,80.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-29256.0,Alive,TUMOR FREE,541.0,0.0,541.0,0.0,541.0,0.0,541.0
TCGA-D8-A1X7-01,TCGA-D8-A1X7,BRCA,40.0,FEMALE,WHITE,Stage IIA,"Other, specify",2010.0,-14858.0,Alive,TUMOR FREE,509.0,0.0,509.0,0.0,509.0,0.0,509.0
TCGA-D8-A1X9-01,TCGA-D8-A1X9,BRCA,66.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-24417.0,Alive,TUMOR FREE,727.0,0.0,727.0,0.0,727.0,0.0,727.0
TCGA-D8-A1XA-01,TCGA-D8-A1XA,BRCA,64.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-23387.0,Alive,TUMOR FREE,839.0,0.0,839.0,0.0,839.0,0.0,839.0
TCGA-D8-A1XB-01,TCGA-D8-A1XB,BRCA,62.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-22976.0,Alive,TUMOR FREE,552.0,0.0,552.0,0.0,552.0,0.0,552.0
TCGA-D8-A1XC-01,TCGA-D8-A1XC,BRCA,85.0,FEMALE,WHITE,Stage IIIB,Mucinous Carcinoma,2010.0,-31220.0,Dead,WITH TUMOR,,1.0,377.0,1.0,377.0,1.0,377.0
TCGA-D8-A1XF-01,TCGA-D8-A1XF,BRCA,45.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-16787.0,Alive,TUMOR FREE,463.0,0.0,463.0,0.0,463.0,0.0,463.0
TCGA-D8-A1XG-01,TCGA-D8-A1XG,BRCA,86.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,2010.0,-31748.0,Alive,TUMOR FREE,448.0,0.0,448.0,0.0,448.0,0.0,448.0
TCGA-D8-A1XK-01,TCGA-D8-A1XK,BRCA,55.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-20092.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-D8-A1XL-01,TCGA-D8-A1XL,BRCA,34.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-12668.0,Alive,TUMOR FREE,606.0,0.0,606.0,0.0,606.0,0.0,606.0
TCGA-D8-A1XM-01,TCGA-D8-A1XM,BRCA,57.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-21056.0,Alive,TUMOR FREE,538.0,0.0,538.0,0.0,538.0,0.0,538.0
TCGA-D8-A1XO-01,TCGA-D8-A1XO,BRCA,56.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-20606.0,Alive,TUMOR FREE,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0
TCGA-D8-A1XQ-01,TCGA-D8-A1XQ,BRCA,69.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-25345.0,Alive,TUMOR FREE,499.0,0.0,499.0,0.0,499.0,0.0,499.0
TCGA-D8-A1XR-01,TCGA-D8-A1XR,BRCA,56.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-20488.0,Alive,TUMOR FREE,482.0,0.0,482.0,0.0,482.0,0.0,482.0
TCGA-D8-A1XS-01,TCGA-D8-A1XS,BRCA,48.0,MALE,WHITE,Stage IIIC,"Other, specify",2010.0,-17708.0,Alive,TUMOR FREE,496.0,0.0,496.0,0.0,496.0,0.0,496.0
TCGA-D8-A1XT-01,TCGA-D8-A1XT,BRCA,61.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-22448.0,Alive,TUMOR FREE,506.0,0.0,506.0,0.0,506.0,0.0,506.0
TCGA-D8-A1XU-01,TCGA-D8-A1XU,BRCA,56.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-20715.0,Alive,TUMOR FREE,395.0,0.0,395.0,0.0,395.0,0.0,395.0
TCGA-D8-A1XV-01,TCGA-D8-A1XV,BRCA,84.0,FEMALE,WHITE,Stage IIA,Mucinous Carcinoma,2010.0,-30830.0,Alive,TUMOR FREE,461.0,0.0,461.0,0.0,461.0,0.0,461.0
TCGA-D8-A1XW-01,TCGA-D8-A1XW,BRCA,53.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-19478.0,Alive,TUMOR FREE,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0
TCGA-D8-A1XY-01,TCGA-D8-A1XY,BRCA,74.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-27106.0,Alive,TUMOR FREE,503.0,0.0,503.0,0.0,503.0,0.0,503.0
TCGA-D8-A1XZ-01,TCGA-D8-A1XZ,BRCA,81.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-29916.0,Alive,TUMOR FREE,466.0,0.0,466.0,0.0,466.0,0.0,466.0
TCGA-D8-A1Y0-01,TCGA-D8-A1Y0,BRCA,65.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-24083.0,Alive,TUMOR FREE,472.0,0.0,472.0,0.0,472.0,0.0,472.0
TCGA-D8-A1Y1-01,TCGA-D8-A1Y1,BRCA,80.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-29474.0,Dead,WITH TUMOR,,1.0,302.0,1.0,302.0,1.0,302.0
TCGA-D8-A1Y2-01,TCGA-D8-A1Y2,BRCA,71.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-26021.0,Alive,TUMOR FREE,433.0,0.0,433.0,0.0,433.0,0.0,433.0
TCGA-D8-A1Y3-01,TCGA-D8-A1Y3,BRCA,61.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-22317.0,Alive,TUMOR FREE,430.0,0.0,430.0,0.0,430.0,0.0,430.0
TCGA-D8-A27E-01,TCGA-D8-A27E,BRCA,66.0,FEMALE,WHITE,Stage IA,"Other, specify",2010.0,-24315.0,Alive,TUMOR FREE,530.0,0.0,530.0,0.0,530.0,0.0,530.0
TCGA-D8-A27F-01,TCGA-D8-A27F,BRCA,40.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-14731.0,Alive,TUMOR FREE,488.0,0.0,488.0,0.0,488.0,0.0,488.0
TCGA-D8-A27G-01,TCGA-D8-A27G,BRCA,75.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-27521.0,Alive,TUMOR FREE,409.0,0.0,409.0,0.0,409.0,0.0,409.0
TCGA-D8-A27H-01,TCGA-D8-A27H,BRCA,72.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-26588.0,Alive,TUMOR FREE,397.0,0.0,397.0,0.0,397.0,0.0,397.0
TCGA-D8-A27I-01,TCGA-D8-A27I,BRCA,58.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2010.0,-21327.0,Alive,TUMOR FREE,439.0,0.0,439.0,0.0,439.0,0.0,439.0
TCGA-D8-A27K-01,TCGA-D8-A27K,BRCA,47.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-17426.0,Alive,TUMOR FREE,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0
TCGA-D8-A27L-01,TCGA-D8-A27L,BRCA,49.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-18025.0,Alive,TUMOR FREE,499.0,0.0,499.0,0.0,499.0,0.0,499.0
TCGA-D8-A27M-01,TCGA-D8-A27M,BRCA,59.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-21910.0,Alive,TUMOR FREE,410.0,0.0,410.0,0.0,410.0,0.0,410.0
TCGA-D8-A27N-01,TCGA-D8-A27N,BRCA,36.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-13243.0,Alive,TUMOR FREE,519.0,0.0,519.0,0.0,519.0,0.0,519.0
TCGA-D8-A27P-01,TCGA-D8-A27P,BRCA,64.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-23576.0,Alive,TUMOR FREE,49.0,0.0,49.0,0.0,49.0,0.0,49.0
TCGA-D8-A27R-01,TCGA-D8-A27R,BRCA,41.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2011.0,-15122.0,Alive,TUMOR FREE,307.0,0.0,307.0,0.0,307.0,0.0,307.0
TCGA-D8-A27T-01,TCGA-D8-A27T,BRCA,53.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2011.0,-19591.0,Alive,TUMOR FREE,398.0,0.0,398.0,0.0,398.0,0.0,398.0
TCGA-D8-A27V-01,TCGA-D8-A27V,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-22958.0,Alive,TUMOR FREE,381.0,0.0,381.0,0.0,381.0,0.0,381.0
TCGA-D8-A27W-01,TCGA-D8-A27W,BRCA,55.0,FEMALE,WHITE,Stage IIIB,Mucinous Carcinoma,2011.0,-20173.0,Alive,TUMOR FREE,373.0,0.0,373.0,0.0,373.0,0.0,373.0
TCGA-D8-A73U-01,TCGA-D8-A73U,BRCA,88.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-32208.0,Alive,WITH TUMOR,492.0,0.0,492.0,0.0,492.0,0.0,492.0
TCGA-D8-A73W-01,TCGA-D8-A73W,BRCA,79.0,FEMALE,WHITE,Stage IIIA,Mucinous Carcinoma,2013.0,-29125.0,Dead,WITH TUMOR,,1.0,385.0,1.0,385.0,1.0,21.0
TCGA-D8-A73X-01,TCGA-D8-A73X,BRCA,53.0,FEMALE,WHITE,Stage IIA,"Other, specify",2013.0,-19607.0,Alive,TUMOR FREE,767.0,0.0,767.0,0.0,767.0,0.0,767.0
TCGA-D9-A3Z4-01,TCGA-D9-A3Z4,SKCM,54.0,MALE,WHITE,Stage IIIC,,2012.0,-19749.0,Dead,WITH TUMOR,,1.0,519.0,1.0,519.0,1.0,192.0
TCGA-D9-A4Z3-01,TCGA-D9-A4Z3,SKCM,73.0,FEMALE,WHITE,Stage IIIC,,2012.0,-26812.0,Alive,TUMOR FREE,505.0,0.0,505.0,0.0,505.0,1.0,100.0
TCGA-D9-A4Z5-01,TCGA-D9-A4Z5,SKCM,68.0,MALE,WHITE,Stage IIB,,2012.0,-24979.0,Alive,TUMOR FREE,218.0,0.0,218.0,0.0,218.0,0.0,218.0
TCGA-DB-5270-01,TCGA-DB-5270,LGG,38.0,FEMALE,WHITE,,Oligoastrocytoma,2002.0,-13904.0,Alive,TUMOR FREE,3733.0,0.0,3733.0,0.0,3733.0,0.0,3733.0
TCGA-DB-5273-01,TCGA-DB-5273,LGG,33.0,MALE,WHITE,,Astrocytoma,2006.0,-12152.0,Alive,TUMOR FREE,2493.0,0.0,2493.0,0.0,2493.0,0.0,2493.0
TCGA-DB-5274-01,TCGA-DB-5274,LGG,37.0,FEMALE,WHITE,,Oligoastrocytoma,2006.0,-13680.0,Alive,TUMOR FREE,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0
TCGA-DB-5275-01,TCGA-DB-5275,LGG,36.0,MALE,WHITE,,Oligoastrocytoma,2006.0,-13371.0,Alive,TUMOR FREE,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0
TCGA-DB-5276-01,TCGA-DB-5276,LGG,32.0,MALE,WHITE,,Oligoastrocytoma,2007.0,-11738.0,Alive,TUMOR FREE,2218.0,0.0,2218.0,0.0,2218.0,0.0,2218.0
TCGA-DB-5277-01,TCGA-DB-5277,LGG,34.0,MALE,WHITE,,Astrocytoma,2007.0,-12725.0,Dead,WITH TUMOR,,1.0,1547.0,1.0,1547.0,1.0,1156.0
TCGA-DB-5278-01,TCGA-DB-5278,LGG,17.0,MALE,WHITE,,Oligodendroglioma,2007.0,-6480.0,Alive,WITH TUMOR,2772.0,0.0,2772.0,0.0,2772.0,1.0,507.0
TCGA-DB-5279-01,TCGA-DB-5279,LGG,59.0,MALE,,,Oligodendroglioma,2007.0,-21908.0,Alive,TUMOR FREE,1354.0,0.0,1354.0,0.0,1354.0,1.0,695.0
TCGA-DB-5280-01,TCGA-DB-5280,LGG,43.0,MALE,WHITE,,Oligoastrocytoma,2007.0,-15836.0,Alive,TUMOR FREE,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0
TCGA-DB-5281-01,TCGA-DB-5281,LGG,61.0,MALE,WHITE,,Oligoastrocytoma,2006.0,-22342.0,Alive,WITH TUMOR,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0
TCGA-DB-A4X9-01,TCGA-DB-A4X9,LGG,33.0,FEMALE,WHITE,,Oligoastrocytoma,2010.0,-12131.0,Alive,TUMOR FREE,1412.0,0.0,1412.0,0.0,1412.0,1.0,501.0
TCGA-DB-A4XA-01,TCGA-DB-A4XA,LGG,30.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-11195.0,Alive,WITH TUMOR,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-DB-A4XB-01,TCGA-DB-A4XB,LGG,38.0,MALE,WHITE,,Astrocytoma,2011.0,-13990.0,Alive,TUMOR FREE,919.0,0.0,919.0,0.0,919.0,0.0,919.0
TCGA-DB-A4XC-01,TCGA-DB-A4XC,LGG,26.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-9705.0,Alive,TUMOR FREE,1421.0,0.0,1421.0,0.0,1421.0,0.0,1421.0
TCGA-DB-A4XD-01,TCGA-DB-A4XD,LGG,32.0,MALE,WHITE,,Astrocytoma,2010.0,-11741.0,Alive,TUMOR FREE,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0
TCGA-DB-A4XE-01,TCGA-DB-A4XE,LGG,27.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-10150.0,Alive,TUMOR FREE,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0
TCGA-DB-A4XF-01,TCGA-DB-A4XF,LGG,41.0,FEMALE,WHITE,,Astrocytoma,2011.0,-15066.0,Alive,TUMOR FREE,1021.0,0.0,1021.0,0.0,1021.0,1.0,468.0
TCGA-DB-A4XG-01,TCGA-DB-A4XG,LGG,34.0,MALE,WHITE,,Oligodendroglioma,2006.0,-12550.0,Alive,WITH TUMOR,2219.0,0.0,2219.0,0.0,2219.0,0.0,2219.0
TCGA-DB-A4XH-01,TCGA-DB-A4XH,LGG,53.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-19710.0,Alive,TUMOR FREE,962.0,0.0,962.0,0.0,962.0,0.0,962.0
TCGA-DB-A64L-01,TCGA-DB-A64L,LGG,67.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-24690.0,Alive,WITH TUMOR,736.0,0.0,736.0,0.0,736.0,1.0,724.0
TCGA-DB-A64O-01,TCGA-DB-A64O,LGG,59.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-21811.0,Dead,WITH TUMOR,,1.0,775.0,1.0,775.0,1.0,430.0
TCGA-DB-A64P-01,TCGA-DB-A64P,LGG,40.0,MALE,WHITE,,Oligodendroglioma,2012.0,-14936.0,Alive,TUMOR FREE,916.0,0.0,916.0,0.0,916.0,0.0,916.0
TCGA-DB-A64Q-01,TCGA-DB-A64Q,LGG,31.0,FEMALE,[Unknown],,Oligoastrocytoma,2012.0,-11637.0,Alive,TUMOR FREE,182.0,0.0,182.0,0.0,182.0,0.0,182.0
TCGA-DB-A64R-01,TCGA-DB-A64R,LGG,24.0,FEMALE,[Not Evaluated],,Oligodendroglioma,2012.0,-8947.0,Alive,TUMOR FREE,955.0,0.0,955.0,0.0,955.0,0.0,955.0
TCGA-DB-A64S-01,TCGA-DB-A64S,LGG,20.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-7389.0,Alive,TUMOR FREE,835.0,0.0,835.0,0.0,835.0,0.0,835.0
TCGA-DB-A64U-01,TCGA-DB-A64U,LGG,38.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-14019.0,Alive,TUMOR FREE,846.0,0.0,846.0,0.0,846.0,0.0,846.0
TCGA-DB-A64V-01,TCGA-DB-A64V,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2012.0,-19950.0,Alive,TUMOR FREE,889.0,0.0,889.0,0.0,889.0,0.0,889.0
TCGA-DB-A64W-01,TCGA-DB-A64W,LGG,65.0,FEMALE,WHITE,,Oligoastrocytoma,2012.0,-23936.0,Dead,TUMOR FREE,,1.0,438.0,0.0,438.0,0.0,438.0
TCGA-DB-A64X-01,TCGA-DB-A64X,LGG,56.0,FEMALE,WHITE,,Astrocytoma,2012.0,-20625.0,Alive,TUMOR FREE,563.0,0.0,563.0,0.0,563.0,0.0,563.0
TCGA-DB-A75K-01,TCGA-DB-A75K,LGG,55.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-20241.0,Alive,TUMOR FREE,368.0,0.0,368.0,0.0,368.0,0.0,368.0
TCGA-DB-A75L-01,TCGA-DB-A75L,LGG,36.0,FEMALE,WHITE,,Astrocytoma,2013.0,-13338.0,Alive,TUMOR FREE,342.0,0.0,342.0,0.0,342.0,0.0,342.0
TCGA-DB-A75M-01,TCGA-DB-A75M,LGG,47.0,MALE,WHITE,,Astrocytoma,2013.0,-17289.0,Alive,TUMOR FREE,544.0,0.0,544.0,0.0,544.0,0.0,544.0
TCGA-DB-A75O-01,TCGA-DB-A75O,LGG,29.0,MALE,WHITE,,Astrocytoma,2010.0,-10812.0,Alive,,935.0,0.0,935.0,0.0,935.0,0.0,935.0
TCGA-DB-A75P-01,TCGA-DB-A75P,LGG,25.0,FEMALE,[Unknown],,Astrocytoma,2013.0,-9413.0,Alive,TUMOR FREE,492.0,0.0,492.0,0.0,492.0,0.0,492.0
TCGA-DC-4745-01,TCGA-DC-4745,READ,49.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-17958.0,Alive,TUMOR FREE,639.0,0.0,639.0,0.0,639.0,0.0,639.0
TCGA-DC-4749-01,TCGA-DC-4749,READ,57.0,MALE,WHITE,Stage I,Rectal Adenocarcinoma,2010.0,-21092.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-DC-5337-01,TCGA-DC-5337,READ,69.0,MALE,WHITE,Stage I,Rectal Adenocarcinoma,2010.0,-25202.0,Alive,TUMOR FREE,792.0,0.0,792.0,0.0,792.0,0.0,792.0
TCGA-DC-5869-01,TCGA-DC-5869,READ,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Rectal Adenocarcinoma,2010.0,-22676.0,Alive,TUMOR FREE,943.0,0.0,943.0,0.0,943.0,0.0,943.0
TCGA-DC-6155-01,TCGA-DC-6155,READ,31.0,FEMALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2010.0,-11381.0,Alive,TUMOR FREE,425.0,0.0,425.0,0.0,425.0,0.0,425.0
TCGA-DC-6157-01,TCGA-DC-6157,READ,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Rectal Adenocarcinoma,2009.0,-17807.0,Alive,TUMOR FREE,1581.0,0.0,1581.0,0.0,1581.0,0.0,1581.0
TCGA-DC-6158-01,TCGA-DC-6158,READ,70.0,MALE,WHITE,Stage I,Rectal Adenocarcinoma,2010.0,-25842.0,Dead,TUMOR FREE,,1.0,334.0,0.0,334.0,0.0,334.0
TCGA-DC-6160-01,TCGA-DC-6160,READ,68.0,MALE,WHITE,Stage I,Rectal Adenocarcinoma,2009.0,-24990.0,Alive,TUMOR FREE,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0
TCGA-DC-6681-01,TCGA-DC-6681,READ,70.0,FEMALE,WHITE,Stage IVA,Rectal Adenocarcinoma,2011.0,-25659.0,Alive,TUMOR FREE,790.0,0.0,790.0,0.0,790.0,0.0,790.0
TCGA-DC-6682-01,TCGA-DC-6682,READ,57.0,MALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2011.0,-21062.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-DC-6683-01,TCGA-DC-6683,READ,43.0,MALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2011.0,-15918.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-DD-A114-01,TCGA-DD-A114,LIHC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Hepatocellular Carcinoma,2005.0,-15410.0,Dead,TUMOR FREE,,1.0,1149.0,0.0,1149.0,0.0,1149.0
TCGA-DD-A115-01,TCGA-DD-A115,LIHC,53.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2002.0,-19697.0,Dead,WITH TUMOR,,1.0,2542.0,1.0,2542.0,1.0,469.0
TCGA-DD-A116-01,TCGA-DD-A116,LIHC,68.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2002.0,-24934.0,Dead,TUMOR FREE,,1.0,1622.0,0.0,1622.0,1.0,828.0
TCGA-DD-A118-01,TCGA-DD-A118,LIHC,77.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2003.0,-28406.0,Alive,,3437.0,0.0,3437.0,0.0,3437.0,1.0,658.0
TCGA-DD-A119-01,TCGA-DD-A119,LIHC,40.0,MALE,ASIAN,Stage IV,Hepatocellular Carcinoma,2003.0,-14613.0,Dead,,,1.0,223.0,,223.0,0.0,223.0
TCGA-DD-A11A-01,TCGA-DD-A11A,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2004.0,-24646.0,Alive,,79.0,0.0,79.0,0.0,79.0,0.0,79.0
TCGA-DD-A11B-01,TCGA-DD-A11B,LIHC,73.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2005.0,-26857.0,Dead,TUMOR FREE,,1.0,14.0,0.0,14.0,0.0,14.0
TCGA-DD-A11C-01,TCGA-DD-A11C,LIHC,69.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2006.0,-25403.0,Alive,TUMOR FREE,662.0,0.0,662.0,0.0,662.0,0.0,662.0
TCGA-DD-A11D-01,TCGA-DD-A11D,LIHC,57.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2006.0,-21003.0,Dead,WITH TUMOR,,1.0,1560.0,1.0,1560.0,1.0,498.0
TCGA-DD-A1EB-01,TCGA-DD-A1EB,LIHC,72.0,FEMALE,,Stage I,Hepatocellular Carcinoma,2001.0,-26471.0,Alive,[Discrepancy],2017.0,0.0,2017.0,0.0,2017.0,1.0,505.0
TCGA-DD-A1EC-01,TCGA-DD-A1EC,LIHC,20.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2004.0,-7363.0,Alive,,602.0,0.0,602.0,0.0,602.0,1.0,299.0
TCGA-DD-A1ED-01,TCGA-DD-A1ED,LIHC,68.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2006.0,-25039.0,Alive,TUMOR FREE,2301.0,0.0,2301.0,0.0,2301.0,0.0,2301.0
TCGA-DD-A1EE-01,TCGA-DD-A1EE,LIHC,73.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2006.0,-26858.0,Dead,WITH TUMOR,,1.0,349.0,1.0,349.0,1.0,44.0
TCGA-DD-A1EF-01,TCGA-DD-A1EF,LIHC,57.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2007.0,-21165.0,Dead,WITH TUMOR,,1.0,394.0,1.0,394.0,1.0,394.0
TCGA-DD-A1EH-01,TCGA-DD-A1EH,LIHC,23.0,MALE,WHITE,Stage III,Hepatocellular Carcinoma,2008.0,-8499.0,Alive,WITH TUMOR,1495.0,0.0,1495.0,0.0,1495.0,1.0,120.0
TCGA-DD-A1EJ-01,TCGA-DD-A1EJ,LIHC,71.0,FEMALE,WHITE,Stage IIIC,Hepatocellular Carcinoma,2008.0,-26009.0,Dead,WITH TUMOR,,1.0,1005.0,1.0,1005.0,1.0,263.0
TCGA-DD-A1EL-01,TCGA-DD-A1EL,LIHC,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Hepatocellular Carcinoma,2009.0,-8573.0,Dead,WITH TUMOR,,1.0,415.0,1.0,415.0,1.0,415.0
TCGA-DD-A39V-01,TCGA-DD-A39V,LIHC,77.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2000.0,-28254.0,Dead,WITH TUMOR,,1.0,643.0,1.0,643.0,1.0,455.0
TCGA-DD-A39W-01,TCGA-DD-A39W,LIHC,29.0,FEMALE,WHITE,Stage III,Hepatocellular Carcinoma,1995.0,-10699.0,Dead,,,1.0,827.0,,827.0,0.0,827.0
TCGA-DD-A39X-01,TCGA-DD-A39X,LIHC,78.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,1998.0,-28528.0,Dead,WITH TUMOR,,1.0,1694.0,1.0,1694.0,1.0,1032.0
TCGA-DD-A39Z-01,TCGA-DD-A39Z,LIHC,43.0,FEMALE,,Stage II,Hepatocellular Carcinoma,1996.0,-15930.0,Dead,TUMOR FREE,,1.0,601.0,0.0,601.0,0.0,601.0
TCGA-DD-A3A2-01,TCGA-DD-A3A2,LIHC,76.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,1998.0,-27930.0,Dead,TUMOR FREE,,1.0,2131.0,0.0,2131.0,0.0,2131.0
TCGA-DD-A3A3-01,TCGA-DD-A3A3,LIHC,45.0,MALE,ASIAN,Stage I,Hepatocellular Carcinoma,1999.0,-16708.0,Dead,,,1.0,535.0,,535.0,0.0,535.0
TCGA-DD-A3A4-01,TCGA-DD-A3A4,LIHC,37.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,1998.0,-13739.0,Dead,WITH TUMOR,,1.0,612.0,1.0,612.0,1.0,87.0
TCGA-DD-A3A5-01,TCGA-DD-A3A5,LIHC,66.0,FEMALE,WHITE,Stage III,Hepatocellular Carcinoma,1996.0,-24288.0,Dead,WITH TUMOR,,1.0,3125.0,1.0,3125.0,1.0,84.0
TCGA-DD-A3A7-01,TCGA-DD-A3A7,LIHC,67.0,MALE,[Unknown],Stage IIIB,Hepatocellular Carcinoma,1998.0,-24599.0,Dead,WITH TUMOR,,1.0,419.0,1.0,419.0,1.0,144.0
TCGA-DD-A3A8-01,TCGA-DD-A3A8,LIHC,75.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2001.0,-27524.0,Dead,TUMOR FREE,,1.0,11.0,0.0,11.0,0.0,11.0
TCGA-DD-A3A9-01,TCGA-DD-A3A9,LIHC,64.0,FEMALE,WHITE,Stage IVB,Hepatocellular Carcinoma,2001.0,-23526.0,Dead,WITH TUMOR,,1.0,931.0,1.0,931.0,1.0,289.0
TCGA-DD-A4NA-01,TCGA-DD-A4NA,LIHC,67.0,FEMALE,WHITE,Stage IIIC,Hepatocellular Carcinoma,2009.0,-24603.0,Alive,TUMOR FREE,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0
TCGA-DD-A4NB-01,TCGA-DD-A4NB,LIHC,25.0,MALE,WHITE,Stage I,Fibrolamellar Carcinoma,2011.0,-9426.0,Alive,TUMOR FREE,989.0,0.0,989.0,0.0,989.0,1.0,912.0
TCGA-DD-A4ND-01,TCGA-DD-A4ND,LIHC,56.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2007.0,-20782.0,Alive,TUMOR FREE,2746.0,0.0,2746.0,0.0,2746.0,1.0,15.0
TCGA-DD-A4NE-01,TCGA-DD-A4NE,LIHC,75.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2011.0,-27549.0,Dead,WITH TUMOR,,1.0,660.0,1.0,660.0,1.0,190.0
TCGA-DD-A4NF-01,TCGA-DD-A4NF,LIHC,72.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-26330.0,Alive,WITH TUMOR,942.0,0.0,942.0,0.0,942.0,1.0,656.0
TCGA-DD-A4NG-01,TCGA-DD-A4NG,LIHC,77.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2011.0,-28234.0,Dead,WITH TUMOR,,1.0,802.0,1.0,802.0,1.0,430.0
TCGA-DD-A4NH-01,TCGA-DD-A4NH,LIHC,65.0,FEMALE,WHITE,Stage IIIB,Hepatocellular Carcinoma,2011.0,-23865.0,Alive,WITH TUMOR,917.0,0.0,917.0,0.0,917.0,1.0,161.0
TCGA-DD-A4NI-01,TCGA-DD-A4NI,LIHC,67.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2011.0,-24516.0,Alive,TUMOR FREE,816.0,0.0,816.0,0.0,816.0,0.0,816.0
TCGA-DD-A4NJ-01,TCGA-DD-A4NJ,LIHC,54.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2011.0,-19964.0,Alive,WITH TUMOR,928.0,0.0,928.0,0.0,928.0,1.0,549.0
TCGA-DD-A4NK-01,TCGA-DD-A4NK,LIHC,80.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2004.0,-29244.0,Dead,WITH TUMOR,,1.0,1210.0,1.0,1210.0,1.0,89.0
TCGA-DD-A4NN-01,TCGA-DD-A4NN,LIHC,56.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2004.0,-20548.0,Dead,WITH TUMOR,,1.0,899.0,1.0,899.0,1.0,166.0
TCGA-DD-A4NO-01,TCGA-DD-A4NO,LIHC,65.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2007.0,-24090.0,Alive,WITH TUMOR,2245.0,0.0,2245.0,0.0,2245.0,1.0,990.0
TCGA-DD-A4NP-01,TCGA-DD-A4NP,LIHC,32.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2005.0,-11838.0,Alive,TUMOR FREE,3308.0,0.0,3308.0,0.0,3308.0,1.0,1286.0
TCGA-DD-A4NQ-01,TCGA-DD-A4NQ,LIHC,60.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2007.0,-22111.0,Dead,WITH TUMOR,,1.0,373.0,1.0,373.0,1.0,126.0
TCGA-DD-A4NS-01,TCGA-DD-A4NS,LIHC,61.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2005.0,-22638.0,Dead,WITH TUMOR,,1.0,2456.0,1.0,2456.0,1.0,893.0
TCGA-DD-A73B-01,TCGA-DD-A73B,LIHC,72.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-26390.0,Dead,WITH TUMOR,,1.0,283.0,1.0,283.0,1.0,240.0
TCGA-DD-A73C-01,TCGA-DD-A73C,LIHC,65.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2012.0,-23782.0,Alive,WITH TUMOR,701.0,0.0,701.0,0.0,701.0,1.0,566.0
TCGA-DD-A73D-01,TCGA-DD-A73D,LIHC,68.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2012.0,-24941.0,Alive,WITH TUMOR,693.0,0.0,693.0,0.0,693.0,1.0,592.0
TCGA-DD-A73E-01,TCGA-DD-A73E,LIHC,66.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-24377.0,Alive,TUMOR FREE,44.0,0.0,44.0,0.0,44.0,0.0,44.0
TCGA-DD-A73F-01,TCGA-DD-A73F,LIHC,77.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2010.0,-28234.0,Alive,TUMOR FREE,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0
TCGA-DD-A73G-01,TCGA-DD-A73G,LIHC,73.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2005.0,-26949.0,Alive,TUMOR FREE,3478.0,0.0,3478.0,0.0,3478.0,0.0,3478.0
TCGA-DE-A0Y2-01,TCGA-DE-A0Y2,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-11227.0,Alive,TUMOR FREE,658.0,0.0,658.0,0.0,658.0,0.0,658.0
TCGA-DE-A2OL-01,TCGA-DE-A2OL,THCA,44.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-16253.0,Alive,TUMOR FREE,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0
TCGA-DE-A3KN-01,TCGA-DE-A3KN,THCA,49.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18098.0,Alive,TUMOR FREE,831.0,0.0,831.0,0.0,831.0,0.0,831.0
TCGA-DE-A4M9-01,TCGA-DE-A4M9,THCA,28.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-10384.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-DE-A4MA-01,TCGA-DE-A4MA,THCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19100.0,Alive,TUMOR FREE,916.0,0.0,916.0,0.0,916.0,0.0,916.0
TCGA-DE-A4MB-01,TCGA-DE-A4MB,THCA,79.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-29011.0,Alive,WITH TUMOR,352.0,0.0,352.0,0.0,352.0,0.0,352.0
TCGA-DE-A4MC-01,TCGA-DE-A4MC,THCA,43.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15996.0,Alive,TUMOR FREE,913.0,0.0,913.0,0.0,913.0,1.0,332.0
TCGA-DF-A2KN-01,TCGA-DF-A2KN,UCEC,,FEMALE,[Not Evaluated],,Endometrioid endometrial adenocarcinoma,,,Alive,TUMOR FREE,67.0,0.0,67.0,0.0,67.0,0.0,67.0
TCGA-DF-A2KU-01,TCGA-DF-A2KU,UCEC,,FEMALE,[Not Evaluated],,Endometrioid endometrial adenocarcinoma,,,Alive,TUMOR FREE,3067.0,0.0,3067.0,0.0,3067.0,0.0,3067.0
TCGA-DF-A2KV-01,TCGA-DF-A2KV,UCEC,55.0,FEMALE,[Not Evaluated],,Endometrioid endometrial adenocarcinoma,,-20160.0,Alive,TUMOR FREE,2717.0,0.0,2717.0,0.0,2717.0,0.0,2717.0
TCGA-DF-A2KZ-01,TCGA-DF-A2KZ,UCEC,87.0,FEMALE,[Not Evaluated],,Endometrioid endometrial adenocarcinoma,,-31973.0,Alive,TUMOR FREE,826.0,0.0,826.0,0.0,826.0,0.0,826.0
TCGA-DF-A2L0-01,TCGA-DF-A2L0,UCEC,60.0,FEMALE,[Not Evaluated],,Endometrioid endometrial adenocarcinoma,,-22200.0,Dead,WITH TUMOR,,1.0,788.0,1.0,788.0,1.0,523.0
TCGA-DH-5140-01,TCGA-DH-5140,LGG,38.0,FEMALE,WHITE,,Oligoastrocytoma,2007.0,-13943.0,Dead,WITH TUMOR,,1.0,607.0,1.0,607.0,1.0,607.0
TCGA-DH-5141-01,TCGA-DH-5141,LGG,32.0,MALE,WHITE,,Oligodendroglioma,2005.0,-11846.0,Alive,,968.0,0.0,968.0,0.0,968.0,0.0,968.0
TCGA-DH-5142-01,TCGA-DH-5142,LGG,29.0,MALE,WHITE,,Astrocytoma,2008.0,-10678.0,Alive,WITH TUMOR,1943.0,0.0,1943.0,0.0,1943.0,1.0,1627.0
TCGA-DH-5143-01,TCGA-DH-5143,LGG,30.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-11291.0,Alive,WITH TUMOR,1401.0,0.0,1401.0,0.0,1401.0,0.0,1401.0
TCGA-DH-5144-01,TCGA-DH-5144,LGG,56.0,FEMALE,WHITE,,Oligodendroglioma,2009.0,-20558.0,Alive,TUMOR FREE,748.0,0.0,748.0,0.0,748.0,0.0,748.0
TCGA-DH-A66B-01,TCGA-DH-A66B,LGG,52.0,MALE,WHITE,,Astrocytoma,2010.0,-19156.0,Alive,WITH TUMOR,1279.0,0.0,1279.0,0.0,1279.0,0.0,1279.0
TCGA-DH-A66D-01,TCGA-DH-A66D,LGG,43.0,FEMALE,WHITE,,Astrocytoma,2012.0,-15866.0,Alive,WITH TUMOR,846.0,0.0,846.0,0.0,846.0,0.0,846.0
TCGA-DH-A66F-01,TCGA-DH-A66F,LGG,49.0,MALE,WHITE,,Oligodendroglioma,2012.0,-18193.0,Alive,TUMOR FREE,523.0,0.0,523.0,0.0,523.0,0.0,523.0
TCGA-DH-A7US-01,TCGA-DH-A7US,LGG,50.0,MALE,WHITE,,Oligodendroglioma,2013.0,-18429.0,Alive,WITH TUMOR,706.0,0.0,706.0,0.0,706.0,0.0,706.0
TCGA-DI-A1BU-01,TCGA-DI-A1BU,UCEC,55.0,FEMALE,WHITE,,Mixed serous and endometrioid,2008.0,-20114.0,Alive,TUMOR FREE,1195.0,0.0,1195.0,0.0,1195.0,0.0,1195.0
TCGA-DI-A2QT-01,TCGA-DI-A2QT,UCEC,51.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,,Serous endometrial adenocarcinoma,2008.0,-18835.0,Dead,WITH TUMOR,,1.0,377.0,1.0,377.0,1.0,377.0
TCGA-DI-A2QY-01,TCGA-DI-A2QY,UCEC,64.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2003.0,-23398.0,Dead,TUMOR FREE,,1.0,3349.0,0.0,3349.0,0.0,3349.0
TCGA-DJ-A13M-01,TCGA-DJ-A13M,THCA,28.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-10530.0,Alive,TUMOR FREE,1484.0,0.0,1484.0,0.0,1484.0,0.0,1484.0
TCGA-DJ-A13O-01,TCGA-DJ-A13O,THCA,56.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20779.0,Alive,TUMOR FREE,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0
TCGA-DJ-A13R-01,TCGA-DJ-A13R,THCA,50.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-18354.0,Alive,TUMOR FREE,565.0,0.0,565.0,0.0,565.0,0.0,565.0
TCGA-DJ-A13S-01,TCGA-DJ-A13S,THCA,19.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-7099.0,Alive,TUMOR FREE,265.0,0.0,265.0,0.0,265.0,0.0,265.0
TCGA-DJ-A13V-01,TCGA-DJ-A13V,THCA,21.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-7915.0,Alive,TUMOR FREE,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0
TCGA-DJ-A13X-01,TCGA-DJ-A13X,THCA,51.0,FEMALE,,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-18689.0,Alive,TUMOR FREE,253.0,0.0,253.0,0.0,253.0,0.0,253.0
TCGA-DJ-A1QD-01,TCGA-DJ-A1QD,THCA,20.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-7460.0,Alive,TUMOR FREE,1462.0,0.0,1462.0,0.0,1462.0,0.0,1462.0
TCGA-DJ-A1QE-01,TCGA-DJ-A1QE,THCA,62.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2003.0,-22645.0,Alive,TUMOR FREE,4134.0,0.0,4134.0,0.0,4134.0,0.0,4134.0
TCGA-DJ-A1QF-01,TCGA-DJ-A1QF,THCA,61.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-22310.0,Alive,TUMOR FREE,931.0,0.0,931.0,0.0,931.0,0.0,931.0
TCGA-DJ-A1QG-01,TCGA-DJ-A1QG,THCA,62.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-22859.0,Alive,TUMOR FREE,1368.0,0.0,1368.0,0.0,1368.0,0.0,1368.0
TCGA-DJ-A1QI-01,TCGA-DJ-A1QI,THCA,63.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-23072.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-DJ-A1QL-01,TCGA-DJ-A1QL,THCA,70.0,MALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-25713.0,Alive,TUMOR FREE,535.0,0.0,535.0,0.0,535.0,0.0,535.0
TCGA-DJ-A1QM-01,TCGA-DJ-A1QM,THCA,42.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-15418.0,Alive,TUMOR FREE,183.0,0.0,183.0,0.0,183.0,0.0,183.0
TCGA-DJ-A1QN-01,TCGA-DJ-A1QN,THCA,42.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-15343.0,Alive,TUMOR FREE,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0
TCGA-DJ-A1QO-01,TCGA-DJ-A1QO,THCA,69.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2010.0,-25232.0,Alive,TUMOR FREE,1442.0,0.0,1442.0,0.0,1442.0,1.0,1062.0
TCGA-DJ-A2PN-01,TCGA-DJ-A2PN,THCA,70.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-25690.0,Alive,TUMOR FREE,307.0,0.0,307.0,0.0,307.0,0.0,307.0
TCGA-DJ-A2PO-01,TCGA-DJ-A2PO,THCA,54.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20058.0,Alive,TUMOR FREE,243.0,0.0,243.0,0.0,243.0,0.0,243.0
TCGA-DJ-A2PP-01,TCGA-DJ-A2PP,THCA,47.0,MALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-17410.0,Alive,TUMOR FREE,930.0,0.0,930.0,0.0,930.0,0.0,930.0
TCGA-DJ-A2PQ-01,TCGA-DJ-A2PQ,THCA,26.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-9664.0,Alive,TUMOR FREE,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0
TCGA-DJ-A2PR-01,TCGA-DJ-A2PR,THCA,27.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-9914.0,Alive,TUMOR FREE,835.0,0.0,835.0,0.0,835.0,0.0,835.0
TCGA-DJ-A2PS-01,TCGA-DJ-A2PS,THCA,40.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14916.0,Alive,TUMOR FREE,797.0,0.0,797.0,0.0,797.0,0.0,797.0
TCGA-DJ-A2PU-01,TCGA-DJ-A2PU,THCA,52.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18998.0,Alive,TUMOR FREE,1033.0,0.0,1033.0,0.0,1033.0,0.0,1033.0
TCGA-DJ-A2PV-01,TCGA-DJ-A2PV,THCA,53.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19547.0,Alive,TUMOR FREE,973.0,0.0,973.0,0.0,973.0,0.0,973.0
TCGA-DJ-A2PW-01,TCGA-DJ-A2PW,THCA,65.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-23987.0,Alive,TUMOR FREE,1060.0,0.0,1060.0,0.0,1060.0,0.0,1060.0
TCGA-DJ-A2PY-01,TCGA-DJ-A2PY,THCA,46.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2011.0,-17056.0,Alive,TUMOR FREE,267.0,0.0,267.0,0.0,267.0,0.0,267.0
TCGA-DJ-A2PZ-01,TCGA-DJ-A2PZ,THCA,63.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-23332.0,Alive,TUMOR FREE,256.0,0.0,256.0,0.0,256.0,0.0,256.0
TCGA-DJ-A2Q0-01,TCGA-DJ-A2Q0,THCA,57.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-20973.0,Alive,TUMOR FREE,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0
TCGA-DJ-A2Q1-01,TCGA-DJ-A2Q1,THCA,44.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-16371.0,Alive,TUMOR FREE,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0
TCGA-DJ-A2Q2-01,TCGA-DJ-A2Q2,THCA,57.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-20951.0,Alive,TUMOR FREE,1337.0,0.0,1337.0,0.0,1337.0,0.0,1337.0
TCGA-DJ-A2Q4-01,TCGA-DJ-A2Q4,THCA,53.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19689.0,Alive,TUMOR FREE,1032.0,0.0,1032.0,0.0,1032.0,0.0,1032.0
TCGA-DJ-A2Q5-01,TCGA-DJ-A2Q5,THCA,51.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18727.0,Alive,TUMOR FREE,1140.0,0.0,1140.0,0.0,1140.0,0.0,1140.0
TCGA-DJ-A2Q6-01,TCGA-DJ-A2Q6,THCA,38.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14193.0,Alive,TUMOR FREE,1109.0,0.0,1109.0,0.0,1109.0,0.0,1109.0
TCGA-DJ-A2Q7-01,TCGA-DJ-A2Q7,THCA,52.0,FEMALE,ASIAN,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19193.0,Alive,TUMOR FREE,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0
TCGA-DJ-A2Q9-01,TCGA-DJ-A2Q9,THCA,65.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2011.0,-23951.0,Alive,TUMOR FREE,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0
TCGA-DJ-A2QA-01,TCGA-DJ-A2QA,THCA,56.0,FEMALE,ASIAN,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-20784.0,Alive,TUMOR FREE,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0
TCGA-DJ-A2QB-01,TCGA-DJ-A2QB,THCA,53.0,FEMALE,ASIAN,Stage IVA,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-19601.0,Alive,TUMOR FREE,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0
TCGA-DJ-A2QC-01,TCGA-DJ-A2QC,THCA,70.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-25690.0,Alive,TUMOR FREE,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0
TCGA-DJ-A3UK-01,TCGA-DJ-A3UK,THCA,35.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-13145.0,Alive,TUMOR FREE,1123.0,0.0,1123.0,0.0,1123.0,0.0,1123.0
TCGA-DJ-A3UN-01,TCGA-DJ-A3UN,THCA,51.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18871.0,Alive,TUMOR FREE,986.0,0.0,986.0,0.0,986.0,0.0,986.0
TCGA-DJ-A3UO-01,TCGA-DJ-A3UO,THCA,63.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-23292.0,Alive,TUMOR FREE,957.0,0.0,957.0,0.0,957.0,1.0,641.0
TCGA-DJ-A3UP-01,TCGA-DJ-A3UP,THCA,38.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-13899.0,Alive,TUMOR FREE,499.0,0.0,499.0,0.0,499.0,0.0,499.0
TCGA-DJ-A3US-01,TCGA-DJ-A3US,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-13634.0,Alive,TUMOR FREE,998.0,0.0,998.0,0.0,998.0,0.0,998.0
TCGA-DJ-A3UU-01,TCGA-DJ-A3UU,THCA,49.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-17919.0,Alive,WITH TUMOR,713.0,0.0,713.0,0.0,713.0,0.0,713.0
TCGA-DJ-A3UY-01,TCGA-DJ-A3UY,THCA,32.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-12004.0,Alive,TUMOR FREE,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0
TCGA-DJ-A3UZ-01,TCGA-DJ-A3UZ,THCA,70.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-25846.0,Alive,TUMOR FREE,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0
TCGA-DJ-A3V0-01,TCGA-DJ-A3V0,THCA,56.0,MALE,[Unknown],Stage IVA,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2010.0,-20496.0,Alive,TUMOR FREE,1125.0,0.0,1125.0,0.0,1125.0,0.0,1125.0
TCGA-DJ-A3V2-01,TCGA-DJ-A3V2,THCA,44.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-16382.0,Alive,TUMOR FREE,615.0,0.0,615.0,0.0,615.0,0.0,615.0
TCGA-DJ-A3V3-01,TCGA-DJ-A3V3,THCA,57.0,FEMALE,ASIAN,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20997.0,Alive,TUMOR FREE,931.0,0.0,931.0,0.0,931.0,0.0,931.0
TCGA-DJ-A3V7-01,TCGA-DJ-A3V7,THCA,44.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2011.0,-16257.0,Alive,TUMOR FREE,706.0,0.0,706.0,0.0,706.0,0.0,706.0
TCGA-DJ-A3V9-01,TCGA-DJ-A3V9,THCA,50.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18399.0,Alive,TUMOR FREE,623.0,0.0,623.0,0.0,623.0,0.0,623.0
TCGA-DJ-A3VA-01,TCGA-DJ-A3VA,THCA,39.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14495.0,Alive,TUMOR FREE,755.0,0.0,755.0,0.0,755.0,0.0,755.0
TCGA-DJ-A3VB-01,TCGA-DJ-A3VB,THCA,52.0,MALE,[Unknown],Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2011.0,-19248.0,Alive,TUMOR FREE,697.0,0.0,697.0,0.0,697.0,0.0,697.0
TCGA-DJ-A3VE-01,TCGA-DJ-A3VE,THCA,50.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18417.0,Alive,TUMOR FREE,577.0,0.0,577.0,0.0,577.0,0.0,577.0
TCGA-DJ-A3VG-01,TCGA-DJ-A3VG,THCA,40.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-14970.0,Alive,TUMOR FREE,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0
TCGA-DJ-A3VI-01,TCGA-DJ-A3VI,THCA,52.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19053.0,Alive,TUMOR FREE,95.0,0.0,95.0,0.0,95.0,0.0,95.0
TCGA-DJ-A3VJ-01,TCGA-DJ-A3VJ,THCA,22.0,MALE,WHITE,Stage I,"Other, specify",2010.0,-8341.0,Alive,TUMOR FREE,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0
TCGA-DJ-A3VK-01,TCGA-DJ-A3VK,THCA,63.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-23255.0,Alive,TUMOR FREE,753.0,0.0,753.0,0.0,753.0,0.0,753.0
TCGA-DJ-A3VM-01,TCGA-DJ-A3VM,THCA,68.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-24896.0,Alive,TUMOR FREE,840.0,0.0,840.0,0.0,840.0,0.0,840.0
TCGA-DJ-A4UL-01,TCGA-DJ-A4UL,THCA,68.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-24939.0,Alive,TUMOR FREE,939.0,0.0,939.0,0.0,939.0,0.0,939.0
TCGA-DJ-A4UP-01,TCGA-DJ-A4UP,THCA,15.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-5655.0,Alive,TUMOR FREE,916.0,0.0,916.0,0.0,916.0,0.0,916.0
TCGA-DJ-A4UR-01,TCGA-DJ-A4UR,THCA,36.0,FEMALE,ASIAN,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-13463.0,Alive,WITH TUMOR,1058.0,0.0,1058.0,0.0,1058.0,1.0,113.0
TCGA-DJ-A4UT-01,TCGA-DJ-A4UT,THCA,32.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-11813.0,Alive,TUMOR FREE,823.0,0.0,823.0,0.0,823.0,0.0,823.0
TCGA-DJ-A4UW-01,TCGA-DJ-A4UW,THCA,34.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2012.0,-12563.0,Alive,TUMOR FREE,819.0,0.0,819.0,0.0,819.0,0.0,819.0
TCGA-DJ-A4V0-01,TCGA-DJ-A4V0,THCA,36.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-13168.0,Alive,TUMOR FREE,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0
TCGA-DJ-A4V2-01,TCGA-DJ-A4V2,THCA,38.0,FEMALE,[Not Evaluated],Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14126.0,Alive,TUMOR FREE,95.0,0.0,95.0,0.0,95.0,0.0,95.0
TCGA-DJ-A4V5-01,TCGA-DJ-A4V5,THCA,55.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-20108.0,Alive,TUMOR FREE,1076.0,0.0,1076.0,0.0,1076.0,0.0,1076.0
TCGA-DK-A1A3-01,TCGA-DK-A1A3,BLCA,60.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-22235.0,Dead,WITH TUMOR,,1.0,665.0,1.0,665.0,1.0,665.0
TCGA-DK-A1A5-01,TCGA-DK-A1A5,BLCA,79.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-29111.0,Dead,TUMOR FREE,,1.0,65.0,0.0,65.0,0.0,65.0
TCGA-DK-A1AA-01,TCGA-DK-A1AA,BLCA,57.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-21093.0,Alive,TUMOR FREE,578.0,0.0,578.0,0.0,578.0,0.0,578.0
TCGA-DK-A1AB-01,TCGA-DK-A1AB,BLCA,74.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-27126.0,Dead,,,1.0,508.0,,508.0,1.0,364.0
TCGA-DK-A1AC-01,TCGA-DK-A1AC,BLCA,72.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2000.0,-26307.0,Alive,TUMOR FREE,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0
TCGA-DK-A1AD-01,TCGA-DK-A1AD,BLCA,69.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2002.0,-25317.0,Alive,TUMOR FREE,3420.0,0.0,3420.0,0.0,3420.0,0.0,3420.0
TCGA-DK-A1AE-01,TCGA-DK-A1AE,BLCA,84.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-30707.0,Alive,WITH TUMOR,491.0,0.0,491.0,0.0,491.0,1.0,211.0
TCGA-DK-A1AF-01,TCGA-DK-A1AF,BLCA,84.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-30914.0,Alive,TUMOR FREE,536.0,0.0,536.0,0.0,536.0,1.0,283.0
TCGA-DK-A1AG-01,TCGA-DK-A1AG,BLCA,65.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-24095.0,Alive,TUMOR FREE,475.0,0.0,475.0,0.0,475.0,0.0,475.0
TCGA-DK-A2HX-01,TCGA-DK-A2HX,BLCA,80.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-29332.0,Dead,TUMOR FREE,,1.0,1420.0,0.0,1420.0,0.0,1420.0
TCGA-DK-A2I1-01,TCGA-DK-A2I1,BLCA,73.0,FEMALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-26726.0,Alive,TUMOR FREE,546.0,0.0,546.0,0.0,546.0,0.0,546.0
TCGA-DK-A2I2-01,TCGA-DK-A2I2,BLCA,63.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-23116.0,Dead,WITH TUMOR,,1.0,237.0,1.0,237.0,1.0,163.0
TCGA-DK-A2I4-01,TCGA-DK-A2I4,BLCA,79.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2001.0,-29037.0,Alive,TUMOR FREE,4343.0,0.0,4343.0,0.0,4343.0,0.0,4343.0
TCGA-DK-A3IK-01,TCGA-DK-A3IK,BLCA,87.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-32076.0,Dead,TUMOR FREE,,1.0,146.0,0.0,146.0,0.0,146.0
TCGA-DK-A3IL-01,TCGA-DK-A3IL,BLCA,79.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-29047.0,Dead,TUMOR FREE,,1.0,413.0,0.0,413.0,0.0,413.0
TCGA-DK-A3IM-01,TCGA-DK-A3IM,BLCA,76.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-28106.0,Dead,WITH TUMOR,,1.0,248.0,1.0,248.0,1.0,201.0
TCGA-DK-A3IN-01,TCGA-DK-A3IN,BLCA,72.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-26562.0,Dead,TUMOR FREE,,1.0,250.0,0.0,250.0,0.0,250.0
TCGA-DK-A3IT-01,TCGA-DK-A3IT,BLCA,62.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-22786.0,Alive,TUMOR FREE,648.0,0.0,648.0,0.0,648.0,0.0,648.0
TCGA-DK-A3IU-01,TCGA-DK-A3IU,BLCA,58.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-21369.0,Dead,WITH TUMOR,,1.0,706.0,1.0,706.0,1.0,462.0
TCGA-DK-A3IV-01,TCGA-DK-A3IV,BLCA,60.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-22237.0,Dead,WITH TUMOR,,1.0,294.0,1.0,294.0,1.0,212.0
TCGA-DK-A3WW-01,TCGA-DK-A3WW,BLCA,57.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-20909.0,Alive,TUMOR FREE,633.0,0.0,633.0,0.0,633.0,0.0,633.0
TCGA-DK-A3WX-01,TCGA-DK-A3WX,BLCA,67.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24553.0,Dead,WITH TUMOR,,1.0,321.0,1.0,321.0,1.0,167.0
TCGA-DK-A3WY-01,TCGA-DK-A3WY,BLCA,67.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2001.0,-24536.0,Alive,TUMOR FREE,4967.0,0.0,4967.0,0.0,4967.0,0.0,4967.0
TCGA-DK-A3X1-01,TCGA-DK-A3X1,BLCA,78.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-28757.0,Alive,TUMOR FREE,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0
TCGA-DK-A3X2-01,TCGA-DK-A3X2,BLCA,85.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-31160.0,Dead,WITH TUMOR,,1.0,547.0,1.0,547.0,1.0,533.0
TCGA-DM-A0X9-01,TCGA-DM-A0X9,COAD,71.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2001.0,-26217.0,Alive,,3641.0,0.0,3641.0,0.0,3641.0,0.0,3641.0
TCGA-DM-A0XF-01,TCGA-DM-A0XF,COAD,68.0,FEMALE,WHITE,Stage IIIC,[Discrepancy],1999.0,-25032.0,Dead,,,1.0,1162.0,,1162.0,0.0,1162.0
TCGA-DM-A1D0-01,TCGA-DM-A1D0,COAD,79.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2001.0,-28875.0,Alive,,3974.0,0.0,3974.0,0.0,3974.0,0.0,3974.0
TCGA-DM-A1D4-01,TCGA-DM-A1D4,COAD,80.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,1999.0,-29403.0,Dead,,2821.0,1.0,2821.0,,2821.0,1.0,1920.0
TCGA-DM-A1D7-01,TCGA-DM-A1D7,COAD,82.0,MALE,WHITE,Stage IIA,[Discrepancy],2000.0,-30142.0,Dead,,,1.0,405.0,,405.0,1.0,80.0
TCGA-DM-A1D8-01,TCGA-DM-A1D8,COAD,50.0,FEMALE,WHITE,,Colon Adenocarcinoma,2000.0,-18311.0,Dead,,383.0,1.0,383.0,,383.0,0.0,383.0
TCGA-DM-A1D9-01,TCGA-DM-A1D9,COAD,67.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2000.0,-24514.0,Alive,,4270.0,0.0,4270.0,0.0,4270.0,0.0,4270.0
TCGA-DM-A1DA-01,TCGA-DM-A1DA,COAD,71.0,FEMALE,WHITE,Stage IIIC,Colon Adenocarcinoma,1999.0,-26169.0,Dead,,228.0,1.0,228.0,,228.0,0.0,228.0
TCGA-DM-A1DB-01,TCGA-DM-A1DB,COAD,68.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2000.0,-24888.0,Dead,,1348.0,1.0,1348.0,,1348.0,0.0,1348.0
TCGA-DM-A1HA-01,TCGA-DM-A1HA,COAD,82.0,MALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2000.0,-30272.0,Alive,,4000.0,0.0,4000.0,0.0,4000.0,0.0,4000.0
TCGA-DM-A1HB-01,TCGA-DM-A1HB,COAD,75.0,MALE,WHITE,Stage IIIB,[Discrepancy],2000.0,-27708.0,Alive,,4126.0,0.0,4126.0,0.0,4126.0,0.0,4126.0
TCGA-DM-A280-01,TCGA-DM-A280,COAD,70.0,FEMALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,1998.0,-25649.0,Dead,,236.0,1.0,236.0,,236.0,0.0,236.0
TCGA-DM-A282-01,TCGA-DM-A282,COAD,60.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2000.0,-22265.0,Alive,,4233.0,0.0,4233.0,0.0,4233.0,0.0,4233.0
TCGA-DM-A288-01,TCGA-DM-A288,COAD,68.0,MALE,WHITE,Stage IIIC,Colon Mucinous Adenocarcinoma,2001.0,-25084.0,Dead,,427.0,1.0,427.0,,427.0,1.0,320.0
TCGA-DM-A28A-01,TCGA-DM-A28A,COAD,78.0,MALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2001.0,-28833.0,Dead,,805.0,1.0,805.0,,805.0,0.0,805.0
TCGA-DM-A28C-01,TCGA-DM-A28C,COAD,74.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2001.0,-27073.0,Dead,,2475.0,1.0,2475.0,,2475.0,1.0,1929.0
TCGA-DM-A28E-01,TCGA-DM-A28E,COAD,72.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2001.0,-26602.0,Alive,,3648.0,0.0,3648.0,0.0,3648.0,0.0,3648.0
TCGA-DM-A28F-01,TCGA-DM-A28F,COAD,73.0,MALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2002.0,-26856.0,Dead,,1094.0,1.0,1094.0,,1094.0,0.0,1094.0
TCGA-DM-A28G-01,TCGA-DM-A28G,COAD,75.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2001.0,-27641.0,Dead,,1849.0,1.0,1849.0,,1849.0,0.0,1849.0
TCGA-DM-A28M-01,TCGA-DM-A28M,COAD,63.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2003.0,-23043.0,Alive,,2895.0,0.0,2895.0,0.0,2895.0,0.0,2895.0
TCGA-DO-A1JZ-01,TCGA-DO-A1JZ,THCA,23.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-8551.0,Alive,TUMOR FREE,1670.0,0.0,1670.0,0.0,1670.0,0.0,1670.0
TCGA-DO-A1K0-01,TCGA-DO-A1K0,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-11216.0,Alive,WITH TUMOR,655.0,0.0,655.0,0.0,655.0,1.0,577.0
TCGA-DQ-7591-01,TCGA-DQ-7591,HNSC,62.0,MALE,WHITE,,Head & Neck Squamous Cell Carcinoma,2011.0,-22798.0,Alive,TUMOR FREE,622.0,0.0,622.0,0.0,622.0,0.0,622.0
TCGA-DT-5265-01,TCGA-DT-5265,READ,51.0,MALE,ASIAN,Stage II,Rectal Mucinous Adenocarcinoma,2010.0,-18669.0,Alive,TUMOR FREE,384.0,0.0,384.0,0.0,384.0,0.0,384.0
TCGA-DU-5847-01,TCGA-DU-5847,LGG,34.0,FEMALE,WHITE,,Astrocytoma,2009.0,-12606.0,Alive,WITH TUMOR,548.0,0.0,548.0,0.0,548.0,0.0,548.0
TCGA-DU-5849-01,TCGA-DU-5849,LGG,48.0,MALE,WHITE,,Oligodendroglioma,2010.0,-17663.0,Alive,TUMOR FREE,443.0,0.0,443.0,0.0,443.0,0.0,443.0
TCGA-DU-5852-01,TCGA-DU-5852,LGG,61.0,FEMALE,WHITE,,Oligoastrocytoma,2010.0,-22348.0,Dead,WITH TUMOR,,1.0,205.0,1.0,205.0,1.0,24.0
TCGA-DU-5853-01,TCGA-DU-5853,LGG,29.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-10624.0,Alive,WITH TUMOR,407.0,0.0,407.0,0.0,407.0,0.0,407.0
TCGA-DU-5854-01,TCGA-DU-5854,LGG,57.0,FEMALE,WHITE,,Astrocytoma,2010.0,-21106.0,Alive,WITH TUMOR,257.0,0.0,257.0,0.0,257.0,1.0,202.0
TCGA-DU-5855-01,TCGA-DU-5855,LGG,49.0,FEMALE,WHITE,,Oligoastrocytoma,2010.0,-18234.0,Alive,WITH TUMOR,207.0,0.0,207.0,0.0,207.0,0.0,207.0
TCGA-DU-5870-01,TCGA-DU-5870,LGG,34.0,FEMALE,WHITE,,Oligodendroglioma,1995.0,-12764.0,Alive,WITH TUMOR,5546.0,0.0,5546.0,0.0,5546.0,1.0,4347.0
TCGA-DU-5871-01,TCGA-DU-5871,LGG,37.0,FEMALE,WHITE,,Oligoastrocytoma,2009.0,-13673.0,Alive,TUMOR FREE,576.0,0.0,576.0,0.0,576.0,0.0,576.0
TCGA-DU-5872-01,TCGA-DU-5872,LGG,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Oligoastrocytoma,2009.0,-15986.0,Alive,WITH TUMOR,532.0,0.0,532.0,0.0,532.0,1.0,265.0
TCGA-DU-5874-01,TCGA-DU-5874,LGG,62.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-22847.0,Alive,TUMOR FREE,461.0,0.0,461.0,0.0,461.0,0.0,461.0
TCGA-DU-6392-01,TCGA-DU-6392,LGG,35.0,FEMALE,WHITE,,Astrocytoma,1993.0,-12836.0,Alive,TUMOR FREE,6423.0,0.0,6423.0,0.0,6423.0,1.0,950.0
TCGA-DU-6393-01,TCGA-DU-6393,LGG,66.0,MALE,WHITE,,Oligodendroglioma,1993.0,-24282.0,Dead,,,1.0,1585.0,,1585.0,0.0,1585.0
TCGA-DU-6394-01,TCGA-DU-6394,LGG,53.0,MALE,WHITE,,Oligodendroglioma,1994.0,-19541.0,Dead,WITH TUMOR,,1.0,682.0,1.0,682.0,1.0,353.0
TCGA-DU-6395-01,TCGA-DU-6395,LGG,31.0,MALE,WHITE,,Oligoastrocytoma,1994.0,-11584.0,Dead,WITH TUMOR,,1.0,1491.0,1.0,1491.0,1.0,1197.0
TCGA-DU-6396-01,TCGA-DU-6396,LGG,31.0,FEMALE,WHITE,,Oligoastrocytoma,1996.0,-11427.0,Dead,WITH TUMOR,,1.0,2286.0,1.0,2286.0,1.0,106.0
TCGA-DU-6399-01,TCGA-DU-6399,LGG,54.0,MALE,WHITE,,Oligodendroglioma,1998.0,-19906.0,Dead,WITH TUMOR,,1.0,2000.0,1.0,2000.0,1.0,1629.0
TCGA-DU-6400-01,TCGA-DU-6400,LGG,66.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-24122.0,Dead,WITH TUMOR,,1.0,37.0,1.0,37.0,1.0,37.0
TCGA-DU-6401-01,TCGA-DU-6401,LGG,31.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-11595.0,Dead,WITH TUMOR,,1.0,2660.0,1.0,2660.0,1.0,1886.0
TCGA-DU-6402-01,TCGA-DU-6402,LGG,52.0,MALE,WHITE,,Astrocytoma,1998.0,-19207.0,Dead,WITH TUMOR,,1.0,214.0,1.0,214.0,1.0,103.0
TCGA-DU-6403-01,TCGA-DU-6403,LGG,60.0,FEMALE,WHITE,,Oligoastrocytoma,1999.0,-22031.0,Dead,WITH TUMOR,,1.0,354.0,1.0,354.0,1.0,354.0
TCGA-DU-6404-01,TCGA-DU-6404,LGG,24.0,FEMALE,WHITE,,Oligodendroglioma,2000.0,-9021.0,Dead,WITH TUMOR,,1.0,4068.0,1.0,4068.0,1.0,1154.0
TCGA-DU-6405-01,TCGA-DU-6405,LGG,51.0,FEMALE,WHITE,,Astrocytoma,2000.0,-18686.0,Dead,WITH TUMOR,,1.0,605.0,1.0,605.0,1.0,486.0
TCGA-DU-6406-01,TCGA-DU-6406,LGG,59.0,FEMALE,WHITE,,Oligoastrocytoma,2001.0,-21634.0,Dead,,,1.0,512.0,,512.0,0.0,512.0
TCGA-DU-6407-01,TCGA-DU-6407,LGG,35.0,FEMALE,WHITE,,Oligodendroglioma,2001.0,-13021.0,Dead,WITH TUMOR,,1.0,2875.0,1.0,2875.0,1.0,2397.0
TCGA-DU-6408-01,TCGA-DU-6408,LGG,23.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-8752.0,Dead,,,1.0,3470.0,,3470.0,1.0,2097.0
TCGA-DU-6410-01,TCGA-DU-6410,LGG,56.0,MALE,WHITE,,Oligodendroglioma,2010.0,-20567.0,Alive,WITH TUMOR,242.0,0.0,242.0,0.0,242.0,0.0,242.0
TCGA-DU-6542-01,TCGA-DU-6542,LGG,25.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-9380.0,Alive,WITH TUMOR,73.0,0.0,73.0,0.0,73.0,0.0,73.0
TCGA-DU-7006-01,TCGA-DU-7006,LGG,60.0,FEMALE,WHITE,,Astrocytoma,1995.0,-21990.0,Dead,WITH TUMOR,,1.0,349.0,1.0,349.0,1.0,349.0
TCGA-DU-7007-01,TCGA-DU-7007,LGG,33.0,MALE,WHITE,,Astrocytoma,1997.0,-12245.0,Dead,,,1.0,1915.0,,1915.0,0.0,1915.0
TCGA-DU-7008-01,TCGA-DU-7008,LGG,41.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-15289.0,Alive,TUMOR FREE,4752.0,0.0,4752.0,0.0,4752.0,1.0,330.0
TCGA-DU-7009-01,TCGA-DU-7009,LGG,32.0,FEMALE,WHITE,,Oligodendroglioma,2000.0,-11854.0,Dead,WITH TUMOR,,1.0,4695.0,1.0,4695.0,1.0,2960.0
TCGA-DU-7010-01,TCGA-DU-7010,LGG,58.0,FEMALE,WHITE,,Astrocytoma,2001.0,-21199.0,Dead,WITH TUMOR,,1.0,456.0,1.0,456.0,1.0,193.0
TCGA-DU-7011-01,TCGA-DU-7011,LGG,25.0,MALE,WHITE,,Oligoastrocytoma,2000.0,-9322.0,Dead,WITH TUMOR,,1.0,3200.0,1.0,3200.0,1.0,3200.0
TCGA-DU-7012-01,TCGA-DU-7012,LGG,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2001.0,-27039.0,Dead,WITH TUMOR,,1.0,199.0,1.0,199.0,1.0,199.0
TCGA-DU-7013-01,TCGA-DU-7013,LGG,59.0,MALE,WHITE,,Astrocytoma,2001.0,-21824.0,Dead,WITH TUMOR,,1.0,269.0,1.0,269.0,1.0,187.0
TCGA-DU-7015-01,TCGA-DU-7015,LGG,41.0,FEMALE,WHITE,,Oligodendroglioma,2004.0,-15041.0,Alive,WITH TUMOR,2761.0,0.0,2761.0,0.0,2761.0,1.0,591.0
TCGA-DU-7018-01,TCGA-DU-7018,LGG,57.0,FEMALE,WHITE,,Oligodendroglioma,2006.0,-21019.0,Dead,WITH TUMOR,,1.0,933.0,1.0,933.0,1.0,338.0
TCGA-DU-7019-01,TCGA-DU-7019,LGG,39.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-14279.0,Alive,TUMOR FREE,800.0,0.0,800.0,0.0,800.0,0.0,800.0
TCGA-DU-7290-01,TCGA-DU-7290,LGG,45.0,FEMALE,WHITE,,Astrocytoma,1995.0,-16667.0,Dead,WITH TUMOR,,1.0,315.0,1.0,315.0,1.0,315.0
TCGA-DU-7292-01,TCGA-DU-7292,LGG,69.0,MALE,WHITE,,Astrocytoma,1997.0,-25266.0,Dead,WITH TUMOR,,1.0,242.0,1.0,242.0,1.0,91.0
TCGA-DU-7294-01,TCGA-DU-7294,LGG,53.0,FEMALE,WHITE,,Oligodendroglioma,2003.0,-19616.0,Alive,TUMOR FREE,2869.0,0.0,2869.0,0.0,2869.0,0.0,2869.0
TCGA-DU-7298-01,TCGA-DU-7298,LGG,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2006.0,-14205.0,Dead,WITH TUMOR,,1.0,576.0,1.0,576.0,1.0,200.0
TCGA-DU-7300-01,TCGA-DU-7300,LGG,53.0,FEMALE,WHITE,,Oligodendroglioma,2006.0,-19610.0,Dead,WITH TUMOR,,1.0,1886.0,1.0,1886.0,1.0,317.0
TCGA-DU-7301-01,TCGA-DU-7301,LGG,53.0,MALE,WHITE,,Oligodendroglioma,2006.0,-19644.0,Dead,WITH TUMOR,,1.0,788.0,1.0,788.0,1.0,366.0
TCGA-DU-7302-01,TCGA-DU-7302,LGG,48.0,FEMALE,WHITE,,Oligodendroglioma,2006.0,-17656.0,Alive,WITH TUMOR,1834.0,0.0,1834.0,0.0,1834.0,1.0,1374.0
TCGA-DU-7306-01,TCGA-DU-7306,LGG,67.0,MALE,WHITE,,Oligoastrocytoma,2008.0,-24800.0,Alive,WITH TUMOR,1277.0,0.0,1277.0,0.0,1277.0,1.0,1250.0
TCGA-DU-7309-01,TCGA-DU-7309,LGG,41.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-15197.0,Alive,WITH TUMOR,84.0,0.0,84.0,0.0,84.0,0.0,84.0
TCGA-DU-8158-01,TCGA-DU-8158,LGG,57.0,FEMALE,WHITE,,Astrocytoma,2001.0,-21129.0,Dead,WITH TUMOR,,1.0,155.0,1.0,155.0,1.0,155.0
TCGA-DU-8161-01,TCGA-DU-8161,LGG,63.0,FEMALE,WHITE,,Oligoastrocytoma,2009.0,-23064.0,Dead,WITH TUMOR,,1.0,722.0,1.0,722.0,1.0,111.0
TCGA-DU-8162-01,TCGA-DU-8162,LGG,61.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-22596.0,Dead,WITH TUMOR,,1.0,444.0,1.0,444.0,1.0,402.0
TCGA-DU-8163-01,TCGA-DU-8163,LGG,29.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-10824.0,Alive,WITH TUMOR,629.0,0.0,629.0,0.0,629.0,1.0,509.0
TCGA-DU-8164-01,TCGA-DU-8164,LGG,51.0,MALE,WHITE,,Oligodendroglioma,2011.0,-18735.0,Alive,TUMOR FREE,651.0,0.0,651.0,0.0,651.0,0.0,651.0
TCGA-DU-8165-01,TCGA-DU-8165,LGG,60.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-21964.0,Alive,TUMOR FREE,582.0,0.0,582.0,0.0,582.0,0.0,582.0
TCGA-DU-8166-01,TCGA-DU-8166,LGG,29.0,FEMALE,WHITE,,Oligoastrocytoma,2012.0,-10641.0,Alive,WITH TUMOR,516.0,0.0,516.0,0.0,516.0,1.0,193.0
TCGA-DU-8167-01,TCGA-DU-8167,LGG,69.0,FEMALE,WHITE,,Oligoastrocytoma,2012.0,-25262.0,Alive,TUMOR FREE,471.0,0.0,471.0,0.0,471.0,0.0,471.0
TCGA-DU-8168-01,TCGA-DU-8168,LGG,55.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-20136.0,Alive,TUMOR FREE,431.0,0.0,431.0,0.0,431.0,0.0,431.0
TCGA-DU-A5TP-01,TCGA-DU-A5TP,LGG,33.0,MALE,WHITE,,Astrocytoma,2012.0,-12111.0,Alive,TUMOR FREE,1012.0,0.0,1012.0,0.0,1012.0,1.0,203.0
TCGA-DU-A5TR-01,TCGA-DU-A5TR,LGG,51.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-18791.0,Alive,TUMOR FREE,908.0,0.0,908.0,0.0,908.0,1.0,848.0
TCGA-DU-A5TS-01,TCGA-DU-A5TS,LGG,42.0,MALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2012.0,-15650.0,Alive,TUMOR FREE,964.0,0.0,964.0,0.0,964.0,1.0,551.0
TCGA-DU-A5TT-01,TCGA-DU-A5TT,LGG,70.0,MALE,WHITE,,Oligodendroglioma,2013.0,-25726.0,Alive,WITH TUMOR,743.0,0.0,743.0,0.0,743.0,1.0,584.0
TCGA-DU-A5TU-01,TCGA-DU-A5TU,LGG,62.0,FEMALE,WHITE,,Astrocytoma,2013.0,-22811.0,Alive,WITH TUMOR,796.0,0.0,796.0,0.0,796.0,1.0,186.0
TCGA-DU-A5TW-01,TCGA-DU-A5TW,LGG,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2012.0,-12107.0,Alive,WITH TUMOR,760.0,0.0,760.0,0.0,760.0,0.0,760.0
TCGA-DU-A5TY-01,TCGA-DU-A5TY,LGG,46.0,FEMALE,WHITE,,Astrocytoma,2012.0,-16945.0,Dead,WITH TUMOR,,1.0,1033.0,1.0,1033.0,1.0,526.0
TCGA-DU-A6S2-01,TCGA-DU-A6S2,LGG,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2013.0,-13597.0,Alive,TUMOR FREE,777.0,0.0,777.0,0.0,777.0,0.0,777.0
TCGA-DU-A6S3-01,TCGA-DU-A6S3,LGG,60.0,MALE,WHITE,,Oligodendroglioma,2013.0,-22038.0,Alive,TUMOR FREE,656.0,0.0,656.0,0.0,656.0,0.0,656.0
TCGA-DU-A6S8-01,TCGA-DU-A6S8,LGG,74.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-27084.0,Alive,WITH TUMOR,678.0,0.0,678.0,0.0,678.0,1.0,641.0
TCGA-DU-A76K-01,TCGA-DU-A76K,LGG,87.0,MALE,WHITE,,Oligodendroglioma,1999.0,-31776.0,Dead,WITH TUMOR,,1.0,347.0,1.0,347.0,1.0,203.0
TCGA-DU-A76L-01,TCGA-DU-A76L,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2000.0,-19823.0,Dead,WITH TUMOR,,1.0,814.0,1.0,814.0,1.0,410.0
TCGA-DU-A76O-01,TCGA-DU-A76O,LGG,30.0,MALE,WHITE,,Astrocytoma,2013.0,-10960.0,Alive,WITH TUMOR,522.0,0.0,522.0,0.0,522.0,0.0,522.0
TCGA-DU-A76R-01,TCGA-DU-A76R,LGG,51.0,MALE,WHITE,,Oligodendroglioma,2006.0,-18939.0,Dead,WITH TUMOR,,1.0,648.0,1.0,648.0,1.0,338.0
TCGA-DU-A7T6-01,TCGA-DU-A7T6,LGG,73.0,FEMALE,WHITE,,Oligodendroglioma,2002.0,-26766.0,Dead,WITH TUMOR,,1.0,547.0,1.0,547.0,1.0,547.0
TCGA-DU-A7TA-01,TCGA-DU-A7TA,LGG,32.0,MALE,WHITE,,Oligodendroglioma,2007.0,-11764.0,Alive,TUMOR FREE,2565.0,0.0,2565.0,0.0,2565.0,0.0,2565.0
TCGA-DU-A7TB-01,TCGA-DU-A7TB,LGG,56.0,MALE,ASIAN,,Oligodendroglioma,2010.0,-20704.0,Alive,TUMOR FREE,1567.0,0.0,1567.0,0.0,1567.0,1.0,74.0
TCGA-DU-A7TD-01,TCGA-DU-A7TD,LGG,52.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-19025.0,Dead,WITH TUMOR,,1.0,228.0,1.0,228.0,1.0,188.0
TCGA-DU-A7TG-01,TCGA-DU-A7TG,LGG,40.0,MALE,WHITE,,Oligodendroglioma,2008.0,-14671.0,Dead,,,1.0,1351.0,,1351.0,0.0,1351.0
TCGA-DU-A7TJ-01,TCGA-DU-A7TJ,LGG,55.0,MALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2013.0,-20394.0,Alive,WITH TUMOR,17.0,0.0,17.0,0.0,17.0,0.0,17.0
TCGA-DV-5565-01,TCGA-DV-5565,KIRC,59.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-21642.0,Alive,WITH TUMOR,1329.0,0.0,1329.0,0.0,1329.0,0.0,1329.0
TCGA-DV-5566-01,TCGA-DV-5566,KIRC,67.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2007.0,-24717.0,Alive,WITH TUMOR,1398.0,0.0,1398.0,0.0,1398.0,0.0,1398.0
TCGA-DV-5567-01,TCGA-DV-5567,KIRC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Clear Cell Renal Carcinoma,2008.0,-14642.0,Alive,WITH TUMOR,2004.0,0.0,2004.0,0.0,2004.0,1.0,2004.0
TCGA-DW-5560-01,TCGA-DW-5560,KIRP,38.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2009.0,-13964.0,Alive,TUMOR FREE,1486.0,0.0,1486.0,0.0,1486.0,0.0,1486.0
TCGA-DW-5561-01,TCGA-DW-5561,KIRP,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2008.0,-18744.0,Alive,[Discrepancy],414.0,0.0,414.0,0.0,414.0,0.0,414.0
TCGA-DW-7834-01,TCGA-DW-7834,KIRP,53.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2001.0,-19660.0,Alive,TUMOR FREE,3950.0,0.0,3950.0,0.0,3950.0,0.0,3950.0
TCGA-DW-7837-01,TCGA-DW-7837,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2007.0,-15891.0,Alive,WITH TUMOR,1142.0,0.0,1142.0,0.0,1142.0,0.0,1142.0
TCGA-DW-7838-01,TCGA-DW-7838,KIRP,66.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2009.0,-24247.0,Alive,WITH TUMOR,744.0,0.0,744.0,0.0,744.0,1.0,380.0
TCGA-DW-7839-01,TCGA-DW-7839,KIRP,58.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-21347.0,Alive,TUMOR FREE,419.0,0.0,419.0,0.0,419.0,0.0,419.0
TCGA-DW-7840-01,TCGA-DW-7840,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-22141.0,Alive,,114.0,0.0,114.0,0.0,114.0,0.0,114.0
TCGA-DW-7841-01,TCGA-DW-7841,KIRP,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-22403.0,Alive,TUMOR FREE,445.0,0.0,445.0,0.0,445.0,0.0,445.0
TCGA-DW-7842-01,TCGA-DW-7842,KIRP,52.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-19166.0,Alive,WITH TUMOR,92.0,0.0,92.0,0.0,92.0,0.0,92.0
TCGA-DW-7963-01,TCGA-DW-7963,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-15967.0,Alive,TUMOR FREE,1240.0,0.0,1240.0,0.0,1240.0,0.0,1240.0
TCGA-DY-A0XA-01,TCGA-DY-A0XA,READ,57.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2001.0,-21115.0,Alive,,3846.0,0.0,3846.0,0.0,3846.0,0.0,3846.0
TCGA-DY-A1DC-01,TCGA-DY-A1DC,READ,72.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2000.0,-26436.0,Dead,,,1.0,1258.0,,1258.0,1.0,630.0
TCGA-DY-A1DD-01,TCGA-DY-A1DD,READ,77.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,1999.0,-28159.0,Dead,,1741.0,1.0,1741.0,,1741.0,0.0,1741.0
TCGA-DY-A1DF-01,TCGA-DY-A1DF,READ,73.0,FEMALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2001.0,-26763.0,Dead,,734.0,1.0,734.0,,734.0,0.0,734.0
TCGA-DY-A1DG-01,TCGA-DY-A1DG,READ,75.0,MALE,WHITE,Stage IVA,Rectal Adenocarcinoma,2000.0,-27396.0,Dead,,,1.0,1566.0,,1566.0,1.0,592.0
TCGA-DY-A1H8-01,TCGA-DY-A1H8,READ,77.0,FEMALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2000.0,-28459.0,Dead,,992.0,1.0,992.0,,992.0,0.0,992.0
TCGA-DZ-6131-01,TCGA-DZ-6131,KIRP,31.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2003.0,-11487.0,Alive,TUMOR FREE,2429.0,0.0,2429.0,0.0,2429.0,0.0,2429.0
TCGA-DZ-6132-01,TCGA-DZ-6132,KIRP,69.0,MALE,,Stage I,Kidney Papillary Renal Cell Carcinoma,2003.0,-25417.0,Alive,TUMOR FREE,2460.0,0.0,2460.0,0.0,2460.0,0.0,2460.0
TCGA-DZ-6133-01,TCGA-DZ-6133,KIRP,66.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2004.0,-24311.0,Dead,TUMOR FREE,,1.0,1557.0,0.0,1557.0,0.0,1557.0
TCGA-DZ-6134-01,TCGA-DZ-6134,KIRP,69.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2005.0,-25529.0,Alive,TUMOR FREE,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0
TCGA-DZ-6135-01,TCGA-DZ-6135,KIRP,45.0,MALE,,Stage I,Kidney Papillary Renal Cell Carcinoma,2006.0,-16468.0,Alive,TUMOR FREE,2269.0,0.0,2269.0,0.0,2269.0,0.0,2269.0
TCGA-E1-5302-01,TCGA-E1-5302,LGG,41.0,MALE,WHITE,,Astrocytoma,1998.0,-15230.0,Dead,WITH TUMOR,,1.0,1525.0,1.0,1525.0,1.0,1242.0
TCGA-E1-5303-01,TCGA-E1-5303,LGG,38.0,MALE,WHITE,,Astrocytoma,1998.0,-14212.0,Dead,WITH TUMOR,,1.0,2052.0,1.0,2052.0,1.0,156.0
TCGA-E1-5304-01,TCGA-E1-5304,LGG,42.0,MALE,WHITE,,Astrocytoma,1999.0,-15481.0,Dead,WITH TUMOR,,1.0,1251.0,1.0,1251.0,1.0,903.0
TCGA-E1-5305-01,TCGA-E1-5305,LGG,34.0,MALE,WHITE,,Astrocytoma,2000.0,-12655.0,Dead,WITH TUMOR,,1.0,2433.0,1.0,2433.0,1.0,1604.0
TCGA-E1-5307-01,TCGA-E1-5307,LGG,62.0,FEMALE,WHITE,,Astrocytoma,2000.0,-22837.0,Dead,WITH TUMOR,,1.0,1762.0,1.0,1762.0,1.0,1452.0
TCGA-E1-5311-01,TCGA-E1-5311,LGG,31.0,MALE,WHITE,,Oligodendroglioma,1994.0,-11332.0,Dead,WITH TUMOR,,1.0,4084.0,1.0,4084.0,1.0,2602.0
TCGA-E1-5318-01,TCGA-E1-5318,LGG,42.0,FEMALE,WHITE,,Oligodendroglioma,1997.0,-15372.0,Dead,WITH TUMOR,2379.0,1.0,2379.0,1.0,2379.0,1.0,362.0
TCGA-E1-5319-01,TCGA-E1-5319,LGG,48.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-17612.0,Dead,WITH TUMOR,,1.0,2907.0,1.0,2907.0,1.0,923.0
TCGA-E1-5322-01,TCGA-E1-5322,LGG,38.0,FEMALE,WHITE,,Oligoastrocytoma,1999.0,-13903.0,Dead,,,1.0,3978.0,,3978.0,1.0,1085.0
TCGA-E1-A7YH-01,TCGA-E1-A7YH,LGG,47.0,FEMALE,WHITE,,Astrocytoma,2005.0,-17465.0,Dead,WITH TUMOR,,1.0,2835.0,1.0,2835.0,1.0,689.0
TCGA-E1-A7YI-01,TCGA-E1-A7YI,LGG,33.0,FEMALE,WHITE,,Astrocytoma,2008.0,-12229.0,Dead,WITH TUMOR,,1.0,111.0,1.0,111.0,1.0,56.0
TCGA-E1-A7YJ-01,TCGA-E1-A7YJ,LGG,55.0,MALE,WHITE,,Astrocytoma,2008.0,-20180.0,Dead,WITH TUMOR,,1.0,592.0,1.0,592.0,1.0,516.0
TCGA-E1-A7YL-01,TCGA-E1-A7YL,LGG,46.0,MALE,WHITE,,Astrocytoma,2009.0,-16982.0,Dead,WITH TUMOR,,1.0,492.0,1.0,492.0,1.0,91.0
TCGA-E1-A7YM-01,TCGA-E1-A7YM,LGG,63.0,MALE,WHITE,,Astrocytoma,2010.0,-23263.0,Dead,WITH TUMOR,,1.0,648.0,1.0,648.0,1.0,88.0
TCGA-E1-A7YN-01,TCGA-E1-A7YN,LGG,63.0,FEMALE,WHITE,,Astrocytoma,2010.0,-23180.0,Dead,WITH TUMOR,,1.0,727.0,1.0,727.0,1.0,420.0
TCGA-E1-A7YQ-01,TCGA-E1-A7YQ,LGG,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2000.0,-21341.0,Dead,WITH TUMOR,,1.0,1578.0,1.0,1578.0,1.0,580.0
TCGA-E1-A7YS-01,TCGA-E1-A7YS,LGG,71.0,MALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2007.0,-26159.0,Dead,WITH TUMOR,,1.0,466.0,1.0,466.0,1.0,466.0
TCGA-E1-A7YV-01,TCGA-E1-A7YV,LGG,26.0,FEMALE,WHITE,,Oligoastrocytoma,2010.0,-9546.0,Dead,WITH TUMOR,,1.0,987.0,1.0,987.0,1.0,97.0
TCGA-E1-A7YW-01,TCGA-E1-A7YW,LGG,28.0,MALE,WHITE,,Oligoastrocytoma,2002.0,-10571.0,Dead,WITH TUMOR,,1.0,1120.0,1.0,1120.0,1.0,409.0
TCGA-E1-A7YY-01,TCGA-E1-A7YY,LGG,27.0,FEMALE,WHITE,,Oligodendroglioma,1998.0,-9867.0,Dead,WITH TUMOR,,1.0,4445.0,1.0,4445.0,1.0,958.0
TCGA-E1-A7Z3-01,TCGA-E1-A7Z3,LGG,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,1992.0,-11330.0,Dead,WITH TUMOR,,1.0,2235.0,1.0,2235.0,1.0,1569.0
TCGA-E1-A7Z6-01,TCGA-E1-A7Z6,LGG,41.0,FEMALE,WHITE,,Astrocytoma,2009.0,-14985.0,Dead,WITH TUMOR,,1.0,984.0,1.0,984.0,1.0,294.0
TCGA-E2-A107-01,TCGA-E2-A107,BRCA,54.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2008.0,-20065.0,Alive,TUMOR FREE,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0
TCGA-E2-A109-01,TCGA-E2-A109,BRCA,64.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-23521.0,Alive,TUMOR FREE,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0
TCGA-E2-A10A-01,TCGA-E2-A10A,BRCA,41.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-15085.0,Alive,WITH TUMOR,1229.0,0.0,1229.0,0.0,1229.0,1.0,75.0
TCGA-E2-A10B-01,TCGA-E2-A10B,BRCA,67.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-24577.0,Alive,TUMOR FREE,1141.0,0.0,1141.0,0.0,1141.0,1.0,195.0
TCGA-E2-A10C-01,TCGA-E2-A10C,BRCA,54.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-19849.0,Alive,TUMOR FREE,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0
TCGA-E2-A14N-01,TCGA-E2-A14N,BRCA,37.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-13743.0,Alive,TUMOR FREE,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0
TCGA-E2-A14O-01,TCGA-E2-A14O,BRCA,76.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-27837.0,Alive,TUMOR FREE,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0
TCGA-E2-A14P-01,TCGA-E2-A14P,BRCA,79.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2008.0,-28923.0,Alive,TUMOR FREE,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0
TCGA-E2-A14Q-01,TCGA-E2-A14Q,BRCA,50.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-18507.0,Alive,TUMOR FREE,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0
TCGA-E2-A14T-01,TCGA-E2-A14T,BRCA,52.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-19237.0,Alive,TUMOR FREE,2311.0,0.0,2311.0,0.0,2311.0,0.0,2311.0
TCGA-E2-A14V-01,TCGA-E2-A14V,BRCA,53.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-19643.0,Alive,TUMOR FREE,1042.0,0.0,1042.0,0.0,1042.0,0.0,1042.0
TCGA-E2-A14W-01,TCGA-E2-A14W,BRCA,78.0,MALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-28664.0,Alive,TUMOR FREE,974.0,0.0,974.0,0.0,974.0,0.0,974.0
TCGA-E2-A14X-01,TCGA-E2-A14X,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2009.0,-20105.0,Alive,TUMOR FREE,972.0,0.0,972.0,0.0,972.0,0.0,972.0
TCGA-E2-A14Y-01,TCGA-E2-A14Y,BRCA,35.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-13004.0,Alive,TUMOR FREE,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0
TCGA-E2-A14Z-01,TCGA-E2-A14Z,BRCA,64.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-23682.0,Dead,WITH TUMOR,,1.0,563.0,1.0,563.0,1.0,188.0
TCGA-E2-A150-01,TCGA-E2-A150,BRCA,48.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-17580.0,Alive,TUMOR FREE,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0
TCGA-E2-A152-01,TCGA-E2-A152,BRCA,56.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-20705.0,Alive,TUMOR FREE,2128.0,0.0,2128.0,0.0,2128.0,1.0,54.0
TCGA-E2-A153-01,TCGA-E2-A153,BRCA,51.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-18875.0,Alive,TUMOR FREE,707.0,0.0,707.0,0.0,707.0,0.0,707.0
TCGA-E2-A154-01,TCGA-E2-A154,BRCA,68.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-24999.0,Alive,TUMOR FREE,591.0,0.0,591.0,0.0,591.0,0.0,591.0
TCGA-E2-A155-01,TCGA-E2-A155,BRCA,58.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-21348.0,Alive,TUMOR FREE,640.0,0.0,640.0,0.0,640.0,0.0,640.0
TCGA-E2-A156-01,TCGA-E2-A156,BRCA,61.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-22422.0,Alive,TUMOR FREE,726.0,0.0,726.0,0.0,726.0,0.0,726.0
TCGA-E2-A158-01,TCGA-E2-A158,BRCA,43.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-15903.0,Alive,TUMOR FREE,450.0,0.0,450.0,0.0,450.0,0.0,450.0
TCGA-E2-A159-01,TCGA-E2-A159,BRCA,50.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-18621.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-E2-A15A-01,TCGA-E2-A15A,BRCA,45.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2009.0,-16750.0,Alive,TUMOR FREE,710.0,0.0,710.0,0.0,710.0,0.0,710.0
TCGA-E2-A15C-01,TCGA-E2-A15C,BRCA,61.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-22583.0,Alive,TUMOR FREE,694.0,0.0,694.0,0.0,694.0,0.0,694.0
TCGA-E2-A15D-01,TCGA-E2-A15D,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-17224.0,Alive,TUMOR FREE,526.0,0.0,526.0,0.0,526.0,0.0,526.0
TCGA-E2-A15E-01,TCGA-E2-A15E,BRCA,40.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-14894.0,Alive,TUMOR FREE,630.0,0.0,630.0,0.0,630.0,0.0,630.0
TCGA-E2-A15F-01,TCGA-E2-A15F,BRCA,64.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-23660.0,Alive,TUMOR FREE,658.0,0.0,658.0,0.0,658.0,0.0,658.0
TCGA-E2-A15G-01,TCGA-E2-A15G,BRCA,76.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),2009.0,-28013.0,Alive,TUMOR FREE,554.0,0.0,554.0,0.0,554.0,0.0,554.0
TCGA-E2-A15H-01,TCGA-E2-A15H,BRCA,38.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-13985.0,Alive,TUMOR FREE,393.0,0.0,393.0,0.0,393.0,0.0,393.0
TCGA-E2-A15I-01,TCGA-E2-A15I,BRCA,44.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-16163.0,Alive,TUMOR FREE,1692.0,0.0,1692.0,0.0,1692.0,0.0,1692.0
TCGA-E2-A15J-01,TCGA-E2-A15J,BRCA,51.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2009.0,-18771.0,Alive,TUMOR FREE,1640.0,0.0,1640.0,0.0,1640.0,0.0,1640.0
TCGA-E2-A15K-01,TCGA-E2-A15K,BRCA,58.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-21514.0,Alive,TUMOR FREE,275.0,0.0,275.0,0.0,275.0,0.0,275.0
TCGA-E2-A15L-01,TCGA-E2-A15L,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-23845.0,Alive,TUMOR FREE,626.0,0.0,626.0,0.0,626.0,0.0,626.0
TCGA-E2-A15M-01,TCGA-E2-A15M,BRCA,66.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-24266.0,Dead,TUMOR FREE,,1.0,336.0,0.0,336.0,0.0,336.0
TCGA-E2-A15O-01,TCGA-E2-A15O,BRCA,89.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2010.0,-32583.0,Alive,TUMOR FREE,1545.0,0.0,1545.0,0.0,1545.0,1.0,1210.0
TCGA-E2-A15P-01,TCGA-E2-A15P,BRCA,61.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-22524.0,Alive,TUMOR FREE,595.0,0.0,595.0,0.0,595.0,0.0,595.0
TCGA-E2-A15R-01,TCGA-E2-A15R,BRCA,64.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-23570.0,Alive,TUMOR FREE,1732.0,0.0,1732.0,0.0,1732.0,0.0,1732.0
TCGA-E2-A15S-01,TCGA-E2-A15S,BRCA,34.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-12671.0,Alive,TUMOR FREE,428.0,0.0,428.0,0.0,428.0,0.0,428.0
TCGA-E2-A15T-01,TCGA-E2-A15T,BRCA,65.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-24054.0,Alive,TUMOR FREE,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0
TCGA-E2-A1AZ-01,TCGA-E2-A1AZ,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2004.0,-23230.0,Alive,TUMOR FREE,2329.0,0.0,2329.0,0.0,2329.0,0.0,2329.0
TCGA-E2-A1B0-01,TCGA-E2-A1B0,BRCA,50.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2007.0,-18346.0,Alive,TUMOR FREE,1631.0,0.0,1631.0,0.0,1631.0,0.0,1631.0
TCGA-E2-A1B1-01,TCGA-E2-A1B1,BRCA,45.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2007.0,-16603.0,Alive,TUMOR FREE,2653.0,0.0,2653.0,0.0,2653.0,0.0,2653.0
TCGA-E2-A1B4-01,TCGA-E2-A1B4,BRCA,74.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-27241.0,Dead,TUMOR FREE,,1.0,1004.0,0.0,1004.0,0.0,1004.0
TCGA-E2-A1B5-01,TCGA-E2-A1B5,BRCA,46.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2008.0,-17039.0,Alive,TUMOR FREE,984.0,0.0,984.0,0.0,984.0,0.0,984.0
TCGA-E2-A1B6-01,TCGA-E2-A1B6,BRCA,44.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-16370.0,Alive,TUMOR FREE,867.0,0.0,867.0,0.0,867.0,0.0,867.0
TCGA-E2-A1BC-01,TCGA-E2-A1BC,BRCA,63.0,FEMALE,,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-23168.0,Alive,TUMOR FREE,501.0,0.0,501.0,0.0,501.0,0.0,501.0
TCGA-E2-A1BD-01,TCGA-E2-A1BD,BRCA,53.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-19627.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0
TCGA-E2-A1IG-01,TCGA-E2-A1IG,BRCA,45.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-16757.0,Alive,TUMOR FREE,2140.0,0.0,2140.0,0.0,2140.0,0.0,2140.0
TCGA-E2-A1IL-01,TCGA-E2-A1IL,BRCA,78.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2009.0,-28495.0,Alive,TUMOR FREE,118.0,0.0,118.0,0.0,118.0,0.0,118.0
TCGA-E2-A1IU-01,TCGA-E2-A1IU,BRCA,60.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2010.0,-22279.0,Alive,TUMOR FREE,337.0,0.0,337.0,0.0,337.0,0.0,337.0
TCGA-E2-A1L6-01,TCGA-E2-A1L6,BRCA,44.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-16403.0,Alive,TUMOR FREE,1648.0,0.0,1648.0,0.0,1648.0,0.0,1648.0
TCGA-E2-A1L7-01,TCGA-E2-A1L7,BRCA,40.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2009.0,-14854.0,Alive,TUMOR FREE,1836.0,0.0,1836.0,0.0,1836.0,1.0,1619.0
TCGA-E2-A1L8-01,TCGA-E2-A1L8,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Lobular Carcinoma,2008.0,-19187.0,Alive,TUMOR FREE,2240.0,0.0,2240.0,0.0,2240.0,0.0,2240.0
TCGA-E2-A1LB-01,TCGA-E2-A1LB,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-15283.0,Alive,TUMOR FREE,2306.0,0.0,2306.0,0.0,2306.0,0.0,2306.0
TCGA-E2-A1LG-01,TCGA-E2-A1LG,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-18492.0,Alive,TUMOR FREE,1523.0,0.0,1523.0,0.0,1523.0,0.0,1523.0
TCGA-E2-A1LK-01,TCGA-E2-A1LK,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2008.0,-30757.0,Dead,WITH TUMOR,,1.0,266.0,1.0,266.0,1.0,155.0
TCGA-E2-A1LL-01,TCGA-E2-A1LL,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2008.0,-27028.0,Alive,WITH TUMOR,1309.0,0.0,1309.0,0.0,1309.0,1.0,1303.0
TCGA-E2-A56Z-01,TCGA-E2-A56Z,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2012.0,-25282.0,Alive,TUMOR FREE,252.0,0.0,252.0,0.0,252.0,0.0,252.0
TCGA-E2-A572-01,TCGA-E2-A572,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-26399.0,Alive,TUMOR FREE,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0
TCGA-E2-A574-01,TCGA-E2-A574,BRCA,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-16195.0,Alive,TUMOR FREE,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0
TCGA-E2-A9RU-01,TCGA-E2-A9RU,BRCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2013.0,-32873.0,Alive,TUMOR FREE,538.0,0.0,538.0,0.0,538.0,0.0,538.0
TCGA-E3-A3DY-01,TCGA-E3-A3DY,THCA,37.0,MALE,WHITE,Stage I,"Other, specify",2007.0,-13860.0,Alive,TUMOR FREE,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0
TCGA-E3-A3DZ-01,TCGA-E3-A3DZ,THCA,55.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-20251.0,Alive,TUMOR FREE,1436.0,0.0,1436.0,0.0,1436.0,0.0,1436.0
TCGA-E3-A3E0-01,TCGA-E3-A3E0,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-12645.0,Alive,TUMOR FREE,2019.0,0.0,2019.0,0.0,2019.0,0.0,2019.0
TCGA-E3-A3E1-01,TCGA-E3-A3E1,THCA,46.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-16895.0,Alive,TUMOR FREE,2449.0,0.0,2449.0,0.0,2449.0,0.0,2449.0
TCGA-E3-A3E3-01,TCGA-E3-A3E3,THCA,49.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-18140.0,Alive,TUMOR FREE,1595.0,0.0,1595.0,0.0,1595.0,1.0,445.0
TCGA-E3-A3E5-01,TCGA-E3-A3E5,THCA,57.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-20993.0,Alive,TUMOR FREE,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0
TCGA-E5-A2PC-01,TCGA-E5-A2PC,BLCA,61.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-22308.0,Alive,TUMOR FREE,1326.0,0.0,1326.0,0.0,1326.0,0.0,1326.0
TCGA-E6-A2P8-01,TCGA-E6-A2P8,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Mixed serous and endometrioid,2010.0,-19448.0,Dead,WITH TUMOR,,1.0,72.0,1.0,72.0,1.0,60.0
TCGA-E6-A2P9-01,TCGA-E6-A2P9,UCEC,65.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-24088.0,Alive,TUMOR FREE,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0
TCGA-E7-A3X6-01,TCGA-E7-A3X6,BLCA,70.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-25584.0,Dead,WITH TUMOR,,1.0,904.0,1.0,904.0,1.0,369.0
TCGA-E7-A3Y1-01,TCGA-E7-A3Y1,BLCA,57.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-20917.0,Alive,TUMOR FREE,163.0,0.0,163.0,0.0,163.0,0.0,163.0
TCGA-E8-A2EA-01,TCGA-E8-A2EA,THCA,52.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19159.0,Alive,TUMOR FREE,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0
TCGA-E8-A2JQ-01,TCGA-E8-A2JQ,THCA,18.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-6684.0,Alive,TUMOR FREE,356.0,0.0,356.0,0.0,356.0,0.0,356.0
TCGA-E8-A3X7-01,TCGA-E8-A3X7,THCA,57.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-20983.0,Alive,TUMOR FREE,951.0,0.0,951.0,0.0,951.0,0.0,951.0
TCGA-E8-A413-01,TCGA-E8-A413,THCA,38.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-13909.0,Alive,TUMOR FREE,912.0,0.0,912.0,0.0,912.0,0.0,912.0
TCGA-E8-A414-01,TCGA-E8-A414,THCA,45.0,FEMALE,ASIAN,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-16754.0,Alive,TUMOR FREE,958.0,0.0,958.0,0.0,958.0,0.0,958.0
TCGA-E8-A415-01,TCGA-E8-A415,THCA,39.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-14288.0,Alive,TUMOR FREE,944.0,0.0,944.0,0.0,944.0,0.0,944.0
TCGA-E8-A416-01,TCGA-E8-A416,THCA,51.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-18932.0,Alive,TUMOR FREE,952.0,0.0,952.0,0.0,952.0,0.0,952.0
TCGA-E8-A417-01,TCGA-E8-A417,THCA,38.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-14019.0,Alive,TUMOR FREE,938.0,0.0,938.0,0.0,938.0,0.0,938.0
TCGA-E8-A418-01,TCGA-E8-A418,THCA,75.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-27737.0,Alive,TUMOR FREE,92.0,0.0,92.0,0.0,92.0,0.0,92.0
TCGA-E8-A419-01,TCGA-E8-A419,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-11306.0,Alive,TUMOR FREE,774.0,0.0,774.0,0.0,774.0,0.0,774.0
TCGA-E8-A432-01,TCGA-E8-A432,THCA,57.0,FEMALE,ASIAN,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-20874.0,Alive,TUMOR FREE,931.0,0.0,931.0,0.0,931.0,1.0,720.0
TCGA-E8-A433-01,TCGA-E8-A433,THCA,25.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-9145.0,Alive,TUMOR FREE,951.0,0.0,951.0,0.0,951.0,0.0,951.0
TCGA-E8-A436-01,TCGA-E8-A436,THCA,53.0,FEMALE,ASIAN,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-19640.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-E8-A437-01,TCGA-E8-A437,THCA,57.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-21073.0,Alive,TUMOR FREE,1213.0,0.0,1213.0,0.0,1213.0,0.0,1213.0
TCGA-E8-A438-01,TCGA-E8-A438,THCA,23.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-8752.0,Alive,TUMOR FREE,1019.0,0.0,1019.0,0.0,1019.0,0.0,1019.0
TCGA-E8-A44K-01,TCGA-E8-A44K,THCA,50.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-18472.0,Alive,TUMOR FREE,943.0,0.0,943.0,0.0,943.0,0.0,943.0
TCGA-E9-A1N3-01,TCGA-E9-A1N3,BRCA,70.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),2010.0,-25714.0,Alive,TUMOR FREE,1059.0,0.0,1059.0,0.0,1059.0,0.0,1059.0
TCGA-E9-A1N4-01,TCGA-E9-A1N4,BRCA,41.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),2010.0,-15055.0,Alive,TUMOR FREE,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0
TCGA-E9-A1N5-01,TCGA-E9-A1N5,BRCA,45.0,FEMALE,WHITE,Stage IIB,Mixed Histology (please specify),2010.0,-16736.0,Alive,TUMOR FREE,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0
TCGA-E9-A1N8-01,TCGA-E9-A1N8,BRCA,48.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-17652.0,Alive,TUMOR FREE,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0
TCGA-E9-A1N9-01,TCGA-E9-A1N9,BRCA,58.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),2011.0,-21228.0,Alive,TUMOR FREE,1101.0,0.0,1101.0,0.0,1101.0,0.0,1101.0
TCGA-E9-A1NA-01,TCGA-E9-A1NA,BRCA,58.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),2011.0,-21397.0,Alive,TUMOR FREE,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0
TCGA-E9-A1NE-01,TCGA-E9-A1NE,BRCA,28.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-10564.0,Alive,TUMOR FREE,1088.0,0.0,1088.0,0.0,1088.0,0.0,1088.0
TCGA-E9-A1NF-01,TCGA-E9-A1NF,BRCA,60.0,FEMALE,WHITE,Stage IIA,Mixed Histology (please specify),2011.0,-21981.0,Dead,WITH TUMOR,,1.0,1072.0,1.0,1072.0,1.0,90.0
TCGA-E9-A1NG-01,TCGA-E9-A1NG,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-22896.0,Dead,TUMOR FREE,,1.0,786.0,0.0,786.0,0.0,786.0
TCGA-E9-A1NH-01,TCGA-E9-A1NH,BRCA,71.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-26221.0,Alive,TUMOR FREE,576.0,0.0,576.0,0.0,576.0,0.0,576.0
TCGA-E9-A1QZ-01,TCGA-E9-A1QZ,BRCA,61.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-22397.0,Alive,TUMOR FREE,755.0,0.0,755.0,0.0,755.0,0.0,755.0
TCGA-E9-A1R0-01,TCGA-E9-A1R0,BRCA,58.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-21394.0,Alive,TUMOR FREE,860.0,0.0,860.0,0.0,860.0,0.0,860.0
TCGA-E9-A1R2-01,TCGA-E9-A1R2,BRCA,51.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2011.0,-18936.0,Alive,TUMOR FREE,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0
TCGA-E9-A1R3-01,TCGA-E9-A1R3,BRCA,70.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2010.0,-25693.0,Alive,TUMOR FREE,78.0,0.0,78.0,0.0,78.0,0.0,78.0
TCGA-E9-A1R4-01,TCGA-E9-A1R4,BRCA,66.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-24181.0,Alive,TUMOR FREE,186.0,0.0,186.0,0.0,186.0,0.0,186.0
TCGA-E9-A1R5-01,TCGA-E9-A1R5,BRCA,63.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-23116.0,Alive,TUMOR FREE,92.0,0.0,92.0,0.0,92.0,0.0,92.0
TCGA-E9-A1R6-01,TCGA-E9-A1R6,BRCA,63.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-23347.0,Alive,TUMOR FREE,339.0,0.0,339.0,0.0,339.0,0.0,339.0
TCGA-E9-A1R7-01,TCGA-E9-A1R7,BRCA,64.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-23397.0,Alive,TUMOR FREE,1467.0,0.0,1467.0,0.0,1467.0,0.0,1467.0
TCGA-E9-A1RA-01,TCGA-E9-A1RA,BRCA,48.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-17699.0,Alive,TUMOR FREE,1369.0,0.0,1369.0,0.0,1369.0,0.0,1369.0
TCGA-E9-A1RB-01,TCGA-E9-A1RB,BRCA,40.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-14755.0,Dead,TUMOR FREE,,1.0,976.0,0.0,976.0,0.0,976.0
TCGA-E9-A1RC-01,TCGA-E9-A1RC,BRCA,56.0,FEMALE,WHITE,Stage IIIC,Mixed Histology (please specify),2007.0,-20795.0,Alive,TUMOR FREE,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0
TCGA-E9-A1RD-01,TCGA-E9-A1RD,BRCA,67.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-24719.0,Alive,TUMOR FREE,34.0,0.0,34.0,0.0,34.0,0.0,34.0
TCGA-E9-A1RE-01,TCGA-E9-A1RE,BRCA,74.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-27392.0,Alive,TUMOR FREE,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0
TCGA-E9-A1RF-01,TCGA-E9-A1RF,BRCA,68.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-25119.0,Alive,TUMOR FREE,200.0,0.0,200.0,0.0,200.0,0.0,200.0
TCGA-E9-A1RG-01,TCGA-E9-A1RG,BRCA,62.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-22788.0,Alive,TUMOR FREE,647.0,0.0,647.0,0.0,647.0,0.0,647.0
TCGA-E9-A1RH-01,TCGA-E9-A1RH,BRCA,63.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-23224.0,Alive,TUMOR FREE,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0
TCGA-E9-A1RI-01,TCGA-E9-A1RI,BRCA,43.0,FEMALE,WHITE,Stage IIIA,Mixed Histology (please specify),2011.0,-15942.0,Alive,TUMOR FREE,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0
TCGA-E9-A226-01,TCGA-E9-A226,BRCA,45.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-16511.0,Dead,WITH TUMOR,,1.0,1048.0,1.0,1048.0,1.0,790.0
TCGA-E9-A227-01,TCGA-E9-A227,BRCA,42.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-15602.0,Alive,TUMOR FREE,975.0,0.0,975.0,0.0,975.0,0.0,975.0
TCGA-E9-A228-01,TCGA-E9-A228,BRCA,58.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-21294.0,Alive,TUMOR FREE,1285.0,0.0,1285.0,0.0,1285.0,0.0,1285.0
TCGA-E9-A229-01,TCGA-E9-A229,BRCA,37.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-13817.0,Alive,TUMOR FREE,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0
TCGA-E9-A22A-01,TCGA-E9-A22A,BRCA,74.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-27288.0,Alive,TUMOR FREE,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0
TCGA-E9-A22B-01,TCGA-E9-A22B,BRCA,71.0,FEMALE,WHITE,Stage IA,Mixed Histology (please specify),2011.0,-26278.0,Alive,TUMOR FREE,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0
TCGA-E9-A22D-01,TCGA-E9-A22D,BRCA,38.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-14115.0,Alive,TUMOR FREE,1248.0,0.0,1248.0,0.0,1248.0,0.0,1248.0
TCGA-E9-A22E-01,TCGA-E9-A22E,BRCA,56.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2011.0,-20574.0,Alive,TUMOR FREE,1269.0,0.0,1269.0,0.0,1269.0,0.0,1269.0
TCGA-E9-A22G-01,TCGA-E9-A22G,BRCA,47.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-17300.0,Alive,TUMOR FREE,1239.0,0.0,1239.0,0.0,1239.0,0.0,1239.0
TCGA-E9-A22H-01,TCGA-E9-A22H,BRCA,42.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-15504.0,Alive,TUMOR FREE,1232.0,0.0,1232.0,0.0,1232.0,0.0,1232.0
TCGA-E9-A243-01,TCGA-E9-A243,BRCA,52.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-19035.0,Alive,WITH TUMOR,612.0,0.0,612.0,0.0,612.0,1.0,305.0
TCGA-E9-A244-01,TCGA-E9-A244,BRCA,54.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-19778.0,Alive,TUMOR FREE,21.0,0.0,21.0,0.0,21.0,0.0,21.0
TCGA-E9-A245-01,TCGA-E9-A245,BRCA,47.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2011.0,-17363.0,Alive,TUMOR FREE,26.0,0.0,26.0,0.0,26.0,0.0,26.0
TCGA-E9-A247-01,TCGA-E9-A247,BRCA,59.0,FEMALE,WHITE,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-21562.0,Alive,TUMOR FREE,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0
TCGA-E9-A248-01,TCGA-E9-A248,BRCA,51.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-18684.0,Alive,TUMOR FREE,59.0,0.0,59.0,0.0,59.0,0.0,59.0
TCGA-E9-A249-01,TCGA-E9-A249,BRCA,45.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-16689.0,Alive,TUMOR FREE,217.0,0.0,217.0,0.0,217.0,0.0,217.0
TCGA-E9-A24A-01,TCGA-E9-A24A,BRCA,69.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-25370.0,Alive,TUMOR FREE,747.0,0.0,747.0,0.0,747.0,0.0,747.0
TCGA-E9-A295-01,TCGA-E9-A295,BRCA,71.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-25957.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-E9-A2JS-01,TCGA-E9-A2JS,BRCA,72.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-26407.0,Dead,WITH TUMOR,,1.0,904.0,1.0,904.0,1.0,524.0
TCGA-E9-A2JT-01,TCGA-E9-A2JT,BRCA,63.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-23318.0,Alive,TUMOR FREE,288.0,0.0,288.0,0.0,288.0,0.0,288.0
TCGA-E9-A3HO-01,TCGA-E9-A3HO,BRCA,49.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,-18046.0,Alive,TUMOR FREE,1158.0,0.0,1158.0,0.0,1158.0,0.0,1158.0
TCGA-E9-A3QA-01,TCGA-E9-A3QA,BRCA,33.0,FEMALE,WHITE,Stage IIA,Medullary Carcinoma,2011.0,-12142.0,Alive,TUMOR FREE,918.0,0.0,918.0,0.0,918.0,0.0,918.0
TCGA-E9-A3X8-01,TCGA-E9-A3X8,BRCA,48.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-17588.0,Alive,TUMOR FREE,926.0,0.0,926.0,0.0,926.0,0.0,926.0
TCGA-E9-A54Y-01,TCGA-E9-A54Y,BRCA,63.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2012.0,-23057.0,Alive,TUMOR FREE,725.0,0.0,725.0,0.0,725.0,0.0,725.0
TCGA-E9-A5FK-01,TCGA-E9-A5FK,BRCA,60.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2012.0,-22199.0,Alive,TUMOR FREE,812.0,0.0,812.0,0.0,812.0,0.0,812.0
TCGA-E9-A5FL-01,TCGA-E9-A5FL,BRCA,65.0,FEMALE,WHITE,Stage IIB,Metaplastic Carcinoma,2012.0,-24053.0,Alive,TUMOR FREE,24.0,0.0,24.0,0.0,24.0,0.0,24.0
TCGA-E9-A5UO-01,TCGA-E9-A5UO,BRCA,41.0,FEMALE,WHITE,Stage IIA,Mucinous Carcinoma,2012.0,-15050.0,Alive,TUMOR FREE,785.0,0.0,785.0,0.0,785.0,0.0,785.0
TCGA-E9-A6HE-01,TCGA-E9-A6HE,BRCA,45.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2012.0,-16697.0,Alive,TUMOR FREE,847.0,0.0,847.0,0.0,847.0,0.0,847.0
TCGA-EB-A1NK-01,TCGA-EB-A1NK,SKCM,48.0,MALE,WHITE,Stage IIC,,2010.0,-17569.0,Alive,TUMOR FREE,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0
TCGA-EB-A24C-01,TCGA-EB-A24C,SKCM,56.0,MALE,WHITE,,,2011.0,-20539.0,Alive,TUMOR FREE,632.0,0.0,632.0,0.0,632.0,1.0,465.0
TCGA-EB-A24D-01,TCGA-EB-A24D,SKCM,72.0,MALE,WHITE,Stage IIIB,,2011.0,-26439.0,Alive,TUMOR FREE,645.0,0.0,645.0,0.0,645.0,1.0,500.0
TCGA-EB-A299-01,TCGA-EB-A299,SKCM,63.0,MALE,WHITE,Stage IIA,,2011.0,-23322.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-EB-A3HV-01,TCGA-EB-A3HV,SKCM,37.0,MALE,WHITE,Stage IIC,,2011.0,-13712.0,Alive,WITH TUMOR,39.0,0.0,39.0,0.0,39.0,0.0,39.0
TCGA-EB-A3XB-01,TCGA-EB-A3XB,SKCM,63.0,MALE,WHITE,Stage II,,2011.0,-23091.0,Alive,TUMOR FREE,796.0,0.0,796.0,0.0,796.0,0.0,796.0
TCGA-EB-A3XC-01,TCGA-EB-A3XC,SKCM,74.0,MALE,WHITE,Stage IIC,,2012.0,-27124.0,Alive,TUMOR FREE,650.0,0.0,650.0,0.0,650.0,1.0,74.0
TCGA-EB-A3XD-01,TCGA-EB-A3XD,SKCM,53.0,FEMALE,WHITE,Stage IIC,,2011.0,-19431.0,Alive,TUMOR FREE,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0
TCGA-EB-A3XE-01,TCGA-EB-A3XE,SKCM,77.0,FEMALE,WHITE,Stage IIA,,2012.0,-28148.0,Alive,TUMOR FREE,180.0,0.0,180.0,0.0,180.0,0.0,180.0
TCGA-EB-A3XF-01,TCGA-EB-A3XF,SKCM,57.0,MALE,WHITE,Stage IIC,,2012.0,-20910.0,Alive,TUMOR FREE,278.0,0.0,278.0,0.0,278.0,0.0,278.0
TCGA-EB-A3Y6-01,TCGA-EB-A3Y6,SKCM,56.0,FEMALE,WHITE,Stage IIC,,2012.0,-20605.0,Alive,TUMOR FREE,126.0,0.0,126.0,0.0,126.0,0.0,126.0
TCGA-EB-A3Y7-01,TCGA-EB-A3Y7,SKCM,86.0,FEMALE,WHITE,Stage IIIB,,2012.0,-31622.0,Dead,TUMOR FREE,,1.0,326.0,0.0,326.0,0.0,326.0
TCGA-EB-A41A-01,TCGA-EB-A41A,SKCM,90.0,MALE,WHITE,Stage IIC,,2012.0,-32872.0,Alive,TUMOR FREE,262.0,0.0,262.0,0.0,262.0,0.0,262.0
TCGA-EB-A41B-01,TCGA-EB-A41B,SKCM,76.0,FEMALE,WHITE,Stage IIC,,2012.0,-27998.0,Alive,TUMOR FREE,291.0,0.0,291.0,0.0,291.0,0.0,291.0
TCGA-EB-A42Y-01,TCGA-EB-A42Y,SKCM,73.0,FEMALE,ASIAN,Stage IIC,,2012.0,-26712.0,Dead,WITH TUMOR,,1.0,721.0,1.0,721.0,1.0,721.0
TCGA-EB-A42Z-01,TCGA-EB-A42Z,SKCM,49.0,MALE,ASIAN,Stage IIIC,,2012.0,-18157.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-EB-A430-01,TCGA-EB-A430,SKCM,83.0,MALE,WHITE,Stage IIC,,2012.0,-30344.0,Alive,TUMOR FREE,-2.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-EB-A431-01,TCGA-EB-A431,SKCM,34.0,MALE,WHITE,Stage IIC,,2012.0,-12484.0,Alive,TUMOR FREE,568.0,0.0,568.0,0.0,568.0,0.0,568.0
TCGA-EB-A44N-01,TCGA-EB-A44N,SKCM,59.0,MALE,WHITE,Stage IIC,,2012.0,-21623.0,Dead,WITH TUMOR,,1.0,205.0,1.0,205.0,1.0,115.0
TCGA-EB-A44O-01,TCGA-EB-A44O,SKCM,69.0,MALE,WHITE,Stage IIB,,2012.0,-25537.0,Alive,WITH TUMOR,81.0,0.0,81.0,0.0,81.0,1.0,60.0
TCGA-EB-A44P-01,TCGA-EB-A44P,SKCM,58.0,FEMALE,WHITE,Stage IIC,,2012.0,-21519.0,Alive,TUMOR FREE,741.0,0.0,741.0,0.0,741.0,0.0,741.0
TCGA-EB-A4IQ-01,TCGA-EB-A4IQ,SKCM,42.0,FEMALE,ASIAN,Stage IIIB,,2012.0,-15516.0,Dead,TUMOR FREE,,1.0,636.0,0.0,636.0,1.0,337.0
TCGA-EB-A4IS-01,TCGA-EB-A4IS,SKCM,77.0,MALE,WHITE,Stage IIB,,2012.0,-28315.0,Alive,TUMOR FREE,774.0,0.0,774.0,0.0,774.0,0.0,774.0
TCGA-EB-A4OY-01,TCGA-EB-A4OY,SKCM,65.0,FEMALE,WHITE,Stage IIIB,,2012.0,-23773.0,Alive,TUMOR FREE,977.0,0.0,977.0,0.0,977.0,0.0,977.0
TCGA-EB-A4OZ-01,TCGA-EB-A4OZ,SKCM,41.0,FEMALE,WHITE,Stage IIIC,,2012.0,-15337.0,Alive,TUMOR FREE,620.0,0.0,620.0,0.0,620.0,0.0,620.0
TCGA-EB-A4XL-01,TCGA-EB-A4XL,SKCM,56.0,FEMALE,WHITE,Stage IIC,,2012.0,-20486.0,Alive,TUMOR FREE,777.0,0.0,777.0,0.0,777.0,0.0,777.0
TCGA-EB-A550-01,TCGA-EB-A550,SKCM,75.0,FEMALE,WHITE,Stage IIC,,2012.0,-27556.0,Dead,TUMOR FREE,,1.0,264.0,0.0,264.0,0.0,264.0
TCGA-EB-A551-01,TCGA-EB-A551,SKCM,78.0,FEMALE,WHITE,Stage IIIC,,2012.0,-28671.0,Alive,TUMOR FREE,590.0,0.0,590.0,0.0,590.0,0.0,590.0
TCGA-EB-A553-01,TCGA-EB-A553,SKCM,62.0,MALE,WHITE,Stage IIC,,2012.0,-22972.0,Alive,TUMOR FREE,226.0,0.0,226.0,0.0,226.0,0.0,226.0
TCGA-EB-A5FP-01,TCGA-EB-A5FP,SKCM,65.0,FEMALE,WHITE,Stage IV,,2012.0,-23833.0,Dead,WITH TUMOR,,1.0,454.0,1.0,454.0,1.0,24.0
TCGA-ED-A459-01,TCGA-ED-A459,LIHC,47.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2012.0,-17402.0,Alive,TUMOR FREE,910.0,0.0,910.0,0.0,910.0,0.0,910.0
TCGA-ED-A4XI-01,TCGA-ED-A4XI,LIHC,58.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2012.0,-21497.0,Alive,TUMOR FREE,819.0,0.0,819.0,0.0,819.0,0.0,819.0
TCGA-ED-A5KG-01,TCGA-ED-A5KG,LIHC,60.0,FEMALE,ASIAN,Stage II,Hepatocellular Carcinoma,2012.0,-22258.0,Alive,WITH TUMOR,854.0,0.0,854.0,0.0,854.0,1.0,110.0
TCGA-ED-A627-01,TCGA-ED-A627,LIHC,74.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-27303.0,Alive,TUMOR FREE,423.0,0.0,423.0,0.0,423.0,0.0,423.0
TCGA-ED-A66X-01,TCGA-ED-A66X,LIHC,35.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-12947.0,Alive,TUMOR FREE,406.0,0.0,406.0,0.0,406.0,1.0,124.0
TCGA-ED-A66Y-01,TCGA-ED-A66Y,LIHC,51.0,FEMALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-18797.0,Dead,TUMOR FREE,,1.0,296.0,0.0,296.0,0.0,296.0
TCGA-ED-A7PX-01,TCGA-ED-A7PX,LIHC,48.0,FEMALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-17638.0,Alive,TUMOR FREE,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-ED-A7PY-01,TCGA-ED-A7PY,LIHC,20.0,FEMALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-7556.0,Alive,TUMOR FREE,390.0,0.0,390.0,0.0,390.0,0.0,390.0
TCGA-ED-A7PZ-01,TCGA-ED-A7PZ,LIHC,61.0,MALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-22601.0,Alive,TUMOR FREE,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-ED-A7XO-01,TCGA-ED-A7XO,LIHC,29.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-10828.0,Alive,WITH TUMOR,427.0,0.0,427.0,0.0,427.0,1.0,262.0
TCGA-ED-A7XP-01,TCGA-ED-A7XP,LIHC,53.0,FEMALE,ASIAN,Stage II,Hepatocellular Carcinoma,2013.0,-19504.0,Alive,WITH TUMOR,400.0,0.0,400.0,0.0,400.0,1.0,187.0
TCGA-ED-A82E-01,TCGA-ED-A82E,LIHC,60.0,FEMALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2013.0,-22234.0,Alive,TUMOR FREE,408.0,0.0,408.0,0.0,408.0,0.0,408.0
TCGA-EF-5830-01,TCGA-EF-5830,READ,54.0,MALE,WHITE,Stage IIB,Rectal Adenocarcinoma,2010.0,-19802.0,Alive,TUMOR FREE,106.0,0.0,106.0,0.0,106.0,0.0,106.0
TCGA-EI-6506-01,TCGA-EI-6506,READ,78.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2010.0,-28587.0,Alive,TUMOR FREE,625.0,0.0,625.0,0.0,625.0,0.0,625.0
TCGA-EI-6507-01,TCGA-EI-6507,READ,60.0,MALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2010.0,-22176.0,Alive,TUMOR FREE,607.0,0.0,607.0,0.0,607.0,0.0,607.0
TCGA-EI-6508-01,TCGA-EI-6508,READ,48.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-17827.0,Alive,TUMOR FREE,636.0,0.0,636.0,0.0,636.0,0.0,636.0
TCGA-EI-6509-01,TCGA-EI-6509,READ,53.0,MALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2010.0,-19666.0,Alive,WITH TUMOR,517.0,0.0,517.0,0.0,517.0,1.0,90.0
TCGA-EI-6510-01,TCGA-EI-6510,READ,77.0,FEMALE,WHITE,[Discrepancy],Rectal Adenocarcinoma,2010.0,-28328.0,Alive,TUMOR FREE,556.0,0.0,556.0,0.0,556.0,0.0,556.0
TCGA-EI-6511-01,TCGA-EI-6511,READ,52.0,MALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-19237.0,Alive,TUMOR FREE,482.0,0.0,482.0,0.0,482.0,0.0,482.0
TCGA-EI-6512-01,TCGA-EI-6512,READ,64.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-23537.0,Alive,TUMOR FREE,538.0,0.0,538.0,0.0,538.0,0.0,538.0
TCGA-EI-6513-01,TCGA-EI-6513,READ,59.0,MALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2010.0,-21776.0,Alive,TUMOR FREE,497.0,0.0,497.0,0.0,497.0,0.0,497.0
TCGA-EI-6514-01,TCGA-EI-6514,READ,59.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2010.0,-21618.0,Alive,TUMOR FREE,496.0,0.0,496.0,0.0,496.0,0.0,496.0
TCGA-EI-6881-01,TCGA-EI-6881,READ,60.0,MALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2010.0,-22057.0,Alive,TUMOR FREE,499.0,0.0,499.0,0.0,499.0,0.0,499.0
TCGA-EI-6882-01,TCGA-EI-6882,READ,59.0,MALE,WHITE,Stage IIA,Rectal Mucinous Adenocarcinoma,2011.0,-21682.0,Alive,TUMOR FREE,262.0,0.0,262.0,0.0,262.0,0.0,262.0
TCGA-EI-6884-01,TCGA-EI-6884,READ,71.0,MALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2011.0,-25995.0,Alive,TUMOR FREE,328.0,0.0,328.0,0.0,328.0,0.0,328.0
TCGA-EI-6885-01,TCGA-EI-6885,READ,57.0,FEMALE,WHITE,Stage IV,Rectal Adenocarcinoma,2011.0,-21140.0,Alive,WITH TUMOR,415.0,0.0,415.0,0.0,415.0,1.0,295.0
TCGA-EI-6917-01,TCGA-EI-6917,READ,33.0,MALE,WHITE,Stage IIIA,Rectal Adenocarcinoma,2010.0,-12113.0,Alive,TUMOR FREE,531.0,0.0,531.0,0.0,531.0,0.0,531.0
TCGA-EJ-5494-01,TCGA-EJ-5494,PRAD,50.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-18596.0,Alive,TUMOR FREE,1477.0,0.0,1477.0,0.0,1477.0,0.0,1477.0
TCGA-EJ-5495-01,TCGA-EJ-5495,PRAD,68.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-24904.0,Alive,TUMOR FREE,1760.0,0.0,1760.0,0.0,1760.0,0.0,1760.0
TCGA-EJ-5496-01,TCGA-EJ-5496,PRAD,59.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-21897.0,Alive,TUMOR FREE,595.0,0.0,595.0,0.0,595.0,0.0,595.0
TCGA-EJ-5497-01,TCGA-EJ-5497,PRAD,47.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-17523.0,Alive,TUMOR FREE,405.0,0.0,405.0,0.0,405.0,0.0,405.0
TCGA-EJ-5498-01,TCGA-EJ-5498,PRAD,56.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-20472.0,Alive,TUMOR FREE,1720.0,0.0,1720.0,0.0,1720.0,0.0,1720.0
TCGA-EJ-5499-01,TCGA-EJ-5499,PRAD,61.0,MALE,ASIAN,,Prostate Adenocarcinoma Acinar Type,2010.0,-22286.0,Alive,TUMOR FREE,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0
TCGA-EJ-5501-01,TCGA-EJ-5501,PRAD,55.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-20409.0,Alive,TUMOR FREE,1365.0,0.0,1365.0,0.0,1365.0,0.0,1365.0
TCGA-EJ-5502-01,TCGA-EJ-5502,PRAD,50.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-18447.0,Alive,TUMOR FREE,1171.0,0.0,1171.0,0.0,1171.0,0.0,1171.0
TCGA-EJ-5503-01,TCGA-EJ-5503,PRAD,50.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-18395.0,Alive,TUMOR FREE,1391.0,0.0,1391.0,0.0,1391.0,0.0,1391.0
TCGA-EJ-5504-01,TCGA-EJ-5504,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-24072.0,Alive,WITH TUMOR,1427.0,0.0,1427.0,0.0,1427.0,0.0,1427.0
TCGA-EJ-5505-01,TCGA-EJ-5505,PRAD,57.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-21164.0,Alive,TUMOR FREE,922.0,0.0,922.0,0.0,922.0,0.0,922.0
TCGA-EJ-5506-01,TCGA-EJ-5506,PRAD,67.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-24617.0,Alive,TUMOR FREE,1381.0,0.0,1381.0,0.0,1381.0,0.0,1381.0
TCGA-EJ-5507-01,TCGA-EJ-5507,PRAD,54.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-19759.0,Alive,TUMOR FREE,1457.0,0.0,1457.0,0.0,1457.0,0.0,1457.0
TCGA-EJ-5508-01,TCGA-EJ-5508,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23758.0,Alive,TUMOR FREE,1965.0,0.0,1965.0,0.0,1965.0,0.0,1965.0
TCGA-EJ-5509-01,TCGA-EJ-5509,PRAD,63.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-23368.0,Alive,TUMOR FREE,1464.0,0.0,1464.0,0.0,1464.0,0.0,1464.0
TCGA-EJ-5510-01,TCGA-EJ-5510,PRAD,48.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-17895.0,Alive,TUMOR FREE,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0
TCGA-EJ-5511-01,TCGA-EJ-5511,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2009.0,-20409.0,Alive,TUMOR FREE,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0
TCGA-EJ-5512-01,TCGA-EJ-5512,PRAD,46.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-17127.0,Alive,TUMOR FREE,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0
TCGA-EJ-5514-01,TCGA-EJ-5514,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-24165.0,Alive,TUMOR FREE,1829.0,0.0,1829.0,0.0,1829.0,0.0,1829.0
TCGA-EJ-5515-01,TCGA-EJ-5515,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22097.0,Alive,TUMOR FREE,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0
TCGA-EJ-5516-01,TCGA-EJ-5516,PRAD,49.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-17980.0,Alive,TUMOR FREE,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0
TCGA-EJ-5517-01,TCGA-EJ-5517,PRAD,55.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-20422.0,Alive,TUMOR FREE,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0
TCGA-EJ-5518-01,TCGA-EJ-5518,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-24313.0,Alive,WITH TUMOR,2118.0,0.0,2118.0,0.0,2118.0,1.0,2104.0
TCGA-EJ-5519-01,TCGA-EJ-5519,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23669.0,Alive,TUMOR FREE,1962.0,0.0,1962.0,0.0,1962.0,0.0,1962.0
TCGA-EJ-5521-01,TCGA-EJ-5521,PRAD,63.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-23304.0,Alive,TUMOR FREE,2279.0,0.0,2279.0,0.0,2279.0,0.0,2279.0
TCGA-EJ-5522-01,TCGA-EJ-5522,PRAD,51.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-18802.0,Alive,TUMOR FREE,2079.0,0.0,2079.0,0.0,2079.0,0.0,2079.0
TCGA-EJ-5524-01,TCGA-EJ-5524,PRAD,57.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-20854.0,Alive,WITH TUMOR,1882.0,0.0,1882.0,0.0,1882.0,1.0,265.0
TCGA-EJ-5525-01,TCGA-EJ-5525,PRAD,67.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-24535.0,Alive,WITH TUMOR,1115.0,0.0,1115.0,0.0,1115.0,1.0,546.0
TCGA-EJ-5526-01,TCGA-EJ-5526,PRAD,56.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-20558.0,Alive,WITH TUMOR,1909.0,0.0,1909.0,0.0,1909.0,1.0,537.0
TCGA-EJ-5527-01,TCGA-EJ-5527,PRAD,69.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-25234.0,Alive,TUMOR FREE,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0
TCGA-EJ-5530-01,TCGA-EJ-5530,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-22316.0,Alive,TUMOR FREE,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0
TCGA-EJ-5531-01,TCGA-EJ-5531,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22760.0,Alive,TUMOR FREE,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0
TCGA-EJ-5532-01,TCGA-EJ-5532,PRAD,57.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-21110.0,Alive,TUMOR FREE,1828.0,0.0,1828.0,0.0,1828.0,0.0,1828.0
TCGA-EJ-5542-01,TCGA-EJ-5542,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-21942.0,Alive,TUMOR FREE,1513.0,0.0,1513.0,0.0,1513.0,0.0,1513.0
TCGA-EJ-7115-01,TCGA-EJ-7115,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-23986.0,Alive,TUMOR FREE,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0
TCGA-EJ-7125-01,TCGA-EJ-7125,PRAD,44.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2005.0,-16425.0,Alive,TUMOR FREE,2850.0,0.0,2850.0,0.0,2850.0,0.0,2850.0
TCGA-EJ-7218-01,TCGA-EJ-7218,PRAD,71.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2006.0,-26181.0,Alive,TUMOR FREE,2542.0,0.0,2542.0,0.0,2542.0,0.0,2542.0
TCGA-EJ-7314-01,TCGA-EJ-7314,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-22766.0,Alive,TUMOR FREE,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0
TCGA-EJ-7315-01,TCGA-EJ-7315,PRAD,68.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-25154.0,Alive,TUMOR FREE,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0
TCGA-EJ-7317-01,TCGA-EJ-7317,PRAD,71.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-26064.0,Alive,TUMOR FREE,771.0,0.0,771.0,0.0,771.0,0.0,771.0
TCGA-EJ-7318-01,TCGA-EJ-7318,PRAD,51.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-18686.0,Alive,TUMOR FREE,1029.0,0.0,1029.0,0.0,1029.0,1.0,380.0
TCGA-EJ-7321-01,TCGA-EJ-7321,PRAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2011.0,-21108.0,Alive,TUMOR FREE,824.0,0.0,824.0,0.0,824.0,0.0,824.0
TCGA-EJ-7328-01,TCGA-EJ-7328,PRAD,70.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-25756.0,Alive,TUMOR FREE,842.0,0.0,842.0,0.0,842.0,0.0,842.0
TCGA-EJ-7330-01,TCGA-EJ-7330,PRAD,68.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-25050.0,Alive,TUMOR FREE,191.0,0.0,191.0,0.0,191.0,0.0,191.0
TCGA-EJ-7331-01,TCGA-EJ-7331,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-23458.0,Alive,TUMOR FREE,742.0,0.0,742.0,0.0,742.0,0.0,742.0
TCGA-EJ-7781-01,TCGA-EJ-7781,PRAD,65.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-23937.0,Alive,TUMOR FREE,1073.0,0.0,1073.0,0.0,1073.0,0.0,1073.0
TCGA-EJ-7782-01,TCGA-EJ-7782,PRAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2010.0,-25965.0,Alive,TUMOR FREE,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0
TCGA-EJ-7783-01,TCGA-EJ-7783,PRAD,70.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-25600.0,Alive,TUMOR FREE,787.0,0.0,787.0,0.0,787.0,0.0,787.0
TCGA-EJ-7784-01,TCGA-EJ-7784,PRAD,63.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-23183.0,Alive,TUMOR FREE,781.0,0.0,781.0,0.0,781.0,0.0,781.0
TCGA-EJ-7785-01,TCGA-EJ-7785,PRAD,54.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-19939.0,Alive,TUMOR FREE,1177.0,0.0,1177.0,0.0,1177.0,0.0,1177.0
TCGA-EJ-7786-01,TCGA-EJ-7786,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-22793.0,Alive,TUMOR FREE,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0
TCGA-EJ-7788-01,TCGA-EJ-7788,PRAD,53.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-19623.0,Alive,TUMOR FREE,859.0,0.0,859.0,0.0,859.0,0.0,859.0
TCGA-EJ-7789-01,TCGA-EJ-7789,PRAD,66.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2011.0,-24107.0,Alive,TUMOR FREE,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0
TCGA-EJ-7791-01,TCGA-EJ-7791,PRAD,67.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-24621.0,Alive,TUMOR FREE,1118.0,0.0,1118.0,0.0,1118.0,0.0,1118.0
TCGA-EJ-7792-01,TCGA-EJ-7792,PRAD,53.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-19454.0,Alive,TUMOR FREE,1396.0,0.0,1396.0,0.0,1396.0,0.0,1396.0
TCGA-EJ-7793-01,TCGA-EJ-7793,PRAD,49.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-17982.0,Alive,TUMOR FREE,114.0,0.0,114.0,0.0,114.0,0.0,114.0
TCGA-EJ-7794-01,TCGA-EJ-7794,PRAD,67.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-24478.0,Alive,TUMOR FREE,1306.0,0.0,1306.0,0.0,1306.0,0.0,1306.0
TCGA-EJ-7797-01,TCGA-EJ-7797,PRAD,53.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-19616.0,Alive,TUMOR FREE,983.0,0.0,983.0,0.0,983.0,0.0,983.0
TCGA-EJ-8468-01,TCGA-EJ-8468,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2007.0,-23371.0,Alive,TUMOR FREE,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0
TCGA-EJ-8470-01,TCGA-EJ-8470,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-21209.0,Alive,TUMOR FREE,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0
TCGA-EJ-8474-01,TCGA-EJ-8474,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-25561.0,Alive,TUMOR FREE,766.0,0.0,766.0,0.0,766.0,0.0,766.0
TCGA-EJ-A46D-01,TCGA-EJ-A46D,PRAD,53.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-19466.0,Alive,TUMOR FREE,626.0,0.0,626.0,0.0,626.0,0.0,626.0
TCGA-EJ-A46G-01,TCGA-EJ-A46G,PRAD,71.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2012.0,-26219.0,Alive,TUMOR FREE,668.0,0.0,668.0,0.0,668.0,0.0,668.0
TCGA-EJ-A65E-01,TCGA-EJ-A65E,PRAD,67.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2012.0,-24558.0,Alive,TUMOR FREE,417.0,0.0,417.0,0.0,417.0,0.0,417.0
TCGA-EJ-A65F-01,TCGA-EJ-A65F,PRAD,59.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2012.0,-21681.0,Alive,[Discrepancy],560.0,0.0,560.0,0.0,560.0,1.0,75.0
TCGA-EJ-A65J-01,TCGA-EJ-A65J,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-22904.0,Alive,TUMOR FREE,451.0,0.0,451.0,0.0,451.0,0.0,451.0
TCGA-EJ-A6RA-01,TCGA-EJ-A6RA,PRAD,70.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-25679.0,Alive,TUMOR FREE,353.0,0.0,353.0,0.0,353.0,1.0,353.0
TCGA-EJ-A6RC-01,TCGA-EJ-A6RC,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-23598.0,Alive,TUMOR FREE,873.0,0.0,873.0,0.0,873.0,0.0,873.0
TCGA-EJ-A7NF-01,TCGA-EJ-A7NF,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-20587.0,Alive,TUMOR FREE,250.0,0.0,250.0,0.0,250.0,0.0,250.0
TCGA-EJ-A7NG-01,TCGA-EJ-A7NG,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23458.0,Alive,TUMOR FREE,432.0,0.0,432.0,0.0,432.0,0.0,432.0
TCGA-EJ-A7NH-01,TCGA-EJ-A7NH,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-20734.0,Alive,TUMOR FREE,474.0,0.0,474.0,0.0,474.0,0.0,474.0
TCGA-EJ-A7NJ-01,TCGA-EJ-A7NJ,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-21748.0,Alive,TUMOR FREE,197.0,0.0,197.0,0.0,197.0,0.0,197.0
TCGA-EJ-A7NK-01,TCGA-EJ-A7NK,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-21530.0,Alive,TUMOR FREE,476.0,0.0,476.0,0.0,476.0,0.0,476.0
TCGA-EJ-A7NM-01,TCGA-EJ-A7NM,PRAD,64.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2013.0,-23603.0,Alive,TUMOR FREE,128.0,0.0,128.0,0.0,128.0,0.0,128.0
TCGA-EJ-A8FN-01,TCGA-EJ-A8FN,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-21506.0,Alive,TUMOR FREE,329.0,0.0,329.0,0.0,329.0,0.0,329.0
TCGA-EJ-A8FS-01,TCGA-EJ-A8FS,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-24380.0,Alive,TUMOR FREE,266.0,0.0,266.0,0.0,266.0,1.0,216.0
TCGA-EJ-A8FU-01,TCGA-EJ-A8FU,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23472.0,Alive,TUMOR FREE,138.0,0.0,138.0,0.0,138.0,0.0,138.0
TCGA-EL-A3CL-01,TCGA-EL-A3CL,THCA,70.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,1994.0,-25761.0,Dead,,,1.0,963.0,,963.0,0.0,963.0
TCGA-EL-A3CM-01,TCGA-EL-A3CM,THCA,64.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,1996.0,-23406.0,Dead,,,1.0,813.0,,813.0,0.0,813.0
TCGA-EL-A3CN-01,TCGA-EL-A3CN,THCA,47.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,1999.0,-17456.0,Alive,TUMOR FREE,4731.0,0.0,4731.0,0.0,4731.0,0.0,4731.0
TCGA-EL-A3CO-01,TCGA-EL-A3CO,THCA,88.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,1999.0,-32146.0,Dead,,,1.0,2973.0,,2973.0,0.0,2973.0
TCGA-EL-A3CP-01,TCGA-EL-A3CP,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),1999.0,-18298.0,Alive,TUMOR FREE,4831.0,0.0,4831.0,0.0,4831.0,0.0,4831.0
TCGA-EL-A3CR-01,TCGA-EL-A3CR,THCA,78.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-28785.0,Dead,,,1.0,233.0,,233.0,0.0,233.0
TCGA-EL-A3CS-01,TCGA-EL-A3CS,THCA,62.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-22993.0,Dead,WITH TUMOR,,1.0,1385.0,1.0,1385.0,1.0,1385.0
TCGA-EL-A3CT-01,TCGA-EL-A3CT,THCA,78.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-28597.0,Dead,,,1.0,1854.0,,1854.0,0.0,1854.0
TCGA-EL-A3CU-01,TCGA-EL-A3CU,THCA,70.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2000.0,-25881.0,Alive,TUMOR FREE,4780.0,0.0,4780.0,0.0,4780.0,0.0,4780.0
TCGA-EL-A3CV-01,TCGA-EL-A3CV,THCA,40.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-14785.0,Alive,TUMOR FREE,1154.0,0.0,1154.0,0.0,1154.0,0.0,1154.0
TCGA-EL-A3CW-01,TCGA-EL-A3CW,THCA,87.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2000.0,-31934.0,Dead,,,1.0,1734.0,,1734.0,0.0,1734.0
TCGA-EL-A3CX-01,TCGA-EL-A3CX,THCA,22.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-8344.0,Alive,TUMOR FREE,3243.0,0.0,3243.0,0.0,3243.0,0.0,3243.0
TCGA-EL-A3CY-01,TCGA-EL-A3CY,THCA,28.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2000.0,-10423.0,Alive,TUMOR FREE,127.0,0.0,127.0,0.0,127.0,0.0,127.0
TCGA-EL-A3CZ-01,TCGA-EL-A3CZ,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-13718.0,Alive,WITH TUMOR,2418.0,0.0,2418.0,0.0,2418.0,1.0,1426.0
TCGA-EL-A3D1-01,TCGA-EL-A3D1,THCA,39.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-14245.0,Alive,TUMOR FREE,2997.0,0.0,2997.0,0.0,2997.0,0.0,2997.0
TCGA-EL-A3D4-01,TCGA-EL-A3D4,THCA,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-22923.0,Alive,TUMOR FREE,2116.0,0.0,2116.0,0.0,2116.0,0.0,2116.0
TCGA-EL-A3D6-01,TCGA-EL-A3D6,THCA,51.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,1999.0,-18640.0,Alive,,3296.0,0.0,3296.0,0.0,3296.0,0.0,3296.0
TCGA-EL-A3GO-01,TCGA-EL-A3GO,THCA,31.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-11604.0,Alive,WITH TUMOR,1973.0,0.0,1973.0,0.0,1973.0,1.0,6.0
TCGA-EL-A3GP-01,TCGA-EL-A3GP,THCA,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-25696.0,Alive,,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0
TCGA-EL-A3GQ-01,TCGA-EL-A3GQ,THCA,72.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-26478.0,Alive,TUMOR FREE,1528.0,0.0,1528.0,0.0,1528.0,0.0,1528.0
TCGA-EL-A3GR-01,TCGA-EL-A3GR,THCA,31.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-11598.0,Alive,TUMOR FREE,3501.0,0.0,3501.0,0.0,3501.0,0.0,3501.0
TCGA-EL-A3GS-01,TCGA-EL-A3GS,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-13542.0,Alive,TUMOR FREE,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0
TCGA-EL-A3GU-01,TCGA-EL-A3GU,THCA,72.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-26632.0,Alive,WITH TUMOR,4137.0,0.0,4137.0,0.0,4137.0,1.0,544.0
TCGA-EL-A3GV-01,TCGA-EL-A3GV,THCA,65.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-23787.0,Alive,TUMOR FREE,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0
TCGA-EL-A3GW-01,TCGA-EL-A3GW,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-13670.0,Alive,TUMOR FREE,1527.0,0.0,1527.0,0.0,1527.0,0.0,1527.0
TCGA-EL-A3GX-01,TCGA-EL-A3GX,THCA,41.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2000.0,-15212.0,Alive,TUMOR FREE,4494.0,0.0,4494.0,0.0,4494.0,1.0,439.0
TCGA-EL-A3GY-01,TCGA-EL-A3GY,THCA,40.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-14814.0,Alive,WITH TUMOR,3076.0,0.0,3076.0,0.0,3076.0,0.0,3076.0
TCGA-EL-A3GZ-01,TCGA-EL-A3GZ,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2001.0,-12665.0,Alive,TUMOR FREE,4258.0,0.0,4258.0,0.0,4258.0,0.0,4258.0
TCGA-EL-A3H1-01,TCGA-EL-A3H1,THCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,1993.0,-24328.0,Dead,TUMOR FREE,,1.0,1500.0,0.0,1500.0,0.0,1500.0
TCGA-EL-A3H2-01,TCGA-EL-A3H2,THCA,58.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-21266.0,Dead,WITH TUMOR,,1.0,1019.0,1.0,1019.0,1.0,1019.0
TCGA-EL-A3H3-01,TCGA-EL-A3H3,THCA,19.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-7000.0,Alive,TUMOR FREE,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0
TCGA-EL-A3H4-01,TCGA-EL-A3H4,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-16944.0,Alive,TUMOR FREE,1512.0,0.0,1512.0,0.0,1512.0,0.0,1512.0
TCGA-EL-A3H5-01,TCGA-EL-A3H5,THCA,57.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-20926.0,Alive,TUMOR FREE,2542.0,0.0,2542.0,0.0,2542.0,0.0,2542.0
TCGA-EL-A3H7-01,TCGA-EL-A3H7,THCA,36.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-13407.0,Alive,TUMOR FREE,4228.0,0.0,4228.0,0.0,4228.0,0.0,4228.0
TCGA-EL-A3H8-01,TCGA-EL-A3H8,THCA,35.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-12992.0,Alive,TUMOR FREE,4577.0,0.0,4577.0,0.0,4577.0,0.0,4577.0
TCGA-EL-A3MW-01,TCGA-EL-A3MW,THCA,55.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2003.0,-20186.0,Alive,TUMOR FREE,3305.0,0.0,3305.0,0.0,3305.0,0.0,3305.0
TCGA-EL-A3MX-01,TCGA-EL-A3MX,THCA,66.0,FEMALE,WHITE,Stage IVC,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-24178.0,Dead,WITH TUMOR,,1.0,1753.0,1.0,1753.0,1.0,1708.0
TCGA-EL-A3MY-01,TCGA-EL-A3MY,THCA,81.0,MALE,WHITE,Stage IVC,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-29706.0,Dead,WITH TUMOR,,1.0,533.0,1.0,533.0,1.0,533.0
TCGA-EL-A3MZ-01,TCGA-EL-A3MZ,THCA,66.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,1998.0,-24208.0,Dead,TUMOR FREE,,1.0,1597.0,0.0,1597.0,0.0,1597.0
TCGA-EL-A3N2-01,TCGA-EL-A3N2,THCA,24.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-8989.0,Alive,TUMOR FREE,902.0,0.0,902.0,0.0,902.0,0.0,902.0
TCGA-EL-A3N3-01,TCGA-EL-A3N3,THCA,53.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2000.0,-19513.0,Alive,TUMOR FREE,5423.0,0.0,5423.0,0.0,5423.0,0.0,5423.0
TCGA-EL-A3T0-01,TCGA-EL-A3T0,THCA,45.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2001.0,-16798.0,Alive,TUMOR FREE,4335.0,0.0,4335.0,0.0,4335.0,0.0,4335.0
TCGA-EL-A3T1-01,TCGA-EL-A3T1,THCA,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-14025.0,Alive,TUMOR FREE,3941.0,0.0,3941.0,0.0,3941.0,0.0,3941.0
TCGA-EL-A3T2-01,TCGA-EL-A3T2,THCA,55.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-20403.0,Alive,WITH TUMOR,988.0,0.0,988.0,0.0,988.0,1.0,903.0
TCGA-EL-A3T3-01,TCGA-EL-A3T3,THCA,63.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-23043.0,Alive,TUMOR FREE,4017.0,0.0,4017.0,0.0,4017.0,0.0,4017.0
TCGA-EL-A3T6-01,TCGA-EL-A3T6,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2003.0,-12777.0,Alive,TUMOR FREE,2988.0,0.0,2988.0,0.0,2988.0,0.0,2988.0
TCGA-EL-A3T7-01,TCGA-EL-A3T7,THCA,47.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-17302.0,Alive,TUMOR FREE,1256.0,0.0,1256.0,0.0,1256.0,0.0,1256.0
TCGA-EL-A3T8-01,TCGA-EL-A3T8,THCA,36.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-13290.0,Alive,TUMOR FREE,3269.0,0.0,3269.0,0.0,3269.0,0.0,3269.0
TCGA-EL-A3T9-01,TCGA-EL-A3T9,THCA,69.0,FEMALE,WHITE,Stage IV,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-25484.0,Dead,WITH TUMOR,,1.0,174.0,1.0,174.0,1.0,174.0
TCGA-EL-A3TA-01,TCGA-EL-A3TA,THCA,42.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-15366.0,Alive,TUMOR FREE,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0
TCGA-EL-A3TB-01,TCGA-EL-A3TB,THCA,47.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-17195.0,Alive,TUMOR FREE,2519.0,0.0,2519.0,0.0,2519.0,0.0,2519.0
TCGA-EL-A3ZG-01,TCGA-EL-A3ZG,THCA,15.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-5612.0,Alive,TUMOR FREE,2724.0,0.0,2724.0,0.0,2724.0,0.0,2724.0
TCGA-EL-A3ZH-01,TCGA-EL-A3ZH,THCA,42.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-15685.0,Alive,TUMOR FREE,2773.0,0.0,2773.0,0.0,2773.0,0.0,2773.0
TCGA-EL-A3ZK-01,TCGA-EL-A3ZK,THCA,41.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-15121.0,Alive,TUMOR FREE,1575.0,0.0,1575.0,0.0,1575.0,0.0,1575.0
TCGA-EL-A3ZL-01,TCGA-EL-A3ZL,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-12649.0,Alive,TUMOR FREE,1895.0,0.0,1895.0,0.0,1895.0,0.0,1895.0
TCGA-EL-A3ZN-01,TCGA-EL-A3ZN,THCA,28.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-10266.0,Alive,TUMOR FREE,1614.0,0.0,1614.0,0.0,1614.0,0.0,1614.0
TCGA-EL-A3ZO-01,TCGA-EL-A3ZO,THCA,79.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-28924.0,Alive,TUMOR FREE,2211.0,0.0,2211.0,0.0,2211.0,0.0,2211.0
TCGA-EL-A3ZP-01,TCGA-EL-A3ZP,THCA,19.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-7101.0,Alive,TUMOR FREE,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0
TCGA-EL-A3ZQ-01,TCGA-EL-A3ZQ,THCA,78.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-28783.0,Alive,TUMOR FREE,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0
TCGA-EL-A3ZR-01,TCGA-EL-A3ZR,THCA,46.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-16852.0,Alive,TUMOR FREE,1830.0,0.0,1830.0,0.0,1830.0,0.0,1830.0
TCGA-EL-A3ZS-01,TCGA-EL-A3ZS,THCA,22.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-8076.0,Alive,TUMOR FREE,215.0,0.0,215.0,0.0,215.0,0.0,215.0
TCGA-EL-A3ZT-01,TCGA-EL-A3ZT,THCA,35.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-13103.0,Alive,TUMOR FREE,1808.0,0.0,1808.0,0.0,1808.0,0.0,1808.0
TCGA-EL-A4JV-01,TCGA-EL-A4JV,THCA,41.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-15065.0,Alive,TUMOR FREE,1748.0,0.0,1748.0,0.0,1748.0,0.0,1748.0
TCGA-EL-A4JW-01,TCGA-EL-A4JW,THCA,38.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-13928.0,Alive,TUMOR FREE,1056.0,0.0,1056.0,0.0,1056.0,0.0,1056.0
TCGA-EL-A4JX-01,TCGA-EL-A4JX,THCA,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-11465.0,Alive,TUMOR FREE,1398.0,0.0,1398.0,0.0,1398.0,0.0,1398.0
TCGA-EL-A4JZ-01,TCGA-EL-A4JZ,THCA,55.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-20290.0,Alive,TUMOR FREE,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0
TCGA-EL-A4K1-01,TCGA-EL-A4K1,THCA,68.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-24846.0,Alive,TUMOR FREE,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0
TCGA-EL-A4K2-01,TCGA-EL-A4K2,THCA,43.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-15962.0,Alive,TUMOR FREE,928.0,0.0,928.0,0.0,928.0,0.0,928.0
TCGA-EL-A4K4-01,TCGA-EL-A4K4,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-12368.0,Alive,WITH TUMOR,1623.0,0.0,1623.0,0.0,1623.0,0.0,1623.0
TCGA-EL-A4K6-01,TCGA-EL-A4K6,THCA,75.0,MALE,WHITE,Stage IV,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-27416.0,Alive,WITH TUMOR,1343.0,0.0,1343.0,0.0,1343.0,1.0,874.0
TCGA-EL-A4K7-01,TCGA-EL-A4K7,THCA,74.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-27306.0,Alive,TUMOR FREE,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0
TCGA-EL-A4K9-01,TCGA-EL-A4K9,THCA,68.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-24980.0,Alive,TUMOR FREE,1455.0,0.0,1455.0,0.0,1455.0,0.0,1455.0
TCGA-EL-A4KD-01,TCGA-EL-A4KD,THCA,41.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-15291.0,Alive,TUMOR FREE,1326.0,0.0,1326.0,0.0,1326.0,0.0,1326.0
TCGA-EL-A4KG-01,TCGA-EL-A4KG,THCA,35.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-12978.0,Alive,TUMOR FREE,739.0,0.0,739.0,0.0,739.0,0.0,739.0
TCGA-EL-A4KH-01,TCGA-EL-A4KH,THCA,36.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-13275.0,Alive,TUMOR FREE,823.0,0.0,823.0,0.0,823.0,0.0,823.0
TCGA-EL-A4KI-01,TCGA-EL-A4KI,THCA,63.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-23182.0,Alive,WITH TUMOR,727.0,0.0,727.0,0.0,727.0,1.0,265.0
TCGA-EM-A1CT-01,TCGA-EM-A1CT,THCA,76.0,MALE,,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-27944.0,Alive,TUMOR FREE,553.0,0.0,553.0,0.0,553.0,0.0,553.0
TCGA-EM-A1CU-01,TCGA-EM-A1CU,THCA,31.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-11470.0,Alive,TUMOR FREE,636.0,0.0,636.0,0.0,636.0,0.0,636.0
TCGA-EM-A1CV-01,TCGA-EM-A1CV,THCA,32.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-11932.0,Alive,TUMOR FREE,1475.0,0.0,1475.0,0.0,1475.0,0.0,1475.0
TCGA-EM-A1CW-01,TCGA-EM-A1CW,THCA,39.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-14263.0,Alive,TUMOR FREE,549.0,0.0,549.0,0.0,549.0,0.0,549.0
TCGA-EM-A1YA-01,TCGA-EM-A1YA,THCA,74.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-27224.0,Alive,TUMOR FREE,602.0,0.0,602.0,0.0,602.0,0.0,602.0
TCGA-EM-A1YB-01,TCGA-EM-A1YB,THCA,73.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-26852.0,Alive,TUMOR FREE,592.0,0.0,592.0,0.0,592.0,0.0,592.0
TCGA-EM-A1YC-01,TCGA-EM-A1YC,THCA,71.0,FEMALE,,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-26143.0,Alive,TUMOR FREE,2391.0,0.0,2391.0,0.0,2391.0,0.0,2391.0
TCGA-EM-A1YD-01,TCGA-EM-A1YD,THCA,53.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-19366.0,Alive,TUMOR FREE,1734.0,0.0,1734.0,0.0,1734.0,0.0,1734.0
TCGA-EM-A1YE-01,TCGA-EM-A1YE,THCA,47.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-17297.0,Alive,TUMOR FREE,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0
TCGA-EM-A22I-01,TCGA-EM-A22I,THCA,52.0,FEMALE,,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19003.0,Alive,TUMOR FREE,448.0,0.0,448.0,0.0,448.0,0.0,448.0
TCGA-EM-A22J-01,TCGA-EM-A22J,THCA,56.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-20539.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-EM-A22L-01,TCGA-EM-A22L,THCA,33.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-12092.0,Alive,TUMOR FREE,318.0,0.0,318.0,0.0,318.0,0.0,318.0
TCGA-EM-A22M-01,TCGA-EM-A22M,THCA,52.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19059.0,Alive,TUMOR FREE,442.0,0.0,442.0,0.0,442.0,0.0,442.0
TCGA-EM-A22O-01,TCGA-EM-A22O,THCA,75.0,MALE,ASIAN,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-27758.0,Alive,TUMOR FREE,1344.0,0.0,1344.0,0.0,1344.0,0.0,1344.0
TCGA-EM-A22Q-01,TCGA-EM-A22Q,THCA,36.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-13341.0,Alive,TUMOR FREE,433.0,0.0,433.0,0.0,433.0,0.0,433.0
TCGA-EM-A2CJ-01,TCGA-EM-A2CJ,THCA,49.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-18168.0,Alive,TUMOR FREE,1447.0,0.0,1447.0,0.0,1447.0,0.0,1447.0
TCGA-EM-A2CK-01,TCGA-EM-A2CK,THCA,28.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-10485.0,Alive,TUMOR FREE,544.0,0.0,544.0,0.0,544.0,0.0,544.0
TCGA-EM-A2CL-01,TCGA-EM-A2CL,THCA,31.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-11649.0,Alive,TUMOR FREE,401.0,0.0,401.0,0.0,401.0,0.0,401.0
TCGA-EM-A2CN-01,TCGA-EM-A2CN,THCA,62.0,MALE,,Stage IVC,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-22817.0,Alive,WITH TUMOR,715.0,0.0,715.0,0.0,715.0,0.0,715.0
TCGA-EM-A2CO-01,TCGA-EM-A2CO,THCA,77.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-28424.0,Alive,TUMOR FREE,184.0,0.0,184.0,0.0,184.0,0.0,184.0
TCGA-EM-A2CP-01,TCGA-EM-A2CP,THCA,26.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-9759.0,Alive,TUMOR FREE,91.0,0.0,91.0,0.0,91.0,0.0,91.0
TCGA-EM-A2CQ-01,TCGA-EM-A2CQ,THCA,40.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-14776.0,Alive,TUMOR FREE,374.0,0.0,374.0,0.0,374.0,0.0,374.0
TCGA-EM-A2CR-01,TCGA-EM-A2CR,THCA,46.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-16807.0,Alive,TUMOR FREE,415.0,0.0,415.0,0.0,415.0,0.0,415.0
TCGA-EM-A2CS-01,TCGA-EM-A2CS,THCA,51.0,FEMALE,,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-18990.0,Alive,WITH TUMOR,841.0,0.0,841.0,0.0,841.0,0.0,841.0
TCGA-EM-A2CU-01,TCGA-EM-A2CU,THCA,47.0,FEMALE,,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-17231.0,Alive,WITH TUMOR,400.0,0.0,400.0,0.0,400.0,0.0,400.0
TCGA-EM-A2OV-01,TCGA-EM-A2OV,THCA,64.0,FEMALE,ASIAN,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-23656.0,Alive,TUMOR FREE,674.0,0.0,674.0,0.0,674.0,0.0,674.0
TCGA-EM-A2OY-01,TCGA-EM-A2OY,THCA,46.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-17075.0,Alive,TUMOR FREE,983.0,0.0,983.0,0.0,983.0,0.0,983.0
TCGA-EM-A2P1-01,TCGA-EM-A2P1,THCA,33.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-12320.0,Alive,WITH TUMOR,531.0,0.0,531.0,0.0,531.0,1.0,363.0
TCGA-EM-A3AI-01,TCGA-EM-A3AI,THCA,67.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2010.0,-24820.0,Alive,TUMOR FREE,685.0,0.0,685.0,0.0,685.0,0.0,685.0
TCGA-EM-A3AJ-01,TCGA-EM-A3AJ,THCA,39.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-14399.0,Alive,TUMOR FREE,941.0,0.0,941.0,0.0,941.0,0.0,941.0
TCGA-EM-A3AL-01,TCGA-EM-A3AL,THCA,45.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-16439.0,Alive,TUMOR FREE,430.0,0.0,430.0,0.0,430.0,0.0,430.0
TCGA-EM-A3AN-01,TCGA-EM-A3AN,THCA,36.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-13188.0,Alive,TUMOR FREE,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0
TCGA-EM-A3AO-01,TCGA-EM-A3AO,THCA,61.0,MALE,,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-22347.0,Alive,TUMOR FREE,1354.0,0.0,1354.0,0.0,1354.0,0.0,1354.0
TCGA-EM-A3AP-01,TCGA-EM-A3AP,THCA,31.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-11592.0,Alive,TUMOR FREE,254.0,0.0,254.0,0.0,254.0,0.0,254.0
TCGA-EM-A3FJ-01,TCGA-EM-A3FJ,THCA,24.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-9042.0,Alive,TUMOR FREE,850.0,0.0,850.0,0.0,850.0,0.0,850.0
TCGA-EM-A3FL-01,TCGA-EM-A3FL,THCA,63.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-23183.0,Alive,TUMOR FREE,1441.0,0.0,1441.0,0.0,1441.0,0.0,1441.0
TCGA-EM-A3FN-01,TCGA-EM-A3FN,THCA,42.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-15655.0,Alive,TUMOR FREE,367.0,0.0,367.0,0.0,367.0,0.0,367.0
TCGA-EM-A3FO-01,TCGA-EM-A3FO,THCA,40.0,MALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14864.0,Alive,TUMOR FREE,532.0,0.0,532.0,0.0,532.0,0.0,532.0
TCGA-EM-A3FP-01,TCGA-EM-A3FP,THCA,71.0,FEMALE,,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-26158.0,Alive,TUMOR FREE,529.0,0.0,529.0,0.0,529.0,0.0,529.0
TCGA-EM-A3O3-01,TCGA-EM-A3O3,THCA,83.0,FEMALE,[Unknown],Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-30500.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-EM-A3O6-01,TCGA-EM-A3O6,THCA,54.0,FEMALE,[Unknown],Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-19856.0,Alive,TUMOR FREE,458.0,0.0,458.0,0.0,458.0,0.0,458.0
TCGA-EM-A3O7-01,TCGA-EM-A3O7,THCA,46.0,FEMALE,[Unknown],Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-16842.0,Alive,TUMOR FREE,223.0,0.0,223.0,0.0,223.0,0.0,223.0
TCGA-EM-A3O9-01,TCGA-EM-A3O9,THCA,40.0,MALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-14783.0,Alive,TUMOR FREE,281.0,0.0,281.0,0.0,281.0,0.0,281.0
TCGA-EM-A3ST-01,TCGA-EM-A3ST,THCA,62.0,FEMALE,[Unknown],Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-22990.0,Alive,WITH TUMOR,1182.0,0.0,1182.0,0.0,1182.0,1.0,966.0
TCGA-EM-A3SU-01,TCGA-EM-A3SU,THCA,43.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15768.0,Alive,TUMOR FREE,911.0,0.0,911.0,0.0,911.0,0.0,911.0
TCGA-EM-A3SX-01,TCGA-EM-A3SX,THCA,28.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-10447.0,Alive,WITH TUMOR,908.0,0.0,908.0,0.0,908.0,0.0,908.0
TCGA-EM-A3SY-01,TCGA-EM-A3SY,THCA,36.0,MALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-13461.0,Alive,TUMOR FREE,411.0,0.0,411.0,0.0,411.0,0.0,411.0
TCGA-EM-A3SZ-01,TCGA-EM-A3SZ,THCA,42.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15659.0,Alive,TUMOR FREE,389.0,0.0,389.0,0.0,389.0,0.0,389.0
TCGA-EM-A4FH-01,TCGA-EM-A4FH,THCA,69.0,MALE,[Unknown],Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-25500.0,Alive,TUMOR FREE,892.0,0.0,892.0,0.0,892.0,0.0,892.0
TCGA-EM-A4G1-01,TCGA-EM-A4G1,THCA,26.0,FEMALE,[Unknown],Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-9844.0,Alive,TUMOR FREE,416.0,0.0,416.0,0.0,416.0,0.0,416.0
TCGA-EO-A1Y7-01,TCGA-EO-A1Y7,UCEC,65.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2010.0,-24085.0,Alive,WITH TUMOR,1495.0,0.0,1495.0,0.0,1495.0,1.0,880.0
TCGA-EO-A22U-01,TCGA-EO-A22U,UCEC,83.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-30557.0,Alive,TUMOR FREE,1407.0,0.0,1407.0,0.0,1407.0,0.0,1407.0
TCGA-EO-A22X-01,TCGA-EO-A22X,UCEC,36.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2008.0,-13245.0,Alive,TUMOR FREE,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0
TCGA-EO-A22Y-01,TCGA-EO-A22Y,UCEC,68.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2009.0,-25127.0,Alive,TUMOR FREE,1567.0,0.0,1567.0,0.0,1567.0,0.0,1567.0
TCGA-EO-A3AU-01,TCGA-EO-A3AU,UCEC,72.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2010.0,-26406.0,Alive,TUMOR FREE,1543.0,0.0,1543.0,0.0,1543.0,1.0,1178.0
TCGA-EO-A3AV-01,TCGA-EO-A3AV,UCEC,51.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2010.0,-18713.0,Alive,TUMOR FREE,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0
TCGA-EO-A3AY-01,TCGA-EO-A3AY,UCEC,58.0,FEMALE,,,Endometrioid endometrial adenocarcinoma,2011.0,-21291.0,Alive,WITH TUMOR,1158.0,0.0,1158.0,0.0,1158.0,1.0,1163.0
TCGA-EO-A3AZ-01,TCGA-EO-A3AZ,UCEC,80.0,FEMALE,,,Mixed serous and endometrioid,2011.0,-29234.0,Alive,TUMOR FREE,826.0,0.0,826.0,0.0,826.0,0.0,826.0
TCGA-EO-A3B0-01,TCGA-EO-A3B0,UCEC,43.0,FEMALE,ASIAN,,Endometrioid endometrial adenocarcinoma,2011.0,-15954.0,Alive,TUMOR FREE,1412.0,0.0,1412.0,0.0,1412.0,0.0,1412.0
TCGA-EO-A3B1-01,TCGA-EO-A3B1,UCEC,63.0,FEMALE,,,Serous endometrial adenocarcinoma,2011.0,-23162.0,Alive,TUMOR FREE,820.0,0.0,820.0,0.0,820.0,0.0,820.0
TCGA-EO-A3KU-01,TCGA-EO-A3KU,UCEC,68.0,FEMALE,,,Serous endometrial adenocarcinoma,2011.0,-25116.0,Alive,TUMOR FREE,677.0,0.0,677.0,0.0,677.0,0.0,677.0
TCGA-EO-A3KW-01,TCGA-EO-A3KW,UCEC,72.0,FEMALE,,,Serous endometrial adenocarcinoma,2011.0,-26492.0,Alive,TUMOR FREE,497.0,0.0,497.0,0.0,497.0,0.0,497.0
TCGA-EO-A3KX-01,TCGA-EO-A3KX,UCEC,80.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-29260.0,Alive,TUMOR FREE,1170.0,0.0,1170.0,0.0,1170.0,0.0,1170.0
TCGA-EO-A3L0-01,TCGA-EO-A3L0,UCEC,76.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-28003.0,Alive,TUMOR FREE,1554.0,0.0,1554.0,0.0,1554.0,0.0,1554.0
TCGA-EP-A12J-01,TCGA-EP-A12J,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2010.0,-22997.0,Alive,TUMOR FREE,570.0,0.0,570.0,0.0,570.0,0.0,570.0
TCGA-EP-A26S-01,TCGA-EP-A26S,LIHC,70.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-25677.0,Alive,TUMOR FREE,608.0,0.0,608.0,0.0,608.0,0.0,608.0
TCGA-EP-A2KA-01,TCGA-EP-A2KA,LIHC,52.0,FEMALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2011.0,-19214.0,Dead,WITH TUMOR,,1.0,627.0,1.0,627.0,1.0,293.0
TCGA-EP-A2KB-01,TCGA-EP-A2KB,LIHC,46.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-16835.0,Dead,WITH TUMOR,,1.0,596.0,1.0,596.0,1.0,161.0
TCGA-EP-A2KC-01,TCGA-EP-A2KC,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2011.0,-22677.0,Dead,TUMOR FREE,,1.0,19.0,0.0,19.0,0.0,19.0
TCGA-EP-A3JL-01,TCGA-EP-A3JL,LIHC,76.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-27886.0,Alive,TUMOR FREE,303.0,0.0,303.0,0.0,303.0,0.0,303.0
TCGA-EP-A3RK-01,TCGA-EP-A3RK,LIHC,73.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2012.0,-26985.0,Alive,WITH TUMOR,363.0,0.0,363.0,0.0,363.0,1.0,320.0
TCGA-EQ-8122-01,TCGA-EQ-8122,STAD,71.0,FEMALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-26289.0,Dead,,,1.0,243.0,,243.0,0.0,243.0
TCGA-EQ-A4SO-01,TCGA-EQ-A4SO,STAD,70.0,MALE,WHITE,Stage IIIB,[Discrepancy],2012.0,-25897.0,Alive,TUMOR FREE,494.0,0.0,494.0,0.0,494.0,0.0,494.0
TCGA-ER-A194-01,TCGA-ER-A194,SKCM,77.0,MALE,WHITE,,,2005.0,-28175.0,Dead,WITH TUMOR,,1.0,1354.0,1.0,1354.0,1.0,1354.0
TCGA-ER-A196-01,TCGA-ER-A196,SKCM,64.0,FEMALE,WHITE,Stage IIC,,2007.0,-23533.0,Alive,TUMOR FREE,1785.0,0.0,1785.0,0.0,1785.0,0.0,1785.0
TCGA-ER-A19K-01,TCGA-ER-A19K,SKCM,79.0,FEMALE,WHITE,Stage IIC,,2006.0,-28916.0,Dead,WITH TUMOR,,1.0,469.0,1.0,469.0,1.0,211.0
TCGA-ER-A19T-01,TCGA-ER-A19T,SKCM,51.0,MALE,WHITE,Stage IV,,2006.0,-18732.0,Dead,WITH TUMOR,,1.0,270.0,1.0,270.0,1.0,118.0
TCGA-ER-A2NB-01,TCGA-ER-A2NB,SKCM,57.0,MALE,WHITE,Stage IIIB,,2010.0,-20938.0,Dead,WITH TUMOR,,1.0,857.0,1.0,857.0,1.0,461.0
TCGA-ER-A2NF-01,TCGA-ER-A2NF,SKCM,53.0,MALE,WHITE,Stage IIIB,,2010.0,-19499.0,Dead,WITH TUMOR,,1.0,877.0,1.0,877.0,1.0,230.0
TCGA-ER-A42H-01,TCGA-ER-A42H,SKCM,76.0,MALE,WHITE,,,2010.0,-28110.0,Dead,WITH TUMOR,,1.0,426.0,1.0,426.0,1.0,259.0
TCGA-ES-A2HS-01,TCGA-ES-A2HS,LIHC,80.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2008.0,-29268.0,Dead,TUMOR FREE,,1.0,688.0,0.0,688.0,0.0,688.0
TCGA-ES-A2HT-01,TCGA-ES-A2HT,LIHC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2007.0,-20023.0,Dead,TUMOR FREE,,1.0,438.0,0.0,438.0,0.0,438.0
TCGA-ET-A25G-01,TCGA-ET-A25G,THCA,56.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2008.0,-20816.0,Alive,TUMOR FREE,2492.0,0.0,2492.0,0.0,2492.0,0.0,2492.0
TCGA-ET-A25O-01,TCGA-ET-A25O,THCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-12924.0,Alive,TUMOR FREE,1986.0,0.0,1986.0,0.0,1986.0,0.0,1986.0
TCGA-ET-A2MX-01,TCGA-ET-A2MX,THCA,27.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-10044.0,Alive,TUMOR FREE,2689.0,0.0,2689.0,0.0,2689.0,0.0,2689.0
TCGA-ET-A2MY-01,TCGA-ET-A2MY,THCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-26406.0,Alive,TUMOR FREE,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0
TCGA-ET-A2MZ-01,TCGA-ET-A2MZ,THCA,39.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-14408.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0
TCGA-ET-A2N0-01,TCGA-ET-A2N0,THCA,51.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-18692.0,Alive,TUMOR FREE,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0
TCGA-ET-A2N3-01,TCGA-ET-A2N3,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2008.0,-12603.0,Alive,TUMOR FREE,2535.0,0.0,2535.0,0.0,2535.0,0.0,2535.0
TCGA-ET-A2N4-01,TCGA-ET-A2N4,THCA,53.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2008.0,-19671.0,Alive,TUMOR FREE,81.0,0.0,81.0,0.0,81.0,0.0,81.0
TCGA-ET-A2N5-01,TCGA-ET-A2N5,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2008.0,-17137.0,Alive,TUMOR FREE,2460.0,0.0,2460.0,0.0,2460.0,0.0,2460.0
TCGA-ET-A39I-01,TCGA-ET-A39I,THCA,83.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-30349.0,Dead,TUMOR FREE,,1.0,1011.0,0.0,1011.0,0.0,1011.0
TCGA-ET-A39J-01,TCGA-ET-A39J,THCA,23.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-8491.0,Alive,TUMOR FREE,3227.0,0.0,3227.0,0.0,3227.0,0.0,3227.0
TCGA-ET-A39L-01,TCGA-ET-A39L,THCA,20.0,FEMALE,,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-7636.0,Alive,TUMOR FREE,3299.0,0.0,3299.0,0.0,3299.0,0.0,3299.0
TCGA-ET-A39M-01,TCGA-ET-A39M,THCA,34.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-12441.0,Alive,TUMOR FREE,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0
TCGA-ET-A39N-01,TCGA-ET-A39N,THCA,35.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-12904.0,Alive,TUMOR FREE,3751.0,0.0,3751.0,0.0,3751.0,0.0,3751.0
TCGA-ET-A39P-01,TCGA-ET-A39P,THCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-26817.0,Alive,TUMOR FREE,2900.0,0.0,2900.0,0.0,2900.0,0.0,2900.0
TCGA-ET-A39R-01,TCGA-ET-A39R,THCA,24.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-8828.0,Alive,TUMOR FREE,2863.0,0.0,2863.0,0.0,2863.0,0.0,2863.0
TCGA-ET-A39T-01,TCGA-ET-A39T,THCA,55.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2006.0,-20164.0,Alive,TUMOR FREE,2987.0,0.0,2987.0,0.0,2987.0,0.0,2987.0
TCGA-ET-A3BN-01,TCGA-ET-A3BN,THCA,33.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-12122.0,Alive,TUMOR FREE,859.0,0.0,859.0,0.0,859.0,0.0,859.0
TCGA-ET-A3BP-01,TCGA-ET-A3BP,THCA,34.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-12594.0,Alive,TUMOR FREE,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0
TCGA-ET-A3BS-01,TCGA-ET-A3BS,THCA,42.0,MALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-15421.0,Alive,TUMOR FREE,176.0,0.0,176.0,0.0,176.0,0.0,176.0
TCGA-ET-A3BT-01,TCGA-ET-A3BT,THCA,60.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2007.0,-22108.0,Alive,TUMOR FREE,2665.0,0.0,2665.0,0.0,2665.0,1.0,267.0
TCGA-ET-A3BU-01,TCGA-ET-A3BU,THCA,28.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-10510.0,Alive,TUMOR FREE,2367.0,0.0,2367.0,0.0,2367.0,0.0,2367.0
TCGA-ET-A3BV-01,TCGA-ET-A3BV,THCA,47.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-17441.0,Alive,TUMOR FREE,2294.0,0.0,2294.0,0.0,2294.0,1.0,1204.0
TCGA-ET-A3BW-01,TCGA-ET-A3BW,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-11032.0,Alive,TUMOR FREE,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0
TCGA-ET-A3BX-01,TCGA-ET-A3BX,THCA,24.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-8791.0,Alive,TUMOR FREE,1596.0,0.0,1596.0,0.0,1596.0,0.0,1596.0
TCGA-ET-A3DO-01,TCGA-ET-A3DO,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-12158.0,Alive,TUMOR FREE,3552.0,0.0,3552.0,0.0,3552.0,1.0,570.0
TCGA-ET-A3DP-01,TCGA-ET-A3DP,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-15876.0,Alive,TUMOR FREE,2877.0,0.0,2877.0,0.0,2877.0,0.0,2877.0
TCGA-ET-A3DS-01,TCGA-ET-A3DS,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-12252.0,Alive,TUMOR FREE,2033.0,0.0,2033.0,0.0,2033.0,0.0,2033.0
TCGA-ET-A3DT-01,TCGA-ET-A3DT,THCA,23.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-8761.0,Alive,TUMOR FREE,1330.0,0.0,1330.0,0.0,1330.0,0.0,1330.0
TCGA-ET-A3DV-01,TCGA-ET-A3DV,THCA,68.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2001.0,-24905.0,Alive,TUMOR FREE,5068.0,0.0,5068.0,0.0,5068.0,0.0,5068.0
TCGA-ET-A3DW-01,TCGA-ET-A3DW,THCA,64.0,MALE,ASIAN,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2003.0,-23603.0,Alive,TUMOR FREE,752.0,0.0,752.0,0.0,752.0,0.0,752.0
TCGA-ET-A40P-01,TCGA-ET-A40P,THCA,32.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-11843.0,Alive,TUMOR FREE,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0
TCGA-ET-A40Q-01,TCGA-ET-A40Q,THCA,38.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2011.0,-14136.0,Alive,TUMOR FREE,1407.0,0.0,1407.0,0.0,1407.0,1.0,218.0
TCGA-ET-A4KN-01,TCGA-ET-A4KN,THCA,51.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2012.0,-18889.0,Alive,TUMOR FREE,1009.0,0.0,1009.0,0.0,1009.0,0.0,1009.0
TCGA-ET-A4KQ-01,TCGA-ET-A4KQ,THCA,45.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-16685.0,Alive,TUMOR FREE,955.0,0.0,955.0,0.0,955.0,0.0,955.0
TCGA-EU-5904-01,TCGA-EU-5904,KIRC,47.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2009.0,-17468.0,Alive,TUMOR FREE,551.0,0.0,551.0,0.0,551.0,0.0,551.0
TCGA-EU-5905-01,TCGA-EU-5905,KIRC,67.0,FEMALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-24475.0,Alive,TUMOR FREE,119.0,0.0,119.0,0.0,119.0,0.0,119.0
TCGA-EU-5906-01,TCGA-EU-5906,KIRC,55.0,MALE,WHITE,Stage I,Kidney Clear Cell Renal Carcinoma,2010.0,-20246.0,Alive,TUMOR FREE,206.0,0.0,206.0,0.0,206.0,0.0,206.0
TCGA-EU-5907-01,TCGA-EU-5907,KIRC,81.0,MALE,WHITE,Stage III,Kidney Clear Cell Renal Carcinoma,2010.0,-29863.0,Alive,TUMOR FREE,127.0,0.0,127.0,0.0,127.0,0.0,127.0
TCGA-EV-5901-01,TCGA-EV-5901,KIRP,47.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-17275.0,Alive,TUMOR FREE,1040.0,0.0,1040.0,0.0,1040.0,0.0,1040.0
TCGA-EV-5902-01,TCGA-EV-5902,KIRP,58.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-21344.0,Alive,TUMOR FREE,578.0,0.0,578.0,0.0,578.0,0.0,578.0
TCGA-EV-5903-01,TCGA-EV-5903,KIRP,57.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-20888.0,Alive,TUMOR FREE,757.0,0.0,757.0,0.0,757.0,0.0,757.0
TCGA-EW-A1IX-01,TCGA-EW-A1IX,BRCA,48.0,FEMALE,ASIAN,Stage IIA,"Other, specify",2008.0,-17597.0,Alive,TUMOR FREE,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0
TCGA-EW-A1IZ-01,TCGA-EW-A1IZ,BRCA,53.0,FEMALE,WHITE,Stage IIIA,Infiltrating Ductal Carcinoma,2010.0,-19706.0,Alive,TUMOR FREE,554.0,0.0,554.0,0.0,554.0,0.0,554.0
TCGA-EW-A1J1-01,TCGA-EW-A1J1,BRCA,38.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-14122.0,Alive,TUMOR FREE,575.0,0.0,575.0,0.0,575.0,0.0,575.0
TCGA-EW-A1J3-01,TCGA-EW-A1J3,BRCA,61.0,FEMALE,WHITE,Stage IA,Infiltrating Lobular Carcinoma,2010.0,-22332.0,Alive,TUMOR FREE,504.0,0.0,504.0,0.0,504.0,0.0,504.0
TCGA-EW-A1J5-01,TCGA-EW-A1J5,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2010.0,-21559.0,Alive,TUMOR FREE,477.0,0.0,477.0,0.0,477.0,0.0,477.0
TCGA-EW-A1OV-01,TCGA-EW-A1OV,BRCA,56.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-20764.0,Alive,TUMOR FREE,789.0,0.0,789.0,0.0,789.0,0.0,789.0
TCGA-EW-A1OX-01,TCGA-EW-A1OX,BRCA,43.0,FEMALE,WHITE,Stage IIA,Mucinous Carcinoma,2009.0,-15837.0,Alive,TUMOR FREE,911.0,0.0,911.0,0.0,911.0,0.0,911.0
TCGA-EW-A1OZ-01,TCGA-EW-A1OZ,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-20664.0,Alive,TUMOR FREE,1229.0,0.0,1229.0,0.0,1229.0,0.0,1229.0
TCGA-EW-A1P0-01,TCGA-EW-A1P0,BRCA,55.0,FEMALE,WHITE,Stage IIB,"Other, specify",2008.0,-20107.0,Alive,TUMOR FREE,1251.0,0.0,1251.0,0.0,1251.0,1.0,1094.0
TCGA-EW-A1P1-01,TCGA-EW-A1P1,BRCA,68.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2008.0,-24923.0,Alive,TUMOR FREE,1210.0,0.0,1210.0,0.0,1210.0,1.0,1014.0
TCGA-EW-A1P3-01,TCGA-EW-A1P3,BRCA,48.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2008.0,-17637.0,Alive,TUMOR FREE,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0
TCGA-EW-A1P4-01,TCGA-EW-A1P4,BRCA,43.0,FEMALE,WHITE,Stage IIA,Medullary Carcinoma,2009.0,-15989.0,Alive,TUMOR FREE,907.0,0.0,907.0,0.0,907.0,0.0,907.0
TCGA-EW-A1P5-01,TCGA-EW-A1P5,BRCA,77.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-28177.0,Alive,TUMOR FREE,703.0,0.0,703.0,0.0,703.0,0.0,703.0
TCGA-EW-A1P8-01,TCGA-EW-A1P8,BRCA,58.0,FEMALE,WHITE,Stage IIIC,Infiltrating Ductal Carcinoma,2010.0,-21501.0,Dead,WITH TUMOR,,1.0,239.0,1.0,239.0,1.0,207.0
TCGA-EW-A1PA-01,TCGA-EW-A1PA,BRCA,59.0,FEMALE,WHITE,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,-21837.0,Alive,TUMOR FREE,575.0,0.0,575.0,0.0,575.0,0.0,575.0
TCGA-EW-A1PB-01,TCGA-EW-A1PB,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2009.0,-25770.0,Alive,TUMOR FREE,608.0,0.0,608.0,0.0,608.0,0.0,608.0
TCGA-EW-A1PE-01,TCGA-EW-A1PE,BRCA,56.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2011.0,-20694.0,Alive,TUMOR FREE,320.0,0.0,320.0,0.0,320.0,0.0,320.0
TCGA-EW-A1PG-01,TCGA-EW-A1PG,BRCA,53.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2008.0,-19464.0,Alive,TUMOR FREE,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0
TCGA-EW-A2FR-01,TCGA-EW-A2FR,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2008.0,-21628.0,Alive,TUMOR FREE,1673.0,0.0,1673.0,0.0,1673.0,0.0,1673.0
TCGA-EW-A2FS-01,TCGA-EW-A2FS,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2008.0,-15302.0,Alive,TUMOR FREE,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0
TCGA-EW-A2FV-01,TCGA-EW-A2FV,BRCA,39.0,FEMALE,WHITE,Stage IIIC,"Other, specify",2011.0,-14316.0,Alive,TUMOR FREE,788.0,0.0,788.0,0.0,788.0,0.0,788.0
TCGA-EW-A2FW-01,TCGA-EW-A2FW,BRCA,52.0,FEMALE,WHITE,Stage IIA,"Other, specify",2011.0,-19085.0,Alive,TUMOR FREE,672.0,0.0,672.0,0.0,672.0,0.0,672.0
TCGA-EW-A423-01,TCGA-EW-A423,BRCA,75.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-27627.0,Alive,TUMOR FREE,533.0,0.0,533.0,0.0,533.0,0.0,533.0
TCGA-EW-A6S9-01,TCGA-EW-A6S9,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-12755.0,Alive,TUMOR FREE,463.0,0.0,463.0,0.0,463.0,0.0,463.0
TCGA-EW-A6SB-01,TCGA-EW-A6SB,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Infiltrating Ductal Carcinoma,2012.0,-22844.0,Alive,TUMOR FREE,760.0,0.0,760.0,0.0,760.0,0.0,760.0
TCGA-EW-A6SC-01,TCGA-EW-A6SC,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-21918.0,Alive,TUMOR FREE,952.0,0.0,952.0,0.0,952.0,0.0,952.0
TCGA-EW-A6SD-01,TCGA-EW-A6SD,BRCA,32.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2012.0,-12006.0,Alive,TUMOR FREE,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0
TCGA-EY-A1GL-01,TCGA-EY-A1GL,UCEC,51.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-18761.0,Alive,TUMOR FREE,1014.0,0.0,1014.0,0.0,1014.0,0.0,1014.0
TCGA-EY-A1GO-01,TCGA-EY-A1GO,UCEC,65.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-23853.0,Alive,WITH TUMOR,586.0,0.0,586.0,0.0,586.0,1.0,517.0
TCGA-EY-A1GP-01,TCGA-EY-A1GP,UCEC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2010.0,-20011.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-EY-A1GX-01,TCGA-EY-A1GX,UCEC,76.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-27962.0,Dead,TUMOR FREE,,1.0,1127.0,0.0,1127.0,1.0,743.0
TCGA-EY-A210-01,TCGA-EY-A210,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Mixed serous and endometrioid,2011.0,-30095.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-EY-A2ON-01,TCGA-EY-A2ON,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Serous endometrial adenocarcinoma,2011.0,-22624.0,Dead,WITH TUMOR,,1.0,610.0,1.0,610.0,1.0,226.0
TCGA-EY-A2OO-01,TCGA-EY-A2OO,UCEC,56.0,FEMALE,WHITE,,Mixed serous and endometrioid,2009.0,-20797.0,Alive,TUMOR FREE,1392.0,0.0,1392.0,0.0,1392.0,0.0,1392.0
TCGA-EY-A2OP-01,TCGA-EY-A2OP,UCEC,63.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2010.0,-23090.0,Alive,TUMOR FREE,944.0,0.0,944.0,0.0,944.0,0.0,944.0
TCGA-EY-A2OQ-01,TCGA-EY-A2OQ,UCEC,61.0,FEMALE,WHITE,,Endometrioid endometrial adenocarcinoma,2011.0,-22309.0,Alive,TUMOR FREE,885.0,0.0,885.0,0.0,885.0,0.0,885.0
TCGA-EY-A3L3-01,TCGA-EY-A3L3,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Serous endometrial adenocarcinoma,2011.0,-30138.0,Alive,TUMOR FREE,832.0,0.0,832.0,0.0,832.0,0.0,832.0
TCGA-EY-A3QX-01,TCGA-EY-A3QX,UCEC,64.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2011.0,-23663.0,Dead,WITH TUMOR,,1.0,989.0,1.0,989.0,1.0,896.0
TCGA-EZ-7264-01,TCGA-EZ-7264,LGG,47.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-17432.0,Alive,WITH TUMOR,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0
TCGA-F1-6177-01,TCGA-F1-6177,STAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-32873.0,Alive,TUMOR FREE,200.0,0.0,200.0,0.0,200.0,0.0,200.0
TCGA-F1-6874-01,TCGA-F1-6874,STAD,79.0,MALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-29083.0,Alive,TUMOR FREE,440.0,0.0,440.0,0.0,440.0,0.0,440.0
TCGA-F1-6875-01,TCGA-F1-6875,STAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",1996.0,-29209.0,Dead,TUMOR FREE,,1.0,2197.0,0.0,2197.0,0.0,2197.0
TCGA-F1-A448-01,TCGA-F1-A448,STAD,70.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2012.0,-25846.0,Alive,TUMOR FREE,647.0,0.0,647.0,0.0,647.0,0.0,647.0
TCGA-F1-A72C-01,TCGA-F1-A72C,STAD,68.0,MALE,ASIAN,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-25104.0,Alive,WITH TUMOR,346.0,0.0,346.0,0.0,346.0,1.0,343.0
TCGA-F4-6459-01,TCGA-F4-6459,COAD,61.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2011.0,-22574.0,Dead,TUMOR FREE,,1.0,262.0,0.0,262.0,0.0,262.0
TCGA-F4-6460-01,TCGA-F4-6460,COAD,51.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2011.0,-18637.0,Dead,WITH TUMOR,,1.0,972.0,1.0,972.0,1.0,313.0
TCGA-F4-6461-01,TCGA-F4-6461,COAD,41.0,FEMALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2011.0,-15151.0,Dead,WITH TUMOR,,1.0,338.0,1.0,338.0,1.0,288.0
TCGA-F4-6463-01,TCGA-F4-6463,COAD,51.0,MALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,2011.0,-18804.0,Alive,TUMOR FREE,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0
TCGA-F4-6569-01,TCGA-F4-6569,COAD,60.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-22203.0,Alive,TUMOR FREE,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0
TCGA-F4-6570-01,TCGA-F4-6570,COAD,78.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-28772.0,Dead,TUMOR FREE,,1.0,188.0,0.0,188.0,0.0,188.0
TCGA-F4-6703-01,TCGA-F4-6703,COAD,64.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-23644.0,Alive,TUMOR FREE,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0
TCGA-F4-6704-01,TCGA-F4-6704,COAD,60.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,Colon Mucinous Adenocarcinoma,2011.0,-21949.0,Alive,TUMOR FREE,47.0,0.0,47.0,0.0,47.0,0.0,47.0
TCGA-F4-6805-01,TCGA-F4-6805,COAD,58.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-21241.0,Alive,TUMOR FREE,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0
TCGA-F4-6806-01,TCGA-F4-6806,COAD,59.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-21625.0,Alive,WITH TUMOR,1260.0,0.0,1260.0,0.0,1260.0,1.0,336.0
TCGA-F4-6807-01,TCGA-F4-6807,COAD,51.0,FEMALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2011.0,-18690.0,Alive,TUMOR FREE,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0
TCGA-F4-6808-01,TCGA-F4-6808,COAD,54.0,FEMALE,WHITE,Stage I,Colon Adenocarcinoma,2011.0,-19803.0,Alive,TUMOR FREE,1024.0,0.0,1024.0,0.0,1024.0,0.0,1024.0
TCGA-F4-6809-01,TCGA-F4-6809,COAD,52.0,FEMALE,WHITE,Stage IVA,Colon Adenocarcinoma,2011.0,-19039.0,Dead,WITH TUMOR,,1.0,403.0,1.0,403.0,1.0,403.0
TCGA-F4-6854-01,TCGA-F4-6854,COAD,77.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-28272.0,Alive,TUMOR FREE,16.0,0.0,16.0,0.0,16.0,0.0,16.0
TCGA-F4-6855-01,TCGA-F4-6855,COAD,70.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2011.0,-25890.0,Alive,TUMOR FREE,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0
TCGA-F4-6856-01,TCGA-F4-6856,COAD,45.0,MALE,WHITE,Stage I,Colon Mucinous Adenocarcinoma,2011.0,-16519.0,Alive,TUMOR FREE,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0
TCGA-F5-6464-01,TCGA-F5-6464,READ,77.0,FEMALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2011.0,-28168.0,Dead,,,1.0,303.0,,303.0,0.0,303.0
TCGA-F5-6465-01,TCGA-F5-6465,READ,64.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2010.0,-23432.0,Alive,TUMOR FREE,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0
TCGA-F5-6571-01,TCGA-F5-6571,READ,62.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2011.0,-22666.0,Alive,WITH TUMOR,1288.0,0.0,1288.0,0.0,1288.0,1.0,122.0
TCGA-F5-6702-01,TCGA-F5-6702,READ,71.0,MALE,WHITE,Stage IVA,Rectal Adenocarcinoma,2010.0,-26123.0,Alive,WITH TUMOR,452.0,0.0,452.0,0.0,452.0,1.0,368.0
TCGA-F5-6811-01,TCGA-F5-6811,READ,72.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2011.0,-26575.0,Alive,TUMOR FREE,979.0,0.0,979.0,0.0,979.0,0.0,979.0
TCGA-F5-6812-01,TCGA-F5-6812,READ,67.0,MALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2011.0,-24490.0,Alive,TUMOR FREE,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0
TCGA-F5-6813-01,TCGA-F5-6813,READ,70.0,MALE,WHITE,Stage IIIC,Rectal Adenocarcinoma,2011.0,-25651.0,Dead,WITH TUMOR,,1.0,598.0,1.0,598.0,1.0,65.0
TCGA-F5-6861-01,TCGA-F5-6861,READ,60.0,FEMALE,WHITE,Stage IIA,Rectal Adenocarcinoma,2011.0,-21936.0,Alive,TUMOR FREE,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0
TCGA-F5-6863-01,TCGA-F5-6863,READ,71.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2011.0,-25936.0,Dead,WITH TUMOR,,1.0,361.0,1.0,361.0,1.0,191.0
TCGA-F5-6864-01,TCGA-F5-6864,READ,74.0,FEMALE,WHITE,Stage IIIB,Rectal Adenocarcinoma,2011.0,-27058.0,Alive,TUMOR FREE,379.0,0.0,379.0,0.0,379.0,0.0,379.0
TCGA-F6-A8O3-01,TCGA-F6-A8O3,LGG,34.0,MALE,ASIAN,,Oligodendroglioma,2013.0,-12578.0,Alive,TUMOR FREE,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-F6-A8O4-01,TCGA-F6-A8O4,LGG,44.0,MALE,ASIAN,,Astrocytoma,2013.0,-16202.0,Alive,TUMOR FREE,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-F9-A4JJ-01,TCGA-F9-A4JJ,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2012.0,-12893.0,Dead,WITH TUMOR,,1.0,325.0,1.0,325.0,1.0,109.0
TCGA-FC-7708-01,TCGA-FC-7708,PRAD,52.0,MALE,ASIAN,,Prostate Adenocarcinoma Acinar Type,2011.0,-19144.0,Alive,TUMOR FREE,864.0,0.0,864.0,0.0,864.0,0.0,864.0
TCGA-FC-7961-01,TCGA-FC-7961,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-22888.0,Alive,TUMOR FREE,469.0,0.0,469.0,0.0,469.0,0.0,469.0
TCGA-FC-A4JI-01,TCGA-FC-A4JI,PRAD,70.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-25931.0,Alive,TUMOR FREE,877.0,0.0,877.0,0.0,877.0,0.0,877.0
TCGA-FC-A5OB-01,TCGA-FC-A5OB,PRAD,53.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-19413.0,Alive,WITH TUMOR,680.0,0.0,680.0,0.0,680.0,0.0,680.0
TCGA-FC-A8O0-01,TCGA-FC-A8O0,PRAD,68.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-25115.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-FD-A3B3-01,TCGA-FD-A3B3,BLCA,74.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27068.0,Dead,TUMOR FREE,,1.0,974.0,0.0,974.0,0.0,974.0
TCGA-FD-A3B5-01,TCGA-FD-A3B5,BLCA,86.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-31442.0,Dead,WITH TUMOR,,1.0,272.0,1.0,272.0,1.0,272.0
TCGA-FD-A3B6-01,TCGA-FD-A3B6,BLCA,75.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27541.0,Dead,TUMOR FREE,,1.0,1005.0,0.0,1005.0,0.0,1005.0
TCGA-FD-A3B7-01,TCGA-FD-A3B7,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24245.0,Dead,WITH TUMOR,,1.0,122.0,1.0,122.0,1.0,110.0
TCGA-FD-A3B8-01,TCGA-FD-A3B8,BLCA,56.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-20555.0,Alive,TUMOR FREE,384.0,0.0,384.0,0.0,384.0,0.0,384.0
TCGA-FD-A3N5-01,TCGA-FD-A3N5,BLCA,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-25342.0,Dead,WITH TUMOR,,1.0,685.0,1.0,685.0,1.0,346.0
TCGA-FD-A3NA-01,TCGA-FD-A3NA,BLCA,60.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-21936.0,Alive,TUMOR FREE,1845.0,0.0,1845.0,0.0,1845.0,1.0,1338.0
TCGA-FD-A3SJ-01,TCGA-FD-A3SJ,BLCA,59.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-21615.0,Dead,WITH TUMOR,,1.0,739.0,1.0,739.0,1.0,281.0
TCGA-FD-A3SL-01,TCGA-FD-A3SL,BLCA,60.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-22020.0,Dead,WITH TUMOR,,1.0,712.0,1.0,712.0,1.0,260.0
TCGA-FD-A3SM-01,TCGA-FD-A3SM,BLCA,70.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-25852.0,Dead,WITH TUMOR,,1.0,547.0,1.0,547.0,1.0,144.0
TCGA-FD-A3SN-01,TCGA-FD-A3SN,BLCA,79.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-29169.0,Alive,TUMOR FREE,887.0,0.0,887.0,0.0,887.0,1.0,110.0
TCGA-FD-A3SO-01,TCGA-FD-A3SO,BLCA,68.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-25147.0,Dead,WITH TUMOR,,1.0,168.0,1.0,168.0,1.0,143.0
TCGA-FD-A3SP-01,TCGA-FD-A3SP,BLCA,60.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-22005.0,Alive,TUMOR FREE,783.0,0.0,783.0,0.0,783.0,0.0,783.0
TCGA-FD-A3SQ-01,TCGA-FD-A3SQ,BLCA,62.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-22687.0,Dead,WITH TUMOR,,1.0,1423.0,1.0,1423.0,1.0,991.0
TCGA-FD-A3SR-01,TCGA-FD-A3SR,BLCA,68.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-24979.0,Dead,WITH TUMOR,,1.0,602.0,1.0,602.0,1.0,372.0
TCGA-FD-A3SS-01,TCGA-FD-A3SS,BLCA,66.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-24408.0,Dead,WITH TUMOR,,1.0,391.0,1.0,391.0,1.0,220.0
TCGA-FE-A22Z-01,TCGA-FE-A22Z,THCA,61.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2007.0,-22286.0,Alive,WITH TUMOR,2243.0,0.0,2243.0,0.0,2243.0,1.0,1215.0
TCGA-FE-A230-01,TCGA-FE-A230,THCA,30.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-10999.0,Alive,TUMOR FREE,2173.0,0.0,2173.0,0.0,2173.0,1.0,526.0
TCGA-FE-A231-01,TCGA-FE-A231,THCA,70.0,MALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-25703.0,Alive,TUMOR FREE,961.0,0.0,961.0,0.0,961.0,0.0,961.0
TCGA-FE-A232-01,TCGA-FE-A232,THCA,44.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-16280.0,Alive,TUMOR FREE,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0
TCGA-FE-A233-01,TCGA-FE-A233,THCA,18.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-6770.0,Alive,TUMOR FREE,751.0,0.0,751.0,0.0,751.0,1.0,567.0
TCGA-FE-A234-01,TCGA-FE-A234,THCA,26.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-9724.0,Alive,WITH TUMOR,2075.0,0.0,2075.0,0.0,2075.0,1.0,483.0
TCGA-FE-A235-01,TCGA-FE-A235,THCA,26.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-9859.0,Alive,TUMOR FREE,3571.0,0.0,3571.0,0.0,3571.0,0.0,3571.0
TCGA-FE-A236-01,TCGA-FE-A236,THCA,33.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2004.0,-12348.0,Alive,TUMOR FREE,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0
TCGA-FE-A237-01,TCGA-FE-A237,THCA,19.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2005.0,-7207.0,Alive,TUMOR FREE,3431.0,0.0,3431.0,0.0,3431.0,1.0,492.0
TCGA-FE-A23A-01,TCGA-FE-A23A,THCA,27.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-10177.0,Alive,TUMOR FREE,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0
TCGA-FE-A3PA-01,TCGA-FE-A3PA,THCA,16.0,MALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2002.0,-6068.0,Alive,TUMOR FREE,3235.0,0.0,3235.0,0.0,3235.0,0.0,3235.0
TCGA-FE-A3PC-01,TCGA-FE-A3PC,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2006.0,-13817.0,Alive,TUMOR FREE,2606.0,0.0,2606.0,0.0,2606.0,0.0,2606.0
TCGA-FE-A3PD-01,TCGA-FE-A3PD,THCA,17.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2006.0,-6386.0,Alive,TUMOR FREE,2396.0,0.0,2396.0,0.0,2396.0,0.0,2396.0
TCGA-FG-5962-01,TCGA-FG-5962,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2009.0,-19818.0,Alive,WITH TUMOR,1453.0,0.0,1453.0,0.0,1453.0,0.0,1453.0
TCGA-FG-5963-01,TCGA-FG-5963,LGG,23.0,MALE,WHITE,,Astrocytoma,2009.0,-8571.0,Dead,WITH TUMOR,,1.0,775.0,1.0,775.0,1.0,395.0
TCGA-FG-5964-01,TCGA-FG-5964,LGG,62.0,MALE,WHITE,,Oligodendroglioma,2010.0,-22735.0,Alive,WITH TUMOR,1588.0,0.0,1588.0,0.0,1588.0,0.0,1588.0
TCGA-FG-5965-01,TCGA-FG-5965,LGG,39.0,FEMALE,WHITE,,Oligoastrocytoma,2008.0,-14249.0,Dead,WITH TUMOR,,1.0,1120.0,1.0,1120.0,1.0,715.0
TCGA-FG-6688-01,TCGA-FG-6688,LGG,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2010.0,-21745.0,Alive,WITH TUMOR,571.0,0.0,571.0,0.0,571.0,1.0,405.0
TCGA-FG-6689-01,TCGA-FG-6689,LGG,30.0,MALE,WHITE,,Astrocytoma,2011.0,-11312.0,Alive,WITH TUMOR,454.0,0.0,454.0,0.0,454.0,1.0,119.0
TCGA-FG-6690-01,TCGA-FG-6690,LGG,70.0,MALE,WHITE,,Oligodendroglioma,2011.0,-25667.0,Alive,WITH TUMOR,1294.0,0.0,1294.0,0.0,1294.0,0.0,1294.0
TCGA-FG-6691-01,TCGA-FG-6691,LGG,23.0,FEMALE,WHITE,,Astrocytoma,2011.0,-8403.0,Alive,WITH TUMOR,1257.0,0.0,1257.0,0.0,1257.0,1.0,913.0
TCGA-FG-7634-01,TCGA-FG-7634,LGG,28.0,MALE,WHITE,,Oligodendroglioma,2008.0,-10476.0,Alive,WITH TUMOR,467.0,0.0,467.0,0.0,467.0,0.0,467.0
TCGA-FG-7636-01,TCGA-FG-7636,LGG,48.0,MALE,WHITE,,Astrocytoma,2011.0,-17843.0,Alive,TUMOR FREE,544.0,0.0,544.0,0.0,544.0,0.0,544.0
TCGA-FG-7637-01,TCGA-FG-7637,LGG,49.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-18084.0,Alive,WITH TUMOR,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0
TCGA-FG-7638-01,TCGA-FG-7638,LGG,31.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-11528.0,Alive,WITH TUMOR,686.0,0.0,686.0,0.0,686.0,1.0,407.0
TCGA-FG-7641-01,TCGA-FG-7641,LGG,31.0,MALE,WHITE,,Oligodendroglioma,2011.0,-11357.0,Alive,TUMOR FREE,627.0,0.0,627.0,0.0,627.0,0.0,627.0
TCGA-FG-7643-01,TCGA-FG-7643,LGG,49.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-18206.0,Alive,WITH TUMOR,611.0,0.0,611.0,0.0,611.0,1.0,254.0
TCGA-FG-8181-01,TCGA-FG-8181,LGG,23.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-8642.0,Alive,WITH TUMOR,862.0,0.0,862.0,0.0,862.0,0.0,862.0
TCGA-FG-8182-01,TCGA-FG-8182,LGG,35.0,MALE,WHITE,,Oligodendroglioma,2012.0,-12972.0,Alive,WITH TUMOR,416.0,0.0,416.0,0.0,416.0,0.0,416.0
TCGA-FG-8185-01,TCGA-FG-8185,LGG,37.0,MALE,WHITE,,Astrocytoma,2012.0,-13621.0,Alive,TUMOR FREE,433.0,0.0,433.0,0.0,433.0,0.0,433.0
TCGA-FG-8186-01,TCGA-FG-8186,LGG,42.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-15431.0,Alive,WITH TUMOR,487.0,0.0,487.0,0.0,487.0,0.0,487.0
TCGA-FG-8187-01,TCGA-FG-8187,LGG,31.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-11684.0,Alive,TUMOR FREE,611.0,0.0,611.0,0.0,611.0,0.0,611.0
TCGA-FG-8188-01,TCGA-FG-8188,LGG,41.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-15051.0,Alive,WITH TUMOR,455.0,0.0,455.0,0.0,455.0,1.0,384.0
TCGA-FG-8189-01,TCGA-FG-8189,LGG,33.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-12384.0,Alive,WITH TUMOR,685.0,0.0,685.0,0.0,685.0,0.0,685.0
TCGA-FG-8191-01,TCGA-FG-8191,LGG,30.0,MALE,WHITE,,Oligodendroglioma,2011.0,-11252.0,Alive,WITH TUMOR,992.0,0.0,992.0,0.0,992.0,0.0,992.0
TCGA-FG-A4MT-01,TCGA-FG-A4MT,LGG,27.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-10082.0,Alive,TUMOR FREE,1164.0,0.0,1164.0,0.0,1164.0,1.0,499.0
TCGA-FG-A4MU-01,TCGA-FG-A4MU,LGG,58.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-21450.0,Alive,WITH TUMOR,326.0,0.0,326.0,0.0,326.0,0.0,326.0
TCGA-FG-A4MW-01,TCGA-FG-A4MW,LGG,63.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-23077.0,Dead,WITH TUMOR,,1.0,559.0,1.0,559.0,1.0,226.0
TCGA-FG-A4MX-01,TCGA-FG-A4MX,LGG,47.0,MALE,WHITE,,Astrocytoma,2012.0,-17381.0,Alive,TUMOR FREE,569.0,0.0,569.0,0.0,569.0,0.0,569.0
TCGA-FG-A4MY-01,TCGA-FG-A4MY,LGG,44.0,FEMALE,WHITE,,Oligoastrocytoma,2012.0,-16310.0,Alive,WITH TUMOR,721.0,0.0,721.0,0.0,721.0,0.0,721.0
TCGA-FG-A60J-01,TCGA-FG-A60J,LGG,47.0,FEMALE,WHITE,,Oligoastrocytoma,2012.0,-17339.0,Alive,TUMOR FREE,449.0,0.0,449.0,0.0,449.0,0.0,449.0
TCGA-FG-A60L-01,TCGA-FG-A60L,LGG,34.0,FEMALE,WHITE,,Astrocytoma,2012.0,-12580.0,Alive,TUMOR FREE,655.0,0.0,655.0,0.0,655.0,0.0,655.0
TCGA-FG-A6IZ-01,TCGA-FG-A6IZ,LGG,60.0,MALE,WHITE,,Oligodendroglioma,2013.0,-22275.0,Alive,TUMOR FREE,457.0,0.0,457.0,0.0,457.0,0.0,457.0
TCGA-FG-A6J3-01,TCGA-FG-A6J3,LGG,52.0,FEMALE,WHITE,,Astrocytoma,2012.0,-19138.0,Alive,WITH TUMOR,677.0,0.0,677.0,0.0,677.0,1.0,285.0
TCGA-FG-A70Y-01,TCGA-FG-A70Y,LGG,20.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-7421.0,Alive,WITH TUMOR,868.0,0.0,868.0,0.0,868.0,1.0,490.0
TCGA-FG-A70Z-01,TCGA-FG-A70Z,LGG,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Oligoastrocytoma,2011.0,-19717.0,Alive,WITH TUMOR,328.0,0.0,328.0,0.0,328.0,0.0,328.0
TCGA-FG-A710-01,TCGA-FG-A710,LGG,50.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-18415.0,Alive,WITH TUMOR,1115.0,0.0,1115.0,0.0,1115.0,0.0,1115.0
TCGA-FG-A713-01,TCGA-FG-A713,LGG,74.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-27232.0,Alive,TUMOR FREE,622.0,0.0,622.0,0.0,622.0,0.0,622.0
TCGA-FG-A87N-01,TCGA-FG-A87N,LGG,37.0,FEMALE,ASIAN,,Astrocytoma,2013.0,-13606.0,Alive,WITH TUMOR,567.0,0.0,567.0,0.0,567.0,0.0,567.0
TCGA-FG-A87Q-01,TCGA-FG-A87Q,LGG,61.0,FEMALE,WHITE,,Astrocytoma,2013.0,-22565.0,Alive,TUMOR FREE,174.0,0.0,174.0,0.0,174.0,0.0,174.0
TCGA-FI-A2EY-01,TCGA-FI-A2EY,UCEC,63.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2006.0,-23042.0,Dead,TUMOR FREE,,1.0,880.0,0.0,880.0,1.0,577.0
TCGA-FI-A3PX-01,TCGA-FI-A3PX,UCEC,57.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2008.0,-21063.0,Alive,TUMOR FREE,2384.0,0.0,2384.0,0.0,2384.0,0.0,2384.0
TCGA-FJ-A3Z7-01,TCGA-FJ-A3Z7,BLCA,76.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-28052.0,Alive,TUMOR FREE,945.0,0.0,945.0,0.0,945.0,0.0,945.0
TCGA-FJ-A3ZE-01,TCGA-FJ-A3ZE,BLCA,65.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-23866.0,Dead,WITH TUMOR,,1.0,324.0,1.0,324.0,1.0,152.0
TCGA-FJ-A3ZF-01,TCGA-FJ-A3ZF,BLCA,73.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-26825.0,Alive,TUMOR FREE,524.0,0.0,524.0,0.0,524.0,0.0,524.0
TCGA-FK-A3SD-01,TCGA-FK-A3SD,THCA,61.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-22560.0,Alive,TUMOR FREE,32.0,0.0,32.0,0.0,32.0,0.0,32.0
TCGA-FK-A3SE-01,TCGA-FK-A3SE,THCA,31.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-11472.0,Alive,TUMOR FREE,670.0,0.0,670.0,0.0,670.0,0.0,670.0
TCGA-FP-7916-01,TCGA-FP-7916,STAD,77.0,MALE,ASIAN,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-28475.0,Dead,WITH TUMOR,,1.0,428.0,1.0,428.0,1.0,428.0
TCGA-FP-7998-01,TCGA-FP-7998,STAD,77.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-28302.0,Alive,TUMOR FREE,678.0,0.0,678.0,0.0,678.0,0.0,678.0
TCGA-FR-A3R1-01,TCGA-FR-A3R1,SKCM,69.0,MALE,WHITE,Stage IIC,,2011.0,-25271.0,Alive,WITH TUMOR,685.0,0.0,685.0,0.0,685.0,1.0,678.0
TCGA-FS-A1ZN-01,TCGA-FS-A1ZN,SKCM,43.0,MALE,WHITE,Stage IIIA,,2002.0,-15890.0,Dead,WITH TUMOR,,1.0,730.0,1.0,730.0,1.0,361.0
TCGA-FV-A23B-01,TCGA-FV-A23B,LIHC,70.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2005.0,-25788.0,Dead,WITH TUMOR,,1.0,1852.0,1.0,1852.0,1.0,1453.0
TCGA-FV-A2QQ-01,TCGA-FV-A2QQ,LIHC,80.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-29354.0,Alive,TUMOR FREE,729.0,0.0,729.0,0.0,729.0,0.0,729.0
TCGA-FV-A2QR-01,TCGA-FV-A2QR,LIHC,75.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2006.0,,Dead,WITH TUMOR,,1.0,581.0,1.0,581.0,1.0,561.0
TCGA-FV-A3R2-01,TCGA-FV-A3R2,LIHC,75.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2005.0,-27530.0,Dead,TUMOR FREE,,1.0,194.0,0.0,194.0,0.0,194.0
TCGA-FV-A3R3-01,TCGA-FV-A3R3,LIHC,38.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-14231.0,Dead,TUMOR FREE,,1.0,366.0,0.0,366.0,0.0,366.0
TCGA-FV-A496-01,TCGA-FV-A496,LIHC,84.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-30950.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-FV-A4ZP-01,TCGA-FV-A4ZP,LIHC,78.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2005.0,-28771.0,Dead,TUMOR FREE,,1.0,2486.0,0.0,2486.0,0.0,2486.0
TCGA-FV-A4ZQ-01,TCGA-FV-A4ZQ,LIHC,52.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-19090.0,Alive,TUMOR FREE,12.0,0.0,12.0,0.0,12.0,0.0,12.0
TCGA-FY-A2QD-01,TCGA-FY-A2QD,THCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-22491.0,Alive,TUMOR FREE,38.0,0.0,38.0,0.0,38.0,0.0,38.0
TCGA-FY-A3BL-01,TCGA-FY-A3BL,THCA,29.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-10667.0,Alive,TUMOR FREE,621.0,0.0,621.0,0.0,621.0,0.0,621.0
TCGA-FY-A3I5-01,TCGA-FY-A3I5,THCA,64.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-23654.0,Alive,TUMOR FREE,238.0,0.0,238.0,0.0,238.0,0.0,238.0
TCGA-FY-A3ON-01,TCGA-FY-A3ON,THCA,20.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-7403.0,Alive,TUMOR FREE,595.0,0.0,595.0,0.0,595.0,0.0,595.0
TCGA-FY-A3TY-01,TCGA-FY-A3TY,THCA,61.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-22556.0,Alive,TUMOR FREE,709.0,0.0,709.0,0.0,709.0,0.0,709.0
TCGA-FY-A3W9-01,TCGA-FY-A3W9,THCA,66.0,FEMALE,WHITE,Stage II,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-24136.0,Alive,TUMOR FREE,658.0,0.0,658.0,0.0,658.0,0.0,658.0
TCGA-FY-A3WA-01,TCGA-FY-A3WA,THCA,52.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2012.0,-18993.0,Alive,TUMOR FREE,519.0,0.0,519.0,0.0,519.0,0.0,519.0
TCGA-FY-A40L-01,TCGA-FY-A40L,THCA,55.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-20243.0,Alive,TUMOR FREE,726.0,0.0,726.0,0.0,726.0,0.0,726.0
TCGA-FY-A40M-01,TCGA-FY-A40M,THCA,51.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-18722.0,Alive,TUMOR FREE,684.0,0.0,684.0,0.0,684.0,0.0,684.0
TCGA-G2-A2EC-01,TCGA-G2-A2EC,BLCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-21215.0,Dead,WITH TUMOR,,1.0,696.0,1.0,696.0,1.0,679.0
TCGA-G2-A2EF-01,TCGA-G2-A2EF,BLCA,50.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,-18467.0,Alive,TUMOR FREE,1884.0,0.0,1884.0,0.0,1884.0,0.0,1884.0
TCGA-G2-A2EJ-01,TCGA-G2-A2EJ,BLCA,56.0,FEMALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-20649.0,Alive,TUMOR FREE,1460.0,0.0,1460.0,0.0,1460.0,1.0,910.0
TCGA-G2-A2EK-01,TCGA-G2-A2EK,BLCA,57.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-20995.0,Alive,WITH TUMOR,485.0,0.0,485.0,0.0,485.0,1.0,485.0
TCGA-G2-A2EO-01,TCGA-G2-A2EO,BLCA,69.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-25440.0,Dead,TUMOR FREE,,1.0,1804.0,0.0,1804.0,0.0,1804.0
TCGA-G2-A2ES-01,TCGA-G2-A2ES,BLCA,85.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2009.0,-31293.0,Dead,WITH TUMOR,,1.0,1004.0,1.0,1004.0,1.0,897.0
TCGA-G2-A3IB-01,TCGA-G2-A3IB,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2008.0,-24149.0,Dead,WITH TUMOR,,1.0,220.0,1.0,220.0,1.0,220.0
TCGA-G2-A3IE-01,TCGA-G2-A3IE,BLCA,51.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,-18983.0,Dead,WITH TUMOR,,1.0,612.0,1.0,612.0,1.0,612.0
TCGA-G2-A3VY-01,TCGA-G2-A3VY,BLCA,66.0,MALE,ASIAN,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-24112.0,Alive,WITH TUMOR,536.0,0.0,536.0,0.0,536.0,0.0,536.0
TCGA-G3-A25S-01,TCGA-G3-A25S,LIHC,64.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2009.0,-23571.0,Dead,WITH TUMOR,,1.0,416.0,1.0,416.0,1.0,37.0
TCGA-G3-A25U-01,TCGA-G3-A25U,LIHC,63.0,FEMALE,ASIAN,Stage I,Hepatocellular Carcinoma,2007.0,-23207.0,Alive,TUMOR FREE,1636.0,0.0,1636.0,0.0,1636.0,0.0,1636.0
TCGA-G3-A25V-01,TCGA-G3-A25V,LIHC,68.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2010.0,-25144.0,Alive,WITH TUMOR,860.0,0.0,860.0,0.0,860.0,1.0,489.0
TCGA-G3-A25Y-01,TCGA-G3-A25Y,LIHC,52.0,FEMALE,ASIAN,Stage I,Hepatocellular Carcinoma,2006.0,-19055.0,Dead,WITH TUMOR,,1.0,452.0,1.0,452.0,1.0,355.0
TCGA-G3-A25Z-01,TCGA-G3-A25Z,LIHC,58.0,MALE,ASIAN,Stage I,Hepatocellular Carcinoma,2010.0,-21509.0,Alive,TUMOR FREE,655.0,0.0,655.0,0.0,655.0,0.0,655.0
TCGA-G3-A3CH-01,TCGA-G3-A3CH,LIHC,53.0,MALE,ASIAN,Stage IIIA,Hepatocellular Carcinoma,2010.0,-19473.0,Alive,WITH TUMOR,780.0,0.0,780.0,0.0,780.0,1.0,116.0
TCGA-G3-A3CI-01,TCGA-G3-A3CI,LIHC,71.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2011.0,-26224.0,Alive,TUMOR FREE,180.0,0.0,180.0,0.0,180.0,0.0,180.0
TCGA-G3-A3CK-01,TCGA-G3-A3CK,LIHC,61.0,MALE,ASIAN,Stage I,Hepatocellular Carcinoma,2011.0,-22462.0,Alive,TUMOR FREE,585.0,0.0,585.0,0.0,585.0,0.0,585.0
TCGA-G3-A5SJ-01,TCGA-G3-A5SJ,LIHC,59.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-21848.0,Alive,TUMOR FREE,698.0,0.0,698.0,0.0,698.0,1.0,308.0
TCGA-G3-A5SK-01,TCGA-G3-A5SK,LIHC,58.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-21320.0,Alive,WITH TUMOR,744.0,0.0,744.0,0.0,744.0,1.0,483.0
TCGA-G3-A5SL-01,TCGA-G3-A5SL,LIHC,70.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2012.0,-25671.0,Alive,TUMOR FREE,621.0,0.0,621.0,0.0,621.0,0.0,621.0
TCGA-G3-A5SM-01,TCGA-G3-A5SM,LIHC,58.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2012.0,-21236.0,Alive,TUMOR FREE,520.0,0.0,520.0,0.0,520.0,1.0,252.0
TCGA-G3-A7M5-01,TCGA-G3-A7M5,LIHC,76.0,MALE,ASIAN,Stage I,Hepatocellular Carcinoma,2013.0,-27963.0,Alive,TUMOR FREE,447.0,0.0,447.0,0.0,447.0,0.0,447.0
TCGA-G3-A7M6-01,TCGA-G3-A7M6,LIHC,60.0,FEMALE,WHITE,Stage I,Hepatocellular Carcinoma,2013.0,-22205.0,Alive,WITH TUMOR,632.0,0.0,632.0,0.0,632.0,1.0,293.0
TCGA-G3-A7M7-01,TCGA-G3-A7M7,LIHC,65.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2013.0,-24002.0,Alive,TUMOR FREE,361.0,0.0,361.0,0.0,361.0,0.0,361.0
TCGA-G3-A7M8-01,TCGA-G3-A7M8,LIHC,31.0,MALE,ASIAN,Stage I,Hepatocellular Carcinoma,2013.0,-11527.0,Alive,TUMOR FREE,430.0,0.0,430.0,0.0,430.0,0.0,430.0
TCGA-G3-A7M9-01,TCGA-G3-A7M9,LIHC,70.0,MALE,WHITE,Stage IIIB,Hepatocellular Carcinoma,2013.0,-25588.0,Dead,,,1.0,56.0,,56.0,0.0,56.0
TCGA-G4-6293-01,TCGA-G4-6293,COAD,49.0,FEMALE,WHITE,Stage III,Colon Adenocarcinoma,2002.0,-18076.0,Alive,TUMOR FREE,4051.0,0.0,4051.0,0.0,4051.0,0.0,4051.0
TCGA-G4-6294-01,TCGA-G4-6294,COAD,75.0,MALE,WHITE,Stage IV,Colon Adenocarcinoma,2004.0,-27755.0,Dead,WITH TUMOR,,1.0,858.0,1.0,858.0,1.0,517.0
TCGA-G4-6295-01,TCGA-G4-6295,COAD,70.0,FEMALE,WHITE,Stage II,Colon Adenocarcinoma,2004.0,-25758.0,Alive,TUMOR FREE,254.0,0.0,254.0,0.0,254.0,0.0,254.0
TCGA-G4-6297-01,TCGA-G4-6297,COAD,55.0,FEMALE,WHITE,Stage IV,Colon Adenocarcinoma,2005.0,-20103.0,Alive,WITH TUMOR,2506.0,0.0,2506.0,0.0,2506.0,1.0,439.0
TCGA-G4-6298-01,TCGA-G4-6298,COAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2005.0,-32873.0,Dead,WITH TUMOR,,1.0,715.0,1.0,715.0,1.0,291.0
TCGA-G4-6299-01,TCGA-G4-6299,COAD,69.0,MALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2005.0,-25318.0,Alive,TUMOR FREE,2268.0,0.0,2268.0,0.0,2268.0,0.0,2268.0
TCGA-G4-6302-01,TCGA-G4-6302,COAD,90.0,FEMALE,WHITE,Stage IIA,Colon Mucinous Adenocarcinoma,2006.0,-32872.0,Dead,TUMOR FREE,,1.0,2047.0,0.0,2047.0,0.0,2047.0
TCGA-G4-6303-01,TCGA-G4-6303,COAD,54.0,FEMALE,WHITE,Stage IV,Colon Adenocarcinoma,2006.0,-19800.0,Dead,WITH TUMOR,,1.0,2003.0,1.0,2003.0,1.0,872.0
TCGA-G4-6304-01,TCGA-G4-6304,COAD,66.0,FEMALE,WHITE,Stage IIB,Colon Adenocarcinoma,2006.0,-24172.0,Alive,TUMOR FREE,1631.0,0.0,1631.0,0.0,1631.0,1.0,859.0
TCGA-G4-6306-01,TCGA-G4-6306,COAD,71.0,MALE,WHITE,[Discrepancy],Colon Adenocarcinoma,2007.0,-26163.0,Alive,TUMOR FREE,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0
TCGA-G4-6307-01,TCGA-G4-6307,COAD,37.0,FEMALE,WHITE,Stage IIIB,Colon Adenocarcinoma,2007.0,-13648.0,Alive,TUMOR FREE,1674.0,0.0,1674.0,0.0,1674.0,0.0,1674.0
TCGA-G4-6309-01,TCGA-G4-6309,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2007.0,-14729.0,Alive,TUMOR FREE,2600.0,0.0,2600.0,0.0,2600.0,1.0,2176.0
TCGA-G4-6311-01,TCGA-G4-6311,COAD,80.0,MALE,WHITE,Stage III,Colon Adenocarcinoma,2008.0,-29297.0,Alive,TUMOR FREE,1199.0,0.0,1199.0,0.0,1199.0,0.0,1199.0
TCGA-G4-6315-01,TCGA-G4-6315,COAD,66.0,MALE,WHITE,Stage IV,Colon Adenocarcinoma,2008.0,-24174.0,Alive,TUMOR FREE,1883.0,0.0,1883.0,0.0,1883.0,0.0,1883.0
TCGA-G4-6317-01,TCGA-G4-6317,COAD,51.0,FEMALE,WHITE,Stage IIIC,Colon Adenocarcinoma,2008.0,-18822.0,Alive,TUMOR FREE,1095.0,0.0,1095.0,0.0,1095.0,1.0,592.0
TCGA-G4-6320-01,TCGA-G4-6320,COAD,73.0,MALE,WHITE,Stage III,Colon Adenocarcinoma,2009.0,-26840.0,Alive,TUMOR FREE,804.0,0.0,804.0,0.0,804.0,0.0,804.0
TCGA-G4-6321-01,TCGA-G4-6321,COAD,60.0,FEMALE,WHITE,Stage III,Colon Adenocarcinoma,2009.0,-21921.0,Alive,TUMOR FREE,672.0,0.0,672.0,0.0,672.0,0.0,672.0
TCGA-G4-6322-01,TCGA-G4-6322,COAD,65.0,MALE,WHITE,Stage IIIB,Colon Mucinous Adenocarcinoma,2009.0,-23825.0,Alive,WITH TUMOR,792.0,0.0,792.0,0.0,792.0,1.0,789.0
TCGA-G4-6586-01,TCGA-G4-6586,COAD,73.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2008.0,-27020.0,Alive,TUMOR FREE,1089.0,0.0,1089.0,0.0,1089.0,0.0,1089.0
TCGA-G4-6588-01,TCGA-G4-6588,COAD,58.0,FEMALE,WHITE,Stage IIA,Colon Adenocarcinoma,2009.0,-21532.0,Alive,TUMOR FREE,796.0,0.0,796.0,0.0,796.0,0.0,796.0
TCGA-G4-6626-01,TCGA-G4-6626,COAD,90.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2006.0,-32871.0,Dead,TUMOR FREE,,1.0,1422.0,0.0,1422.0,0.0,1422.0
TCGA-G4-6627-01,TCGA-G4-6627,COAD,84.0,MALE,WHITE,Stage IIA,Colon Adenocarcinoma,2007.0,-30697.0,Alive,TUMOR FREE,2275.0,0.0,2275.0,0.0,2275.0,1.0,1003.0
TCGA-G4-6628-01,TCGA-G4-6628,COAD,78.0,MALE,WHITE,Stage I,Colon Adenocarcinoma,2006.0,-28772.0,Alive,TUMOR FREE,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0
TCGA-G5-6641-01,TCGA-G5-6641,READ,67.0,MALE,WHITE,Stage IIIA,Rectal Mucinous Adenocarcinoma,2009.0,-24486.0,Alive,TUMOR FREE,804.0,0.0,804.0,0.0,804.0,0.0,804.0
TCGA-G7-6789-01,TCGA-G7-6789,KIRP,53.0,FEMALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2004.0,-19593.0,Dead,WITH TUMOR,,1.0,122.0,1.0,122.0,1.0,122.0
TCGA-G7-6790-01,TCGA-G7-6790,KIRP,57.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2007.0,-21169.0,Alive,TUMOR FREE,1575.0,0.0,1575.0,0.0,1575.0,1.0,1558.0
TCGA-G7-6792-01,TCGA-G7-6792,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2007.0,-14664.0,Alive,TUMOR FREE,2765.0,0.0,2765.0,0.0,2765.0,0.0,2765.0
TCGA-G7-6793-01,TCGA-G7-6793,KIRP,60.0,FEMALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,2007.0,-22215.0,Dead,WITH TUMOR,,1.0,336.0,1.0,336.0,1.0,336.0
TCGA-G7-6795-01,TCGA-G7-6795,KIRP,56.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2008.0,-20478.0,Alive,TUMOR FREE,1194.0,0.0,1194.0,0.0,1194.0,0.0,1194.0
TCGA-G7-6796-01,TCGA-G7-6796,KIRP,58.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2008.0,-21252.0,Alive,TUMOR FREE,2173.0,0.0,2173.0,0.0,2173.0,0.0,2173.0
TCGA-G7-6797-01,TCGA-G7-6797,KIRP,46.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2010.0,-17004.0,Alive,TUMOR FREE,765.0,0.0,765.0,0.0,765.0,0.0,765.0
TCGA-G7-7501-01,TCGA-G7-7501,KIRP,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-20165.0,Dead,WITH TUMOR,,1.0,624.0,1.0,624.0,1.0,110.0
TCGA-G7-7502-01,TCGA-G7-7502,KIRP,83.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-30346.0,Alive,TUMOR FREE,786.0,0.0,786.0,0.0,786.0,0.0,786.0
TCGA-G7-A4TM-01,TCGA-G7-A4TM,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-14966.0,Alive,TUMOR FREE,768.0,0.0,768.0,0.0,768.0,0.0,768.0
TCGA-G9-6329-01,TCGA-G9-6329,PRAD,67.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-24797.0,Alive,TUMOR FREE,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0
TCGA-G9-6342-01,TCGA-G9-6342,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-22472.0,Alive,TUMOR FREE,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0
TCGA-G9-6351-01,TCGA-G9-6351,PRAD,51.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-18723.0,Alive,TUMOR FREE,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0
TCGA-G9-6353-01,TCGA-G9-6353,PRAD,58.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-21221.0,Alive,TUMOR FREE,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0
TCGA-G9-6356-01,TCGA-G9-6356,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22010.0,Alive,TUMOR FREE,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0
TCGA-G9-6361-01,TCGA-G9-6361,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22565.0,Alive,TUMOR FREE,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0
TCGA-G9-6363-01,TCGA-G9-6363,PRAD,64.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-23480.0,Alive,TUMOR FREE,1378.0,0.0,1378.0,0.0,1378.0,0.0,1378.0
TCGA-G9-6364-01,TCGA-G9-6364,PRAD,72.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-26603.0,Alive,TUMOR FREE,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0
TCGA-G9-6365-01,TCGA-G9-6365,PRAD,71.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-26207.0,Alive,TUMOR FREE,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0
TCGA-G9-6366-01,TCGA-G9-6366,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22428.0,Alive,,1947.0,0.0,1947.0,0.0,1947.0,0.0,1947.0
TCGA-G9-6367-01,TCGA-G9-6367,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22176.0,Alive,WITH TUMOR,1222.0,0.0,1222.0,0.0,1222.0,0.0,1222.0
TCGA-G9-6370-01,TCGA-G9-6370,PRAD,52.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-19149.0,Alive,TUMOR FREE,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0
TCGA-G9-6371-01,TCGA-G9-6371,PRAD,58.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-21365.0,Alive,TUMOR FREE,1226.0,0.0,1226.0,0.0,1226.0,0.0,1226.0
TCGA-G9-6377-01,TCGA-G9-6377,PRAD,61.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2009.0,-22419.0,Alive,TUMOR FREE,958.0,0.0,958.0,0.0,958.0,0.0,958.0
TCGA-G9-6378-01,TCGA-G9-6378,PRAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2009.0,-19879.0,Alive,TUMOR FREE,1155.0,0.0,1155.0,0.0,1155.0,0.0,1155.0
TCGA-G9-6384-01,TCGA-G9-6384,PRAD,53.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-19620.0,Alive,TUMOR FREE,765.0,0.0,765.0,0.0,765.0,0.0,765.0
TCGA-G9-6494-01,TCGA-G9-6494,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-24381.0,Alive,WITH TUMOR,1771.0,0.0,1771.0,0.0,1771.0,0.0,1771.0
TCGA-G9-6499-01,TCGA-G9-6499,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-24388.0,Alive,TUMOR FREE,1543.0,0.0,1543.0,0.0,1543.0,0.0,1543.0
TCGA-G9-7510-01,TCGA-G9-7510,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-24187.0,Alive,TUMOR FREE,1185.0,0.0,1185.0,0.0,1185.0,0.0,1185.0
TCGA-G9-7521-01,TCGA-G9-7521,PRAD,52.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-19216.0,Alive,[Discrepancy],942.0,0.0,942.0,0.0,942.0,0.0,942.0
TCGA-G9-7522-01,TCGA-G9-7522,PRAD,49.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-18033.0,Alive,TUMOR FREE,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0
TCGA-G9-7523-01,TCGA-G9-7523,PRAD,44.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-16269.0,Alive,TUMOR FREE,857.0,0.0,857.0,0.0,857.0,0.0,857.0
TCGA-GC-A3BM-01,TCGA-GC-A3BM,BLCA,70.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-25609.0,Dead,WITH TUMOR,,1.0,651.0,1.0,651.0,1.0,651.0
TCGA-GC-A3I6-01,TCGA-GC-A3I6,BLCA,45.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-16504.0,Dead,WITH TUMOR,,1.0,630.0,1.0,630.0,1.0,546.0
TCGA-GC-A3WC-01,TCGA-GC-A3WC,BLCA,80.0,FEMALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-29295.0,Alive,TUMOR FREE,540.0,0.0,540.0,0.0,540.0,0.0,540.0
TCGA-GC-A3YS-01,TCGA-GC-A3YS,BLCA,61.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-22515.0,Alive,TUMOR FREE,758.0,0.0,758.0,0.0,758.0,0.0,758.0
TCGA-GD-A2C5-01,TCGA-GD-A2C5,BLCA,53.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-19498.0,Alive,WITH TUMOR,812.0,0.0,812.0,0.0,812.0,1.0,214.0
TCGA-GD-A3OP-01,TCGA-GD-A3OP,BLCA,84.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-30956.0,Alive,,64.0,0.0,64.0,0.0,64.0,0.0,64.0
TCGA-GD-A3OQ-01,TCGA-GD-A3OQ,BLCA,48.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-17682.0,Alive,,95.0,0.0,95.0,0.0,95.0,0.0,95.0
TCGA-GD-A3OS-01,TCGA-GD-A3OS,BLCA,54.0,FEMALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-19776.0,Alive,WITH TUMOR,638.0,0.0,638.0,0.0,638.0,1.0,223.0
TCGA-GE-A2C6-01,TCGA-GE-A2C6,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-12068.0,Alive,TUMOR FREE,381.0,0.0,381.0,0.0,381.0,0.0,381.0
TCGA-GF-A2C7-01,TCGA-GF-A2C7,SKCM,48.0,MALE,WHITE,Stage IIC,,2011.0,-17545.0,Alive,TUMOR FREE,21.0,0.0,21.0,0.0,21.0,0.0,21.0
TCGA-GI-A2C8-01,TCGA-GI-A2C8,BRCA,63.0,FEMALE,WHITE,Stage IIIB,Infiltrating Ductal Carcinoma,2004.0,-23103.0,Alive,,225.0,0.0,225.0,0.0,225.0,0.0,225.0
TCGA-GL-6846-01,TCGA-GL-6846,KIRP,52.0,MALE,WHITE,Stage IV,Kidney Papillary Renal Cell Carcinoma,1996.0,-19012.0,Alive,TUMOR FREE,5925.0,0.0,5925.0,0.0,5925.0,0.0,5925.0
TCGA-GL-7773-01,TCGA-GL-7773,KIRP,63.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-23239.0,Alive,TUMOR FREE,393.0,0.0,393.0,0.0,393.0,0.0,393.0
TCGA-GL-7966-01,TCGA-GL-7966,KIRP,28.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-10428.0,Alive,WITH TUMOR,112.0,0.0,112.0,0.0,112.0,0.0,112.0
TCGA-GL-8500-01,TCGA-GL-8500,KIRP,63.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-23338.0,Alive,TUMOR FREE,841.0,0.0,841.0,0.0,841.0,0.0,841.0
TCGA-GL-A4EM-01,TCGA-GL-A4EM,KIRP,61.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-22635.0,Alive,TUMOR FREE,32.0,0.0,32.0,0.0,32.0,0.0,32.0
TCGA-GL-A59R-01,TCGA-GL-A59R,KIRP,79.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2012.0,-29046.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-GM-A2D9-01,TCGA-GM-A2D9,BRCA,69.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2006.0,-25490.0,Dead,WITH TUMOR,,1.0,1812.0,1.0,1812.0,1.0,536.0
TCGA-GM-A2DB-01,TCGA-GM-A2DB,BRCA,62.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-22883.0,Alive,TUMOR FREE,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0
TCGA-GM-A2DC-01,TCGA-GM-A2DC,BRCA,57.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2006.0,-21122.0,Alive,TUMOR FREE,2535.0,0.0,2535.0,0.0,2535.0,0.0,2535.0
TCGA-GM-A2DD-01,TCGA-GM-A2DD,BRCA,53.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-19415.0,Alive,TUMOR FREE,2282.0,0.0,2282.0,0.0,2282.0,0.0,2282.0
TCGA-GM-A2DF-01,TCGA-GM-A2DF,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-19614.0,Alive,TUMOR FREE,2155.0,0.0,2155.0,0.0,2155.0,0.0,2155.0
TCGA-GM-A2DH-01,TCGA-GM-A2DH,BRCA,58.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2007.0,-21344.0,Alive,TUMOR FREE,2193.0,0.0,2193.0,0.0,2193.0,0.0,2193.0
TCGA-GM-A2DI-01,TCGA-GM-A2DI,BRCA,52.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2005.0,-19030.0,Alive,TUMOR FREE,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0
TCGA-GM-A2DK-01,TCGA-GM-A2DK,BRCA,58.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2005.0,-21198.0,Alive,TUMOR FREE,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0
TCGA-GM-A2DL-01,TCGA-GM-A2DL,BRCA,50.0,FEMALE,WHITE,Stage I,Infiltrating Ductal Carcinoma,2003.0,-18475.0,Alive,TUMOR FREE,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0
TCGA-GM-A2DM-01,TCGA-GM-A2DM,BRCA,57.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2004.0,-21160.0,Alive,TUMOR FREE,3226.0,0.0,3226.0,0.0,3226.0,0.0,3226.0
TCGA-GM-A2DN-01,TCGA-GM-A2DN,BRCA,58.0,FEMALE,WHITE,Stage IIA,Infiltrating Ductal Carcinoma,2004.0,-21288.0,Alive,TUMOR FREE,3091.0,0.0,3091.0,0.0,3091.0,0.0,3091.0
TCGA-GM-A2DO-01,TCGA-GM-A2DO,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Lobular Carcinoma,2006.0,-19842.0,Alive,TUMOR FREE,2596.0,0.0,2596.0,0.0,2596.0,0.0,2596.0
TCGA-GM-A3XL-01,TCGA-GM-A3XL,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2007.0,-18171.0,Alive,TUMOR FREE,2108.0,0.0,2108.0,0.0,2108.0,0.0,2108.0
TCGA-GM-A4E0-01,TCGA-GM-A4E0,BRCA,67.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2007.0,-24788.0,Alive,TUMOR FREE,2191.0,0.0,2191.0,0.0,2191.0,0.0,2191.0
TCGA-GM-A5PV-01,TCGA-GM-A5PV,BRCA,63.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-23215.0,Alive,TUMOR FREE,412.0,0.0,412.0,0.0,412.0,0.0,412.0
TCGA-GM-A5PX-01,TCGA-GM-A5PX,BRCA,65.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2011.0,-23753.0,Alive,TUMOR FREE,551.0,0.0,551.0,0.0,551.0,0.0,551.0
TCGA-GN-A263-01,TCGA-GN-A263,SKCM,24.0,MALE,WHITE,Stage IV,,2004.0,-8952.0,Dead,WITH TUMOR,,1.0,467.0,1.0,467.0,1.0,39.0
TCGA-GN-A26C-01,TCGA-GN-A26C,SKCM,77.0,MALE,WHITE,Stage IIIC,,2006.0,-28336.0,Dead,WITH TUMOR,,1.0,821.0,1.0,821.0,1.0,593.0
TCGA-GU-A42R-01,TCGA-GU-A42R,BLCA,68.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-25134.0,Dead,WITH TUMOR,,1.0,577.0,1.0,577.0,1.0,91.0
TCGA-GV-A3JV-01,TCGA-GV-A3JV,BLCA,66.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24243.0,Dead,WITH TUMOR,,1.0,434.0,1.0,434.0,1.0,134.0
TCGA-GV-A3JW-01,TCGA-GV-A3JW,BLCA,74.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-27091.0,Alive,WITH TUMOR,649.0,0.0,649.0,0.0,649.0,1.0,271.0
TCGA-GV-A3JZ-01,TCGA-GV-A3JZ,BLCA,55.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-20420.0,Alive,WITH TUMOR,603.0,0.0,603.0,0.0,603.0,0.0,603.0
TCGA-GV-A3QF-01,TCGA-GV-A3QF,BLCA,79.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-28890.0,Dead,TUMOR FREE,,1.0,617.0,0.0,617.0,0.0,617.0
TCGA-GV-A3QG-01,TCGA-GV-A3QG,BLCA,65.0,MALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-23847.0,Dead,WITH TUMOR,,1.0,,1.0,,1.0,84.0
TCGA-GV-A3QH-01,TCGA-GV-A3QH,BLCA,67.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24681.0,Dead,TUMOR FREE,,1.0,258.0,0.0,258.0,1.0,125.0
TCGA-GV-A3QI-01,TCGA-GV-A3QI,BLCA,47.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-17383.0,Alive,WITH TUMOR,1110.0,0.0,1110.0,0.0,1110.0,1.0,768.0
TCGA-GV-A3QK-01,TCGA-GV-A3QK,BLCA,56.0,FEMALE,WHITE,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-20802.0,Alive,WITH TUMOR,832.0,0.0,832.0,0.0,832.0,0.0,832.0
TCGA-GV-A40E-01,TCGA-GV-A40E,BLCA,75.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-27569.0,Dead,WITH TUMOR,,1.0,261.0,1.0,261.0,1.0,219.0
TCGA-GV-A40G-01,TCGA-GV-A40G,BLCA,77.0,MALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-28204.0,Alive,TUMOR FREE,580.0,0.0,580.0,0.0,580.0,0.0,580.0
TCGA-H2-A2K9-01,TCGA-H2-A2K9,THCA,25.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-9221.0,Alive,TUMOR FREE,659.0,0.0,659.0,0.0,659.0,0.0,659.0
TCGA-H2-A3RH-01,TCGA-H2-A3RH,THCA,41.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-15068.0,Alive,TUMOR FREE,379.0,0.0,379.0,0.0,379.0,0.0,379.0
TCGA-H2-A3RI-01,TCGA-H2-A3RI,THCA,29.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-10956.0,Alive,[Discrepancy],335.0,0.0,335.0,0.0,335.0,1.0,279.0
TCGA-H2-A422-01,TCGA-H2-A422,THCA,40.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-14721.0,Alive,TUMOR FREE,566.0,0.0,566.0,0.0,566.0,0.0,566.0
TCGA-H4-A2HO-01,TCGA-H4-A2HO,BLCA,53.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-19630.0,Alive,TUMOR FREE,46.0,0.0,46.0,0.0,46.0,0.0,46.0
TCGA-H4-A2HQ-01,TCGA-H4-A2HQ,BLCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,Muscle invasive urothelial carcinoma (pT2 or above),2010.0,-23538.0,Alive,WITH TUMOR,590.0,0.0,590.0,0.0,590.0,1.0,318.0
TCGA-H5-A2HR-01,TCGA-H5-A2HR,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Endometrioid endometrial adenocarcinoma,2006.0,-25986.0,Alive,TUMOR FREE,53.0,0.0,53.0,0.0,53.0,0.0,53.0
TCGA-H9-7775-01,TCGA-H9-7775,PRAD,68.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-24898.0,Alive,TUMOR FREE,185.0,0.0,185.0,0.0,185.0,0.0,185.0
TCGA-HC-7077-01,TCGA-HC-7077,PRAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,,Prostate Adenocarcinoma Acinar Type,2006.0,-23636.0,Alive,TUMOR FREE,2115.0,0.0,2115.0,0.0,2115.0,0.0,2115.0
TCGA-HC-7081-01,TCGA-HC-7081,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,,Alive,WITH TUMOR,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0
TCGA-HC-7210-01,TCGA-HC-7210,PRAD,74.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-27343.0,Alive,TUMOR FREE,868.0,0.0,868.0,0.0,868.0,0.0,868.0
TCGA-HC-7211-01,TCGA-HC-7211,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-22768.0,Alive,TUMOR FREE,1221.0,0.0,1221.0,0.0,1221.0,0.0,1221.0
TCGA-HC-7212-01,TCGA-HC-7212,PRAD,56.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-20576.0,Alive,TUMOR FREE,870.0,0.0,870.0,0.0,870.0,0.0,870.0
TCGA-HC-7213-01,TCGA-HC-7213,PRAD,53.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-19699.0,Alive,TUMOR FREE,1219.0,0.0,1219.0,0.0,1219.0,1.0,170.0
TCGA-HC-7232-01,TCGA-HC-7232,PRAD,66.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-24324.0,Alive,WITH TUMOR,1161.0,0.0,1161.0,0.0,1161.0,1.0,766.0
TCGA-HC-7233-01,TCGA-HC-7233,PRAD,73.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,,Alive,TUMOR FREE,1355.0,0.0,1355.0,0.0,1355.0,0.0,1355.0
TCGA-HC-7736-01,TCGA-HC-7736,PRAD,59.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2010.0,-21703.0,Alive,TUMOR FREE,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0
TCGA-HC-7740-01,TCGA-HC-7740,PRAD,59.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-21883.0,Alive,TUMOR FREE,717.0,0.0,717.0,0.0,717.0,0.0,717.0
TCGA-HC-7744-01,TCGA-HC-7744,PRAD,46.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-17065.0,Alive,TUMOR FREE,531.0,0.0,531.0,0.0,531.0,0.0,531.0
TCGA-HC-7748-01,TCGA-HC-7748,PRAD,60.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2011.0,-22072.0,Alive,TUMOR FREE,792.0,0.0,792.0,0.0,792.0,0.0,792.0
TCGA-HC-8264-01,TCGA-HC-8264,PRAD,60.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-22177.0,Alive,WITH TUMOR,48.0,0.0,48.0,0.0,48.0,0.0,48.0
TCGA-HC-A76X-01,TCGA-HC-A76X,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-22756.0,Alive,TUMOR FREE,150.0,0.0,150.0,0.0,150.0,0.0,150.0
TCGA-HE-7128-01,TCGA-HE-7128,KIRP,,MALE,,Stage I,Kidney Papillary Renal Cell Carcinoma,2008.0,,Alive,TUMOR FREE,,0.0,,0.0,,0.0,
TCGA-HE-7129-01,TCGA-HE-7129,KIRP,,MALE,,Stage II,Kidney Papillary Renal Cell Carcinoma,2008.0,,Alive,TUMOR FREE,2492.0,0.0,2492.0,0.0,2492.0,1.0,2399.0
TCGA-HE-A5NF-01,TCGA-HE-A5NF,KIRP,58.0,MALE,[Not Evaluated],Stage I,Kidney Papillary Renal Cell Carcinoma,,-21524.0,Alive,TUMOR FREE,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0
TCGA-HE-A5NH-01,TCGA-HE-A5NH,KIRP,62.0,MALE,[Not Evaluated],Stage I,Kidney Papillary Renal Cell Carcinoma,,-22888.0,Alive,TUMOR FREE,791.0,0.0,791.0,0.0,791.0,0.0,791.0
TCGA-HE-A5NI-01,TCGA-HE-A5NI,KIRP,73.0,MALE,[Not Evaluated],Stage I,Kidney Papillary Renal Cell Carcinoma,,-26985.0,Alive,TUMOR FREE,360.0,0.0,360.0,0.0,360.0,0.0,360.0
TCGA-HE-A5NJ-01,TCGA-HE-A5NJ,KIRP,58.0,MALE,[Not Evaluated],,Kidney Papillary Renal Cell Carcinoma,,-21485.0,Alive,TUMOR FREE,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0
TCGA-HE-A5NL-01,TCGA-HE-A5NL,KIRP,51.0,MALE,[Not Evaluated],Stage I,Kidney Papillary Renal Cell Carcinoma,,-18913.0,Alive,TUMOR FREE,767.0,0.0,767.0,0.0,767.0,0.0,767.0
TCGA-HF-7132-01,TCGA-HF-7132,STAD,,MALE,,Stage II,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2006.0,,Alive,TUMOR FREE,2351.0,0.0,2351.0,0.0,2351.0,0.0,2351.0
TCGA-HF-7133-01,TCGA-HF-7133,STAD,,FEMALE,,Stage IV,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2007.0,,Alive,TUMOR FREE,1918.0,0.0,1918.0,0.0,1918.0,0.0,1918.0
TCGA-HF-7136-01,TCGA-HF-7136,STAD,,MALE,,Stage IIIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2008.0,,Alive,WITH TUMOR,,0.0,,0.0,,0.0,
TCGA-HF-A5NB-01,TCGA-HF-A5NB,STAD,75.0,FEMALE,[Not Evaluated],Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,-27676.0,Alive,TUMOR FREE,928.0,0.0,928.0,0.0,928.0,0.0,928.0
TCGA-HI-7168-01,TCGA-HI-7168,PRAD,62.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2005.0,-22881.0,Alive,WITH TUMOR,3323.0,0.0,3323.0,0.0,3323.0,1.0,2505.0
TCGA-HI-7170-01,TCGA-HI-7170,PRAD,58.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2006.0,-21199.0,Alive,TUMOR FREE,2522.0,0.0,2522.0,0.0,2522.0,0.0,2522.0
TCGA-HI-7171-01,TCGA-HI-7171,PRAD,56.0,MALE,WHITE,,Prostate Adenocarcinoma Acinar Type,2008.0,-20776.0,Dead,WITH TUMOR,,1.0,1329.0,1.0,1329.0,1.0,1329.0
TCGA-HN-A2NL-01,TCGA-HN-A2NL,BRCA,56.0,FEMALE,[Not Evaluated],Stage IIA,Infiltrating Lobular Carcinoma,,-20483.0,Alive,TUMOR FREE,79.0,0.0,79.0,0.0,79.0,0.0,79.0
TCGA-HN-A2OB-01,TCGA-HN-A2OB,BRCA,45.0,FEMALE,[Not Evaluated],Stage IIB,Infiltrating Lobular Carcinoma,,-16672.0,Dead,WITH TUMOR,,1.0,1900.0,1.0,1900.0,1.0,1543.0
TCGA-HP-A5MZ-01,TCGA-HP-A5MZ,LIHC,78.0,MALE,[Not Evaluated],Stage I,Hepatocellular Carcinoma,,-22702.0,Dead,TUMOR FREE,,1.0,91.0,0.0,91.0,0.0,91.0
TCGA-HP-A5N0-01,TCGA-HP-A5N0,LIHC,90.0,FEMALE,[Not Evaluated],,Hepatocellular Carcinoma,,-32120.0,Dead,WITH TUMOR,,1.0,1147.0,1.0,1147.0,1.0,179.0
TCGA-HQ-A2OE-01,TCGA-HQ-A2OE,BLCA,69.0,MALE,[Not Evaluated],,Muscle invasive urothelial carcinoma (pT2 or above),2007.0,,Alive,,1174.0,0.0,1174.0,0.0,1174.0,0.0,1174.0
TCGA-HR-A5NC-01,TCGA-HR-A5NC,SKCM,90.0,FEMALE,[Not Evaluated],,,,-32871.0,Alive,TUMOR FREE,1000.0,0.0,1000.0,0.0,1000.0,1.0,154.0
TCGA-HT-7467-01,TCGA-HT-7467,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2011.0,-19944.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-7468-01,TCGA-HT-7468,LGG,30.0,MALE,WHITE,,Oligodendroglioma,2011.0,-11209.0,Alive,TUMOR FREE,203.0,0.0,203.0,0.0,203.0,0.0,203.0
TCGA-HT-7469-01,TCGA-HT-7469,LGG,30.0,MALE,WHITE,,Oligodendroglioma,2011.0,-11097.0,Dead,WITH TUMOR,,1.0,351.0,1.0,351.0,1.0,92.0
TCGA-HT-7470-01,TCGA-HT-7470,LGG,37.0,MALE,WHITE,,Oligodendroglioma,2011.0,-13611.0,Dead,TUMOR FREE,,1.0,1220.0,0.0,1220.0,0.0,1220.0
TCGA-HT-7471-01,TCGA-HT-7471,LGG,37.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-13564.0,Alive,TUMOR FREE,4.0,0.0,4.0,0.0,4.0,0.0,4.0
TCGA-HT-7472-01,TCGA-HT-7472,LGG,38.0,MALE,WHITE,,Oligodendroglioma,2010.0,-13968.0,Alive,TUMOR FREE,1.0,0.0,1.0,0.0,1.0,0.0,1.0
TCGA-HT-7473-01,TCGA-HT-7473,LGG,28.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-10306.0,Alive,TUMOR FREE,503.0,0.0,503.0,0.0,503.0,0.0,503.0
TCGA-HT-7474-01,TCGA-HT-7474,LGG,52.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-19149.0,Alive,TUMOR FREE,114.0,0.0,114.0,0.0,114.0,0.0,114.0
TCGA-HT-7475-01,TCGA-HT-7475,LGG,67.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-24686.0,Alive,TUMOR FREE,530.0,0.0,530.0,0.0,530.0,0.0,530.0
TCGA-HT-7476-01,TCGA-HT-7476,LGG,26.0,MALE,WHITE,,Astrocytoma,2011.0,-9614.0,Alive,TUMOR FREE,199.0,0.0,199.0,0.0,199.0,0.0,199.0
TCGA-HT-7477-01,TCGA-HT-7477,LGG,62.0,MALE,WHITE,,Astrocytoma,2011.0,-22948.0,Alive,TUMOR FREE,738.0,0.0,738.0,0.0,738.0,0.0,738.0
TCGA-HT-7478-01,TCGA-HT-7478,LGG,36.0,MALE,WHITE,,Astrocytoma,2011.0,-13216.0,Alive,TUMOR FREE,194.0,0.0,194.0,0.0,194.0,0.0,194.0
TCGA-HT-7479-01,TCGA-HT-7479,LGG,44.0,MALE,WHITE,,Astrocytoma,2011.0,-16137.0,Alive,TUMOR FREE,1227.0,0.0,1227.0,0.0,1227.0,1.0,705.0
TCGA-HT-7480-01,TCGA-HT-7480,LGG,33.0,MALE,WHITE,,Oligodendroglioma,2005.0,-12291.0,Alive,WITH TUMOR,2287.0,0.0,2287.0,0.0,2287.0,1.0,1943.0
TCGA-HT-7481-01,TCGA-HT-7481,LGG,39.0,MALE,WHITE,,Oligodendroglioma,2006.0,-14306.0,Alive,WITH TUMOR,2918.0,0.0,2918.0,0.0,2918.0,1.0,880.0
TCGA-HT-7482-01,TCGA-HT-7482,LGG,18.0,FEMALE,WHITE,,Oligoastrocytoma,2005.0,-6857.0,Alive,TUMOR FREE,3253.0,0.0,3253.0,0.0,3253.0,1.0,374.0
TCGA-HT-7483-01,TCGA-HT-7483,LGG,14.0,MALE,WHITE,,Oligoastrocytoma,1998.0,-5267.0,Alive,TUMOR FREE,5255.0,0.0,5255.0,0.0,5255.0,0.0,5255.0
TCGA-HT-7485-01,TCGA-HT-7485,LGG,42.0,MALE,WHITE,,Astrocytoma,2006.0,-15589.0,Alive,TUMOR FREE,122.0,0.0,122.0,0.0,122.0,0.0,122.0
TCGA-HT-7601-01,TCGA-HT-7601,LGG,30.0,FEMALE,WHITE,,Astrocytoma,2008.0,-10989.0,Alive,TUMOR FREE,153.0,0.0,153.0,0.0,153.0,0.0,153.0
TCGA-HT-7602-01,TCGA-HT-7602,LGG,21.0,MALE,WHITE,,Oligodendroglioma,2008.0,-7946.0,Alive,TUMOR FREE,908.0,0.0,908.0,0.0,908.0,0.0,908.0
TCGA-HT-7603-01,TCGA-HT-7603,LGG,29.0,MALE,WHITE,,Oligodendroglioma,2008.0,-10883.0,Alive,TUMOR FREE,705.0,0.0,705.0,0.0,705.0,0.0,705.0
TCGA-HT-7604-01,TCGA-HT-7604,LGG,50.0,MALE,BLACK OR AFRICAN AMERICAN,,Astrocytoma,2003.0,-18443.0,Alive,TUMOR FREE,3725.0,0.0,3725.0,0.0,3725.0,0.0,3725.0
TCGA-HT-7605-01,TCGA-HT-7605,LGG,38.0,MALE,WHITE,,Oligodendroglioma,2008.0,-13892.0,Alive,,139.0,0.0,139.0,0.0,139.0,0.0,139.0
TCGA-HT-7606-01,TCGA-HT-7606,LGG,30.0,FEMALE,WHITE,,Astrocytoma,2008.0,-11233.0,Alive,TUMOR FREE,526.0,0.0,526.0,0.0,526.0,0.0,526.0
TCGA-HT-7607-01,TCGA-HT-7607,LGG,61.0,FEMALE,WHITE,,Astrocytoma,2008.0,-22585.0,Dead,WITH TUMOR,,1.0,96.0,1.0,96.0,1.0,96.0
TCGA-HT-7608-01,TCGA-HT-7608,LGG,61.0,MALE,BLACK OR AFRICAN AMERICAN,,Oligoastrocytoma,2007.0,-22302.0,Alive,TUMOR FREE,671.0,0.0,671.0,0.0,671.0,0.0,671.0
TCGA-HT-7609-01,TCGA-HT-7609,LGG,34.0,MALE,WHITE,,Oligoastrocytoma,2007.0,-12607.0,Alive,TUMOR FREE,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0
TCGA-HT-7610-01,TCGA-HT-7610,LGG,25.0,FEMALE,WHITE,,Oligoastrocytoma,2007.0,-9447.0,Alive,TUMOR FREE,1706.0,0.0,1706.0,0.0,1706.0,1.0,1205.0
TCGA-HT-7611-01,TCGA-HT-7611,LGG,36.0,MALE,WHITE,,Oligoastrocytoma,2007.0,-13314.0,Alive,TUMOR FREE,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0
TCGA-HT-7616-01,TCGA-HT-7616,LGG,75.0,MALE,WHITE,,Oligodendroglioma,2007.0,-27685.0,Dead,WITH TUMOR,,1.0,7.0,1.0,7.0,1.0,7.0
TCGA-HT-7620-01,TCGA-HT-7620,LGG,40.0,MALE,WHITE,,Oligodendroglioma,2007.0,-14659.0,Alive,TUMOR FREE,434.0,0.0,434.0,0.0,434.0,1.0,280.0
TCGA-HT-7676-01,TCGA-HT-7676,LGG,26.0,MALE,WHITE,,Oligodendroglioma,2009.0,-9667.0,Alive,TUMOR FREE,5.0,0.0,5.0,0.0,5.0,0.0,5.0
TCGA-HT-7677-01,TCGA-HT-7677,LGG,53.0,MALE,WHITE,,Oligodendroglioma,2009.0,-19610.0,Alive,[Discrepancy],494.0,0.0,494.0,0.0,494.0,0.0,494.0
TCGA-HT-7680-01,TCGA-HT-7680,LGG,32.0,FEMALE,WHITE,,Astrocytoma,2010.0,-11970.0,Alive,TUMOR FREE,23.0,0.0,23.0,0.0,23.0,0.0,23.0
TCGA-HT-7681-01,TCGA-HT-7681,LGG,29.0,FEMALE,WHITE,,Oligoastrocytoma,2009.0,-10790.0,Alive,TUMOR FREE,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0
TCGA-HT-7684-01,TCGA-HT-7684,LGG,58.0,MALE,WHITE,,Oligoastrocytoma,2008.0,-21352.0,Alive,TUMOR FREE,184.0,0.0,184.0,0.0,184.0,0.0,184.0
TCGA-HT-7686-01,TCGA-HT-7686,LGG,29.0,FEMALE,WHITE,,Astrocytoma,2008.0,-10724.0,Alive,TUMOR FREE,1300.0,0.0,1300.0,0.0,1300.0,0.0,1300.0
TCGA-HT-7687-01,TCGA-HT-7687,LGG,74.0,MALE,WHITE,,Oligodendroglioma,2010.0,-27186.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-7688-01,TCGA-HT-7688,LGG,59.0,MALE,WHITE,,Oligodendroglioma,2009.0,-21844.0,Alive,TUMOR FREE,964.0,0.0,964.0,0.0,964.0,0.0,964.0
TCGA-HT-7689-01,TCGA-HT-7689,LGG,58.0,FEMALE,WHITE,,Oligodendroglioma,2009.0,-21331.0,Alive,TUMOR FREE,455.0,0.0,455.0,0.0,455.0,0.0,455.0
TCGA-HT-7690-01,TCGA-HT-7690,LGG,29.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-10673.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-7691-01,TCGA-HT-7691,LGG,31.0,FEMALE,WHITE,,Astrocytoma,2008.0,-11465.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-7692-01,TCGA-HT-7692,LGG,43.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-15727.0,Alive,TUMOR FREE,90.0,0.0,90.0,0.0,90.0,0.0,90.0
TCGA-HT-7693-01,TCGA-HT-7693,LGG,51.0,FEMALE,WHITE,,Oligodendroglioma,2008.0,-18956.0,Alive,TUMOR FREE,533.0,0.0,533.0,0.0,533.0,0.0,533.0
TCGA-HT-7694-01,TCGA-HT-7694,LGG,60.0,MALE,WHITE,,Oligodendroglioma,2008.0,-21930.0,Alive,TUMOR FREE,210.0,0.0,210.0,0.0,210.0,0.0,210.0
TCGA-HT-7695-01,TCGA-HT-7695,LGG,29.0,FEMALE,WHITE,,Oligodendroglioma,2009.0,-10827.0,Alive,TUMOR FREE,442.0,0.0,442.0,0.0,442.0,0.0,442.0
TCGA-HT-7854-01,TCGA-HT-7854,LGG,62.0,MALE,WHITE,,Astrocytoma,2010.0,-22738.0,Alive,TUMOR FREE,1201.0,0.0,1201.0,0.0,1201.0,1.0,1147.0
TCGA-HT-7855-01,TCGA-HT-7855,LGG,39.0,MALE,WHITE,,Astrocytoma,2008.0,-14496.0,Alive,TUMOR FREE,585.0,0.0,585.0,0.0,585.0,0.0,585.0
TCGA-HT-7856-01,TCGA-HT-7856,LGG,35.0,MALE,WHITE,,Oligodendroglioma,2008.0,-13145.0,Alive,TUMOR FREE,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0
TCGA-HT-7857-01,TCGA-HT-7857,LGG,24.0,FEMALE,WHITE,,Astrocytoma,2006.0,-8912.0,Alive,TUMOR FREE,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-HT-7858-01,TCGA-HT-7858,LGG,28.0,MALE,WHITE,,Astrocytoma,2007.0,-10422.0,Alive,TUMOR FREE,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0
TCGA-HT-7860-01,TCGA-HT-7860,LGG,60.0,FEMALE,WHITE,,Astrocytoma,2009.0,-22034.0,Alive,TUMOR FREE,15.0,0.0,15.0,0.0,15.0,0.0,15.0
TCGA-HT-7873-01,TCGA-HT-7873,LGG,29.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-10805.0,Alive,WITH TUMOR,718.0,0.0,718.0,0.0,718.0,0.0,718.0
TCGA-HT-7874-01,TCGA-HT-7874,LGG,41.0,FEMALE,WHITE,,Oligodendroglioma,2008.0,-15045.0,Alive,TUMOR FREE,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0
TCGA-HT-7875-01,TCGA-HT-7875,LGG,56.0,MALE,WHITE,,Oligodendroglioma,2008.0,-20613.0,Alive,TUMOR FREE,10.0,0.0,10.0,0.0,10.0,0.0,10.0
TCGA-HT-7877-01,TCGA-HT-7877,LGG,20.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-7581.0,Alive,TUMOR FREE,4.0,0.0,4.0,0.0,4.0,0.0,4.0
TCGA-HT-7879-01,TCGA-HT-7879,LGG,31.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-11622.0,Alive,TUMOR FREE,112.0,0.0,112.0,0.0,112.0,0.0,112.0
TCGA-HT-7880-01,TCGA-HT-7880,LGG,30.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-11043.0,Alive,TUMOR FREE,162.0,0.0,162.0,0.0,162.0,0.0,162.0
TCGA-HT-7881-01,TCGA-HT-7881,LGG,38.0,MALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2011.0,-14171.0,Alive,TUMOR FREE,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0
TCGA-HT-7882-01,TCGA-HT-7882,LGG,66.0,MALE,WHITE,,Oligodendroglioma,2010.0,-24450.0,Dead,WITH TUMOR,,1.0,113.0,1.0,113.0,1.0,113.0
TCGA-HT-7884-01,TCGA-HT-7884,LGG,44.0,FEMALE,WHITE,,Astrocytoma,2011.0,-16280.0,Alive,[Discrepancy],343.0,0.0,343.0,0.0,343.0,0.0,343.0
TCGA-HT-7902-01,TCGA-HT-7902,LGG,30.0,FEMALE,WHITE,,Oligoastrocytoma,2009.0,-11118.0,Alive,TUMOR FREE,956.0,0.0,956.0,0.0,956.0,0.0,956.0
TCGA-HT-8010-01,TCGA-HT-8010,LGG,64.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-23680.0,Alive,TUMOR FREE,50.0,0.0,50.0,0.0,50.0,0.0,50.0
TCGA-HT-8011-01,TCGA-HT-8011,LGG,55.0,MALE,WHITE,,Astrocytoma,2009.0,-20175.0,Alive,WITH TUMOR,494.0,0.0,494.0,0.0,494.0,1.0,278.0
TCGA-HT-8012-01,TCGA-HT-8012,LGG,30.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-11295.0,Alive,WITH TUMOR,286.0,0.0,286.0,0.0,286.0,1.0,133.0
TCGA-HT-8015-01,TCGA-HT-8015,LGG,21.0,MALE,WHITE,,Astrocytoma,2008.0,-7760.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-8018-01,TCGA-HT-8018,LGG,40.0,FEMALE,WHITE,,Oligoastrocytoma,2010.0,-14910.0,Dead,TUMOR FREE,,1.0,1152.0,0.0,1152.0,0.0,1152.0
TCGA-HT-8104-01,TCGA-HT-8104,LGG,51.0,FEMALE,WHITE,,Astrocytoma,2010.0,-18748.0,Alive,TUMOR FREE,372.0,0.0,372.0,0.0,372.0,0.0,372.0
TCGA-HT-8105-01,TCGA-HT-8105,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2011.0,-20041.0,Alive,TUMOR FREE,190.0,0.0,190.0,0.0,190.0,0.0,190.0
TCGA-HT-8106-01,TCGA-HT-8106,LGG,53.0,MALE,WHITE,,Astrocytoma,2010.0,-19555.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-8107-01,TCGA-HT-8107,LGG,62.0,MALE,WHITE,,Oligodendroglioma,2011.0,-22880.0,Alive,TUMOR FREE,14.0,0.0,14.0,0.0,14.0,0.0,14.0
TCGA-HT-8109-01,TCGA-HT-8109,LGG,64.0,MALE,WHITE,,Oligodendroglioma,2011.0,-23486.0,Alive,TUMOR FREE,169.0,0.0,169.0,0.0,169.0,0.0,169.0
TCGA-HT-8110-01,TCGA-HT-8110,LGG,57.0,MALE,WHITE,,Astrocytoma,2011.0,-21183.0,Alive,TUMOR FREE,419.0,0.0,419.0,0.0,419.0,0.0,419.0
TCGA-HT-8111-01,TCGA-HT-8111,LGG,32.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-11810.0,Alive,,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-HT-8113-01,TCGA-HT-8113,LGG,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Oligodendroglioma,2006.0,-18173.0,Alive,TUMOR FREE,900.0,0.0,900.0,0.0,900.0,0.0,900.0
TCGA-HT-8114-01,TCGA-HT-8114,LGG,36.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-13198.0,Alive,TUMOR FREE,1040.0,0.0,1040.0,0.0,1040.0,0.0,1040.0
TCGA-HT-8558-01,TCGA-HT-8558,LGG,29.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-10950.0,Alive,TUMOR FREE,418.0,0.0,418.0,0.0,418.0,0.0,418.0
TCGA-HT-8564-01,TCGA-HT-8564,LGG,47.0,MALE,WHITE,,Astrocytoma,2012.0,-17499.0,Alive,WITH TUMOR,478.0,0.0,478.0,0.0,478.0,1.0,120.0
TCGA-HT-A4DV-01,TCGA-HT-A4DV,LGG,51.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-18799.0,Alive,TUMOR FREE,792.0,0.0,792.0,0.0,792.0,0.0,792.0
TCGA-HT-A5R5-01,TCGA-HT-A5R5,LGG,33.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-12403.0,Alive,TUMOR FREE,4.0,0.0,4.0,0.0,4.0,0.0,4.0
TCGA-HT-A5R7-01,TCGA-HT-A5R7,LGG,33.0,FEMALE,WHITE,,Astrocytoma,2012.0,-12092.0,Alive,TUMOR FREE,615.0,0.0,615.0,0.0,615.0,0.0,615.0
TCGA-HT-A5R9-01,TCGA-HT-A5R9,LGG,48.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-17775.0,Alive,,2.0,0.0,2.0,0.0,2.0,0.0,2.0
TCGA-HT-A5RB-01,TCGA-HT-A5RB,LGG,24.0,MALE,WHITE,,Astrocytoma,2011.0,-8820.0,Alive,,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HT-A614-01,TCGA-HT-A614,LGG,47.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-17392.0,Alive,WITH TUMOR,82.0,0.0,82.0,0.0,82.0,0.0,82.0
TCGA-HT-A615-01,TCGA-HT-A615,LGG,38.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-13892.0,Alive,TUMOR FREE,515.0,0.0,515.0,0.0,515.0,0.0,515.0
TCGA-HT-A616-01,TCGA-HT-A616,LGG,36.0,FEMALE,WHITE,,Astrocytoma,2013.0,-13222.0,Alive,,55.0,0.0,55.0,0.0,55.0,0.0,55.0
TCGA-HT-A617-01,TCGA-HT-A617,LGG,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,,Oligodendroglioma,2010.0,-17331.0,Alive,,491.0,0.0,491.0,0.0,491.0,1.0,395.0
TCGA-HT-A618-01,TCGA-HT-A618,LGG,37.0,FEMALE,WHITE,,Astrocytoma,2013.0,-13595.0,Alive,TUMOR FREE,512.0,0.0,512.0,0.0,512.0,0.0,512.0
TCGA-HT-A61A-01,TCGA-HT-A61A,LGG,20.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-7664.0,Alive,TUMOR FREE,194.0,0.0,194.0,0.0,194.0,0.0,194.0
TCGA-HT-A61B-01,TCGA-HT-A61B,LGG,22.0,MALE,WHITE,,Astrocytoma,2012.0,-8335.0,Alive,TUMOR FREE,533.0,0.0,533.0,0.0,533.0,0.0,533.0
TCGA-HT-A74H-01,TCGA-HT-A74H,LGG,62.0,MALE,WHITE,,Astrocytoma,2013.0,-22850.0,Alive,,74.0,0.0,74.0,0.0,74.0,0.0,74.0
TCGA-HT-A74J-01,TCGA-HT-A74J,LGG,33.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-12393.0,Alive,,320.0,0.0,320.0,0.0,320.0,0.0,320.0
TCGA-HT-A74L-01,TCGA-HT-A74L,LGG,22.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-8240.0,Alive,WITH TUMOR,336.0,0.0,336.0,0.0,336.0,0.0,336.0
TCGA-HT-A74O-01,TCGA-HT-A74O,LGG,34.0,MALE,WHITE,,Astrocytoma,2013.0,-12460.0,Alive,,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-HU-8602-01,TCGA-HU-8602,STAD,58.0,FEMALE,ASIAN,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-21522.0,Alive,TUMOR FREE,679.0,0.0,679.0,0.0,679.0,0.0,679.0
TCGA-HU-8608-01,TCGA-HU-8608,STAD,70.0,MALE,ASIAN,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-25789.0,Alive,WITH TUMOR,641.0,0.0,641.0,0.0,641.0,1.0,277.0
TCGA-HU-8610-01,TCGA-HU-8610,STAD,75.0,MALE,ASIAN,Stage IA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-27594.0,Alive,TUMOR FREE,23.0,0.0,23.0,0.0,23.0,0.0,23.0
TCGA-HU-A4GF-01,TCGA-HU-A4GF,STAD,69.0,MALE,ASIAN,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-25223.0,Alive,TUMOR FREE,785.0,0.0,785.0,0.0,785.0,0.0,785.0
TCGA-HU-A4GQ-01,TCGA-HU-A4GQ,STAD,71.0,MALE,ASIAN,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-26200.0,Dead,[Discrepancy],,1.0,3.0,1.0,3.0,0.0,3.0
TCGA-HU-A4GT-01,TCGA-HU-A4GT,STAD,71.0,FEMALE,ASIAN,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-26231.0,Alive,TUMOR FREE,198.0,0.0,198.0,0.0,198.0,0.0,198.0
TCGA-HU-A4GU-01,TCGA-HU-A4GU,STAD,73.0,MALE,ASIAN,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-27024.0,Alive,TUMOR FREE,200.0,0.0,200.0,0.0,200.0,0.0,200.0
TCGA-HU-A4GX-01,TCGA-HU-A4GX,STAD,70.0,FEMALE,ASIAN,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-25913.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-HU-A4GY-01,TCGA-HU-A4GY,STAD,76.0,FEMALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2012.0,-28113.0,Alive,TUMOR FREE,8.0,0.0,8.0,0.0,8.0,0.0,8.0
TCGA-HU-A4H2-01,TCGA-HU-A4H2,STAD,58.0,FEMALE,ASIAN,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-21496.0,Alive,TUMOR FREE,394.0,0.0,394.0,0.0,394.0,0.0,394.0
TCGA-HU-A4H3-01,TCGA-HU-A4H3,STAD,56.0,FEMALE,ASIAN,Stage IIIC,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-20790.0,Alive,WITH TUMOR,882.0,0.0,882.0,0.0,882.0,1.0,410.0
TCGA-HU-A4H4-01,TCGA-HU-A4H4,STAD,53.0,FEMALE,ASIAN,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-19665.0,Alive,TUMOR FREE,725.0,0.0,725.0,0.0,725.0,0.0,725.0
TCGA-HU-A4H5-01,TCGA-HU-A4H5,STAD,71.0,MALE,ASIAN,Stage IB,"Stomach, Intestinal Adenocarcinoma, Papillary Type",2011.0,-26232.0,Alive,TUMOR FREE,724.0,0.0,724.0,0.0,724.0,0.0,724.0
TCGA-HU-A4HD-01,TCGA-HU-A4HD,STAD,73.0,MALE,ASIAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-26699.0,Alive,TUMOR FREE,1016.0,0.0,1016.0,0.0,1016.0,0.0,1016.0
TCGA-HW-7486-01,TCGA-HW-7486,LGG,37.0,MALE,WHITE,,Oligodendroglioma,2010.0,-13546.0,Alive,TUMOR FREE,1721.0,0.0,1721.0,0.0,1721.0,0.0,1721.0
TCGA-HW-7487-01,TCGA-HW-7487,LGG,39.0,MALE,WHITE,,Oligodendroglioma,2010.0,-14535.0,Alive,WITH TUMOR,1382.0,0.0,1382.0,0.0,1382.0,1.0,840.0
TCGA-HW-7489-01,TCGA-HW-7489,LGG,38.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-14201.0,Dead,WITH TUMOR,,1.0,1262.0,1.0,1262.0,1.0,1262.0
TCGA-HW-7490-01,TCGA-HW-7490,LGG,41.0,MALE,WHITE,,Astrocytoma,2011.0,-15092.0,Alive,WITH TUMOR,1387.0,0.0,1387.0,0.0,1387.0,0.0,1387.0
TCGA-HW-7491-01,TCGA-HW-7491,LGG,35.0,MALE,WHITE,,Oligodendroglioma,2009.0,-12874.0,Alive,WITH TUMOR,2078.0,0.0,2078.0,0.0,2078.0,1.0,2197.0
TCGA-HW-7495-01,TCGA-HW-7495,LGG,45.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-16460.0,Alive,WITH TUMOR,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0
TCGA-HW-8319-01,TCGA-HW-8319,LGG,34.0,FEMALE,WHITE,,Astrocytoma,2011.0,-12557.0,Dead,WITH TUMOR,,1.0,1209.0,1.0,1209.0,1.0,997.0
TCGA-HW-8320-01,TCGA-HW-8320,LGG,36.0,MALE,WHITE,,Astrocytoma,2011.0,-13503.0,Alive,WITH TUMOR,1217.0,0.0,1217.0,0.0,1217.0,0.0,1217.0
TCGA-HW-8321-01,TCGA-HW-8321,LGG,31.0,MALE,WHITE,,Astrocytoma,2011.0,-11474.0,Alive,WITH TUMOR,1294.0,0.0,1294.0,0.0,1294.0,0.0,1294.0
TCGA-HW-8322-01,TCGA-HW-8322,LGG,39.0,MALE,WHITE,,Oligodendroglioma,2012.0,-14548.0,Alive,WITH TUMOR,758.0,0.0,758.0,0.0,758.0,0.0,758.0
TCGA-HW-A5KJ-01,TCGA-HW-A5KJ,LGG,68.0,MALE,WHITE,,Oligodendroglioma,2012.0,-24966.0,Dead,WITH TUMOR,,1.0,962.0,1.0,962.0,1.0,615.0
TCGA-HW-A5KK-01,TCGA-HW-A5KK,LGG,64.0,MALE,WHITE,,Astrocytoma,2012.0,-23484.0,Dead,WITH TUMOR,,1.0,388.0,1.0,388.0,1.0,388.0
TCGA-HW-A5KM-01,TCGA-HW-A5KM,LGG,35.0,MALE,WHITE,,Astrocytoma,2012.0,-12845.0,Alive,WITH TUMOR,630.0,0.0,630.0,0.0,630.0,0.0,630.0
TCGA-IA-A40U-01,TCGA-IA-A40U,KIRP,56.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-20463.0,Alive,TUMOR FREE,511.0,0.0,511.0,0.0,511.0,0.0,511.0
TCGA-IA-A40X-01,TCGA-IA-A40X,KIRP,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-18239.0,Alive,TUMOR FREE,608.0,0.0,608.0,0.0,608.0,0.0,608.0
TCGA-IA-A40Y-01,TCGA-IA-A40Y,KIRP,60.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-21996.0,Alive,TUMOR FREE,62.0,0.0,62.0,0.0,62.0,0.0,62.0
TCGA-IC-A6RE-01,TCGA-IC-A6RE,ESCA,59.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2013.0,-21640.0,Alive,WITH TUMOR,234.0,0.0,234.0,0.0,234.0,0.0,234.0
TCGA-IG-A3I8-01,TCGA-IG-A3I8,ESCA,51.0,FEMALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-18786.0,Alive,TUMOR FREE,1012.0,0.0,1012.0,0.0,1012.0,0.0,1012.0
TCGA-IG-A3QL-01,TCGA-IG-A3QL,ESCA,54.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-19755.0,Alive,TUMOR FREE,1071.0,0.0,1071.0,0.0,1071.0,0.0,1071.0
TCGA-IG-A3Y9-01,TCGA-IG-A3Y9,ESCA,72.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2012.0,-26330.0,Dead,TUMOR FREE,,1.0,26.0,0.0,26.0,0.0,26.0
TCGA-IG-A3YA-01,TCGA-IG-A3YA,ESCA,53.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2012.0,-19567.0,Alive,TUMOR FREE,632.0,0.0,632.0,0.0,632.0,0.0,632.0
TCGA-IG-A3YB-01,TCGA-IG-A3YB,ESCA,61.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2012.0,-22316.0,Alive,TUMOR FREE,80.0,0.0,80.0,0.0,80.0,0.0,80.0
TCGA-IG-A3YC-01,TCGA-IG-A3YC,ESCA,62.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2012.0,-22774.0,Alive,WITH TUMOR,612.0,0.0,612.0,0.0,612.0,1.0,542.0
TCGA-IG-A4P3-01,TCGA-IG-A4P3,ESCA,48.0,MALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2012.0,-17860.0,Dead,WITH TUMOR,,1.0,567.0,1.0,567.0,1.0,567.0
TCGA-IG-A4QS-01,TCGA-IG-A4QS,ESCA,71.0,MALE,WHITE,Stage IIIB,"Esophagus Adenocarcinoma, NOS",2012.0,-26273.0,Dead,TUMOR FREE,,1.0,118.0,0.0,118.0,0.0,118.0
TCGA-IG-A50L-01,TCGA-IG-A50L,ESCA,58.0,MALE,ASIAN,Stage IIIA,Esophagus Squamous Cell Carcinoma,2012.0,-21214.0,Alive,TUMOR FREE,16.0,0.0,16.0,0.0,16.0,0.0,16.0
TCGA-IG-A51D-01,TCGA-IG-A51D,ESCA,63.0,MALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2012.0,-23259.0,Alive,TUMOR FREE,518.0,0.0,518.0,0.0,518.0,0.0,518.0
TCGA-IG-A5B8-01,TCGA-IG-A5B8,ESCA,72.0,MALE,WHITE,Stage IB,Esophagus Squamous Cell Carcinoma,2012.0,-26574.0,Dead,TUMOR FREE,,1.0,24.0,0.0,24.0,0.0,24.0
TCGA-IG-A5S3-01,TCGA-IG-A5S3,ESCA,69.0,FEMALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2012.0,-25414.0,Alive,TUMOR FREE,712.0,0.0,712.0,0.0,712.0,0.0,712.0
TCGA-IG-A625-01,TCGA-IG-A625,ESCA,60.0,MALE,ASIAN,Stage IIIB,Esophagus Squamous Cell Carcinoma,2012.0,-22070.0,Dead,TUMOR FREE,,1.0,390.0,0.0,390.0,0.0,390.0
TCGA-IG-A6QS-01,TCGA-IG-A6QS,ESCA,54.0,MALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2013.0,-19900.0,Dead,TUMOR FREE,,1.0,303.0,0.0,303.0,0.0,303.0
TCGA-IG-A8O2-01,TCGA-IG-A8O2,ESCA,62.0,MALE,ASIAN,Stage IIIB,Esophagus Squamous Cell Carcinoma,2013.0,-22869.0,Dead,TUMOR FREE,,1.0,142.0,0.0,142.0,0.0,142.0
TCGA-IG-A97H-01,TCGA-IG-A97H,ESCA,36.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-13166.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-IG-A97I-01,TCGA-IG-A97I,ESCA,58.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-21271.0,Alive,TUMOR FREE,370.0,0.0,370.0,0.0,370.0,0.0,370.0
TCGA-IH-A3EA-01,TCGA-IH-A3EA,SKCM,61.0,MALE,WHITE,Stage IIC,,2008.0,-22577.0,Alive,WITH TUMOR,524.0,0.0,524.0,0.0,524.0,1.0,314.0
TCGA-IK-7675-01,TCGA-IK-7675,LGG,43.0,MALE,WHITE,,Oligodendroglioma,2009.0,-15900.0,Dead,WITH TUMOR,,1.0,578.0,1.0,578.0,1.0,123.0
TCGA-IK-8125-01,TCGA-IK-8125,LGG,62.0,MALE,WHITE,,Oligoastrocytoma,2009.0,-22745.0,Alive,TUMOR FREE,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0
TCGA-IM-A3EB-01,TCGA-IM-A3EB,THCA,32.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-11822.0,Alive,TUMOR FREE,1488.0,0.0,1488.0,0.0,1488.0,0.0,1488.0
TCGA-IM-A3ED-01,TCGA-IM-A3ED,THCA,58.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2008.0,-21278.0,Alive,TUMOR FREE,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0
TCGA-IM-A41Y-01,TCGA-IM-A41Y,THCA,42.0,FEMALE,WHITE,Stage I,"Other, specify",2012.0,-15694.0,Alive,TUMOR FREE,664.0,0.0,664.0,0.0,664.0,0.0,664.0
TCGA-IN-7806-01,TCGA-IN-7806,STAD,50.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-18404.0,Alive,TUMOR FREE,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0
TCGA-IN-7808-01,TCGA-IN-7808,STAD,59.0,MALE,WHITE,[Discrepancy],"Stomach, Adenocarcinoma, Diffuse Type",2011.0,-21569.0,Dead,WITH TUMOR,,1.0,105.0,1.0,105.0,1.0,105.0
TCGA-IN-8462-01,TCGA-IN-8462,STAD,80.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-29242.0,Alive,WITH TUMOR,572.0,0.0,572.0,0.0,572.0,1.0,270.0
TCGA-IN-8663-01,TCGA-IN-8663,STAD,68.0,MALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25172.0,Dead,TUMOR FREE,,1.0,103.0,0.0,103.0,0.0,103.0
TCGA-IN-A6RI-01,TCGA-IN-A6RI,STAD,45.0,MALE,WHITE,Stage I,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-16788.0,Alive,TUMOR FREE,559.0,0.0,559.0,0.0,559.0,0.0,559.0
TCGA-IN-A6RL-01,TCGA-IN-A6RL,STAD,84.0,MALE,WHITE,[Discrepancy],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-30783.0,Dead,WITH TUMOR,,1.0,406.0,1.0,406.0,1.0,307.0
TCGA-IN-A6RO-01,TCGA-IN-A6RO,STAD,70.0,MALE,ASIAN,Stage IA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25789.0,Dead,WITH TUMOR,,1.0,,1.0,,1.0,154.0
TCGA-IN-A6RR-01,TCGA-IN-A6RR,STAD,84.0,MALE,WHITE,[Discrepancy],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-30734.0,Dead,TUMOR FREE,,1.0,205.0,0.0,205.0,0.0,205.0
TCGA-IN-A6RS-01,TCGA-IN-A6RS,STAD,76.0,MALE,WHITE,Stage IA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-27808.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-IN-A7NR-01,TCGA-IN-A7NR,STAD,64.0,FEMALE,WHITE,Stage IV,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-23415.0,Alive,TUMOR FREE,198.0,0.0,198.0,0.0,198.0,0.0,198.0
TCGA-IN-A7NT-01,TCGA-IN-A7NT,STAD,73.0,FEMALE,WHITE,Stage IIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-26727.0,Alive,TUMOR FREE,323.0,0.0,323.0,0.0,323.0,0.0,323.0
TCGA-IN-A7NU-01,TCGA-IN-A7NU,STAD,69.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-25515.0,Alive,WITH TUMOR,356.0,0.0,356.0,0.0,356.0,1.0,337.0
TCGA-IN-AB1V-01,TCGA-IN-AB1V,STAD,63.0,MALE,WHITE,Stage IA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-23030.0,Alive,TUMOR FREE,479.0,0.0,479.0,0.0,479.0,0.0,479.0
TCGA-IN-AB1X-01,TCGA-IN-AB1X,STAD,78.0,FEMALE,WHITE,Stage IIA,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-28493.0,Alive,TUMOR FREE,411.0,0.0,411.0,0.0,411.0,0.0,411.0
TCGA-IP-7968-01,TCGA-IP-7968,STAD,74.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-27114.0,Alive,TUMOR FREE,77.0,0.0,77.0,0.0,77.0,0.0,77.0
TCGA-IQ-7630-01,TCGA-IQ-7630,HNSC,49.0,MALE,WHITE,Stage II,Head & Neck Squamous Cell Carcinoma,2011.0,-18131.0,Alive,TUMOR FREE,485.0,0.0,485.0,0.0,485.0,0.0,485.0
TCGA-IQ-7632-01,TCGA-IQ-7632,HNSC,68.0,FEMALE,WHITE,Stage IVA,Head & Neck Squamous Cell Carcinoma,2011.0,-24986.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-IZ-8195-01,TCGA-IZ-8195,KIRP,82.0,MALE,WHITE,Stage II,Kidney Papillary Renal Cell Carcinoma,2012.0,-29963.0,Alive,TUMOR FREE,677.0,0.0,677.0,0.0,677.0,0.0,677.0
TCGA-IZ-8196-01,TCGA-IZ-8196,KIRP,50.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-18540.0,Alive,TUMOR FREE,649.0,0.0,649.0,0.0,649.0,0.0,649.0
TCGA-IZ-A6M8-01,TCGA-IZ-A6M8,KIRP,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2013.0,-25545.0,Alive,TUMOR FREE,497.0,0.0,497.0,0.0,497.0,0.0,497.0
TCGA-J4-8198-01,TCGA-J4-8198,PRAD,49.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-17935.0,Alive,TUMOR FREE,614.0,0.0,614.0,0.0,614.0,0.0,614.0
TCGA-J4-8200-01,TCGA-J4-8200,PRAD,47.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-17167.0,Alive,TUMOR FREE,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0
TCGA-J4-A67T-01,TCGA-J4-A67T,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-23211.0,Alive,TUMOR FREE,183.0,0.0,183.0,0.0,183.0,0.0,183.0
TCGA-J4-A6M7-01,TCGA-J4-A6M7,PRAD,53.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-19640.0,Alive,TUMOR FREE,512.0,0.0,512.0,0.0,512.0,0.0,512.0
TCGA-J4-A83I-01,TCGA-J4-A83I,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23240.0,Alive,TUMOR FREE,685.0,0.0,685.0,0.0,685.0,0.0,685.0
TCGA-J4-A83N-01,TCGA-J4-A83N,PRAD,57.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-20841.0,Alive,TUMOR FREE,992.0,0.0,992.0,0.0,992.0,1.0,433.0
TCGA-J7-6720-01,TCGA-J7-6720,KIRP,42.0,MALE,ASIAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2010.0,-15620.0,Alive,TUMOR FREE,388.0,0.0,388.0,0.0,388.0,0.0,388.0
TCGA-J7-8537-01,TCGA-J7-8537,KIRP,37.0,FEMALE,ASIAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2011.0,-13628.0,Dead,WITH TUMOR,,1.0,321.0,1.0,321.0,1.0,220.0
TCGA-J8-A3NZ-01,TCGA-J8-A3NZ,THCA,52.0,FEMALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-19058.0,Alive,TUMOR FREE,524.0,0.0,524.0,0.0,524.0,0.0,524.0
TCGA-J8-A3O0-01,TCGA-J8-A3O0,THCA,38.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-14214.0,Alive,TUMOR FREE,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0
TCGA-J8-A3O1-01,TCGA-J8-A3O1,THCA,33.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-12113.0,Alive,TUMOR FREE,827.0,0.0,827.0,0.0,827.0,0.0,827.0
TCGA-J8-A3O2-01,TCGA-J8-A3O2,THCA,39.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-14339.0,Alive,TUMOR FREE,342.0,0.0,342.0,0.0,342.0,0.0,342.0
TCGA-J8-A3YF-01,TCGA-J8-A3YF,THCA,83.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2009.0,-30661.0,Alive,TUMOR FREE,751.0,0.0,751.0,0.0,751.0,0.0,751.0
TCGA-J8-A3YH-01,TCGA-J8-A3YH,THCA,39.0,MALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-14470.0,Alive,TUMOR FREE,175.0,0.0,175.0,0.0,175.0,0.0,175.0
TCGA-J8-A42S-01,TCGA-J8-A42S,THCA,45.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-16609.0,Alive,,75.0,0.0,75.0,0.0,75.0,0.0,75.0
TCGA-J8-A4HY-01,TCGA-J8-A4HY,THCA,68.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2012.0,-25106.0,Alive,TUMOR FREE,6.0,0.0,6.0,0.0,6.0,0.0,6.0
TCGA-J9-A8CK-01,TCGA-J9-A8CK,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-24285.0,Alive,TUMOR FREE,321.0,0.0,321.0,0.0,321.0,0.0,321.0
TCGA-J9-A8CM-01,TCGA-J9-A8CM,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-24118.0,Alive,WITH TUMOR,463.0,0.0,463.0,0.0,463.0,1.0,344.0
TCGA-J9-A8CN-01,TCGA-J9-A8CN,PRAD,53.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-19662.0,Alive,TUMOR FREE,1237.0,0.0,1237.0,0.0,1237.0,0.0,1237.0
TCGA-J9-A8CP-01,TCGA-J9-A8CP,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-24299.0,Alive,TUMOR FREE,386.0,0.0,386.0,0.0,386.0,0.0,386.0
TCGA-JL-A3YX-01,TCGA-JL-A3YX,BRCA,46.0,FEMALE,ASIAN,Stage IIA,Infiltrating Lobular Carcinoma,2011.0,,Alive,,352.0,0.0,352.0,0.0,352.0,0.0,352.0
TCGA-JY-A6F8-01,TCGA-JY-A6F8,ESCA,56.0,MALE,WHITE,Stage I,"Esophagus Adenocarcinoma, NOS",2003.0,-20550.0,Alive,TUMOR FREE,3714.0,0.0,3714.0,0.0,3714.0,0.0,3714.0
TCGA-JY-A6FB-01,TCGA-JY-A6FB,ESCA,77.0,MALE,WHITE,Stage I,"Esophagus Adenocarcinoma, NOS",2007.0,-28269.0,Alive,TUMOR FREE,1837.0,0.0,1837.0,0.0,1837.0,0.0,1837.0
TCGA-JY-A6FD-01,TCGA-JY-A6FD,ESCA,51.0,FEMALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2008.0,-18808.0,Alive,TUMOR FREE,2069.0,0.0,2069.0,0.0,2069.0,0.0,2069.0
TCGA-JY-A6FE-01,TCGA-JY-A6FE,ESCA,49.0,MALE,WHITE,Stage III,Esophagus Squamous Cell Carcinoma,2009.0,-18105.0,Dead,WITH TUMOR,,1.0,112.0,1.0,112.0,1.0,55.0
TCGA-JY-A6FG-01,TCGA-JY-A6FG,ESCA,50.0,MALE,WHITE,Stage III,Esophagus Squamous Cell Carcinoma,2009.0,-18348.0,Dead,TUMOR FREE,,1.0,1263.0,0.0,1263.0,0.0,1263.0
TCGA-JY-A93E-01,TCGA-JY-A93E,ESCA,61.0,MALE,WHITE,Stage IIIA,"Esophagus Adenocarcinoma, NOS",2012.0,-22427.0,Alive,WITH TUMOR,767.0,0.0,767.0,0.0,767.0,0.0,767.0
TCGA-JY-A93F-01,TCGA-JY-A93F,ESCA,58.0,FEMALE,WHITE,Stage IB,Esophagus Squamous Cell Carcinoma,2012.0,-21257.0,Alive,TUMOR FREE,731.0,0.0,731.0,0.0,731.0,0.0,731.0
TCGA-K4-A3WS-01,TCGA-K4-A3WS,BLCA,66.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-24124.0,Alive,TUMOR FREE,761.0,0.0,761.0,0.0,761.0,0.0,761.0
TCGA-K4-A3WU-01,TCGA-K4-A3WU,BLCA,87.0,MALE,WHITE,Stage III,Muscle invasive urothelial carcinoma (pT2 or above),2012.0,-32134.0,Alive,TUMOR FREE,105.0,0.0,105.0,0.0,105.0,0.0,105.0
TCGA-K4-A3WV-01,TCGA-K4-A3WV,BLCA,77.0,FEMALE,WHITE,Stage II,Muscle invasive urothelial carcinoma (pT2 or above),2011.0,-28444.0,Alive,TUMOR FREE,646.0,0.0,646.0,0.0,646.0,0.0,646.0
TCGA-K6-A3WQ-01,TCGA-K6-A3WQ,UCEC,60.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2012.0,-22092.0,Dead,WITH TUMOR,,1.0,427.0,1.0,427.0,1.0,351.0
TCGA-K7-A5RF-01,TCGA-K7-A5RF,LIHC,64.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-23557.0,Alive,TUMOR FREE,631.0,0.0,631.0,0.0,631.0,1.0,205.0
TCGA-K7-A5RG-01,TCGA-K7-A5RG,LIHC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2012.0,-24218.0,Alive,TUMOR FREE,519.0,0.0,519.0,0.0,519.0,0.0,519.0
TCGA-KC-A4BL-01,TCGA-KC-A4BL,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2006.0,-24081.0,Alive,WITH TUMOR,934.0,0.0,934.0,0.0,934.0,1.0,193.0
TCGA-KC-A4BN-01,TCGA-KC-A4BN,PRAD,55.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-20392.0,Alive,TUMOR FREE,1815.0,0.0,1815.0,0.0,1815.0,0.0,1815.0
TCGA-KC-A4BR-01,TCGA-KC-A4BR,PRAD,75.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-27741.0,Alive,WITH TUMOR,1349.0,0.0,1349.0,0.0,1349.0,1.0,1022.0
TCGA-KC-A4BV-01,TCGA-KC-A4BV,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-24138.0,Alive,WITH TUMOR,1328.0,0.0,1328.0,0.0,1328.0,1.0,1328.0
TCGA-KC-A7F3-01,TCGA-KC-A7F3,PRAD,67.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-24676.0,Alive,TUMOR FREE,665.0,0.0,665.0,0.0,665.0,0.0,665.0
TCGA-KC-A7F6-01,TCGA-KC-A7F6,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23367.0,Alive,TUMOR FREE,263.0,0.0,263.0,0.0,263.0,0.0,263.0
TCGA-KC-A7FA-01,TCGA-KC-A7FA,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23208.0,Alive,TUMOR FREE,598.0,0.0,598.0,0.0,598.0,0.0,598.0
TCGA-KC-A7FD-01,TCGA-KC-A7FD,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-22745.0,Alive,TUMOR FREE,270.0,0.0,270.0,0.0,270.0,0.0,270.0
TCGA-KC-A7FE-01,TCGA-KC-A7FE,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-22718.0,Alive,TUMOR FREE,352.0,0.0,352.0,0.0,352.0,0.0,352.0
TCGA-KK-A59X-01,TCGA-KK-A59X,PRAD,55.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-20416.0,Alive,WITH TUMOR,2535.0,0.0,2535.0,0.0,2535.0,1.0,2233.0
TCGA-KK-A59Y-01,TCGA-KK-A59Y,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-20768.0,Alive,TUMOR FREE,1968.0,0.0,1968.0,0.0,1968.0,0.0,1968.0
TCGA-KK-A59Z-01,TCGA-KK-A59Z,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2007.0,-24306.0,Alive,TUMOR FREE,2628.0,0.0,2628.0,0.0,2628.0,0.0,2628.0
TCGA-KK-A6E0-01,TCGA-KK-A6E0,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-21700.0,Alive,TUMOR FREE,1483.0,0.0,1483.0,0.0,1483.0,1.0,941.0
TCGA-KK-A6E1-01,TCGA-KK-A6E1,PRAD,57.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-21063.0,Alive,TUMOR FREE,2198.0,0.0,2198.0,0.0,2198.0,0.0,2198.0
TCGA-KK-A6E2-01,TCGA-KK-A6E2,PRAD,54.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2000.0,-19974.0,Alive,TUMOR FREE,5024.0,0.0,5024.0,0.0,5024.0,0.0,5024.0
TCGA-KK-A7AP-01,TCGA-KK-A7AP,PRAD,55.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-20403.0,Alive,,196.0,0.0,196.0,0.0,196.0,0.0,196.0
TCGA-KK-A7AU-01,TCGA-KK-A7AU,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-23118.0,Alive,TUMOR FREE,1775.0,0.0,1775.0,0.0,1775.0,1.0,207.0
TCGA-KK-A7B1-01,TCGA-KK-A7B1,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-23803.0,Alive,,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0
TCGA-KK-A7B3-01,TCGA-KK-A7B3,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-22830.0,Alive,TUMOR FREE,899.0,0.0,899.0,0.0,899.0,1.0,294.0
TCGA-KK-A7B4-01,TCGA-KK-A7B4,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-23644.0,Alive,WITH TUMOR,987.0,0.0,987.0,0.0,987.0,1.0,637.0
TCGA-KK-A8I4-01,TCGA-KK-A8I4,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-23706.0,Alive,WITH TUMOR,2259.0,0.0,2259.0,0.0,2259.0,1.0,1162.0
TCGA-KK-A8I5-01,TCGA-KK-A8I5,PRAD,55.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2006.0,-20337.0,Alive,TUMOR FREE,3096.0,0.0,3096.0,0.0,3096.0,0.0,3096.0
TCGA-KK-A8I6-01,TCGA-KK-A8I6,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-21499.0,Alive,TUMOR FREE,668.0,0.0,668.0,0.0,668.0,0.0,668.0
TCGA-KK-A8I8-01,TCGA-KK-A8I8,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-25546.0,Alive,TUMOR FREE,967.0,0.0,967.0,0.0,967.0,0.0,967.0
TCGA-KK-A8IA-01,TCGA-KK-A8IA,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-25284.0,Alive,,1931.0,0.0,1931.0,0.0,1931.0,0.0,1931.0
TCGA-KK-A8IB-01,TCGA-KK-A8IB,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-24041.0,Alive,,83.0,0.0,83.0,0.0,83.0,0.0,83.0
TCGA-KK-A8IC-01,TCGA-KK-A8IC,PRAD,54.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-19902.0,Alive,WITH TUMOR,2051.0,0.0,2051.0,0.0,2051.0,1.0,1060.0
TCGA-KK-A8ID-01,TCGA-KK-A8ID,PRAD,70.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-25851.0,Alive,TUMOR FREE,2107.0,0.0,2107.0,0.0,2107.0,0.0,2107.0
TCGA-KK-A8IF-01,TCGA-KK-A8IF,PRAD,57.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2007.0,-20888.0,Alive,WITH TUMOR,804.0,0.0,804.0,0.0,804.0,1.0,648.0
TCGA-KK-A8IH-01,TCGA-KK-A8IH,PRAD,50.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-18560.0,Alive,TUMOR FREE,2013.0,0.0,2013.0,0.0,2013.0,0.0,2013.0
TCGA-KK-A8II-01,TCGA-KK-A8II,PRAD,61.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2004.0,-22460.0,Dead,WITH TUMOR,,1.0,3467.0,1.0,3467.0,1.0,626.0
TCGA-KK-A8IJ-01,TCGA-KK-A8IJ,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-21793.0,Alive,,1559.0,0.0,1559.0,0.0,1559.0,1.0,307.0
TCGA-KL-8324-01,TCGA-KL-8324,KICH,67.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2000.0,-24650.0,Alive,TUMOR FREE,4676.0,0.0,4676.0,0.0,4676.0,0.0,4676.0
TCGA-KL-8325-01,TCGA-KL-8325,KICH,56.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2000.0,-20768.0,Dead,TUMOR FREE,,1.0,725.0,0.0,725.0,0.0,725.0
TCGA-KL-8326-01,TCGA-KL-8326,KICH,69.0,MALE,WHITE,Stage III,Kidney Chromophobe,2001.0,-25267.0,Alive,TUMOR FREE,3322.0,0.0,3322.0,0.0,3322.0,0.0,3322.0
TCGA-KL-8327-01,TCGA-KL-8327,KICH,46.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2001.0,-17121.0,Alive,TUMOR FREE,4169.0,0.0,4169.0,0.0,4169.0,0.0,4169.0
TCGA-KL-8328-01,TCGA-KL-8328,KICH,60.0,MALE,WHITE,Stage II,Kidney Chromophobe,2003.0,-21976.0,Alive,TUMOR FREE,3127.0,0.0,3127.0,0.0,3127.0,0.0,3127.0
TCGA-KL-8329-01,TCGA-KL-8329,KICH,57.0,FEMALE,ASIAN,Stage I,Kidney Chromophobe,2003.0,-20972.0,Alive,TUMOR FREE,2752.0,0.0,2752.0,0.0,2752.0,0.0,2752.0
TCGA-KL-8330-01,TCGA-KL-8330,KICH,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Chromophobe,2003.0,-16250.0,Alive,TUMOR FREE,3304.0,0.0,3304.0,0.0,3304.0,0.0,3304.0
TCGA-KL-8331-01,TCGA-KL-8331,KICH,48.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2004.0,-17710.0,Alive,TUMOR FREE,3010.0,0.0,3010.0,0.0,3010.0,0.0,3010.0
TCGA-KL-8332-01,TCGA-KL-8332,KICH,55.0,MALE,WHITE,Stage I,Kidney Chromophobe,2004.0,-20128.0,Alive,TUMOR FREE,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0
TCGA-KL-8333-01,TCGA-KL-8333,KICH,69.0,MALE,WHITE,Stage II,Kidney Chromophobe,2005.0,-25229.0,Alive,TUMOR FREE,2991.0,0.0,2991.0,0.0,2991.0,0.0,2991.0
TCGA-KL-8334-01,TCGA-KL-8334,KICH,37.0,FEMALE,WHITE,Stage III,Kidney Chromophobe,2005.0,-13602.0,Alive,TUMOR FREE,2949.0,0.0,2949.0,0.0,2949.0,0.0,2949.0
TCGA-KL-8335-01,TCGA-KL-8335,KICH,67.0,MALE,WHITE,Stage III,Kidney Chromophobe,2005.0,-24832.0,Alive,TUMOR FREE,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0
TCGA-KL-8336-01,TCGA-KL-8336,KICH,51.0,FEMALE,WHITE,Stage IV,Kidney Chromophobe,2006.0,-18821.0,Dead,WITH TUMOR,,1.0,920.0,1.0,920.0,1.0,47.0
TCGA-KL-8337-01,TCGA-KL-8337,KICH,26.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Chromophobe,2006.0,-9819.0,Alive,TUMOR FREE,1364.0,0.0,1364.0,0.0,1364.0,0.0,1364.0
TCGA-KL-8338-01,TCGA-KL-8338,KICH,51.0,MALE,WHITE,Stage III,Kidney Chromophobe,2006.0,-18667.0,Alive,TUMOR FREE,2633.0,0.0,2633.0,0.0,2633.0,0.0,2633.0
TCGA-KL-8339-01,TCGA-KL-8339,KICH,67.0,MALE,WHITE,Stage IV,Kidney Chromophobe,2006.0,-24545.0,Dead,WITH TUMOR,,1.0,855.0,1.0,855.0,1.0,64.0
TCGA-KL-8340-01,TCGA-KL-8340,KICH,34.0,MALE,WHITE,Stage II,Kidney Chromophobe,2006.0,-12696.0,Alive,TUMOR FREE,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0
TCGA-KL-8341-01,TCGA-KL-8341,KICH,41.0,MALE,ASIAN,Stage IV,Kidney Chromophobe,2006.0,-15045.0,Dead,WITH TUMOR,,1.0,754.0,1.0,754.0,1.0,175.0
TCGA-KL-8342-01,TCGA-KL-8342,KICH,45.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2006.0,-16550.0,Alive,TUMOR FREE,2248.0,0.0,2248.0,0.0,2248.0,0.0,2248.0
TCGA-KL-8343-01,TCGA-KL-8343,KICH,72.0,MALE,WHITE,Stage III,Kidney Chromophobe,2007.0,-26562.0,Dead,WITH TUMOR,,1.0,2172.0,1.0,2172.0,1.0,2172.0
TCGA-KL-8344-01,TCGA-KL-8344,KICH,51.0,MALE,WHITE,Stage III,Kidney Chromophobe,2007.0,-18742.0,Alive,TUMOR FREE,876.0,0.0,876.0,0.0,876.0,0.0,876.0
TCGA-KL-8345-01,TCGA-KL-8345,KICH,75.0,MALE,WHITE,Stage III,Kidney Chromophobe,2008.0,-27412.0,Alive,TUMOR FREE,1665.0,0.0,1665.0,0.0,1665.0,0.0,1665.0
TCGA-KL-8346-01,TCGA-KL-8346,KICH,62.0,MALE,WHITE,Stage II,Kidney Chromophobe,2008.0,-22651.0,Alive,TUMOR FREE,1897.0,0.0,1897.0,0.0,1897.0,0.0,1897.0
TCGA-KM-8438-01,TCGA-KM-8438,KICH,45.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2000.0,-16683.0,Alive,WITH TUMOR,4622.0,0.0,4622.0,0.0,4622.0,1.0,2317.0
TCGA-KM-8439-01,TCGA-KM-8439,KICH,30.0,MALE,WHITE,Stage I,Kidney Chromophobe,2011.0,-11266.0,Alive,WITH TUMOR,708.0,0.0,708.0,0.0,708.0,0.0,708.0
TCGA-KM-8440-01,TCGA-KM-8440,KICH,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Chromophobe,2009.0,-13860.0,Alive,TUMOR FREE,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0
TCGA-KM-8441-01,TCGA-KM-8441,KICH,61.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2011.0,-22303.0,Alive,WITH TUMOR,876.0,0.0,876.0,0.0,876.0,1.0,876.0
TCGA-KM-8442-01,TCGA-KM-8442,KICH,38.0,MALE,[Unknown],Stage II,Kidney Chromophobe,2009.0,-14212.0,Alive,TUMOR FREE,1437.0,0.0,1437.0,0.0,1437.0,0.0,1437.0
TCGA-KM-8443-01,TCGA-KM-8443,KICH,57.0,MALE,WHITE,Stage II,Kidney Chromophobe,2009.0,-21183.0,Alive,TUMOR FREE,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0
TCGA-KM-8476-01,TCGA-KM-8476,KICH,47.0,MALE,WHITE,Stage I,Kidney Chromophobe,2002.0,-17240.0,Alive,TUMOR FREE,3745.0,0.0,3745.0,0.0,3745.0,0.0,3745.0
TCGA-KM-8639-01,TCGA-KM-8639,KICH,67.0,MALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-24640.0,Alive,TUMOR FREE,953.0,0.0,953.0,0.0,953.0,0.0,953.0
TCGA-KN-8418-01,TCGA-KN-8418,KICH,41.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2002.0,-15086.0,Alive,TUMOR FREE,3935.0,0.0,3935.0,0.0,3935.0,0.0,3935.0
TCGA-KN-8419-01,TCGA-KN-8419,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Kidney Chromophobe,2004.0,-15769.0,Alive,TUMOR FREE,714.0,0.0,714.0,0.0,714.0,0.0,714.0
TCGA-KN-8421-01,TCGA-KN-8421,KICH,47.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2004.0,-17524.0,Alive,TUMOR FREE,2674.0,0.0,2674.0,0.0,2674.0,0.0,2674.0
TCGA-KN-8423-01,TCGA-KN-8423,KICH,44.0,MALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-16335.0,Alive,TUMOR FREE,788.0,0.0,788.0,0.0,788.0,0.0,788.0
TCGA-KN-8424-01,TCGA-KN-8424,KICH,42.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-15384.0,Alive,TUMOR FREE,1983.0,0.0,1983.0,0.0,1983.0,0.0,1983.0
TCGA-KN-8425-01,TCGA-KN-8425,KICH,53.0,MALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-19692.0,Alive,TUMOR FREE,3179.0,0.0,3179.0,0.0,3179.0,0.0,3179.0
TCGA-KN-8426-01,TCGA-KN-8426,KICH,50.0,MALE,WHITE,Stage IV,Kidney Chromophobe,2006.0,-18345.0,Alive,WITH TUMOR,108.0,0.0,108.0,0.0,108.0,0.0,108.0
TCGA-KN-8427-01,TCGA-KN-8427,KICH,54.0,MALE,WHITE,Stage IV,Kidney Chromophobe,2006.0,-19854.0,Alive,TUMOR FREE,30.0,0.0,30.0,0.0,30.0,0.0,30.0
TCGA-KN-8428-01,TCGA-KN-8428,KICH,71.0,MALE,WHITE,Stage II,Kidney Chromophobe,2006.0,-26252.0,Dead,WITH TUMOR,,1.0,1590.0,1.0,1590.0,1.0,478.0
TCGA-KN-8429-01,TCGA-KN-8429,KICH,38.0,FEMALE,WHITE,Stage III,Kidney Chromophobe,2006.0,-13903.0,Alive,TUMOR FREE,2650.0,0.0,2650.0,0.0,2650.0,1.0,1989.0
TCGA-KN-8431-01,TCGA-KN-8431,KICH,35.0,FEMALE,[Not Evaluated],Stage II,Kidney Chromophobe,2007.0,-13043.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-KN-8432-01,TCGA-KN-8432,KICH,86.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2010.0,-31591.0,Alive,,76.0,0.0,76.0,0.0,76.0,0.0,76.0
TCGA-KN-8433-01,TCGA-KN-8433,KICH,46.0,FEMALE,WHITE,Stage III,Kidney Chromophobe,2008.0,-17108.0,Alive,TUMOR FREE,341.0,0.0,341.0,0.0,341.0,0.0,341.0
TCGA-KN-8434-01,TCGA-KN-8434,KICH,65.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2009.0,-23934.0,Alive,TUMOR FREE,1797.0,0.0,1797.0,0.0,1797.0,0.0,1797.0
TCGA-KN-8435-01,TCGA-KN-8435,KICH,59.0,MALE,WHITE,Stage II,Kidney Chromophobe,2004.0,-21891.0,Alive,TUMOR FREE,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0
TCGA-KN-8436-01,TCGA-KN-8436,KICH,62.0,MALE,WHITE,Stage II,Kidney Chromophobe,2009.0,-22997.0,Alive,TUMOR FREE,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0
TCGA-KN-8437-01,TCGA-KN-8437,KICH,42.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2006.0,-15475.0,Alive,TUMOR FREE,3068.0,0.0,3068.0,0.0,3068.0,0.0,3068.0
TCGA-KO-8403-01,TCGA-KO-8403,KICH,49.0,MALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-18171.0,Alive,TUMOR FREE,3208.0,0.0,3208.0,0.0,3208.0,0.0,3208.0
TCGA-KO-8404-01,TCGA-KO-8404,KICH,78.0,MALE,WHITE,Stage IV,Kidney Chromophobe,2005.0,-28705.0,Dead,WITH TUMOR,,1.0,325.0,1.0,325.0,1.0,148.0
TCGA-KO-8405-01,TCGA-KO-8405,KICH,29.0,MALE,WHITE,Stage III,Kidney Chromophobe,2005.0,-10671.0,Alive,TUMOR FREE,3056.0,0.0,3056.0,0.0,3056.0,0.0,3056.0
TCGA-KO-8406-01,TCGA-KO-8406,KICH,17.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2005.0,-6556.0,Alive,TUMOR FREE,3145.0,0.0,3145.0,0.0,3145.0,0.0,3145.0
TCGA-KO-8407-01,TCGA-KO-8407,KICH,42.0,MALE,WHITE,Stage II,Kidney Chromophobe,2005.0,-15407.0,Alive,TUMOR FREE,2820.0,0.0,2820.0,0.0,2820.0,0.0,2820.0
TCGA-KO-8408-01,TCGA-KO-8408,KICH,47.0,MALE,WHITE,Stage III,Kidney Chromophobe,2004.0,-17299.0,Dead,TUMOR FREE,,1.0,507.0,0.0,507.0,1.0,46.0
TCGA-KO-8409-01,TCGA-KO-8409,KICH,69.0,MALE,WHITE,Stage II,Kidney Chromophobe,2004.0,-25419.0,Alive,TUMOR FREE,3180.0,0.0,3180.0,0.0,3180.0,0.0,3180.0
TCGA-KO-8410-01,TCGA-KO-8410,KICH,74.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2004.0,-27084.0,Alive,TUMOR FREE,3136.0,0.0,3136.0,0.0,3136.0,0.0,3136.0
TCGA-KO-8411-01,TCGA-KO-8411,KICH,58.0,MALE,WHITE,Stage I,Kidney Chromophobe,2004.0,-21371.0,Alive,TUMOR FREE,3958.0,0.0,3958.0,0.0,3958.0,0.0,3958.0
TCGA-KO-8413-01,TCGA-KO-8413,KICH,46.0,MALE,WHITE,Stage I,Kidney Chromophobe,2006.0,-17067.0,Alive,TUMOR FREE,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0
TCGA-KO-8414-01,TCGA-KO-8414,KICH,50.0,FEMALE,WHITE,Stage II,Kidney Chromophobe,2006.0,-18502.0,Alive,TUMOR FREE,3212.0,0.0,3212.0,0.0,3212.0,0.0,3212.0
TCGA-KO-8415-01,TCGA-KO-8415,KICH,44.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2007.0,-16395.0,Alive,TUMOR FREE,2939.0,0.0,2939.0,0.0,2939.0,0.0,2939.0
TCGA-KO-8416-01,TCGA-KO-8416,KICH,41.0,MALE,WHITE,Stage III,Kidney Chromophobe,2007.0,-15261.0,Alive,TUMOR FREE,2752.0,0.0,2752.0,0.0,2752.0,0.0,2752.0
TCGA-KO-8417-01,TCGA-KO-8417,KICH,30.0,FEMALE,WHITE,Stage I,Kidney Chromophobe,2007.0,-11139.0,Alive,TUMOR FREE,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0
TCGA-KP-A3VZ-01,TCGA-KP-A3VZ,UCEC,69.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2010.0,-25366.0,Alive,WITH TUMOR,722.0,0.0,722.0,0.0,722.0,0.0,722.0
TCGA-KP-A3W0-01,TCGA-KP-A3W0,UCEC,72.0,FEMALE,[Not Evaluated],,Serous endometrial adenocarcinoma,2011.0,-26378.0,Alive,TUMOR FREE,404.0,0.0,404.0,0.0,404.0,0.0,404.0
TCGA-KP-A3W1-01,TCGA-KP-A3W1,UCEC,76.0,FEMALE,[Not Evaluated],,Serous endometrial adenocarcinoma,2011.0,-27902.0,Alive,TUMOR FREE,288.0,0.0,288.0,0.0,288.0,0.0,288.0
TCGA-KP-A3W3-01,TCGA-KP-A3W3,UCEC,72.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2010.0,-26310.0,Alive,WITH TUMOR,794.0,0.0,794.0,0.0,794.0,1.0,661.0
TCGA-KP-A3W4-01,TCGA-KP-A3W4,UCEC,63.0,FEMALE,WHITE,,Serous endometrial adenocarcinoma,2010.0,-23200.0,Dead,WITH TUMOR,,1.0,554.0,1.0,554.0,1.0,321.0
TCGA-KR-A7K7-01,TCGA-KR-A7K7,LIHC,61.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2012.0,-22587.0,Alive,WITH TUMOR,951.0,0.0,951.0,0.0,951.0,1.0,239.0
TCGA-KS-A41F-01,TCGA-KS-A41F,THCA,37.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2002.0,-13545.0,Alive,TUMOR FREE,4367.0,0.0,4367.0,0.0,4367.0,0.0,4367.0
TCGA-KS-A4I5-01,TCGA-KS-A4I5,THCA,49.0,FEMALE,WHITE,Stage IVA,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-17963.0,Alive,TUMOR FREE,567.0,0.0,567.0,0.0,567.0,0.0,567.0
TCGA-KS-A4IB-01,TCGA-KS-A4IB,THCA,41.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2007.0,-15157.0,Alive,TUMOR FREE,2577.0,0.0,2577.0,0.0,2577.0,0.0,2577.0
TCGA-KT-A74X-01,TCGA-KT-A74X,LGG,26.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-9590.0,Alive,WITH TUMOR,438.0,0.0,438.0,0.0,438.0,0.0,438.0
TCGA-KV-A6GD-01,TCGA-KV-A6GD,KIRP,85.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2013.0,-31217.0,Alive,TUMOR FREE,560.0,0.0,560.0,0.0,560.0,0.0,560.0
TCGA-KV-A6GE-01,TCGA-KV-A6GE,KIRP,65.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-23979.0,Alive,TUMOR FREE,885.0,0.0,885.0,0.0,885.0,0.0,885.0
TCGA-L5-A43C-01,TCGA-L5-A43C,ESCA,81.0,MALE,WHITE,,"Esophagus Adenocarcinoma, NOS",2009.0,-29753.0,Alive,TUMOR FREE,96.0,0.0,96.0,0.0,96.0,0.0,96.0
TCGA-L5-A43H-01,TCGA-L5-A43H,ESCA,75.0,MALE,WHITE,Stage III,Esophagus Squamous Cell Carcinoma,2011.0,-27592.0,Dead,WITH TUMOR,,1.0,9.0,1.0,9.0,1.0,9.0
TCGA-L5-A43I-01,TCGA-L5-A43I,ESCA,77.0,MALE,WHITE,Stage IIIA,"Esophagus Adenocarcinoma, NOS",2011.0,-28367.0,Dead,TUMOR FREE,,1.0,556.0,0.0,556.0,0.0,556.0
TCGA-L5-A43J-01,TCGA-L5-A43J,ESCA,90.0,MALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2011.0,-32872.0,Dead,WITH TUMOR,,1.0,131.0,1.0,131.0,1.0,98.0
TCGA-L5-A4OE-01,TCGA-L5-A4OE,ESCA,81.0,MALE,WHITE,Stage IIIB,"Esophagus Adenocarcinoma, NOS",2011.0,-29591.0,Dead,,,1.0,730.0,,730.0,0.0,730.0
TCGA-L5-A4OF-01,TCGA-L5-A4OF,ESCA,63.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2012.0,-23194.0,Dead,,,1.0,801.0,,801.0,0.0,801.0
TCGA-L5-A4OG-01,TCGA-L5-A4OG,ESCA,79.0,FEMALE,WHITE,Stage I,"Esophagus Adenocarcinoma, NOS",2012.0,-29105.0,Alive,,143.0,0.0,143.0,0.0,143.0,0.0,143.0
TCGA-L5-A4OH-01,TCGA-L5-A4OH,ESCA,71.0,MALE,WHITE,Stage I,"Esophagus Adenocarcinoma, NOS",2012.0,-26180.0,Alive,TUMOR FREE,992.0,0.0,992.0,0.0,992.0,0.0,992.0
TCGA-L5-A4OI-01,TCGA-L5-A4OI,ESCA,79.0,MALE,WHITE,Stage IIIC,"Esophagus Adenocarcinoma, NOS",2012.0,-29190.0,Alive,WITH TUMOR,608.0,0.0,608.0,0.0,608.0,1.0,267.0
TCGA-L5-A4OJ-01,TCGA-L5-A4OJ,ESCA,70.0,FEMALE,WHITE,Stage I,"Esophagus Adenocarcinoma, NOS",2012.0,-25657.0,Alive,TUMOR FREE,639.0,0.0,639.0,0.0,639.0,0.0,639.0
TCGA-L5-A4ON-01,TCGA-L5-A4ON,ESCA,65.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2010.0,-23970.0,Dead,TUMOR FREE,,1.0,558.0,0.0,558.0,0.0,558.0
TCGA-L5-A4OP-01,TCGA-L5-A4OP,ESCA,67.0,FEMALE,WHITE,Stage IA,"Esophagus Adenocarcinoma, NOS",2010.0,-24829.0,Alive,TUMOR FREE,218.0,0.0,218.0,0.0,218.0,0.0,218.0
TCGA-L5-A4OQ-01,TCGA-L5-A4OQ,ESCA,75.0,MALE,WHITE,Stage IIIA,"Esophagus Adenocarcinoma, NOS",2010.0,-27565.0,Dead,WITH TUMOR,,1.0,42.0,1.0,42.0,1.0,29.0
TCGA-L5-A4OR-01,TCGA-L5-A4OR,ESCA,83.0,MALE,WHITE,Stage IA,"Esophagus Adenocarcinoma, NOS",2010.0,-30417.0,Dead,TUMOR FREE,,1.0,96.0,0.0,96.0,0.0,96.0
TCGA-L5-A4OS-01,TCGA-L5-A4OS,ESCA,86.0,FEMALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2010.0,-31601.0,Alive,TUMOR FREE,1782.0,0.0,1782.0,0.0,1782.0,0.0,1782.0
TCGA-L5-A4OT-01,TCGA-L5-A4OT,ESCA,77.0,MALE,WHITE,Stage IV,"Esophagus Adenocarcinoma, NOS",2006.0,-28162.0,Dead,WITH TUMOR,,1.0,149.0,1.0,149.0,1.0,149.0
TCGA-L5-A4OU-01,TCGA-L5-A4OU,ESCA,81.0,MALE,WHITE,Stage IIA,"Esophagus Adenocarcinoma, NOS",2009.0,-29674.0,Alive,TUMOR FREE,882.0,0.0,882.0,0.0,882.0,0.0,882.0
TCGA-L5-A4OW-01,TCGA-L5-A4OW,ESCA,56.0,FEMALE,[Not Evaluated],Stage IIB,"Esophagus Adenocarcinoma, NOS",2006.0,-20796.0,Dead,TUMOR FREE,,1.0,217.0,0.0,217.0,0.0,217.0
TCGA-L5-A4OX-01,TCGA-L5-A4OX,ESCA,60.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2006.0,-22015.0,Dead,TUMOR FREE,,1.0,226.0,0.0,226.0,0.0,226.0
TCGA-L5-A88W-01,TCGA-L5-A88W,ESCA,67.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2007.0,-24716.0,Dead,WITH TUMOR,,1.0,764.0,1.0,764.0,1.0,315.0
TCGA-L5-A891-01,TCGA-L5-A891,ESCA,51.0,MALE,WHITE,[Unknown],"Esophagus Adenocarcinoma, NOS",2005.0,-18925.0,Alive,TUMOR FREE,114.0,0.0,114.0,0.0,114.0,0.0,114.0
TCGA-L5-A8NE-01,TCGA-L5-A8NE,ESCA,77.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2000.0,-28243.0,Alive,TUMOR FREE,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0
TCGA-L5-A8NF-01,TCGA-L5-A8NF,ESCA,57.0,MALE,WHITE,Stage IVA,"Esophagus Adenocarcinoma, NOS",2001.0,-21134.0,Dead,TUMOR FREE,,1.0,81.0,0.0,81.0,0.0,81.0
TCGA-L5-A8NI-01,TCGA-L5-A8NI,ESCA,79.0,MALE,WHITE,Stage III,"Esophagus Adenocarcinoma, NOS",2004.0,-29135.0,Dead,WITH TUMOR,,1.0,410.0,1.0,410.0,1.0,401.0
TCGA-L5-A8NJ-01,TCGA-L5-A8NJ,ESCA,77.0,MALE,WHITE,Stage III,"Esophagus Adenocarcinoma, NOS",2000.0,-28200.0,Alive,WITH TUMOR,501.0,0.0,501.0,0.0,501.0,1.0,396.0
TCGA-L5-A8NK-01,TCGA-L5-A8NK,ESCA,84.0,FEMALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2004.0,-30719.0,Alive,WITH TUMOR,412.0,0.0,412.0,0.0,412.0,1.0,325.0
TCGA-L5-A8NL-01,TCGA-L5-A8NL,ESCA,56.0,MALE,WHITE,Stage III,"Esophagus Adenocarcinoma, NOS",2004.0,-20542.0,Alive,TUMOR FREE,402.0,0.0,402.0,0.0,402.0,0.0,402.0
TCGA-L5-A8NQ-01,TCGA-L5-A8NQ,ESCA,71.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2001.0,-26250.0,Dead,WITH TUMOR,,1.0,650.0,1.0,650.0,1.0,337.0
TCGA-L5-A8NS-01,TCGA-L5-A8NS,ESCA,76.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2001.0,-27800.0,Alive,WITH TUMOR,408.0,0.0,408.0,0.0,408.0,1.0,300.0
TCGA-L5-A8NT-01,TCGA-L5-A8NT,ESCA,69.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2001.0,-25259.0,Alive,WITH TUMOR,825.0,0.0,825.0,0.0,825.0,1.0,825.0
TCGA-L5-A8NV-01,TCGA-L5-A8NV,ESCA,75.0,MALE,WHITE,Stage IIA,"Esophagus Adenocarcinoma, NOS",2001.0,-27546.0,Dead,WITH TUMOR,,1.0,1599.0,1.0,1599.0,1.0,1252.0
TCGA-L5-A8NW-01,TCGA-L5-A8NW,ESCA,55.0,MALE,WHITE,[Discrepancy],"Esophagus Adenocarcinoma, NOS",2001.0,-20194.0,Dead,WITH TUMOR,,1.0,1402.0,1.0,1402.0,1.0,1147.0
TCGA-L6-A4EP-01,TCGA-L6-A4EP,THCA,41.0,FEMALE,ASIAN,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-15292.0,Alive,TUMOR FREE,1016.0,0.0,1016.0,0.0,1016.0,0.0,1016.0
TCGA-L6-A4EQ-01,TCGA-L6-A4EQ,THCA,47.0,MALE,WHITE,Stage III,Thyroid Papillary Carcinoma - Classical/usual,2010.0,-17351.0,Alive,TUMOR FREE,1228.0,0.0,1228.0,0.0,1228.0,0.0,1228.0
TCGA-L6-A4ET-01,TCGA-L6-A4ET,THCA,49.0,FEMALE,WHITE,Stage IVC,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),2011.0,-17978.0,Alive,TUMOR FREE,664.0,0.0,664.0,0.0,664.0,0.0,664.0
TCGA-L6-A4EU-01,TCGA-L6-A4EU,THCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),2012.0,-21192.0,Alive,TUMOR FREE,289.0,0.0,289.0,0.0,289.0,0.0,289.0
TCGA-L7-A56G-01,TCGA-L7-A56G,ESCA,65.0,MALE,BLACK OR AFRICAN AMERICAN,,Esophagus Squamous Cell Carcinoma,2012.0,-24106.0,Dead,WITH TUMOR,,1.0,330.0,1.0,330.0,1.0,270.0
TCGA-L7-A6VZ-01,TCGA-L7-A6VZ,ESCA,62.0,MALE,WHITE,Stage IIIC,"Esophagus Adenocarcinoma, NOS",2013.0,-22730.0,Alive,TUMOR FREE,315.0,0.0,315.0,0.0,315.0,0.0,315.0
TCGA-LD-A74U-01,TCGA-LD-A74U,BRCA,79.0,FEMALE,WHITE,Stage IIIC,"Other, specify",2013.0,-28981.0,Alive,WITH TUMOR,402.0,0.0,402.0,0.0,402.0,0.0,402.0
TCGA-LD-A7W5-01,TCGA-LD-A7W5,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2013.0,-19169.0,Alive,WITH TUMOR,216.0,0.0,216.0,0.0,216.0,0.0,216.0
TCGA-LD-A7W6-01,TCGA-LD-A7W6,BRCA,54.0,FEMALE,WHITE,Stage IIB,"Other, specify",2013.0,-20077.0,Alive,TUMOR FREE,404.0,0.0,404.0,0.0,404.0,0.0,404.0
TCGA-LD-A9QF-01,TCGA-LD-A9QF,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2013.0,-26869.0,Alive,TUMOR FREE,323.0,0.0,323.0,0.0,323.0,0.0,323.0
TCGA-LG-A6GG-01,TCGA-LG-A6GG,LIHC,79.0,FEMALE,WHITE,Stage II,Hepatocellular Carcinoma,2013.0,-28871.0,Alive,TUMOR FREE,387.0,0.0,387.0,0.0,387.0,0.0,387.0
TCGA-LL-A440-01,TCGA-LL-A440,BRCA,61.0,FEMALE,WHITE,Stage IA,Infiltrating Lobular Carcinoma,2012.0,-22497.0,Alive,TUMOR FREE,759.0,0.0,759.0,0.0,759.0,0.0,759.0
TCGA-LL-A50Y-01,TCGA-LL-A50Y,BRCA,84.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-30934.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-LL-A5YL-01,TCGA-LL-A5YL,BRCA,64.0,FEMALE,WHITE,Stage IIB,Infiltrating Lobular Carcinoma,2012.0,-23395.0,Alive,,519.0,0.0,519.0,0.0,519.0,0.0,519.0
TCGA-LL-A5YM-01,TCGA-LL-A5YM,BRCA,88.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Infiltrating Ductal Carcinoma,2012.0,-32478.0,Alive,WITH TUMOR,466.0,0.0,466.0,0.0,466.0,1.0,258.0
TCGA-LL-A5YN-01,TCGA-LL-A5YN,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-16884.0,Alive,TUMOR FREE,447.0,0.0,447.0,0.0,447.0,0.0,447.0
TCGA-LL-A5YO-01,TCGA-LL-A5YO,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2013.0,-18354.0,Alive,TUMOR FREE,440.0,0.0,440.0,0.0,440.0,0.0,440.0
TCGA-LL-A5YP-01,TCGA-LL-A5YP,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-18041.0,Alive,,450.0,0.0,450.0,0.0,450.0,0.0,450.0
TCGA-LL-A6FP-01,TCGA-LL-A6FP,BRCA,90.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-32873.0,Alive,TUMOR FREE,677.0,0.0,677.0,0.0,677.0,0.0,677.0
TCGA-LL-A6FQ-01,TCGA-LL-A6FQ,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2013.0,-28375.0,Alive,,80.0,0.0,80.0,0.0,80.0,0.0,80.0
TCGA-LL-A6FR-01,TCGA-LL-A6FR,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-18520.0,Alive,TUMOR FREE,489.0,0.0,489.0,0.0,489.0,0.0,489.0
TCGA-LL-A73Z-01,TCGA-LL-A73Z,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,Infiltrating Ductal Carcinoma,2013.0,-20118.0,Dead,WITH TUMOR,,1.0,227.0,1.0,227.0,1.0,192.0
TCGA-LL-A740-01,TCGA-LL-A740,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2013.0,-22416.0,Alive,TUMOR FREE,441.0,0.0,441.0,0.0,441.0,0.0,441.0
TCGA-LL-A7SZ-01,TCGA-LL-A7SZ,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-18161.0,Alive,TUMOR FREE,594.0,0.0,594.0,0.0,594.0,0.0,594.0
TCGA-LL-A8F5-01,TCGA-LL-A8F5,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-22544.0,Alive,TUMOR FREE,596.0,0.0,596.0,0.0,596.0,0.0,596.0
TCGA-LL-A9Q3-01,TCGA-LL-A9Q3,BRCA,69.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2013.0,-25477.0,Alive,TUMOR FREE,532.0,0.0,532.0,0.0,532.0,0.0,532.0
TCGA-LN-A49K-01,TCGA-LN-A49K,ESCA,66.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2010.0,-24379.0,Dead,TUMOR FREE,,1.0,180.0,0.0,180.0,0.0,180.0
TCGA-LN-A49L-01,TCGA-LN-A49L,ESCA,44.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2010.0,-16164.0,Dead,TUMOR FREE,,1.0,318.0,0.0,318.0,0.0,318.0
TCGA-LN-A49M-01,TCGA-LN-A49M,ESCA,62.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2010.0,-22933.0,Alive,TUMOR FREE,385.0,0.0,385.0,0.0,385.0,0.0,385.0
TCGA-LN-A49N-01,TCGA-LN-A49N,ESCA,50.0,MALE,ASIAN,Stage IIB,Esophagus Squamous Cell Carcinoma,2010.0,-18503.0,Alive,TUMOR FREE,378.0,0.0,378.0,0.0,378.0,0.0,378.0
TCGA-LN-A49O-01,TCGA-LN-A49O,ESCA,47.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-17237.0,Alive,WITH TUMOR,408.0,0.0,408.0,0.0,408.0,1.0,193.0
TCGA-LN-A49P-01,TCGA-LN-A49P,ESCA,71.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-26189.0,Alive,WITH TUMOR,375.0,0.0,375.0,0.0,375.0,1.0,320.0
TCGA-LN-A49R-01,TCGA-LN-A49R,ESCA,46.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2011.0,-17109.0,Alive,TUMOR FREE,407.0,0.0,407.0,0.0,407.0,0.0,407.0
TCGA-LN-A49S-01,TCGA-LN-A49S,ESCA,59.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-21865.0,Alive,WITH TUMOR,400.0,0.0,400.0,0.0,400.0,1.0,49.0
TCGA-LN-A49W-01,TCGA-LN-A49W,ESCA,73.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2011.0,-26910.0,Alive,TUMOR FREE,403.0,0.0,403.0,0.0,403.0,0.0,403.0
TCGA-LN-A49X-01,TCGA-LN-A49X,ESCA,44.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-16154.0,Alive,TUMOR FREE,384.0,0.0,384.0,0.0,384.0,0.0,384.0
TCGA-LN-A49Y-01,TCGA-LN-A49Y,ESCA,77.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-28125.0,Alive,WITH TUMOR,379.0,0.0,379.0,0.0,379.0,1.0,90.0
TCGA-LN-A4A1-01,TCGA-LN-A4A1,ESCA,60.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-21954.0,Alive,WITH TUMOR,383.0,0.0,383.0,0.0,383.0,1.0,205.0
TCGA-LN-A4A2-01,TCGA-LN-A4A2,ESCA,57.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-21122.0,Alive,TUMOR FREE,380.0,0.0,380.0,0.0,380.0,0.0,380.0
TCGA-LN-A4A3-01,TCGA-LN-A4A3,ESCA,61.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2011.0,-22313.0,Alive,TUMOR FREE,388.0,0.0,388.0,0.0,388.0,0.0,388.0
TCGA-LN-A4A4-01,TCGA-LN-A4A4,ESCA,36.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2011.0,-13419.0,Alive,TUMOR FREE,383.0,0.0,383.0,0.0,383.0,0.0,383.0
TCGA-LN-A4A5-01,TCGA-LN-A4A5,ESCA,49.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2011.0,-18160.0,Dead,WITH TUMOR,,1.0,681.0,1.0,681.0,1.0,224.0
TCGA-LN-A4A6-01,TCGA-LN-A4A6,ESCA,65.0,MALE,ASIAN,Stage II,Esophagus Squamous Cell Carcinoma,2012.0,-24011.0,Alive,TUMOR FREE,391.0,0.0,391.0,0.0,391.0,1.0,158.0
TCGA-LN-A4A9-01,TCGA-LN-A4A9,ESCA,58.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2012.0,-21217.0,Dead,WITH TUMOR,,1.0,351.0,1.0,351.0,1.0,274.0
TCGA-LN-A4MQ-01,TCGA-LN-A4MQ,ESCA,46.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2010.0,-16990.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,1.0,25.0
TCGA-LN-A4MR-01,TCGA-LN-A4MR,ESCA,57.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2012.0,-21142.0,Alive,TUMOR FREE,402.0,0.0,402.0,0.0,402.0,1.0,226.0
TCGA-LN-A5U5-01,TCGA-LN-A5U5,ESCA,57.0,MALE,ASIAN,Stage IV,Esophagus Squamous Cell Carcinoma,2012.0,-20993.0,Dead,WITH TUMOR,,1.0,136.0,1.0,136.0,1.0,136.0
TCGA-LN-A5U6-01,TCGA-LN-A5U6,ESCA,54.0,MALE,ASIAN,Stage IIB,Esophagus Squamous Cell Carcinoma,2012.0,-19840.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-LN-A5U7-01,TCGA-LN-A5U7,ESCA,46.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2012.0,-16928.0,Alive,TUMOR FREE,768.0,0.0,768.0,0.0,768.0,1.0,535.0
TCGA-LN-A7HW-01,TCGA-LN-A7HW,ESCA,59.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-21840.0,Alive,TUMOR FREE,365.0,0.0,365.0,0.0,365.0,1.0,97.0
TCGA-LN-A7HX-01,TCGA-LN-A7HX,ESCA,72.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-26517.0,Alive,TUMOR FREE,372.0,0.0,372.0,0.0,372.0,0.0,372.0
TCGA-LN-A7HY-01,TCGA-LN-A7HY,ESCA,50.0,MALE,ASIAN,Stage III,Esophagus Squamous Cell Carcinoma,2013.0,-18296.0,Alive,TUMOR FREE,366.0,0.0,366.0,0.0,366.0,1.0,88.0
TCGA-LN-A7HZ-01,TCGA-LN-A7HZ,ESCA,49.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-17931.0,Alive,TUMOR FREE,401.0,0.0,401.0,0.0,401.0,1.0,117.0
TCGA-LN-A8HZ-01,TCGA-LN-A8HZ,ESCA,56.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-20510.0,Alive,TUMOR FREE,375.0,0.0,375.0,0.0,375.0,0.0,375.0
TCGA-LN-A8I0-01,TCGA-LN-A8I0,ESCA,52.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-19328.0,Alive,TUMOR FREE,407.0,0.0,407.0,0.0,407.0,1.0,57.0
TCGA-LN-A8I1-01,TCGA-LN-A8I1,ESCA,67.0,FEMALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-24551.0,Alive,TUMOR FREE,401.0,0.0,401.0,0.0,401.0,0.0,401.0
TCGA-LN-A9FO-01,TCGA-LN-A9FO,ESCA,42.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-15551.0,Alive,TUMOR FREE,4.0,0.0,4.0,0.0,4.0,0.0,4.0
TCGA-LN-A9FP-01,TCGA-LN-A9FP,ESCA,60.0,FEMALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-22104.0,Alive,WITH TUMOR,366.0,0.0,366.0,0.0,366.0,1.0,290.0
TCGA-LN-A9FQ-01,TCGA-LN-A9FQ,ESCA,62.0,MALE,ASIAN,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-22717.0,Alive,TUMOR FREE,391.0,0.0,391.0,0.0,391.0,1.0,82.0
TCGA-LN-A9FR-01,TCGA-LN-A9FR,ESCA,70.0,MALE,ASIAN,Stage IIB,Esophagus Squamous Cell Carcinoma,2013.0,-25657.0,Alive,TUMOR FREE,373.0,0.0,373.0,0.0,373.0,0.0,373.0
TCGA-M7-A71Y-01,TCGA-M7-A71Y,PRAD,55.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-20357.0,Alive,TUMOR FREE,493.0,0.0,493.0,0.0,493.0,0.0,493.0
TCGA-M7-A720-01,TCGA-M7-A720,PRAD,53.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-19642.0,Alive,TUMOR FREE,384.0,0.0,384.0,0.0,384.0,0.0,384.0
TCGA-M7-A721-01,TCGA-M7-A721,PRAD,70.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-25585.0,Alive,TUMOR FREE,400.0,0.0,400.0,0.0,400.0,0.0,400.0
TCGA-M7-A725-01,TCGA-M7-A725,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-20474.0,Alive,TUMOR FREE,573.0,0.0,573.0,0.0,573.0,0.0,573.0
TCGA-M9-A5M8-01,TCGA-M9-A5M8,ESCA,58.0,MALE,[Not Evaluated],Stage IIA,"Esophagus Adenocarcinoma, NOS",,-21433.0,Alive,TUMOR FREE,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0
TCGA-MH-A55Z-01,TCGA-MH-A55Z,KIRP,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-24017.0,Alive,TUMOR FREE,845.0,0.0,845.0,0.0,845.0,0.0,845.0
TCGA-MH-A560-01,TCGA-MH-A560,KIRP,62.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2011.0,-22866.0,Alive,TUMOR FREE,924.0,0.0,924.0,0.0,924.0,0.0,924.0
TCGA-MH-A562-01,TCGA-MH-A562,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-20933.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-MK-A4N9-01,TCGA-MK-A4N9,THCA,41.0,FEMALE,WHITE,Stage I,Thyroid Papillary Carcinoma - Classical/usual,2011.0,-15255.0,Alive,TUMOR FREE,919.0,0.0,919.0,0.0,919.0,0.0,919.0
TCGA-MR-A520-01,TCGA-MR-A520,LIHC,58.0,MALE,WHITE,Stage I,Hepatocellular Carcinoma,2012.0,-21398.0,Alive,TUMOR FREE,229.0,0.0,229.0,0.0,229.0,0.0,229.0
TCGA-MX-A5UG-01,TCGA-MX-A5UG,STAD,78.0,MALE,ASIAN,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2007.0,-28714.0,Dead,TUMOR FREE,,1.0,113.0,1.0,113.0,0.0,113.0
TCGA-N5-A4R8-01,TCGA-N5-A4R8,UCS,65.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2003.0,-24102.0,Dead,,,1.0,3115.0,,3115.0,0.0,3115.0
TCGA-N5-A4RA-01,TCGA-N5-A4RA,UCS,63.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2004.0,-23359.0,Dead,,,1.0,1591.0,,1591.0,0.0,1591.0
TCGA-N5-A4RD-01,TCGA-N5-A4RD,UCS,69.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2007.0,-25413.0,Dead,WITH TUMOR,,1.0,142.0,1.0,142.0,1.0,75.0
TCGA-N5-A4RJ-01,TCGA-N5-A4RJ,UCS,61.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2009.0,-22341.0,Dead,WITH TUMOR,,1.0,550.0,1.0,550.0,1.0,287.0
TCGA-N5-A4RM-01,TCGA-N5-A4RM,UCS,62.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2010.0,-22886.0,Dead,WITH TUMOR,,1.0,148.0,1.0,148.0,1.0,144.0
TCGA-N5-A4RN-01,TCGA-N5-A4RN,UCS,71.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2011.0,-26054.0,Alive,WITH TUMOR,1053.0,0.0,1053.0,0.0,1053.0,1.0,570.0
TCGA-N5-A4RO-01,TCGA-N5-A4RO,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/MMMT: Homologous Type,2002.0,-24823.0,Dead,WITH TUMOR,,1.0,685.0,1.0,685.0,1.0,407.0
TCGA-N5-A4RS-01,TCGA-N5-A4RS,UCS,65.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2007.0,-23893.0,Dead,WITH TUMOR,,1.0,911.0,1.0,911.0,1.0,427.0
TCGA-N5-A4RT-01,TCGA-N5-A4RT,UCS,69.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2007.0,-25386.0,Alive,TUMOR FREE,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0
TCGA-N5-A4RV-01,TCGA-N5-A4RV,UCS,62.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2008.0,-22978.0,Alive,TUMOR FREE,2042.0,0.0,2042.0,0.0,2042.0,0.0,2042.0
TCGA-N5-A59E-01,TCGA-N5-A59E,UCS,62.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2011.0,-22650.0,Dead,WITH TUMOR,,1.0,447.0,1.0,447.0,1.0,354.0
TCGA-N5-A59F-01,TCGA-N5-A59F,UCS,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/MMMT: Homologous Type,2012.0,-23826.0,Dead,WITH TUMOR,,1.0,361.0,1.0,361.0,1.0,274.0
TCGA-N6-A4V9-01,TCGA-N6-A4V9,UCS,59.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2011.0,-21677.0,Alive,TUMOR FREE,979.0,0.0,979.0,0.0,979.0,0.0,979.0
TCGA-N6-A4VC-01,TCGA-N6-A4VC,UCS,83.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2009.0,-30643.0,Dead,WITH TUMOR,,1.0,597.0,1.0,597.0,1.0,171.0
TCGA-N6-A4VD-01,TCGA-N6-A4VD,UCS,81.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2009.0,-29658.0,Dead,WITH TUMOR,,1.0,112.0,1.0,112.0,1.0,49.0
TCGA-N6-A4VE-01,TCGA-N6-A4VE,UCS,84.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2006.0,-30794.0,Dead,WITH TUMOR,,1.0,291.0,1.0,291.0,1.0,275.0
TCGA-N7-A4Y0-01,TCGA-N7-A4Y0,UCS,65.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2003.0,-23983.0,Dead,WITH TUMOR,,1.0,771.0,1.0,771.0,1.0,281.0
TCGA-N7-A4Y5-01,TCGA-N7-A4Y5,UCS,87.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2005.0,-32058.0,Dead,WITH TUMOR,,1.0,8.0,1.0,8.0,1.0,8.0
TCGA-N7-A4Y8-01,TCGA-N7-A4Y8,UCS,72.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2010.0,-26650.0,Dead,WITH TUMOR,,1.0,378.0,1.0,378.0,1.0,187.0
TCGA-N7-A59B-01,TCGA-N7-A59B,UCS,69.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2012.0,-25360.0,Alive,TUMOR FREE,827.0,0.0,827.0,0.0,827.0,0.0,827.0
TCGA-N8-A4PI-01,TCGA-N8-A4PI,UCS,71.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2009.0,-26270.0,Dead,WITH TUMOR,,1.0,810.0,1.0,810.0,1.0,255.0
TCGA-N8-A4PL-01,TCGA-N8-A4PL,UCS,82.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2011.0,-30069.0,Dead,WITH TUMOR,,1.0,418.0,1.0,418.0,1.0,138.0
TCGA-N8-A4PM-01,TCGA-N8-A4PM,UCS,73.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2011.0,-26971.0,Alive,WITH TUMOR,829.0,0.0,829.0,0.0,829.0,1.0,524.0
TCGA-N8-A4PN-01,TCGA-N8-A4PN,UCS,68.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2011.0,-25064.0,Alive,TUMOR FREE,812.0,0.0,812.0,0.0,812.0,0.0,812.0
TCGA-N8-A4PO-01,TCGA-N8-A4PO,UCS,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2011.0,-24124.0,Alive,WITH TUMOR,781.0,0.0,781.0,0.0,781.0,1.0,158.0
TCGA-N8-A4PP-01,TCGA-N8-A4PP,UCS,88.0,FEMALE,WHITE,,Uterine Carcinosarcoma/MMMT: Homologous Type,2012.0,-32415.0,Dead,WITH TUMOR,,1.0,611.0,1.0,611.0,1.0,149.0
TCGA-N8-A4PQ-01,TCGA-N8-A4PQ,UCS,76.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2012.0,-27772.0,Alive,TUMOR FREE,572.0,0.0,572.0,0.0,572.0,0.0,572.0
TCGA-N8-A56S-01,TCGA-N8-A56S,UCS,75.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2012.0,-27519.0,Dead,WITH TUMOR,,1.0,371.0,1.0,371.0,1.0,199.0
TCGA-N9-A4PZ-01,TCGA-N9-A4PZ,UCS,77.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2005.0,-28211.0,Dead,WITH TUMOR,,1.0,667.0,1.0,667.0,1.0,487.0
TCGA-N9-A4Q1-01,TCGA-N9-A4Q1,UCS,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2005.0,-25791.0,Dead,WITH TUMOR,,1.0,2043.0,1.0,2043.0,1.0,1839.0
TCGA-N9-A4Q3-01,TCGA-N9-A4Q3,UCS,65.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2009.0,-24031.0,Alive,WITH TUMOR,1672.0,0.0,1672.0,0.0,1672.0,1.0,735.0
TCGA-N9-A4Q4-01,TCGA-N9-A4Q4,UCS,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2010.0,-22575.0,Alive,,1089.0,0.0,1089.0,0.0,1089.0,0.0,1089.0
TCGA-N9-A4Q7-01,TCGA-N9-A4Q7,UCS,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2011.0,-25419.0,Alive,TUMOR FREE,604.0,0.0,604.0,0.0,604.0,0.0,604.0
TCGA-NA-A4QV-01,TCGA-NA-A4QV,UCS,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2002.0,-26379.0,Alive,TUMOR FREE,4269.0,0.0,4269.0,0.0,4269.0,0.0,4269.0
TCGA-NA-A4QW-01,TCGA-NA-A4QW,UCS,61.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2007.0,-22588.0,Alive,TUMOR FREE,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0
TCGA-NA-A4QX-01,TCGA-NA-A4QX,UCS,60.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2009.0,-22264.0,Dead,WITH TUMOR,833.0,1.0,838.0,1.0,838.0,1.0,566.0
TCGA-NA-A4QY-01,TCGA-NA-A4QY,UCS,62.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2009.0,-22756.0,Dead,WITH TUMOR,,1.0,114.0,1.0,114.0,1.0,114.0
TCGA-NA-A4R0-01,TCGA-NA-A4R0,UCS,80.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2010.0,-29449.0,Dead,WITH TUMOR,,1.0,541.0,1.0,541.0,1.0,541.0
TCGA-NA-A4R1-01,TCGA-NA-A4R1,UCS,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2012.0,-27688.0,Dead,WITH TUMOR,,1.0,203.0,1.0,203.0,1.0,203.0
TCGA-ND-A4W6-01,TCGA-ND-A4W6,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2012.0,-24835.0,Dead,WITH TUMOR,,1.0,317.0,1.0,317.0,1.0,317.0
TCGA-ND-A4WA-01,TCGA-ND-A4WA,UCS,90.0,FEMALE,ASIAN,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2004.0,-32872.0,Dead,TUMOR FREE,,1.0,714.0,0.0,714.0,0.0,714.0
TCGA-ND-A4WC-01,TCGA-ND-A4WC,UCS,83.0,FEMALE,ASIAN,,Uterine Carcinosarcoma/MMMT: Homologous Type,2011.0,-30434.0,Alive,TUMOR FREE,766.0,0.0,766.0,0.0,766.0,0.0,766.0
TCGA-ND-A4WF-01,TCGA-ND-A4WF,UCS,77.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2007.0,-28398.0,Dead,WITH TUMOR,,1.0,167.0,1.0,167.0,1.0,167.0
TCGA-NF-A4X2-01,TCGA-NF-A4X2,UCS,59.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ MMMT: Heterologous Type,2012.0,-21908.0,Alive,TUMOR FREE,81.0,0.0,81.0,0.0,81.0,0.0,81.0
TCGA-NF-A5CP-01,TCGA-NF-A5CP,UCS,90.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2007.0,-32871.0,Dead,WITH TUMOR,,1.0,167.0,1.0,167.0,1.0,106.0
TCGA-NG-A4VU-01,TCGA-NG-A4VU,UCS,63.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2011.0,-23323.0,Dead,WITH TUMOR,,1.0,442.0,1.0,442.0,1.0,281.0
TCGA-NG-A4VW-01,TCGA-NG-A4VW,UCS,74.0,FEMALE,WHITE,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2006.0,-27326.0,Dead,WITH TUMOR,,1.0,949.0,1.0,949.0,1.0,937.0
TCGA-NH-A50T-01,TCGA-NH-A50T,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2012.0,-25089.0,Alive,TUMOR FREE,553.0,0.0,553.0,0.0,553.0,0.0,553.0
TCGA-NH-A50V-01,TCGA-NH-A50V,COAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2012.0,-25467.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-NH-A5IV-01,TCGA-NH-A5IV,COAD,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2012.0,-32872.0,Alive,TUMOR FREE,588.0,0.0,588.0,0.0,588.0,0.0,588.0
TCGA-NH-A6GA-01,TCGA-NH-A6GA,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2013.0,-21313.0,Dead,WITH TUMOR,,1.0,302.0,1.0,302.0,1.0,6.0
TCGA-NH-A6GB-01,TCGA-NH-A6GB,COAD,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2013.0,-26100.0,Alive,WITH TUMOR,476.0,0.0,476.0,0.0,476.0,0.0,476.0
TCGA-NH-A6GC-01,TCGA-NH-A6GC,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Colon Mucinous Adenocarcinoma,2013.0,-24355.0,Alive,,389.0,0.0,389.0,0.0,389.0,0.0,389.0
TCGA-NH-A8F7-01,TCGA-NH-A8F7,COAD,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2013.0,-19535.0,Alive,WITH TUMOR,543.0,0.0,543.0,0.0,543.0,0.0,543.0
TCGA-NH-A8F8-01,TCGA-NH-A8F8,COAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Colon Adenocarcinoma,2013.0,-29185.0,Dead,WITH TUMOR,,1.0,511.0,1.0,511.0,1.0,511.0
TCGA-NI-A4U2-01,TCGA-NI-A4U2,LIHC,71.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2005.0,-26011.0,Dead,WITH TUMOR,,1.0,1791.0,1.0,1791.0,1.0,106.0
TCGA-O8-A75V-01,TCGA-O8-A75V,LIHC,54.0,MALE,[Unknown],Stage I,Hepatocellular Carcinoma,2013.0,-19850.0,Alive,TUMOR FREE,538.0,0.0,538.0,0.0,538.0,0.0,538.0
TCGA-OL-A5D7-01,TCGA-OL-A5D7,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2009.0,-25643.0,Alive,TUMOR FREE,1780.0,0.0,1780.0,0.0,1780.0,0.0,1780.0
TCGA-OL-A5D8-01,TCGA-OL-A5D8,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2009.0,-14853.0,Alive,TUMOR FREE,973.0,0.0,973.0,0.0,973.0,0.0,973.0
TCGA-OL-A5DA-01,TCGA-OL-A5DA,BRCA,61.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2009.0,-22411.0,Alive,TUMOR FREE,1783.0,0.0,1783.0,0.0,1783.0,0.0,1783.0
TCGA-OL-A5RU-01,TCGA-OL-A5RU,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-23108.0,Alive,TUMOR FREE,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0
TCGA-OL-A5RV-01,TCGA-OL-A5RV,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2011.0,-15820.0,Alive,TUMOR FREE,1062.0,0.0,1062.0,0.0,1062.0,0.0,1062.0
TCGA-OL-A5RW-01,TCGA-OL-A5RW,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2010.0,-14638.0,Alive,TUMOR FREE,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0
TCGA-OL-A5RX-01,TCGA-OL-A5RX,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2011.0,-18942.0,Alive,TUMOR FREE,878.0,0.0,878.0,0.0,878.0,0.0,878.0
TCGA-OL-A5RZ-01,TCGA-OL-A5RZ,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2012.0,-21038.0,Alive,TUMOR FREE,679.0,0.0,679.0,0.0,679.0,0.0,679.0
TCGA-OL-A5S0-01,TCGA-OL-A5S0,BRCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2012.0,-24139.0,Alive,TUMOR FREE,620.0,0.0,620.0,0.0,620.0,0.0,620.0
TCGA-OL-A66J-01,TCGA-OL-A66J,BRCA,80.0,FEMALE,WHITE,Stage I,Infiltrating Lobular Carcinoma,2008.0,-29345.0,Alive,TUMOR FREE,1996.0,0.0,1996.0,0.0,1996.0,0.0,1996.0
TCGA-OL-A66K-01,TCGA-OL-A66K,BRCA,72.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2010.0,-26299.0,Dead,TUMOR FREE,,1.0,1275.0,0.0,1275.0,0.0,1275.0
TCGA-OL-A66N-01,TCGA-OL-A66N,BRCA,59.0,FEMALE,WHITE,Stage IIIC,Infiltrating Lobular Carcinoma,2011.0,-21608.0,Alive,TUMOR FREE,792.0,0.0,792.0,0.0,792.0,0.0,792.0
TCGA-OL-A66O-01,TCGA-OL-A66O,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2012.0,-14272.0,Alive,TUMOR FREE,528.0,0.0,528.0,0.0,528.0,0.0,528.0
TCGA-OL-A66P-01,TCGA-OL-A66P,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-27489.0,Alive,TUMOR FREE,428.0,0.0,428.0,0.0,428.0,0.0,428.0
TCGA-OL-A6VO-01,TCGA-OL-A6VO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,Infiltrating Ductal Carcinoma,2012.0,-15780.0,Alive,TUMOR FREE,858.0,0.0,858.0,0.0,858.0,0.0,858.0
TCGA-OL-A6VQ-01,TCGA-OL-A6VQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2012.0,-18151.0,Alive,TUMOR FREE,600.0,0.0,600.0,0.0,600.0,0.0,600.0
TCGA-OR-A5J2-01,TCGA-OR-A5J2,ACC,44.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2004.0,-16090.0,Dead,WITH TUMOR,,1.0,1677.0,1.0,1677.0,1.0,289.0
TCGA-OR-A5J3-01,TCGA-OR-A5J3,ACC,23.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2008.0,-8624.0,Alive,WITH TUMOR,2091.0,0.0,2091.0,0.0,2091.0,1.0,53.0
TCGA-OR-A5J6-01,TCGA-OR-A5J6,ACC,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Adrenocortical carcinoma- Usual Type,2006.0,-10839.0,Alive,TUMOR FREE,2703.0,0.0,2703.0,0.0,2703.0,0.0,2703.0
TCGA-OR-A5J7-01,TCGA-OR-A5J7,ACC,30.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2009.0,-11279.0,Dead,WITH TUMOR,,1.0,490.0,1.0,490.0,1.0,162.0
TCGA-OR-A5J8-01,TCGA-OR-A5J8,ACC,66.0,MALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2011.0,-24266.0,Dead,WITH TUMOR,,1.0,579.0,1.0,579.0,1.0,530.0
TCGA-OR-A5J9-01,TCGA-OR-A5J9,ACC,22.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2010.0,-8175.0,Alive,WITH TUMOR,1352.0,0.0,1352.0,0.0,1352.0,1.0,414.0
TCGA-OR-A5JA-01,TCGA-OR-A5JA,ACC,53.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2004.0,-19436.0,Dead,WITH TUMOR,,1.0,922.0,1.0,922.0,1.0,922.0
TCGA-OR-A5JP-01,TCGA-OR-A5JP,ACC,40.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2012.0,-14667.0,Alive,TUMOR FREE,464.0,0.0,464.0,0.0,464.0,0.0,464.0
TCGA-OR-A5JR-01,TCGA-OR-A5JR,ACC,45.0,MALE,WHITE,Stage I,Adrenocortical carcinoma- Usual Type,2002.0,-16604.0,Alive,TUMOR FREE,3688.0,0.0,3688.0,0.0,3688.0,0.0,3688.0
TCGA-OR-A5JS-01,TCGA-OR-A5JS,ACC,65.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2011.0,-24017.0,Alive,WITH TUMOR,383.0,0.0,383.0,0.0,383.0,1.0,166.0
TCGA-OR-A5JT-01,TCGA-OR-A5JT,ACC,65.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2011.0,-23794.0,Alive,WITH TUMOR,907.0,0.0,907.0,0.0,907.0,0.0,907.0
TCGA-OR-A5JV-01,TCGA-OR-A5JV,ACC,55.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2008.0,-20319.0,Alive,TUMOR FREE,2023.0,0.0,2023.0,0.0,2023.0,1.0,953.0
TCGA-OR-A5JW-01,TCGA-OR-A5JW,ACC,47.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2008.0,-17513.0,Alive,TUMOR FREE,2202.0,0.0,2202.0,0.0,2202.0,0.0,2202.0
TCGA-OR-A5JY-01,TCGA-OR-A5JY,ACC,68.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2011.0,-25190.0,Dead,WITH TUMOR,,1.0,552.0,1.0,552.0,1.0,75.0
TCGA-OR-A5JZ-01,TCGA-OR-A5JZ,ACC,60.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2011.0,-22218.0,Alive,WITH TUMOR,822.0,0.0,822.0,0.0,822.0,1.0,247.0
TCGA-OR-A5K0-01,TCGA-OR-A5K0,ACC,69.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2009.0,-25400.0,Alive,WITH TUMOR,1029.0,0.0,1029.0,0.0,1029.0,1.0,659.0
TCGA-OR-A5K1-01,TCGA-OR-A5K1,ACC,48.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2006.0,-17596.0,Alive,TUMOR FREE,3289.0,0.0,3289.0,0.0,3289.0,1.0,826.0
TCGA-OR-A5K3-01,TCGA-OR-A5K3,ACC,53.0,MALE,WHITE,Stage II,Adrenocortical Carcinoma- Oncocytic Type,2005.0,-19375.0,Alive,TUMOR FREE,3465.0,0.0,3465.0,0.0,3465.0,0.0,3465.0
TCGA-OR-A5K4-01,TCGA-OR-A5K4,ACC,64.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2011.0,-23481.0,Alive,TUMOR FREE,1082.0,0.0,1082.0,0.0,1082.0,0.0,1082.0
TCGA-OR-A5K5-01,TCGA-OR-A5K5,ACC,59.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2012.0,-21907.0,Dead,WITH TUMOR,,1.0,498.0,1.0,498.0,1.0,108.0
TCGA-OR-A5K6-01,TCGA-OR-A5K6,ACC,56.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2010.0,-20657.0,Alive,WITH TUMOR,1493.0,0.0,1493.0,0.0,1493.0,1.0,391.0
TCGA-OR-A5K8-01,TCGA-OR-A5K8,ACC,39.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2012.0,-14435.0,Alive,TUMOR FREE,749.0,0.0,749.0,0.0,749.0,0.0,749.0
TCGA-OR-A5KO-01,TCGA-OR-A5KO,ACC,39.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2009.0,-14606.0,Alive,WITH TUMOR,1414.0,0.0,1414.0,0.0,1414.0,1.0,541.0
TCGA-OR-A5KU-01,TCGA-OR-A5KU,ACC,37.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2000.0,-13559.0,Alive,TUMOR FREE,4673.0,0.0,4673.0,0.0,4673.0,0.0,4673.0
TCGA-OR-A5KW-01,TCGA-OR-A5KW,ACC,55.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2009.0,-20328.0,Alive,TUMOR FREE,2076.0,0.0,2076.0,0.0,2076.0,0.0,2076.0
TCGA-OR-A5KX-01,TCGA-OR-A5KX,ACC,25.0,FEMALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2010.0,-9298.0,Alive,WITH TUMOR,1364.0,0.0,1364.0,0.0,1364.0,1.0,62.0
TCGA-OR-A5KY-01,TCGA-OR-A5KY,ACC,23.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2010.0,-8745.0,Dead,WITH TUMOR,,1.0,391.0,1.0,391.0,1.0,178.0
TCGA-OR-A5KZ-01,TCGA-OR-A5KZ,ACC,42.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2012.0,-15594.0,Dead,WITH TUMOR,,1.0,125.0,1.0,125.0,1.0,36.0
TCGA-OR-A5LD-01,TCGA-OR-A5LD,ACC,52.0,MALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,1998.0,-19111.0,Dead,WITH TUMOR,,1.0,1197.0,1.0,1197.0,1.0,444.0
TCGA-OR-A5LG-01,TCGA-OR-A5LG,ACC,46.0,MALE,WHITE,Stage III,Adrenocortical carcinoma- Usual Type,2008.0,-16875.0,Alive,WITH TUMOR,1589.0,0.0,1589.0,0.0,1589.0,1.0,1393.0
TCGA-OR-A5LH-01,TCGA-OR-A5LH,ACC,36.0,FEMALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2005.0,-13182.0,Dead,WITH TUMOR,,1.0,2385.0,1.0,2385.0,1.0,2385.0
TCGA-OR-A5LJ-01,TCGA-OR-A5LJ,ACC,54.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2005.0,-20069.0,Dead,WITH TUMOR,,1.0,1105.0,1.0,1105.0,1.0,98.0
TCGA-OR-A5LK-01,TCGA-OR-A5LK,ACC,62.0,MALE,[Not Evaluated],Stage II,Adrenocortical Carcinoma- Oncocytic Type,2007.0,-22919.0,Alive,TUMOR FREE,2740.0,0.0,2740.0,0.0,2740.0,0.0,2740.0
TCGA-OR-A5LL-01,TCGA-OR-A5LL,ACC,75.0,FEMALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2007.0,-27607.0,Dead,WITH TUMOR,,1.0,1613.0,1.0,1613.0,1.0,213.0
TCGA-OR-A5LM-01,TCGA-OR-A5LM,ACC,23.0,MALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2008.0,-8735.0,Alive,TUMOR FREE,1858.0,0.0,1858.0,0.0,1858.0,0.0,1858.0
TCGA-OR-A5LN-01,TCGA-OR-A5LN,ACC,31.0,FEMALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2008.0,-11414.0,Alive,TUMOR FREE,2342.0,0.0,2342.0,0.0,2342.0,0.0,2342.0
TCGA-OR-A5LO-01,TCGA-OR-A5LO,ACC,61.0,FEMALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2008.0,-22370.0,Dead,WITH TUMOR,,1.0,2405.0,1.0,2405.0,1.0,153.0
TCGA-OR-A5LP-01,TCGA-OR-A5LP,ACC,37.0,FEMALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2009.0,-13574.0,Alive,TUMOR FREE,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0
TCGA-OR-A5LS-01,TCGA-OR-A5LS,ACC,34.0,FEMALE,[Not Evaluated],Stage II,Adrenocortical carcinoma- Usual Type,2011.0,-12663.0,Alive,TUMOR FREE,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0
TCGA-OR-A5LT-01,TCGA-OR-A5LT,ACC,57.0,MALE,[Not Evaluated],Stage III,Adrenocortical carcinoma- Usual Type,2012.0,-21032.0,Alive,TUMOR FREE,549.0,0.0,549.0,0.0,549.0,0.0,549.0
TCGA-OU-A5PI-01,TCGA-OU-A5PI,ACC,53.0,FEMALE,WHITE,Stage IV,Adrenocortical carcinoma- Usual Type,2011.0,-19492.0,Alive,WITH TUMOR,1171.0,0.0,1171.0,0.0,1171.0,1.0,351.0
TCGA-P4-A5E6-01,TCGA-P4-A5E6,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2004.0,-24615.0,Alive,TUMOR FREE,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0
TCGA-P4-A5E7-01,TCGA-P4-A5E7,KIRP,74.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2004.0,-27029.0,Alive,TUMOR FREE,2649.0,0.0,2649.0,0.0,2649.0,0.0,2649.0
TCGA-P4-A5E8-01,TCGA-P4-A5E8,KIRP,57.0,MALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2004.0,-21132.0,Dead,WITH TUMOR,,1.0,1306.0,1.0,1306.0,1.0,42.0
TCGA-P4-A5EA-01,TCGA-P4-A5EA,KIRP,54.0,FEMALE,WHITE,Stage III,Kidney Papillary Renal Cell Carcinoma,2007.0,-19748.0,Dead,WITH TUMOR,,1.0,201.0,1.0,201.0,1.0,44.0
TCGA-P4-A5EB-01,TCGA-P4-A5EB,KIRP,83.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2006.0,-30395.0,Alive,TUMOR FREE,3015.0,0.0,3015.0,0.0,3015.0,0.0,3015.0
TCGA-P4-A5ED-01,TCGA-P4-A5ED,KIRP,51.0,MALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2005.0,-18698.0,Alive,TUMOR FREE,2816.0,0.0,2816.0,0.0,2816.0,0.0,2816.0
TCGA-P5-A5ET-01,TCGA-P5-A5ET,LGG,27.0,MALE,WHITE,,Oligodendroglioma,2012.0,-10027.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-P5-A5EU-01,TCGA-P5-A5EU,LGG,35.0,MALE,WHITE,,Astrocytoma,2012.0,-12851.0,Alive,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-P5-A5EV-01,TCGA-P5-A5EV,LGG,39.0,MALE,WHITE,,Astrocytoma,2012.0,-14310.0,Alive,WITH TUMOR,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-P5-A5EW-01,TCGA-P5-A5EW,LGG,20.0,FEMALE,WHITE,,Astrocytoma,2012.0,-7612.0,Alive,TUMOR FREE,204.0,0.0,204.0,0.0,204.0,0.0,204.0
TCGA-P5-A5EX-01,TCGA-P5-A5EX,LGG,41.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-15091.0,Alive,TUMOR FREE,243.0,0.0,243.0,0.0,243.0,0.0,243.0
TCGA-P5-A5EY-01,TCGA-P5-A5EY,LGG,21.0,MALE,WHITE,,Astrocytoma,2012.0,-7716.0,Alive,,72.0,0.0,72.0,0.0,72.0,0.0,72.0
TCGA-P5-A5EZ-01,TCGA-P5-A5EZ,LGG,39.0,MALE,WHITE,,Astrocytoma,2012.0,-14375.0,Alive,TUMOR FREE,70.0,0.0,70.0,0.0,70.0,0.0,70.0
TCGA-P5-A5F0-01,TCGA-P5-A5F0,LGG,33.0,MALE,WHITE,,Oligodendroglioma,2012.0,-12157.0,Alive,[Discrepancy],287.0,0.0,287.0,0.0,287.0,0.0,287.0
TCGA-P5-A5F1-01,TCGA-P5-A5F1,LGG,30.0,MALE,WHITE,,Astrocytoma,2012.0,-11070.0,Alive,TUMOR FREE,179.0,0.0,179.0,0.0,179.0,0.0,179.0
TCGA-P5-A5F2-01,TCGA-P5-A5F2,LGG,36.0,FEMALE,WHITE,,Astrocytoma,2012.0,-13396.0,Alive,WITH TUMOR,242.0,0.0,242.0,0.0,242.0,0.0,242.0
TCGA-P5-A5F4-01,TCGA-P5-A5F4,LGG,35.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-12851.0,Alive,[Discrepancy],231.0,0.0,231.0,0.0,231.0,0.0,231.0
TCGA-P5-A5F6-01,TCGA-P5-A5F6,LGG,26.0,MALE,WHITE,,Oligodendroglioma,2012.0,-9575.0,Alive,TUMOR FREE,39.0,0.0,39.0,0.0,39.0,0.0,39.0
TCGA-P5-A72U-01,TCGA-P5-A72U,LGG,71.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-26002.0,Alive,TUMOR FREE,7.0,0.0,7.0,0.0,7.0,0.0,7.0
TCGA-P5-A72W-01,TCGA-P5-A72W,LGG,35.0,MALE,WHITE,,Astrocytoma,2013.0,-12848.0,Alive,TUMOR FREE,317.0,0.0,317.0,0.0,317.0,0.0,317.0
TCGA-P5-A72X-01,TCGA-P5-A72X,LGG,21.0,MALE,WHITE,,Astrocytoma,2013.0,-7913.0,Alive,TUMOR FREE,403.0,0.0,403.0,0.0,403.0,0.0,403.0
TCGA-P5-A72Z-01,TCGA-P5-A72Z,LGG,64.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-23482.0,Alive,TUMOR FREE,354.0,0.0,354.0,0.0,354.0,0.0,354.0
TCGA-P5-A730-01,TCGA-P5-A730,LGG,22.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-8043.0,Alive,TUMOR FREE,333.0,0.0,333.0,0.0,333.0,0.0,333.0
TCGA-P5-A731-01,TCGA-P5-A731,LGG,59.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-21715.0,Alive,TUMOR FREE,274.0,0.0,274.0,0.0,274.0,0.0,274.0
TCGA-P5-A733-01,TCGA-P5-A733,LGG,52.0,FEMALE,WHITE,,Astrocytoma,2013.0,-19142.0,Alive,TUMOR FREE,414.0,0.0,414.0,0.0,414.0,0.0,414.0
TCGA-P5-A735-01,TCGA-P5-A735,LGG,38.0,FEMALE,WHITE,,Astrocytoma,2013.0,-14152.0,Alive,TUMOR FREE,292.0,0.0,292.0,0.0,292.0,0.0,292.0
TCGA-P5-A736-01,TCGA-P5-A736,LGG,44.0,FEMALE,WHITE,,Astrocytoma,2013.0,-16300.0,Alive,TUMOR FREE,230.0,0.0,230.0,0.0,230.0,0.0,230.0
TCGA-P5-A737-01,TCGA-P5-A737,LGG,47.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-17390.0,Alive,TUMOR FREE,372.0,0.0,372.0,0.0,372.0,0.0,372.0
TCGA-P5-A77W-01,TCGA-P5-A77W,LGG,37.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-13545.0,Alive,TUMOR FREE,584.0,0.0,584.0,0.0,584.0,0.0,584.0
TCGA-P5-A77X-01,TCGA-P5-A77X,LGG,55.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-20128.0,Alive,TUMOR FREE,105.0,0.0,105.0,0.0,105.0,0.0,105.0
TCGA-P5-A780-01,TCGA-P5-A780,LGG,44.0,FEMALE,WHITE,,Astrocytoma,2013.0,-16161.0,Alive,TUMOR FREE,72.0,0.0,72.0,0.0,72.0,0.0,72.0
TCGA-P5-A781-01,TCGA-P5-A781,LGG,34.0,FEMALE,WHITE,,Astrocytoma,2013.0,-12757.0,Alive,TUMOR FREE,134.0,0.0,134.0,0.0,134.0,0.0,134.0
TCGA-P8-A5KC-01,TCGA-P8-A5KC,PCPG,48.0,MALE,WHITE,,Pheochromocytoma,2011.0,-17790.0,Alive,TUMOR FREE,883.0,0.0,883.0,0.0,883.0,0.0,883.0
TCGA-P8-A5KD-01,TCGA-P8-A5KD,PCPG,35.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-12954.0,Alive,TUMOR FREE,123.0,0.0,123.0,0.0,123.0,0.0,123.0
TCGA-P8-A6RX-01,TCGA-P8-A6RX,PCPG,65.0,MALE,WHITE,,Paraganglioma,2013.0,-23825.0,Alive,TUMOR FREE,540.0,0.0,540.0,0.0,540.0,0.0,540.0
TCGA-P8-A6RY-01,TCGA-P8-A6RY,PCPG,55.0,MALE,WHITE,,Pheochromocytoma,2012.0,-20109.0,Alive,TUMOR FREE,179.0,0.0,179.0,0.0,179.0,0.0,179.0
TCGA-PA-A5YG-01,TCGA-PA-A5YG,ACC,51.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2012.0,-18926.0,Alive,TUMOR FREE,756.0,0.0,756.0,0.0,756.0,0.0,756.0
TCGA-PD-A5DF-01,TCGA-PD-A5DF,LIHC,58.0,FEMALE,WHITE,Stage IIIB,Hepatocellular Carcinoma,2007.0,-21414.0,Dead,WITH TUMOR,,1.0,639.0,1.0,639.0,1.0,639.0
TCGA-PE-A5DC-01,TCGA-PE-A5DC,BRCA,72.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2005.0,-26514.0,Dead,TUMOR FREE,,1.0,1430.0,0.0,1430.0,0.0,1430.0
TCGA-PE-A5DD-01,TCGA-PE-A5DD,BRCA,64.0,FEMALE,ASIAN,Stage IIA,Infiltrating Lobular Carcinoma,2006.0,-23686.0,Alive,TUMOR FREE,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0
TCGA-PE-A5DE-01,TCGA-PE-A5DE,BRCA,41.0,FEMALE,WHITE,Stage IIA,Infiltrating Lobular Carcinoma,2007.0,-15216.0,Alive,TUMOR FREE,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0
TCGA-PJ-A5Z8-01,TCGA-PJ-A5Z8,KIRP,60.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2013.0,-21968.0,Alive,TUMOR FREE,600.0,0.0,600.0,0.0,600.0,0.0,600.0
TCGA-PJ-A5Z9-01,TCGA-PJ-A5Z9,KIRP,80.0,FEMALE,WHITE,Stage I,Kidney Papillary Renal Cell Carcinoma,2012.0,-29365.0,Alive,TUMOR FREE,540.0,0.0,540.0,0.0,540.0,0.0,540.0
TCGA-PK-A5H8-01,TCGA-PK-A5H8,ACC,42.0,MALE,WHITE,Stage II,Adrenocortical carcinoma- Usual Type,2004.0,-15373.0,Alive,TUMOR FREE,3623.0,0.0,3623.0,0.0,3623.0,0.0,3623.0
TCGA-PK-A5H9-01,TCGA-PK-A5H9,ACC,27.0,FEMALE,ASIAN,Stage II,Adrenocortical carcinoma- Usual Type,2012.0,-10173.0,Alive,TUMOR FREE,616.0,0.0,616.0,0.0,616.0,0.0,616.0
TCGA-PK-A5HA-01,TCGA-PK-A5HA,ACC,63.0,MALE,[Unknown],Stage I,Adrenocortical carcinoma- Usual Type,2011.0,-23345.0,Alive,TUMOR FREE,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0
TCGA-PL-A8LV-01,TCGA-PL-A8LV,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Medullary Carcinoma,2013.0,-19746.0,Alive,WITH TUMOR,-7.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-PL-A8LX-01,TCGA-PL-A8LX,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,Infiltrating Ductal Carcinoma,2013.0,-12840.0,Alive,WITH TUMOR,5.0,0.0,5.0,0.0,5.0,0.0,5.0
TCGA-PL-A8LY-01,TCGA-PL-A8LY,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-11199.0,Alive,WITH TUMOR,8.0,0.0,8.0,0.0,8.0,0.0,8.0
TCGA-PR-A5PF-01,TCGA-PR-A5PF,PCPG,62.0,FEMALE,WHITE,,Pheochromocytoma,2011.0,-22987.0,Alive,TUMOR FREE,546.0,0.0,546.0,0.0,546.0,0.0,546.0
TCGA-PR-A5PG-01,TCGA-PR-A5PG,PCPG,42.0,FEMALE,WHITE,,Pheochromocytoma,2007.0,-15577.0,Alive,WITH TUMOR,2485.0,0.0,2485.0,0.0,2485.0,1.0,2278.0
TCGA-PR-A5PH-01,TCGA-PR-A5PH,PCPG,47.0,MALE,WHITE,,Pheochromocytoma,2007.0,-17347.0,Alive,TUMOR FREE,854.0,0.0,854.0,0.0,854.0,0.0,854.0
TCGA-Q2-A5QZ-01,TCGA-Q2-A5QZ,KIRP,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Kidney Papillary Renal Cell Carcinoma,2012.0,-22531.0,Alive,,428.0,0.0,428.0,0.0,428.0,1.0,412.0
TCGA-Q9-A6FU-01,TCGA-Q9-A6FU,ESCA,57.0,FEMALE,WHITE,Stage IIIB,Esophagus Squamous Cell Carcinoma,2012.0,-21108.0,Dead,WITH TUMOR,,1.0,157.0,1.0,157.0,1.0,99.0
TCGA-Q9-A6FW-01,TCGA-Q9-A6FW,ESCA,61.0,MALE,WHITE,Stage IIIB,"Esophagus Adenocarcinoma, NOS",2013.0,-22586.0,Alive,TUMOR FREE,238.0,0.0,238.0,0.0,238.0,0.0,238.0
TCGA-QG-A5YV-01,TCGA-QG-A5YV,COAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Adenocarcinoma,2011.0,-23499.0,Alive,TUMOR FREE,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0
TCGA-QG-A5YW-01,TCGA-QG-A5YW,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Colon Mucinous Adenocarcinoma,2011.0,-20391.0,Alive,TUMOR FREE,896.0,0.0,896.0,0.0,896.0,0.0,896.0
TCGA-QG-A5YX-01,TCGA-QG-A5YX,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2011.0,-22617.0,Alive,TUMOR FREE,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0
TCGA-QG-A5Z1-01,TCGA-QG-A5Z1,COAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2011.0,-26220.0,Dead,TUMOR FREE,,1.0,256.0,0.0,256.0,0.0,256.0
TCGA-QG-A5Z2-01,TCGA-QG-A5Z2,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Colon Adenocarcinoma,2012.0,-22367.0,Alive,TUMOR FREE,952.0,0.0,952.0,0.0,952.0,0.0,952.0
TCGA-QH-A65S-01,TCGA-QH-A65S,LGG,32.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-11861.0,Alive,[Discrepancy],77.0,0.0,77.0,0.0,77.0,0.0,77.0
TCGA-QH-A65V-01,TCGA-QH-A65V,LGG,43.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-15850.0,Alive,WITH TUMOR,384.0,0.0,384.0,0.0,384.0,0.0,384.0
TCGA-QH-A65X-01,TCGA-QH-A65X,LGG,28.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-10440.0,Alive,TUMOR FREE,482.0,0.0,482.0,0.0,482.0,0.0,482.0
TCGA-QH-A65Z-01,TCGA-QH-A65Z,LGG,54.0,MALE,WHITE,,Oligodendroglioma,2013.0,-19921.0,Alive,TUMOR FREE,427.0,0.0,427.0,0.0,427.0,0.0,427.0
TCGA-QH-A6CS-01,TCGA-QH-A6CS,LGG,41.0,MALE,WHITE,,Astrocytoma,2013.0,-15092.0,Alive,WITH TUMOR,588.0,0.0,588.0,0.0,588.0,1.0,498.0
TCGA-QH-A6CU-01,TCGA-QH-A6CU,LGG,52.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-19149.0,Alive,TUMOR FREE,451.0,0.0,451.0,0.0,451.0,0.0,451.0
TCGA-QH-A6CV-01,TCGA-QH-A6CV,LGG,51.0,MALE,ASIAN,,Oligoastrocytoma,2013.0,-18955.0,Alive,WITH TUMOR,442.0,0.0,442.0,0.0,442.0,0.0,442.0
TCGA-QH-A6CW-01,TCGA-QH-A6CW,LGG,43.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-15847.0,Alive,TUMOR FREE,414.0,0.0,414.0,0.0,414.0,0.0,414.0
TCGA-QH-A6CX-01,TCGA-QH-A6CX,LGG,66.0,MALE,WHITE,,Astrocytoma,2013.0,-24252.0,Dead,WITH TUMOR,,1.0,372.0,1.0,372.0,1.0,273.0
TCGA-QH-A6CY-01,TCGA-QH-A6CY,LGG,38.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-14140.0,Alive,WITH TUMOR,408.0,0.0,408.0,0.0,408.0,0.0,408.0
TCGA-QH-A6CZ-01,TCGA-QH-A6CZ,LGG,38.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-14007.0,Alive,TUMOR FREE,279.0,0.0,279.0,0.0,279.0,0.0,279.0
TCGA-QH-A6X4-01,TCGA-QH-A6X4,LGG,47.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-17258.0,Alive,TUMOR FREE,442.0,0.0,442.0,0.0,442.0,0.0,442.0
TCGA-QH-A6X5-01,TCGA-QH-A6X5,LGG,58.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-21239.0,Alive,,497.0,0.0,497.0,0.0,497.0,0.0,497.0
TCGA-QH-A6X8-01,TCGA-QH-A6X8,LGG,56.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-20771.0,Alive,WITH TUMOR,509.0,0.0,509.0,0.0,509.0,0.0,509.0
TCGA-QH-A6X9-01,TCGA-QH-A6X9,LGG,73.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-26992.0,Alive,,58.0,0.0,58.0,0.0,58.0,0.0,58.0
TCGA-QH-A6XA-01,TCGA-QH-A6XA,LGG,23.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-8508.0,Alive,TUMOR FREE,502.0,0.0,502.0,0.0,502.0,0.0,502.0
TCGA-QH-A6XC-01,TCGA-QH-A6XC,LGG,48.0,MALE,WHITE,,Astrocytoma,2013.0,-17692.0,Alive,WITH TUMOR,508.0,0.0,508.0,0.0,508.0,1.0,438.0
TCGA-QH-A86X-01,TCGA-QH-A86X,LGG,33.0,MALE,WHITE,,Oligodendroglioma,2013.0,-12385.0,Alive,TUMOR FREE,337.0,0.0,337.0,0.0,337.0,0.0,337.0
TCGA-QH-A870-01,TCGA-QH-A870,LGG,38.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-14082.0,Alive,WITH TUMOR,395.0,0.0,395.0,0.0,395.0,1.0,335.0
TCGA-QL-A97D-01,TCGA-QL-A97D,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Colon Adenocarcinoma,2012.0,-30914.0,Alive,TUMOR FREE,666.0,0.0,666.0,0.0,666.0,0.0,666.0
TCGA-QN-A5NN-01,TCGA-QN-A5NN,UCS,55.0,FEMALE,ASIAN,,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,2012.0,-20318.0,Alive,TUMOR FREE,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-QR-A6GO-01,TCGA-QR-A6GO,PCPG,43.0,MALE,WHITE,,Pheochromocytoma,2009.0,-15799.0,Alive,TUMOR FREE,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0
TCGA-QR-A6GT-01,TCGA-QR-A6GT,PCPG,63.0,FEMALE,WHITE,,Pheochromocytoma,2002.0,-23208.0,Alive,WITH TUMOR,4185.0,0.0,4185.0,0.0,4185.0,1.0,1476.0
TCGA-QR-A6GU-01,TCGA-QR-A6GU,PCPG,31.0,MALE,WHITE,,Pheochromocytoma,2008.0,-11592.0,Alive,TUMOR FREE,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0
TCGA-QR-A6GZ-01,TCGA-QR-A6GZ,PCPG,31.0,MALE,WHITE,,Pheochromocytoma,2009.0,-11573.0,Alive,TUMOR FREE,928.0,0.0,928.0,0.0,928.0,0.0,928.0
TCGA-QR-A6H2-01,TCGA-QR-A6H2,PCPG,33.0,MALE,ASIAN,,Pheochromocytoma,2003.0,-12281.0,Alive,TUMOR FREE,302.0,0.0,302.0,0.0,302.0,0.0,302.0
TCGA-QR-A70W-01,TCGA-QR-A70W,PCPG,40.0,MALE,WHITE,,Pheochromocytoma,2009.0,-14613.0,Alive,TUMOR FREE,1271.0,0.0,1271.0,0.0,1271.0,0.0,1271.0
TCGA-QT-A5XJ-01,TCGA-QT-A5XJ,PCPG,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2011.0,-15535.0,Alive,WITH TUMOR,1102.0,0.0,1102.0,0.0,1102.0,1.0,77.0
TCGA-QT-A5XK-01,TCGA-QT-A5XK,PCPG,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2011.0,-20724.0,Alive,TUMOR FREE,211.0,0.0,211.0,0.0,211.0,0.0,211.0
TCGA-QT-A5XL-01,TCGA-QT-A5XL,PCPG,27.0,MALE,WHITE,,Pheochromocytoma,2010.0,-10028.0,Alive,TUMOR FREE,55.0,0.0,55.0,0.0,55.0,0.0,55.0
TCGA-QT-A5XM-01,TCGA-QT-A5XM,PCPG,43.0,MALE,WHITE,,Pheochromocytoma,2012.0,-15915.0,Alive,TUMOR FREE,22.0,0.0,22.0,0.0,22.0,0.0,22.0
TCGA-QT-A5XN-01,TCGA-QT-A5XN,PCPG,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2010.0,-18812.0,Alive,TUMOR FREE,766.0,0.0,766.0,0.0,766.0,0.0,766.0
TCGA-QT-A5XO-01,TCGA-QT-A5XO,PCPG,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2012.0,-23154.0,Alive,TUMOR FREE,70.0,0.0,70.0,0.0,70.0,0.0,70.0
TCGA-QT-A5XP-01,TCGA-QT-A5XP,PCPG,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2012.0,-21072.0,Alive,TUMOR FREE,134.0,0.0,134.0,0.0,134.0,0.0,134.0
TCGA-QT-A69Q-01,TCGA-QT-A69Q,PCPG,40.0,MALE,WHITE,,Pheochromocytoma,2012.0,-14866.0,Alive,TUMOR FREE,24.0,0.0,24.0,0.0,24.0,0.0,24.0
TCGA-QT-A7U0-01,TCGA-QT-A7U0,PCPG,56.0,MALE,WHITE,,Paraganglioma; Extra-adrenal Pheochromocytoma,2013.0,-20538.0,Alive,TUMOR FREE,398.0,0.0,398.0,0.0,398.0,0.0,398.0
TCGA-QU-A6IP-01,TCGA-QU-A6IP,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2004.0,-24212.0,Alive,TUMOR FREE,2620.0,0.0,2620.0,0.0,2620.0,0.0,2620.0
TCGA-R8-A6MK-01,TCGA-R8-A6MK,LGG,40.0,MALE,WHITE,,Oligodendroglioma,2005.0,-14716.0,Alive,,2702.0,0.0,2702.0,0.0,2702.0,0.0,2702.0
TCGA-R8-A6ML-01,TCGA-R8-A6ML,LGG,52.0,MALE,WHITE,,Oligodendroglioma,2005.0,-19185.0,Alive,,2860.0,0.0,2860.0,0.0,2860.0,0.0,2860.0
TCGA-R8-A6MO-01,TCGA-R8-A6MO,LGG,53.0,FEMALE,ASIAN,,Oligodendroglioma,2009.0,-19432.0,Alive,,993.0,0.0,993.0,0.0,993.0,0.0,993.0
TCGA-RC-A6M6-01,TCGA-RC-A6M6,LIHC,75.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2011.0,-27649.0,Alive,,9.0,0.0,9.0,0.0,9.0,0.0,9.0
TCGA-RD-A7BS-01,TCGA-RD-A7BS,STAD,46.0,MALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2001.0,-16847.0,Dead,WITH TUMOR,,1.0,336.0,1.0,336.0,1.0,244.0
TCGA-RD-A7BW-01,TCGA-RD-A7BW,STAD,68.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Diffuse Type",2004.0,-25036.0,Dead,TUMOR FREE,,1.0,156.0,0.0,156.0,0.0,156.0
TCGA-RD-A7C1-01,TCGA-RD-A7C1,STAD,82.0,MALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Diffuse Type",2005.0,-30171.0,Dead,WITH TUMOR,,1.0,507.0,1.0,507.0,1.0,438.0
TCGA-RD-A8MV-01,TCGA-RD-A8MV,STAD,56.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2001.0,-20771.0,Alive,TUMOR FREE,3720.0,0.0,3720.0,0.0,3720.0,0.0,3720.0
TCGA-RD-A8MW-01,TCGA-RD-A8MW,STAD,72.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2004.0,-26590.0,Dead,WITH TUMOR,1153.0,1.0,1153.0,1.0,1153.0,1.0,98.0
TCGA-RD-A8N0-01,TCGA-RD-A8N0,STAD,53.0,FEMALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2006.0,-19491.0,Alive,TUMOR FREE,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0
TCGA-RD-A8N1-01,TCGA-RD-A8N1,STAD,70.0,MALE,WHITE,Stage IIIB,"Stomach, Adenocarcinoma, Diffuse Type",2001.0,-25737.0,Alive,TUMOR FREE,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0
TCGA-RD-A8NB-01,TCGA-RD-A8NB,STAD,80.0,FEMALE,WHITE,Stage IIIA,"Stomach, Adenocarcinoma, Diffuse Type",2000.0,-29503.0,Dead,WITH TUMOR,,1.0,513.0,1.0,513.0,1.0,230.0
TCGA-RE-A7BO-01,TCGA-RE-A7BO,ESCA,72.0,FEMALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2006.0,-26348.0,Dead,TUMOR FREE,,1.0,213.0,0.0,213.0,0.0,213.0
TCGA-RG-A7D4-01,TCGA-RG-A7D4,LIHC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Hepatocellular Carcinoma,2012.0,-25302.0,Alive,TUMOR FREE,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0
TCGA-RT-A6Y9-01,TCGA-RT-A6Y9,PCPG,50.0,FEMALE,WHITE,,Pheochromocytoma,2005.0,-18594.0,Alive,TUMOR FREE,3293.0,0.0,3293.0,0.0,3293.0,1.0,3282.0
TCGA-RT-A6YA-01,TCGA-RT-A6YA,PCPG,71.0,FEMALE,WHITE,,Pheochromocytoma,2009.0,-26095.0,Alive,TUMOR FREE,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0
TCGA-RT-A6YC-01,TCGA-RT-A6YC,PCPG,31.0,MALE,WHITE,,Pheochromocytoma,2013.0,-11572.0,Alive,TUMOR FREE,246.0,0.0,246.0,0.0,246.0,0.0,246.0
TCGA-RU-A8FL-01,TCGA-RU-A8FL,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,Colon Adenocarcinoma,2011.0,-18975.0,Alive,WITH TUMOR,1177.0,0.0,1177.0,0.0,1177.0,1.0,256.0
TCGA-RW-A67V-01,TCGA-RW-A67V,PCPG,44.0,FEMALE,WHITE,,Pheochromocytoma,2004.0,-16139.0,Alive,TUMOR FREE,2643.0,0.0,2643.0,0.0,2643.0,1.0,551.0
TCGA-RW-A67X-01,TCGA-RW-A67X,PCPG,47.0,MALE,WHITE,,Pheochromocytoma,2003.0,-17307.0,Alive,TUMOR FREE,89.0,0.0,89.0,0.0,89.0,0.0,89.0
TCGA-RW-A680-01,TCGA-RW-A680,PCPG,57.0,FEMALE,WHITE,,Paraganglioma; Extra-adrenal Pheochromocytoma,2011.0,-21010.0,Alive,TUMOR FREE,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0
TCGA-RW-A681-01,TCGA-RW-A681,PCPG,56.0,MALE,WHITE,,Pheochromocytoma,2011.0,-20812.0,Alive,TUMOR FREE,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0
TCGA-RW-A685-01,TCGA-RW-A685,PCPG,70.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-25790.0,Alive,TUMOR FREE,26.0,0.0,26.0,0.0,26.0,0.0,26.0
TCGA-RW-A688-01,TCGA-RW-A688,PCPG,69.0,FEMALE,WHITE,,Pheochromocytoma,2013.0,-25216.0,Alive,TUMOR FREE,37.0,0.0,37.0,0.0,37.0,1.0,27.0
TCGA-RW-A689-01,TCGA-RW-A689,PCPG,58.0,MALE,WHITE,,Pheochromocytoma,2012.0,-21402.0,Alive,TUMOR FREE,828.0,0.0,828.0,0.0,828.0,0.0,828.0
TCGA-RW-A68A-01,TCGA-RW-A68A,PCPG,19.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-7248.0,Alive,TUMOR FREE,762.0,0.0,762.0,0.0,762.0,0.0,762.0
TCGA-RW-A68B-01,TCGA-RW-A68B,PCPG,31.0,MALE,[Not Evaluated],,Pheochromocytoma,2013.0,-11557.0,Alive,TUMOR FREE,727.0,0.0,727.0,0.0,727.0,0.0,727.0
TCGA-RW-A68C-01,TCGA-RW-A68C,PCPG,43.0,MALE,WHITE,,Pheochromocytoma,2013.0,-15962.0,Alive,TUMOR FREE,191.0,0.0,191.0,0.0,191.0,0.0,191.0
TCGA-RW-A68D-01,TCGA-RW-A68D,PCPG,31.0,FEMALE,ASIAN,,Pheochromocytoma,2006.0,-11438.0,Alive,TUMOR FREE,2214.0,0.0,2214.0,0.0,2214.0,0.0,2214.0
TCGA-RW-A68F-01,TCGA-RW-A68F,PCPG,51.0,FEMALE,WHITE,,Pheochromocytoma,2010.0,-18974.0,Alive,TUMOR FREE,1354.0,0.0,1354.0,0.0,1354.0,0.0,1354.0
TCGA-RW-A68G-01,TCGA-RW-A68G,PCPG,49.0,MALE,WHITE,,Pheochromocytoma,2011.0,-17959.0,Alive,TUMOR FREE,1274.0,0.0,1274.0,0.0,1274.0,0.0,1274.0
TCGA-RW-A8AZ-01,TCGA-RW-A8AZ,PCPG,66.0,MALE,WHITE,,Pheochromocytoma,2013.0,-24268.0,Dead,TUMOR FREE,,1.0,88.0,0.0,88.0,0.0,88.0
TCGA-RX-A8JQ-01,TCGA-RX-A8JQ,PCPG,44.0,MALE,WHITE,,Paraganglioma,2013.0,-16182.0,Alive,TUMOR FREE,611.0,0.0,611.0,0.0,611.0,0.0,611.0
TCGA-RY-A83X-01,TCGA-RY-A83X,LGG,46.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-16911.0,Alive,TUMOR FREE,939.0,0.0,939.0,0.0,939.0,0.0,939.0
TCGA-RY-A83Y-01,TCGA-RY-A83Y,LGG,45.0,MALE,WHITE,,Oligodendroglioma,2012.0,-16470.0,Alive,TUMOR FREE,166.0,0.0,166.0,0.0,166.0,0.0,166.0
TCGA-RY-A83Z-01,TCGA-RY-A83Z,LGG,54.0,FEMALE,WHITE,,Astrocytoma,2012.0,-19903.0,Alive,WITH TUMOR,301.0,0.0,301.0,0.0,301.0,0.0,301.0
TCGA-RY-A843-01,TCGA-RY-A843,LGG,30.0,MALE,WHITE,,Astrocytoma,2012.0,-11083.0,Alive,WITH TUMOR,63.0,0.0,63.0,0.0,63.0,0.0,63.0
TCGA-RY-A845-01,TCGA-RY-A845,LGG,40.0,FEMALE,WHITE,,Oligoastrocytoma,2013.0,-14617.0,Alive,TUMOR FREE,596.0,0.0,596.0,0.0,596.0,0.0,596.0
TCGA-S3-A6ZG-01,TCGA-S3-A6ZG,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Mixed Histology (please specify),2013.0,-26141.0,Alive,TUMOR FREE,562.0,0.0,562.0,0.0,562.0,0.0,562.0
TCGA-S3-A6ZH-01,TCGA-S3-A6ZH,BRCA,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Infiltrating Ductal Carcinoma,2013.0,-10832.0,Alive,TUMOR FREE,641.0,0.0,641.0,0.0,641.0,0.0,641.0
TCGA-S3-AA0Z-01,TCGA-S3-AA0Z,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-23314.0,Alive,TUMOR FREE,629.0,0.0,629.0,0.0,629.0,0.0,629.0
TCGA-S3-AA10-01,TCGA-S3-AA10,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-24075.0,Alive,TUMOR FREE,586.0,0.0,586.0,0.0,586.0,0.0,586.0
TCGA-S3-AA11-01,TCGA-S3-AA11,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-24813.0,Alive,TUMOR FREE,421.0,0.0,421.0,0.0,421.0,0.0,421.0
TCGA-S3-AA12-01,TCGA-S3-AA12,BRCA,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,Infiltrating Ductal Carcinoma,2013.0,-30101.0,Alive,TUMOR FREE,574.0,0.0,574.0,0.0,574.0,0.0,574.0
TCGA-S3-AA14-01,TCGA-S3-AA14,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Infiltrating Ductal Carcinoma,2013.0,-17352.0,Alive,TUMOR FREE,529.0,0.0,529.0,0.0,529.0,0.0,529.0
TCGA-S3-AA15-01,TCGA-S3-AA15,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-18659.0,Alive,TUMOR FREE,525.0,0.0,525.0,0.0,525.0,0.0,525.0
TCGA-S3-AA17-01,TCGA-S3-AA17,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2013.0,-23642.0,Alive,TUMOR FREE,424.0,0.0,424.0,0.0,424.0,0.0,424.0
TCGA-S7-A7WL-01,TCGA-S7-A7WL,PCPG,59.0,MALE,WHITE,,Pheochromocytoma,2012.0,-21643.0,Alive,TUMOR FREE,961.0,0.0,961.0,0.0,961.0,0.0,961.0
TCGA-S7-A7WM-01,TCGA-S7-A7WM,PCPG,76.0,MALE,WHITE,,Pheochromocytoma,2011.0,-27984.0,Alive,TUMOR FREE,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0
TCGA-S7-A7WN-01,TCGA-S7-A7WN,PCPG,40.0,MALE,WHITE,,Pheochromocytoma,2011.0,-14611.0,Alive,TUMOR FREE,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0
TCGA-S7-A7WP-01,TCGA-S7-A7WP,PCPG,25.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-9241.0,Alive,TUMOR FREE,944.0,0.0,944.0,0.0,944.0,0.0,944.0
TCGA-S7-A7WQ-01,TCGA-S7-A7WQ,PCPG,19.0,MALE,WHITE,,Pheochromocytoma,2012.0,-7269.0,Alive,TUMOR FREE,820.0,0.0,820.0,0.0,820.0,0.0,820.0
TCGA-S7-A7WR-01,TCGA-S7-A7WR,PCPG,32.0,FEMALE,WHITE,,Pheochromocytoma,2011.0,-12011.0,Alive,TUMOR FREE,1238.0,0.0,1238.0,0.0,1238.0,0.0,1238.0
TCGA-S7-A7WU-01,TCGA-S7-A7WU,PCPG,63.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-23187.0,Alive,TUMOR FREE,928.0,0.0,928.0,0.0,928.0,0.0,928.0
TCGA-S7-A7WV-01,TCGA-S7-A7WV,PCPG,35.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-12893.0,Alive,TUMOR FREE,849.0,0.0,849.0,0.0,849.0,0.0,849.0
TCGA-S7-A7WW-01,TCGA-S7-A7WW,PCPG,34.0,MALE,WHITE,,Pheochromocytoma,2013.0,-12729.0,Alive,TUMOR FREE,706.0,0.0,706.0,0.0,706.0,0.0,706.0
TCGA-S7-A7WX-01,TCGA-S7-A7WX,PCPG,52.0,MALE,WHITE,,Pheochromocytoma,2012.0,-19190.0,Alive,TUMOR FREE,770.0,0.0,770.0,0.0,770.0,0.0,770.0
TCGA-S7-A7X0-01,TCGA-S7-A7X0,PCPG,75.0,FEMALE,WHITE,,Paraganglioma; Extra-adrenal Pheochromocytoma,2013.0,-27729.0,Alive,TUMOR FREE,546.0,0.0,546.0,0.0,546.0,0.0,546.0
TCGA-S7-A7X1-01,TCGA-S7-A7X1,PCPG,23.0,MALE,WHITE,,Pheochromocytoma,2013.0,-8426.0,Alive,TUMOR FREE,576.0,0.0,576.0,0.0,576.0,0.0,576.0
TCGA-S7-A7X2-01,TCGA-S7-A7X2,PCPG,57.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-21054.0,Alive,TUMOR FREE,736.0,0.0,736.0,0.0,736.0,0.0,736.0
TCGA-S8-A6BV-01,TCGA-S8-A6BV,ESCA,76.0,MALE,WHITE,Stage IIIA,"Esophagus Adenocarcinoma, NOS",2012.0,-28111.0,Alive,WITH TUMOR,609.0,0.0,609.0,0.0,609.0,1.0,267.0
TCGA-S8-A6BW-01,TCGA-S8-A6BW,ESCA,51.0,MALE,WHITE,Stage IB,Esophagus Squamous Cell Carcinoma,2012.0,-18944.0,Alive,TUMOR FREE,620.0,0.0,620.0,0.0,620.0,0.0,620.0
TCGA-S9-A6TS-01,TCGA-S9-A6TS,LGG,48.0,FEMALE,WHITE,,Astrocytoma,2006.0,-17857.0,Dead,WITH TUMOR,,1.0,1891.0,1.0,1891.0,1.0,1324.0
TCGA-S9-A6TU-01,TCGA-S9-A6TU,LGG,38.0,MALE,WHITE,,Astrocytoma,2007.0,-14108.0,Alive,WITH TUMOR,2650.0,0.0,2650.0,0.0,2650.0,1.0,1475.0
TCGA-S9-A6TV-01,TCGA-S9-A6TV,LGG,50.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-18321.0,Alive,TUMOR FREE,571.0,0.0,571.0,0.0,571.0,0.0,571.0
TCGA-S9-A6TX-01,TCGA-S9-A6TX,LGG,46.0,MALE,WHITE,,Oligodendroglioma,2011.0,-17025.0,Alive,WITH TUMOR,1245.0,0.0,1245.0,0.0,1245.0,1.0,856.0
TCGA-S9-A6TY-01,TCGA-S9-A6TY,LGG,50.0,MALE,WHITE,,Oligodendroglioma,2011.0,-18564.0,Alive,WITH TUMOR,1076.0,0.0,1076.0,0.0,1076.0,0.0,1076.0
TCGA-S9-A6U0-01,TCGA-S9-A6U0,LGG,46.0,MALE,WHITE,,Astrocytoma,2012.0,-16890.0,Dead,WITH TUMOR,,1.0,742.0,1.0,742.0,1.0,692.0
TCGA-S9-A6U1-01,TCGA-S9-A6U1,LGG,22.0,FEMALE,WHITE,,Astrocytoma,2012.0,-8271.0,Alive,TUMOR FREE,785.0,0.0,785.0,0.0,785.0,0.0,785.0
TCGA-S9-A6U5-01,TCGA-S9-A6U5,LGG,33.0,MALE,WHITE,,Astrocytoma,2011.0,-12417.0,Alive,TUMOR FREE,992.0,0.0,992.0,0.0,992.0,0.0,992.0
TCGA-S9-A6U6-01,TCGA-S9-A6U6,LGG,28.0,MALE,WHITE,,Astrocytoma,2012.0,-10253.0,Alive,TUMOR FREE,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0
TCGA-S9-A6U9-01,TCGA-S9-A6U9,LGG,36.0,MALE,WHITE,,Astrocytoma,2006.0,-13460.0,Alive,WITH TUMOR,2918.0,0.0,2918.0,0.0,2918.0,0.0,2918.0
TCGA-S9-A6WD-01,TCGA-S9-A6WD,LGG,58.0,MALE,WHITE,,Oligodendroglioma,2008.0,-21231.0,Alive,WITH TUMOR,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0
TCGA-S9-A6WE-01,TCGA-S9-A6WE,LGG,34.0,MALE,WHITE,,Oligodendroglioma,2004.0,-12488.0,Alive,WITH TUMOR,4113.0,0.0,4113.0,0.0,4113.0,0.0,4113.0
TCGA-S9-A6WG-01,TCGA-S9-A6WG,LGG,31.0,MALE,WHITE,,Astrocytoma,2007.0,-11509.0,Alive,WITH TUMOR,2602.0,0.0,2602.0,0.0,2602.0,0.0,2602.0
TCGA-S9-A6WH-01,TCGA-S9-A6WH,LGG,73.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-26904.0,Alive,WITH TUMOR,1173.0,0.0,1173.0,0.0,1173.0,0.0,1173.0
TCGA-S9-A6WN-01,TCGA-S9-A6WN,LGG,38.0,FEMALE,WHITE,,Astrocytoma,2013.0,-13961.0,Alive,WITH TUMOR,805.0,0.0,805.0,0.0,805.0,1.0,303.0
TCGA-S9-A6WP-01,TCGA-S9-A6WP,LGG,42.0,MALE,WHITE,,Oligoastrocytoma,2013.0,-15658.0,Alive,WITH TUMOR,567.0,0.0,567.0,0.0,567.0,0.0,567.0
TCGA-S9-A7IQ-01,TCGA-S9-A7IQ,LGG,45.0,FEMALE,WHITE,,Oligoastrocytoma,2011.0,-16512.0,Alive,WITH TUMOR,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0
TCGA-S9-A7IS-01,TCGA-S9-A7IS,LGG,33.0,FEMALE,WHITE,,Astrocytoma,2004.0,-12402.0,Dead,WITH TUMOR,,1.0,241.0,1.0,241.0,1.0,241.0
TCGA-S9-A7IY-01,TCGA-S9-A7IY,LGG,39.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-14422.0,Alive,WITH TUMOR,715.0,0.0,715.0,0.0,715.0,0.0,715.0
TCGA-S9-A7IZ-01,TCGA-S9-A7IZ,LGG,48.0,FEMALE,WHITE,,Astrocytoma,2013.0,-17874.0,Alive,WITH TUMOR,608.0,0.0,608.0,0.0,608.0,1.0,467.0
TCGA-S9-A7J0-01,TCGA-S9-A7J0,LGG,30.0,FEMALE,WHITE,,Oligodendroglioma,2013.0,-10989.0,Alive,WITH TUMOR,609.0,0.0,609.0,0.0,609.0,1.0,390.0
TCGA-S9-A7J1-01,TCGA-S9-A7J1,LGG,43.0,MALE,WHITE,,Oligodendroglioma,2013.0,-15926.0,Alive,WITH TUMOR,249.0,0.0,249.0,0.0,249.0,0.0,249.0
TCGA-S9-A7J2-01,TCGA-S9-A7J2,LGG,25.0,MALE,WHITE,,Oligodendroglioma,2013.0,-9345.0,Alive,WITH TUMOR,62.0,0.0,62.0,0.0,62.0,0.0,62.0
TCGA-S9-A7QX-01,TCGA-S9-A7QX,LGG,36.0,FEMALE,WHITE,,Astrocytoma,2013.0,-13332.0,Alive,WITH TUMOR,564.0,0.0,564.0,0.0,564.0,0.0,564.0
TCGA-S9-A7QZ-01,TCGA-S9-A7QZ,LGG,41.0,MALE,WHITE,,Oligodendroglioma,2012.0,-15300.0,Alive,WITH TUMOR,826.0,0.0,826.0,0.0,826.0,1.0,774.0
TCGA-S9-A7R1-01,TCGA-S9-A7R1,LGG,35.0,MALE,WHITE,,Oligodendroglioma,1999.0,-12828.0,Dead,WITH TUMOR,,1.0,5166.0,1.0,5166.0,1.0,3637.0
TCGA-S9-A7R4-01,TCGA-S9-A7R4,LGG,46.0,MALE,WHITE,,Astrocytoma,2012.0,-17134.0,Alive,WITH TUMOR,914.0,0.0,914.0,0.0,914.0,0.0,914.0
TCGA-S9-A7R8-01,TCGA-S9-A7R8,LGG,44.0,FEMALE,WHITE,,Astrocytoma,2004.0,-16275.0,Dead,WITH TUMOR,,1.0,961.0,1.0,961.0,1.0,698.0
TCGA-SA-A6C2-01,TCGA-SA-A6C2,PCPG,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Paraganglioma; Extra-adrenal Pheochromocytoma,2012.0,-16805.0,Alive,TUMOR FREE,296.0,0.0,296.0,0.0,296.0,0.0,296.0
TCGA-SP-A6QH-01,TCGA-SP-A6QH,PCPG,35.0,FEMALE,ASIAN,,Pheochromocytoma,2008.0,-12876.0,Alive,TUMOR FREE,2203.0,0.0,2203.0,0.0,2203.0,0.0,2203.0
TCGA-SP-A6QJ-01,TCGA-SP-A6QJ,PCPG,64.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-23406.0,Alive,TUMOR FREE,472.0,0.0,472.0,0.0,472.0,0.0,472.0
TCGA-SR-A6MQ-01,TCGA-SR-A6MQ,PCPG,61.0,FEMALE,ASIAN,,Paraganglioma,2008.0,-22621.0,Alive,TUMOR FREE,2087.0,0.0,2087.0,0.0,2087.0,0.0,2087.0
TCGA-SR-A6MX-01,TCGA-SR-A6MX,PCPG,55.0,MALE,WHITE,,Paraganglioma,2013.0,-20186.0,Dead,WITH TUMOR,,1.0,95.0,1.0,95.0,1.0,95.0
TCGA-SR-A6MY-01,TCGA-SR-A6MY,PCPG,54.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-19892.0,Alive,TUMOR FREE,750.0,0.0,750.0,0.0,750.0,0.0,750.0
TCGA-SR-A6MZ-01,TCGA-SR-A6MZ,PCPG,46.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-16802.0,Alive,TUMOR FREE,797.0,0.0,797.0,0.0,797.0,0.0,797.0
TCGA-SS-A7HO-01,TCGA-SS-A7HO,COAD,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Colon Adenocarcinoma,2010.0,-16416.0,Alive,WITH TUMOR,1829.0,0.0,1829.0,0.0,1829.0,1.0,506.0
TCGA-SU-A7E7-01,TCGA-SU-A7E7,PRAD,60.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-22185.0,Alive,TUMOR FREE,551.0,0.0,551.0,0.0,551.0,0.0,551.0
TCGA-SW-A7EA-01,TCGA-SW-A7EA,STAD,61.0,FEMALE,WHITE,Stage IB,"Stomach, Adenocarcinoma, Diffuse Type",2013.0,-22294.0,Alive,TUMOR FREE,579.0,0.0,579.0,0.0,579.0,0.0,579.0
TCGA-SW-A7EB-01,TCGA-SW-A7EB,STAD,45.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2013.0,-16475.0,Alive,TUMOR FREE,176.0,0.0,176.0,0.0,176.0,0.0,176.0
TCGA-T9-A92H-01,TCGA-T9-A92H,COAD,82.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Colon Adenocarcinoma,2013.0,-30058.0,Alive,WITH TUMOR,362.0,0.0,362.0,0.0,362.0,1.0,81.0
TCGA-TK-A8OK-01,TCGA-TK-A8OK,PRAD,73.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-26976.0,Alive,TUMOR FREE,27.0,0.0,27.0,0.0,27.0,0.0,27.0
TCGA-TM-A7C5-01,TCGA-TM-A7C5,LGG,30.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-11286.0,Alive,TUMOR FREE,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0
TCGA-TM-A84R-01,TCGA-TM-A84R,LGG,46.0,MALE,WHITE,,Oligodendroglioma,2012.0,-16843.0,Alive,TUMOR FREE,566.0,0.0,566.0,0.0,566.0,0.0,566.0
TCGA-TM-A84S-01,TCGA-TM-A84S,LGG,36.0,MALE,WHITE,,Oligodendroglioma,2013.0,-13424.0,Alive,TUMOR FREE,454.0,0.0,454.0,0.0,454.0,0.0,454.0
TCGA-TQ-A7RF-01,TCGA-TQ-A7RF,LGG,27.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-9919.0,Alive,WITH TUMOR,650.0,0.0,650.0,0.0,650.0,0.0,650.0
TCGA-TQ-A7RG-01,TCGA-TQ-A7RG,LGG,36.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-13227.0,Alive,WITH TUMOR,599.0,0.0,599.0,0.0,599.0,0.0,599.0
TCGA-TQ-A7RH-01,TCGA-TQ-A7RH,LGG,39.0,MALE,BLACK OR AFRICAN AMERICAN,,Oligoastrocytoma,2013.0,-14524.0,Alive,WITH TUMOR,486.0,0.0,486.0,0.0,486.0,0.0,486.0
TCGA-TQ-A7RK-01,TCGA-TQ-A7RK,LGG,29.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-10742.0,Alive,TUMOR FREE,1341.0,0.0,1341.0,0.0,1341.0,1.0,858.0
TCGA-TQ-A7RN-01,TCGA-TQ-A7RN,LGG,32.0,MALE,WHITE,,Oligodendroglioma,2011.0,-11823.0,Alive,WITH TUMOR,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0
TCGA-TQ-A7RQ-01,TCGA-TQ-A7RQ,LGG,38.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-14187.0,Alive,TUMOR FREE,795.0,0.0,795.0,0.0,795.0,0.0,795.0
TCGA-TQ-A7RR-01,TCGA-TQ-A7RR,LGG,38.0,MALE,WHITE,,Oligoastrocytoma,2012.0,-14022.0,Alive,TUMOR FREE,787.0,0.0,787.0,0.0,787.0,0.0,787.0
TCGA-TQ-A7RS-01,TCGA-TQ-A7RS,LGG,25.0,FEMALE,WHITE,,Oligodendroglioma,2012.0,-9172.0,Alive,TUMOR FREE,-1.0,0.0,0.0,0.0,0.0,0.0,0.0
TCGA-TQ-A7RV-01,TCGA-TQ-A7RV,LGG,27.0,MALE,WHITE,,Astrocytoma,2009.0,-10167.0,Alive,WITH TUMOR,1868.0,0.0,1868.0,0.0,1868.0,1.0,530.0
TCGA-TQ-A7RW-01,TCGA-TQ-A7RW,LGG,32.0,MALE,WHITE,,Oligodendroglioma,2010.0,-11804.0,Dead,WITH TUMOR,,1.0,821.0,1.0,821.0,1.0,511.0
TCGA-TQ-A8XE-01,TCGA-TQ-A8XE,LGG,42.0,FEMALE,WHITE,,Oligodendroglioma,2010.0,-15629.0,Dead,WITH TUMOR,,1.0,954.0,1.0,954.0,1.0,455.0
TCGA-TT-A6YN-01,TCGA-TT-A6YN,PCPG,37.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-13605.0,Alive,TUMOR FREE,606.0,0.0,606.0,0.0,606.0,0.0,606.0
TCGA-UB-A7MB-01,TCGA-UB-A7MB,LIHC,24.0,MALE,WHITE,Stage II,Hepatocellular Carcinoma,2013.0,-8951.0,Alive,WITH TUMOR,601.0,0.0,601.0,0.0,601.0,1.0,48.0
TCGA-UB-A7MC-01,TCGA-UB-A7MC,LIHC,59.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2013.0,-21733.0,Alive,WITH TUMOR,500.0,0.0,500.0,0.0,500.0,1.0,359.0
TCGA-UB-A7MD-01,TCGA-UB-A7MD,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Hepatocellular Carcinoma,2013.0,-24717.0,Dead,TUMOR FREE,,1.0,52.0,0.0,52.0,0.0,52.0
TCGA-UB-A7MF-01,TCGA-UB-A7MF,LIHC,56.0,MALE,WHITE,Stage IIIA,Hepatocellular Carcinoma,2013.0,-20815.0,Dead,WITH TUMOR,,1.0,214.0,1.0,214.0,1.0,133.0
TCGA-UL-AAZ6-01,TCGA-UL-AAZ6,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,Infiltrating Ductal Carcinoma,2013.0,-26999.0,Alive,TUMOR FREE,518.0,0.0,518.0,0.0,518.0,0.0,518.0
TCGA-UU-A93S-01,TCGA-UU-A93S,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,Infiltrating Ductal Carcinoma,2013.0,-23278.0,Dead,WITH TUMOR,,1.0,116.0,1.0,116.0,1.0,116.0
TCGA-V1-A8MF-01,TCGA-V1-A8MF,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,,-24090.0,Alive,,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0
TCGA-V1-A8MJ-01,TCGA-V1-A8MJ,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,,-21535.0,Alive,,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0
TCGA-V1-A8MU-01,TCGA-V1-A8MU,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,,-20805.0,Alive,,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0
TCGA-V1-A8WL-01,TCGA-V1-A8WL,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,,-23725.0,Alive,,1948.0,0.0,1948.0,0.0,1948.0,0.0,1948.0
TCGA-V1-A8X3-01,TCGA-V1-A8X3,PRAD,51.0,MALE,,,Prostate Adenocarcinoma Acinar Type,,-18980.0,Alive,,202.0,0.0,202.0,0.0,202.0,0.0,202.0
TCGA-VM-A8C8-01,TCGA-VM-A8C8,LGG,50.0,FEMALE,WHITE,,Oligodendroglioma,2011.0,-18494.0,Alive,,1397.0,0.0,1397.0,0.0,1397.0,1.0,456.0
TCGA-VM-A8C9-01,TCGA-VM-A8C9,LGG,37.0,FEMALE,[Not Evaluated],,Astrocytoma,2011.0,-13663.0,Alive,TUMOR FREE,1314.0,0.0,1314.0,0.0,1314.0,0.0,1314.0
TCGA-VM-A8CA-01,TCGA-VM-A8CA,LGG,54.0,MALE,[Unknown],,Oligodendroglioma,2011.0,-19991.0,Alive,WITH TUMOR,411.0,0.0,411.0,0.0,411.0,0.0,411.0
TCGA-VM-A8CB-01,TCGA-VM-A8CB,LGG,33.0,MALE,[Unknown],,Oligodendroglioma,2011.0,-12340.0,Alive,TUMOR FREE,3.0,0.0,3.0,0.0,3.0,0.0,3.0
TCGA-VM-A8CD-01,TCGA-VM-A8CD,LGG,58.0,MALE,WHITE,,Astrocytoma,2012.0,-21200.0,Dead,WITH TUMOR,,1.0,240.0,1.0,240.0,1.0,240.0
TCGA-VM-A8CE-01,TCGA-VM-A8CE,LGG,25.0,MALE,WHITE,,Oligodendroglioma,2011.0,-9363.0,Alive,WITH TUMOR,1191.0,0.0,1191.0,0.0,1191.0,1.0,815.0
TCGA-VM-A8CH-01,TCGA-VM-A8CH,LGG,24.0,FEMALE,WHITE,,Astrocytoma,2013.0,-9005.0,Alive,TUMOR FREE,714.0,0.0,714.0,0.0,714.0,0.0,714.0
TCGA-VN-A88I-01,TCGA-VN-A88I,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-21576.0,Alive,WITH TUMOR,269.0,0.0,269.0,0.0,269.0,0.0,269.0
TCGA-VN-A88K-01,TCGA-VN-A88K,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-21524.0,Alive,,776.0,0.0,776.0,0.0,776.0,0.0,776.0
TCGA-VN-A88L-01,TCGA-VN-A88L,PRAD,54.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-20026.0,Alive,TUMOR FREE,746.0,0.0,746.0,0.0,746.0,0.0,746.0
TCGA-VN-A88P-01,TCGA-VN-A88P,PRAD,60.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-21916.0,Alive,TUMOR FREE,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0
TCGA-VP-A875-01,TCGA-VP-A875,PRAD,67.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2005.0,-24742.0,Alive,TUMOR FREE,2309.0,0.0,2309.0,0.0,2309.0,0.0,2309.0
TCGA-VP-A878-01,TCGA-VP-A878,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2006.0,-21402.0,Alive,WITH TUMOR,3130.0,0.0,3130.0,0.0,3130.0,1.0,98.0
TCGA-VP-A87E-01,TCGA-VP-A87E,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-21811.0,Alive,TUMOR FREE,2037.0,0.0,2037.0,0.0,2037.0,0.0,2037.0
TCGA-VP-A87J-01,TCGA-VP-A87J,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-20792.0,Alive,TUMOR FREE,1774.0,0.0,1774.0,0.0,1774.0,0.0,1774.0
TCGA-VP-A87K-01,TCGA-VP-A87K,PRAD,63.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2010.0,-23030.0,Alive,TUMOR FREE,1306.0,0.0,1306.0,0.0,1306.0,1.0,533.0
TCGA-VQ-A8DT-01,TCGA-VQ-A8DT,STAD,43.0,MALE,[Unknown],Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-15937.0,Alive,WITH TUMOR,1484.0,0.0,1484.0,0.0,1484.0,1.0,1376.0
TCGA-VQ-A8DU-01,TCGA-VQ-A8DU,STAD,63.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-23042.0,Dead,WITH TUMOR,,1.0,166.0,1.0,166.0,1.0,158.0
TCGA-VQ-A8E0-01,TCGA-VQ-A8E0,STAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-24848.0,Dead,WITH TUMOR,,1.0,562.0,1.0,562.0,1.0,531.0
TCGA-VQ-A8E2-01,TCGA-VQ-A8E2,STAD,57.0,MALE,ASIAN,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-21112.0,Alive,TUMOR FREE,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0
TCGA-VQ-A8E3-01,TCGA-VQ-A8E3,STAD,79.0,MALE,WHITE,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-28919.0,Dead,,,1.0,661.0,,661.0,1.0,538.0
TCGA-VQ-A8E7-01,TCGA-VQ-A8E7,STAD,59.0,MALE,WHITE,Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-21664.0,Alive,WITH TUMOR,1138.0,0.0,1138.0,0.0,1138.0,1.0,1048.0
TCGA-VQ-A8P2-01,TCGA-VQ-A8P2,STAD,68.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",2011.0,-25129.0,Alive,TUMOR FREE,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0
TCGA-VQ-A8P3-01,TCGA-VQ-A8P3,STAD,72.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-26582.0,Alive,TUMOR FREE,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0
TCGA-VQ-A8P5-01,TCGA-VQ-A8P5,STAD,67.0,MALE,WHITE,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-24571.0,Dead,,,1.0,235.0,,235.0,0.0,235.0
TCGA-VQ-A8PC-01,TCGA-VQ-A8PC,STAD,65.0,MALE,WHITE,Stage IIIA,"Stomach Adenocarcinoma, Signet Ring Type",2009.0,-23912.0,Dead,WITH TUMOR,,1.0,1407.0,1.0,1407.0,1.0,1287.0
TCGA-VQ-A8PD-01,TCGA-VQ-A8PD,STAD,69.0,MALE,WHITE,Stage IIIC,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25244.0,Dead,WITH TUMOR,,1.0,496.0,1.0,496.0,1.0,134.0
TCGA-VQ-A8PE-01,TCGA-VQ-A8PE,STAD,78.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-28755.0,Dead,WITH TUMOR,,1.0,675.0,1.0,675.0,1.0,265.0
TCGA-VQ-A8PF-01,TCGA-VQ-A8PF,STAD,76.0,MALE,[Not Evaluated],Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-28116.0,Dead,TUMOR FREE,,1.0,76.0,0.0,76.0,0.0,76.0
TCGA-VQ-A8PH-01,TCGA-VQ-A8PH,STAD,62.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-22940.0,Dead,WITH TUMOR,,1.0,389.0,1.0,389.0,1.0,377.0
TCGA-VQ-A8PJ-01,TCGA-VQ-A8PJ,STAD,53.0,MALE,[Unknown],Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-19390.0,Dead,WITH TUMOR,,1.0,82.0,1.0,82.0,1.0,82.0
TCGA-VQ-A8PK-01,TCGA-VQ-A8PK,STAD,58.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-21419.0,Dead,WITH TUMOR,,1.0,543.0,1.0,543.0,1.0,263.0
TCGA-VQ-A8PM-01,TCGA-VQ-A8PM,STAD,56.0,MALE,WHITE,Stage IV,"Stomach Adenocarcinoma, Signet Ring Type",2009.0,-20665.0,Dead,WITH TUMOR,,1.0,57.0,0.0,57.0,1.0,57.0
TCGA-VQ-A8PO-01,TCGA-VQ-A8PO,STAD,74.0,MALE,WHITE,Stage IIB,"Stomach Adenocarcinoma, Signet Ring Type",2008.0,-27250.0,Dead,,,1.0,282.0,1.0,282.0,1.0,256.0
TCGA-VQ-A8PP-01,TCGA-VQ-A8PP,STAD,76.0,MALE,[Unknown],Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2008.0,-27774.0,Dead,WITH TUMOR,,1.0,712.0,1.0,712.0,1.0,502.0
TCGA-VQ-A8PQ-01,TCGA-VQ-A8PQ,STAD,50.0,FEMALE,WHITE,Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2008.0,-18318.0,Dead,WITH TUMOR,,1.0,476.0,1.0,476.0,1.0,91.0
TCGA-VQ-A8PU-01,TCGA-VQ-A8PU,STAD,72.0,FEMALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-26625.0,Dead,TUMOR FREE,,1.0,832.0,0.0,832.0,0.0,832.0
TCGA-VQ-A8PX-01,TCGA-VQ-A8PX,STAD,51.0,MALE,[Unknown],Stage IA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-18902.0,Alive,TUMOR FREE,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0
TCGA-VQ-A91D-01,TCGA-VQ-A91D,STAD,70.0,MALE,WHITE,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-25686.0,Dead,WITH TUMOR,,1.0,356.0,1.0,356.0,1.0,351.0
TCGA-VQ-A91K-01,TCGA-VQ-A91K,STAD,69.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-25424.0,Alive,TUMOR FREE,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0
TCGA-VQ-A91N-01,TCGA-VQ-A91N,STAD,59.0,FEMALE,[Unknown],Stage IV,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2009.0,-21753.0,Dead,WITH TUMOR,,1.0,570.0,1.0,570.0,1.0,438.0
TCGA-VQ-A91S-01,TCGA-VQ-A91S,STAD,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-23187.0,Alive,TUMOR FREE,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0
TCGA-VQ-A91U-01,TCGA-VQ-A91U,STAD,78.0,MALE,ASIAN,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-28791.0,Dead,,,1.0,52.0,,52.0,0.0,52.0
TCGA-VQ-A91V-01,TCGA-VQ-A91V,STAD,58.0,MALE,[Unknown],Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-21505.0,Alive,WITH TUMOR,1297.0,0.0,1297.0,0.0,1297.0,1.0,504.0
TCGA-VQ-A91W-01,TCGA-VQ-A91W,STAD,30.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2009.0,-10963.0,Alive,,1851.0,0.0,1851.0,0.0,1851.0,0.0,1851.0
TCGA-VQ-A91X-01,TCGA-VQ-A91X,STAD,74.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-27314.0,Dead,TUMOR FREE,,1.0,289.0,0.0,289.0,0.0,289.0
TCGA-VQ-A91Y-01,TCGA-VQ-A91Y,STAD,67.0,MALE,WHITE,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2011.0,-24774.0,Dead,WITH TUMOR,,1.0,296.0,1.0,296.0,1.0,258.0
TCGA-VQ-A91Z-01,TCGA-VQ-A91Z,STAD,67.0,FEMALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2010.0,-24652.0,Alive,WITH TUMOR,1690.0,0.0,1690.0,0.0,1690.0,1.0,1310.0
TCGA-VQ-A923-01,TCGA-VQ-A923,STAD,90.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2008.0,-32873.0,Dead,TUMOR FREE,,1.0,61.0,0.0,61.0,0.0,61.0
TCGA-VQ-A925-01,TCGA-VQ-A925,STAD,66.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2012.0,-24230.0,Dead,WITH TUMOR,,1.0,138.0,1.0,138.0,1.0,138.0
TCGA-VQ-A928-01,TCGA-VQ-A928,STAD,49.0,MALE,WHITE,Stage IV,"Stomach, Intestinal Adenocarcinoma, Papillary Type",2010.0,-18058.0,Dead,WITH TUMOR,,1.0,174.0,1.0,174.0,1.0,148.0
TCGA-VQ-A92D-01,TCGA-VQ-A92D,STAD,67.0,MALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2009.0,-24595.0,Alive,TUMOR FREE,2032.0,0.0,2032.0,0.0,2032.0,0.0,2032.0
TCGA-VQ-A94O-01,TCGA-VQ-A94O,STAD,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-27306.0,Dead,WITH TUMOR,,1.0,640.0,1.0,640.0,1.0,185.0
TCGA-VQ-A94P-01,TCGA-VQ-A94P,STAD,57.0,MALE,WHITE,[Discrepancy],"Stomach Adenocarcinoma, Signet Ring Type",2011.0,-21022.0,Dead,WITH TUMOR,,1.0,81.0,1.0,81.0,1.0,81.0
TCGA-VQ-A94R-01,TCGA-VQ-A94R,STAD,63.0,MALE,WHITE,[Discrepancy],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-23246.0,Dead,WITH TUMOR,,1.0,1294.0,1.0,1294.0,1.0,1018.0
TCGA-VQ-A94U-01,TCGA-VQ-A94U,STAD,70.0,MALE,WHITE,Stage IIB,"Stomach Adenocarcinoma, Signet Ring Type",2012.0,-25925.0,Alive,TUMOR FREE,819.0,0.0,819.0,0.0,819.0,0.0,819.0
TCGA-VQ-AA64-01,TCGA-VQ-AA64,STAD,68.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25109.0,Dead,WITH TUMOR,,1.0,560.0,1.0,560.0,1.0,560.0
TCGA-VQ-AA69-01,TCGA-VQ-AA69,STAD,35.0,MALE,WHITE,Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-13087.0,Alive,TUMOR FREE,864.0,0.0,864.0,0.0,864.0,0.0,864.0
TCGA-VQ-AA6A-01,TCGA-VQ-AA6A,STAD,56.0,MALE,WHITE,Stage IIIC,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-20764.0,Alive,TUMOR FREE,1184.0,0.0,1184.0,0.0,1184.0,0.0,1184.0
TCGA-VQ-AA6B-01,TCGA-VQ-AA6B,STAD,48.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-17852.0,Alive,TUMOR FREE,1002.0,0.0,1002.0,0.0,1002.0,0.0,1002.0
TCGA-VQ-AA6D-01,TCGA-VQ-AA6D,STAD,52.0,FEMALE,[Unknown],Stage IIIA,"Stomach, Intestinal Adenocarcinoma, Tubular Type",2013.0,-19090.0,Alive,TUMOR FREE,521.0,0.0,521.0,0.0,521.0,0.0,521.0
TCGA-VQ-AA6F-01,TCGA-VQ-AA6F,STAD,57.0,MALE,WHITE,Stage IIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2010.0,-21170.0,Alive,TUMOR FREE,1646.0,0.0,1646.0,0.0,1646.0,1.0,546.0
TCGA-VQ-AA6G-01,TCGA-VQ-AA6G,STAD,68.0,MALE,WHITE,Stage IIA,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2011.0,-25091.0,Dead,WITH TUMOR,,1.0,792.0,1.0,792.0,1.0,469.0
TCGA-VQ-AA6I-01,TCGA-VQ-AA6I,STAD,68.0,MALE,WHITE,Stage IIIB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2012.0,-25091.0,Dead,WITH TUMOR,,1.0,491.0,1.0,491.0,1.0,475.0
TCGA-VQ-AA6K-01,TCGA-VQ-AA6K,STAD,59.0,MALE,WHITE,Stage IIIC,"Stomach Adenocarcinoma, Signet Ring Type",2012.0,-21901.0,Dead,WITH TUMOR,,1.0,378.0,1.0,378.0,1.0,332.0
TCGA-VR-A8EO-01,TCGA-VR-A8EO,ESCA,49.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-18123.0,Alive,TUMOR FREE,785.0,0.0,785.0,0.0,785.0,0.0,785.0
TCGA-VR-A8EP-01,TCGA-VR-A8EP,ESCA,51.0,MALE,WHITE,Stage IIIB,Esophagus Squamous Cell Carcinoma,2013.0,-18942.0,Alive,TUMOR FREE,824.0,0.0,824.0,0.0,824.0,1.0,242.0
TCGA-VR-A8EQ-01,TCGA-VR-A8EQ,ESCA,73.0,MALE,WHITE,Stage III,"Esophagus Adenocarcinoma, NOS",2009.0,-26912.0,Dead,WITH TUMOR,,1.0,694.0,1.0,694.0,1.0,694.0
TCGA-VR-AA4D-01,TCGA-VR-AA4D,ESCA,53.0,MALE,WHITE,Stage IIB,"Esophagus Adenocarcinoma, NOS",2010.0,-19714.0,Dead,WITH TUMOR,,1.0,1405.0,1.0,1405.0,1.0,832.0
TCGA-VR-AA7B-01,TCGA-VR-AA7B,ESCA,65.0,FEMALE,WHITE,Stage IV,Esophagus Squamous Cell Carcinoma,2011.0,-23915.0,Alive,WITH TUMOR,342.0,0.0,342.0,0.0,342.0,1.0,207.0
TCGA-VV-A829-01,TCGA-VV-A829,LGG,44.0,MALE,WHITE,,Oligoastrocytoma,2011.0,-16163.0,Alive,TUMOR FREE,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0
TCGA-VV-A86M-01,TCGA-VV-A86M,LGG,36.0,FEMALE,[Not Evaluated],,Astrocytoma,2013.0,-13453.0,Alive,TUMOR FREE,487.0,0.0,487.0,0.0,487.0,0.0,487.0
TCGA-VW-A7QS-01,TCGA-VW-A7QS,LGG,35.0,FEMALE,ASIAN,,Oligodendroglioma,2011.0,-12820.0,Alive,WITH TUMOR,706.0,0.0,706.0,0.0,706.0,0.0,706.0
TCGA-W2-A7HC-01,TCGA-W2-A7HC,PCPG,67.0,MALE,WHITE,,Pheochromocytoma,2013.0,-24834.0,Alive,TUMOR FREE,439.0,0.0,439.0,0.0,439.0,0.0,439.0
TCGA-W2-A7HF-01,TCGA-W2-A7HF,PCPG,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Pheochromocytoma,2013.0,-10436.0,Alive,TUMOR FREE,538.0,0.0,538.0,0.0,538.0,0.0,538.0
TCGA-W9-A837-01,TCGA-W9-A837,LGG,47.0,MALE,WHITE,,Oligodendroglioma,2010.0,,Alive,WITH TUMOR,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0
TCGA-WB-A80Q-01,TCGA-WB-A80Q,PCPG,64.0,FEMALE,WHITE,,Pheochromocytoma,2003.0,-23653.0,Alive,TUMOR FREE,3880.0,0.0,3880.0,0.0,3880.0,0.0,3880.0
TCGA-WB-A814-01,TCGA-WB-A814,PCPG,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,,Paraganglioma; Extra-adrenal Pheochromocytoma,2008.0,-12936.0,Alive,TUMOR FREE,2252.0,0.0,2252.0,0.0,2252.0,0.0,2252.0
TCGA-WB-A815-01,TCGA-WB-A815,PCPG,68.0,FEMALE,WHITE,,Pheochromocytoma,2010.0,-24859.0,Alive,TUMOR FREE,1630.0,0.0,1630.0,0.0,1630.0,0.0,1630.0
TCGA-WB-A817-01,TCGA-WB-A817,PCPG,27.0,MALE,WHITE,,Pheochromocytoma,2011.0,-9981.0,Alive,TUMOR FREE,1310.0,0.0,1310.0,0.0,1310.0,0.0,1310.0
TCGA-WB-A818-01,TCGA-WB-A818,PCPG,37.0,MALE,WHITE,,Pheochromocytoma,2011.0,-13596.0,Alive,TUMOR FREE,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0
TCGA-WB-A819-01,TCGA-WB-A819,PCPG,36.0,MALE,WHITE,,Pheochromocytoma,2011.0,-13233.0,Alive,TUMOR FREE,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0
TCGA-WB-A81G-01,TCGA-WB-A81G,PCPG,25.0,MALE,WHITE,,Pheochromocytoma,2011.0,-9248.0,Alive,TUMOR FREE,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0
TCGA-WB-A81M-01,TCGA-WB-A81M,PCPG,42.0,FEMALE,WHITE,,Pheochromocytoma,2010.0,-15505.0,Alive,TUMOR FREE,1394.0,0.0,1394.0,0.0,1394.0,0.0,1394.0
TCGA-WB-A81P-01,TCGA-WB-A81P,PCPG,73.0,FEMALE,WHITE,,Pheochromocytoma,2011.0,-26867.0,Alive,TUMOR FREE,395.0,0.0,395.0,0.0,395.0,0.0,395.0
TCGA-WB-A81S-01,TCGA-WB-A81S,PCPG,59.0,FEMALE,WHITE,,Pheochromocytoma,2012.0,-21587.0,Alive,TUMOR FREE,723.0,0.0,723.0,0.0,723.0,0.0,723.0
TCGA-WB-A81T-01,TCGA-WB-A81T,PCPG,45.0,MALE,WHITE,,Pheochromocytoma,2013.0,-16506.0,Alive,TUMOR FREE,776.0,0.0,776.0,0.0,776.0,0.0,776.0
TCGA-WB-A81V-01,TCGA-WB-A81V,PCPG,57.0,MALE,WHITE,,Pheochromocytoma,2006.0,-21106.0,Alive,TUMOR FREE,2161.0,0.0,2161.0,0.0,2161.0,0.0,2161.0
TCGA-WB-A81W-01,TCGA-WB-A81W,PCPG,41.0,MALE,WHITE,,Pheochromocytoma,2007.0,-15001.0,Alive,TUMOR FREE,2379.0,0.0,2379.0,0.0,2379.0,0.0,2379.0
TCGA-WT-AB41-01,TCGA-WT-AB41,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Infiltrating Ductal Carcinoma,2010.0,,Alive,TUMOR FREE,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0
TCGA-WW-A8ZI-01,TCGA-WW-A8ZI,PRAD,70.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-25593.0,Alive,TUMOR FREE,449.0,0.0,449.0,0.0,449.0,0.0,449.0
TCGA-WY-A85B-01,TCGA-WY-A85B,LGG,24.0,MALE,WHITE,,Astrocytoma,2010.0,-8817.0,Alive,TUMOR FREE,1393.0,0.0,1393.0,0.0,1393.0,0.0,1393.0
TCGA-WY-A85C-01,TCGA-WY-A85C,LGG,36.0,MALE,WHITE,,Astrocytoma,2010.0,-13506.0,Alive,WITH TUMOR,1426.0,0.0,1426.0,0.0,1426.0,1.0,809.0
TCGA-WY-A85D-01,TCGA-WY-A85D,LGG,60.0,MALE,WHITE,,Oligoastrocytoma,2010.0,-21979.0,Alive,WITH TUMOR,1147.0,0.0,1147.0,0.0,1147.0,1.0,887.0
TCGA-X8-AAAR-01,TCGA-X8-AAAR,ESCA,69.0,MALE,WHITE,[Unknown],"Esophagus Adenocarcinoma, NOS",2013.0,-25370.0,Alive,TUMOR FREE,554.0,0.0,554.0,0.0,554.0,0.0,554.0
TCGA-XA-A8JR-01,TCGA-XA-A8JR,PRAD,68.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-25090.0,Alive,TUMOR FREE,376.0,0.0,376.0,0.0,376.0,0.0,376.0
TCGA-XP-A8T6-01,TCGA-XP-A8T6,ESCA,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Esophagus Squamous Cell Carcinoma,2009.0,-19886.0,Dead,TUMOR FREE,,1.0,763.0,0.0,763.0,0.0,763.0
TCGA-XX-A899-01,TCGA-XX-A899,BRCA,46.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2013.0,-17022.0,Alive,TUMOR FREE,467.0,0.0,467.0,0.0,467.0,0.0,467.0
TCGA-Y6-A8TL-01,TCGA-Y6-A8TL,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2012.0,-23776.0,Alive,TUMOR FREE,992.0,0.0,992.0,0.0,992.0,0.0,992.0
TCGA-YJ-A8SW-01,TCGA-YJ-A8SW,PRAD,67.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2008.0,,Alive,,148.0,0.0,148.0,0.0,148.0,0.0,148.0
TCGA-YL-A8HJ-01,TCGA-YL-A8HJ,PRAD,58.0,MALE,,,"Prostate Adenocarcinoma, Other Subtype",2009.0,-21416.0,Alive,TUMOR FREE,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0
TCGA-YL-A8HK-01,TCGA-YL-A8HK,PRAD,59.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-21850.0,Alive,WITH TUMOR,1491.0,0.0,1491.0,0.0,1491.0,1.0,1376.0
TCGA-YL-A8HL-01,TCGA-YL-A8HL,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-21249.0,Alive,,1565.0,0.0,1565.0,0.0,1565.0,0.0,1565.0
TCGA-YL-A8HM-01,TCGA-YL-A8HM,PRAD,66.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-24121.0,Alive,WITH TUMOR,1482.0,0.0,1482.0,0.0,1482.0,1.0,1473.0
TCGA-YL-A8HO-01,TCGA-YL-A8HO,PRAD,67.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-24509.0,Alive,WITH TUMOR,2304.0,0.0,2304.0,0.0,2304.0,1.0,1068.0
TCGA-YL-A8S8-01,TCGA-YL-A8S8,PRAD,68.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-25119.0,Alive,WITH TUMOR,1890.0,0.0,1890.0,0.0,1890.0,1.0,679.0
TCGA-YL-A8S9-01,TCGA-YL-A8S9,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-23204.0,Alive,,1842.0,0.0,1842.0,0.0,1842.0,1.0,1006.0
TCGA-YL-A8SA-01,TCGA-YL-A8SA,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-25340.0,Alive,,512.0,0.0,512.0,0.0,512.0,0.0,512.0
TCGA-YL-A8SF-01,TCGA-YL-A8SF,PRAD,62.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-22844.0,Alive,,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0
TCGA-YL-A8SH-01,TCGA-YL-A8SH,PRAD,69.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2009.0,-25395.0,Dead,TUMOR FREE,,1.0,875.0,0.0,875.0,0.0,875.0
TCGA-YL-A8SJ-01,TCGA-YL-A8SJ,PRAD,60.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-21916.0,Alive,WITH TUMOR,1395.0,0.0,1395.0,0.0,1395.0,1.0,752.0
TCGA-YL-A8SK-01,TCGA-YL-A8SK,PRAD,67.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-24759.0,Alive,,1408.0,0.0,1408.0,0.0,1408.0,0.0,1408.0
TCGA-YL-A8SL-01,TCGA-YL-A8SL,PRAD,74.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-27033.0,Alive,TUMOR FREE,987.0,0.0,987.0,0.0,987.0,0.0,987.0
TCGA-YL-A8SP-01,TCGA-YL-A8SP,PRAD,58.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-21455.0,Alive,WITH TUMOR,2366.0,0.0,2366.0,0.0,2366.0,1.0,2036.0
TCGA-YL-A8SQ-01,TCGA-YL-A8SQ,PRAD,61.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-22482.0,Alive,WITH TUMOR,2083.0,0.0,2083.0,0.0,2083.0,1.0,329.0
TCGA-YL-A8SR-01,TCGA-YL-A8SR,PRAD,64.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2011.0,-23488.0,Alive,,273.0,0.0,273.0,0.0,273.0,0.0,273.0
TCGA-YL-A9WI-01,TCGA-YL-A9WI,PRAD,63.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2010.0,-23184.0,Alive,TUMOR FREE,1623.0,0.0,1623.0,0.0,1623.0,0.0,1623.0
TCGA-YL-A9WJ-01,TCGA-YL-A9WJ,PRAD,47.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2008.0,-17322.0,Dead,WITH TUMOR,,1.0,1855.0,1.0,1855.0,1.0,1476.0
TCGA-Z6-A8JD-01,TCGA-Z6-A8JD,ESCA,53.0,MALE,WHITE,Stage IIB,Esophagus Squamous Cell Carcinoma,2013.0,-19523.0,Alive,TUMOR FREE,104.0,0.0,104.0,0.0,104.0,0.0,104.0
TCGA-Z6-A8JE-01,TCGA-Z6-A8JE,ESCA,57.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2013.0,-20855.0,Alive,TUMOR FREE,64.0,0.0,64.0,0.0,64.0,0.0,64.0
TCGA-Z6-A9VB-01,TCGA-Z6-A9VB,ESCA,53.0,MALE,WHITE,Stage IIIA,Esophagus Squamous Cell Carcinoma,2013.0,-19470.0,Alive,TUMOR FREE,40.0,0.0,40.0,0.0,40.0,0.0,40.0
TCGA-Z6-AAPN-01,TCGA-Z6-AAPN,ESCA,57.0,MALE,WHITE,Stage IIA,Esophagus Squamous Cell Carcinoma,2013.0,-20926.0,Alive,TUMOR FREE,81.0,0.0,81.0,0.0,81.0,0.0,81.0
TCGA-Z7-A8R5-01,TCGA-Z7-A8R5,BRCA,61.0,FEMALE,WHITE,Stage IIIA,Infiltrating Lobular Carcinoma,2005.0,-22280.0,Alive,WITH TUMOR,3287.0,0.0,3287.0,0.0,3287.0,1.0,181.0
TCGA-Z7-A8R6-01,TCGA-Z7-A8R6,BRCA,46.0,FEMALE,WHITE,Stage I,Infiltrating Lobular Carcinoma,2005.0,-16955.0,Alive,TUMOR FREE,3256.0,0.0,3256.0,0.0,3256.0,0.0,3256.0
TCGA-ZA-A8F6-01,TCGA-ZA-A8F6,STAD,71.0,MALE,WHITE,Stage IB,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",2013.0,-26122.0,Alive,TUMOR FREE,525.0,0.0,525.0,0.0,525.0,0.0,525.0
TCGA-ZG-A8QW-01,TCGA-ZG-A8QW,PRAD,72.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-26632.0,Alive,TUMOR FREE,94.0,0.0,94.0,0.0,94.0,0.0,94.0
TCGA-ZG-A8QX-01,TCGA-ZG-A8QX,PRAD,56.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-20683.0,Alive,TUMOR FREE,442.0,0.0,442.0,0.0,442.0,0.0,442.0
TCGA-ZG-A8QY-01,TCGA-ZG-A8QY,PRAD,67.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-24731.0,Alive,WITH TUMOR,404.0,0.0,404.0,0.0,404.0,0.0,404.0
TCGA-ZG-A8QZ-01,TCGA-ZG-A8QZ,PRAD,65.0,MALE,,,Prostate Adenocarcinoma Acinar Type,2013.0,-23980.0,Alive,TUMOR FREE,308.0,0.0,308.0,0.0,308.0,0.0,308.0
